FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Sacchetto, L
   Silva, NIO
   de Rezende, IM
   Arruda, MS
   Costa, TA
   de Mello, EM
   Oliveira, GFG
   Alves, PA
   de Mendonca, VE
   Stumpp, RGAV
   Prado, AIA
   Paglia, AP
   Perini, FA
   Nogueira, ML
   Kroon, EG
   de Thoisy, B
   Trindade, GD
   Drumond, BP
AF Sacchetto, Livia
   Oliveira Silva, Natalia Ingrid
   de Rezende, Izabela Mauricio
   Arruda, Matheus Soares
   Costa, Thais Alkifeles
   de Mello, Erica Munhoz
   Garcia Oliveira, Gabriela Fernanda
   Alves, Pedro Augusto
   de Mendonca, Vitor Emidio
   Antonelli Vidal Stumpp, Rodolfo German
   Alves Prado, Alaine Izabela
   Paglia, Adriano Pereira
   Perini, Fernando Araujo
   Nogueira, Mauricio Lacerda
   Kroon, Erna Geessien
   de Thoisy, Benoit
   Trindade, Giliane de Souza
   Drumond, Betania Paiva
TI Neighbor danger: Yellow fever virus epizootics in urban and urban-rural
   transition areas of Minas Gerais state, during 2017-2018 yellow fever
   outbreaks in Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
AB Background From the end of 2016 until the beginning of 2019, Brazil faced a massive sylvatic yellow fever (YF) outbreak. The 2016-2019 YF epidemics affected densely populated areas, especially the Southeast region, causing thousands of deaths of humans and non-human primates (NHP). Methodology/Principal findings We conducted a molecular investigation of yellow fever virus (YFV) RNA in 781 NHP carcasses collected in the urban, urban-rural interface, and rural areas of Minas Gerais state, from January 2017 to December 2018. Samples were analyzed according to the period of sampling, NHP genera, sampling areas, and sampling areas/NHP genera to compare the proportions of YFV-positive carcasses and the estimated YFV genomic loads. YFV infection was confirmed in 38.1% of NHP carcasses (including specimens of the generaAlouatta,Callicebus,Callithrix, andSapajus), from the urban, urban-rural interface, and rural areas. YFV RNA detection was positively associated with epidemic periods (especially from December to March) and the rural environment. Higher median viral genomic loads (one million times) were estimated in carcasses collected in rural areas compared to urban ones. Conclusions/Significance The results showed the wide occurrence of YF in Minas Gerais in epidemic and non-epidemic periods. According to the sylvatic pattern of YF, a gradient of viral dissemination from rural towards urban areas was observed. A high YF positivity was observed for NHP carcasses collected in urban areas with a widespread occurrence in 67 municipalities of Minas Gerais, including large urban centers. Although there was no documented case of urban/AedesYFV transmission to humans in Brazil during the 2016-2019 outbreaks, YFV-infected NHP in urban areas with high infestation byAedes aegyptiposes risks for YFV urban/Aedestransmission and urbanization.
   Author summary Brazil faced the most massive sylvatic yellow fever (YF) outbreak in 2016-2019. The outbreak affected highly densely populated areas, and Minas Gerais was the most affected state with thousands of deaths of human and non-human primates (NHP). We investigated the yellow fever virus (YFV) RNA in NHP carcasses collected throughout Minas Gerais in 2017 and 2018. We demonstrated the wide occurrence of YFV-infected NHP, including the viral persistence during the non-epidemic dry season of 2017. YFV RNA was detected in NHP carcasses in the urban, urban-rural interface and rural areas. We have also detected new YF cases in 49 municipalities where YF cases have not been previously detected during the outbreaks. Estimates of YFV genomic load in naturally infected NHP carcasses showed high and similar loads in specimens (Alouatta,Callithrix, andCallicebus) collected in rural areas and lower genomic loads in the urban-rural interface and urbanCallithrixspecimens. The presence of YFV inside urban areas poses an imminent risk, although no human case was epidemiologically linked to urban/Aedestransmission during the last outbreaks in Brazil.
C1 [Sacchetto, Livia; Oliveira Silva, Natalia Ingrid; de Rezende, Izabela Mauricio; Arruda, Matheus Soares; Costa, Thais Alkifeles; Garcia Oliveira, Gabriela Fernanda; Kroon, Erna Geessien; Trindade, Giliane de Souza; Drumond, Betania Paiva] Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [de Mello, Erica Munhoz] Ctr Controle Zoonoses, Belo Horizonte, MG, Brazil.
   [Alves, Pedro Augusto] Fundacao Oswaldo Cruz Minas, Inst Rene Rachou, Belo Horizonte, MG, Brazil.
   [de Mendonca, Vitor Emidio; Perini, Fernando Araujo] Univ Fed Minas Gerais, Dept Zool, Belo Horizonte, MG, Brazil.
   [Antonelli Vidal Stumpp, Rodolfo German; Alves Prado, Alaine Izabela; Paglia, Adriano Pereira] Univ Fed Minas Gerais, Dept Genet Ecol & Evolut, Belo Horizonte, MG, Brazil.
   [Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto, Dept Dermatol Infect & Parasit Dis, Sao Paulo, Brazil.
   [de Thoisy, Benoit] Inst Pasteur, Cayenne, French Guiana.
RP Drumond, BP (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil.
EM betaniadrumond@gmail.com
RI Nogueira, Mauricio L/B-7599-2012; Paglia, Adriano P/A-7965-2012
OI Nogueira, Mauricio L/0000-0003-1102-2419; Paglia, Adriano
   P/0000-0001-9957-5506; Alves, Pedro/0000-0002-9659-5621
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas
   Gerais State Research Foundation (FAPEMIG) [APQ-01574-17]; Secretaria de
   Estado de Saude de Minas Gerais (SES-MG)/Secretaria de Estado de
   Planejamento de Minas Gerais (SEPLAG-MG)/Instituto Rene Rachou/Fundacao
   Oswaldo Cruz (IRR/FIOCRUZ) under Grant Yellow fever; Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq) [440593/2016-6];
   Decit/SCTIE/MoH [440593/2016-6]; FAPEMIGMinas Gerais State Research
   Foundation (FAPEMIG); Coodernacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES)CAPES; RESERVOIRS program - European (ERDF/FEDER) funds;
   Collectivite Territoriale de la Guyane; Direction Regionale pour la
   Recherche et la Technologie; MicroBIOME project - Laboratoire
   d'Excellence CEBA "Investissement d'Avenir"French National Research
   Agency (ANR) [ANR10-LABX-2501]; FAPEMIGMinas Gerais State Research
   Foundation (FAPEMIG) [APQ-01989-18]; Fundacao de Amparo a Pesquisa do
   estado de Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [13/21719-3]; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES)/BrazilCAPES [0001]; Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Pro -Reitoria de
   Graduacao-Universidade Federal de Minas Gerais (UFMG); CNPq
   FAPEMIGNational Council for Scientific and Technological Development
   (CNPq)Minas Gerais State Research Foundation (FAPEMIG); CAPESCAPES
FX This work was supported by different agencies. BPD was supported by
   Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), under
   Grant APQ-01574-17, and Secretaria de Estado de Saude de Minas Gerais
   (SES-MG)/Secretaria de Estado de Planejamento de Minas Gerais
   (SEPLAG-MG)/Instituto Rene Rachou/Fundacao Oswaldo Cruz (IRR/FIOCRUZ)
   under Grant Yellow fever. GST was supported by Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) under grant
   440593/2016-6 and Decit/SCTIE/MoH under grant 440593/2016-6. APP was
   supported by FAPEMIG and Coodernacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES). BdT was supported by the RESERVOIRS program
   supported by European (ERDF/FEDER) funds and assistance from
   Collectivite Territoriale de la Guyane and Direction Regionale pour la
   Recherche et la Technologie, and the MicroBIOME project granted by the
   Laboratoire d'Excellence CEBA "Investissement d'Avenir" under Grant
   ANR10-LABX-2501. PAA was supported by FAPEMIG under grant APQ-01989-18.
   MLN was supported by Fundacao de Amparo a Pesquisa do estado de Sao
   Paulo (FAPESP) under grant 13/21719-3. LS and IMR were supported by
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)/Brazil under graduate scholarship grant (0001) and NIOS was
   supported by Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) under graduate scholarship grant, VEM was supported
   by Pro -Reitoria de Graduacao-Universidade Federal de Minas Gerais
   (UFMG) under graduate scholarship grant. MAS, TAC, and GFGO were
   supported by CNPq FAPEMIG, and CAPES undergraduate scholarship grants.
   BPD, APP, GST, EGK, and MLN are CNPq Research Fellows. CNPq:
   http://www.cnpq.br/CAPES: https://www.capes.gov.br/FAPEMIG:
   https://fapemig.br/pt/FAPESP: http://www.fapesp.br/Pro-Reitoria de
   Graduacao-Universidade Federal de Minas Gerais:
   https://www2.ufmg.br/prograd/The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR CAUSEY OR, 1950, AM J TROP MED, V30, P301
   CLARK HC, 1952, AM J TROP MED HYG, V1, P78, DOI 10.4269/ajtmh.1952.1.78
   Cunha MS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41950-3
   Vasconcelos PFD, 2010, REV SAUDE PUBL, V44, P1144, DOI 10.1590/S0034-89102010005000046
   de Rezende IM, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7040206
   de Rezende IM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006538
   Delatorre E, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01079
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Douam F, 2018, TRENDS MICROBIOL, V26, P913, DOI 10.1016/j.tim.2018.05.012
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Gomez MM, 2018, J GEN VIROL, V99, P536, DOI 10.1099/jgv.0.001033
   Gregorin R, 2006, REV BRAS ZOOL, V23, P64, DOI 10.1590/S0101-81752006000100005
   Groves C., 2001, PRIMATE TAXONOMY, P1
   IBGE, 2000, SIN PREL CENS DEM, P415
   IUCN, 2019, IUCN RED LIST THREAT
   KUMM HW, 1950, AM J TROP MED, V30, P733
   Mares-Guia MAMD, 2020, PARASITE VECTOR, V13, DOI 10.1186/s13071-020-3966-x
   Mir D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07873-7
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   MS-BR, 2017, MONT PER SAZ FEBR AM, P1
   MS-BR, 2019, MON FEBR AM BRAS 201, P1
   Mucci LF, 2016, J AM MOSQUITO CONTR, V32, P329, DOI 10.2987/16-6587.1
   Silva NIO, 2020, VIROL J, V17, DOI 10.1186/s12985-019-1277-7
   Paglia AP, 2012, OCCASIONAL PAPERS CO
   Pinheiro GG, 2019, INSECTS, V10, DOI 10.3390/insects10050136
   de Abreu FVS, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760190076
   de Abreu FVS, 2019, EMERG MICROBES INFEC, V8, P218, DOI 10.1080/22221751.2019.1568180
   SES-MG, 2018, FEBR AM MIN GER B EP, P1
   SES-MG, 2017, SIT EP FEBR AM SILV, P1
   SES-MG, 2019, FEBR AM SILV MIN GER, P1
   Stan K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137911
   SVS-MS, 2018, MON PER SAZ FEBR AM, P1
   SVS-MS, 2019, FEBR AM FEBR NIL OC, P727
   SVS-MS, 2019, MON FEBR AM BRAS 201, P1
   SVS-MS, 2017, CTR OP EM SAUD PUBL, P1
   Teixeira B, 2015, WILDLIFE RES, V42, P579, DOI 10.1071/WR14148
   van Roosmalen Marc G.M., 2002, Neotropical Primates, V10, P1
   Vasconcelos Pedro Fernando da Costa, 2003, Rev. Soc. Bras. Med. Trop., V36, P275, DOI 10.1590/S0037-86822003000200012
NR 38
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2020
VL 14
IS 10
AR e0008658
DI 10.1371/journal.pntd.0008658
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA OB2OH
UT WOS:000578312500008
PM 33017419
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Stoffella-Dutra, AG
   de Oliveira, JS
   Costa, GB
   Kroon, EG
   Abrahao, JS
   LaBeaud, AD
   Drumond, BP
   de Oliveira, DB
   Trindade, GD
AF Stoffella-Dutra, Ana Gabriella
   de Oliveira, Jaqueline Silva
   Costa, Galileu Barbosa
   Kroon, Erna Geessien
   Abrahao, Jonatas Santos
   LaBeaud, Angelle Desiree
   Drumond, Betania Paiva
   de Oliveira, Danilo Bretas
   Trindade, Giliane de Souza
TI Absence of YF-neutralizing antibodies in vulnerable populations of
   Brazil: A warning for epidemiological surveillance and the potential
   risks for future outbreaks
SO VACCINE
LA English
DT Article
DE Yellow fever virus; YF-neutralizing antibodies; Epidemiological
   surveillance; Serological survey; Public health
ID YELLOW-FEVER; IMMUNITY
AB Yellow Fever (YF) is an acute febrile illness caused by yellow fever virus (YFV), a mosquito-borne flavivirus transmitted to humans and non-human primates. In Brazil, YF is a public health threat and may cause recurrent epidemics, even with the availability of a vaccine. We evaluated the sero-status for YFV in 581 individuals living in a risk area for YF in Brazil. The area presents history of cases and is located in the southeast region of country where outbreaks of YF have been reported since 2016. Through, a PRNT assay, we found 25.8% of individuals lacking YF-neutralizing antibodies. Furthermore, neutralizing antibodies were not detected in 10 individuals with proven vaccination. Our findings reinforce the importance of surveillance systems and the need of an urgent intensification of immunization programs in regions with YFV circulation. Monitoring susceptible individuals that could act as potential disseminators for YFV in risk areas should also be considered. (C) 2020 Elsevier Ltd. All rights reserved.
C1 [Stoffella-Dutra, Ana Gabriella; de Oliveira, Jaqueline Silva; Kroon, Erna Geessien; Abrahao, Jonatas Santos; Drumond, Betania Paiva; Trindade, Giliane de Souza] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Av Antonio Carlos 6627,Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
   [Costa, Galileu Barbosa] Fiocruz MS, Ctr Pesquisas Goncalo Moniz, Nucleo Epidemiol & Bioestat, Salvador, BA, Brazil.
   [LaBeaud, Angelle Desiree] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA USA.
   [de Oliveira, Danilo Bretas] Univ Fed Vales Jequitinhonha & Mucuri, Fac Med, Diamantina, MG, Brazil.
RP Stoffella-Dutra, AG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Av Antonio Carlos 6627,Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM anagstoffella@gmail.com; giliane@icb.ufmg.br
OI Barbosa Costa, Galileu/0000-0001-7360-6722
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq/MCTI) grantNational Council for Scientific and Technological
   Development (CNPq) [440593/2016-6]; Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais (FAPEMIG)Minas Gerais State Research Foundation
   (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES/MEC)CAPES; Departamento de Ciencia e Tecnologia (DECIT);
   Secretaria de Ciencia, Tecnologia, Inovacao e Insumos Estrategicos em
   Saude (SCTIE); Ministerio da Saude and Pro-Reitoria de Pesquisa/UFMG
   (PRPq-UFMG)
FX We thank colleagues from the Laboratorio de Virus (ICB-UFMG) for their
   excellent technical support. Financial support was provided by the
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq/MCTI) grant number 440593/2016-6, Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais (FAPEMIG), Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES/MEC), Departamento de Ciencia e
   Tecnologia (DECIT), Secretaria de Ciencia, Tecnologia, Inovacao e
   Insumos Estrategicos em Saude (SCTIE), Ministerio da Saude and
   Pro-Reitoria de Pesquisa/UFMG (PRPq-UFMG). EG Kroon, JS Abrahao, BP
   Drumond, and GS Trindade are researchers from CNPq.
CR Amaral CD, 2018, ECOHEALTH, V15, P577, DOI 10.1007/s10393-018-1353-2
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Caldas IR, 2014, VACCINE, V32, P4977, DOI 10.1016/j.vaccine.2014.07.021
   Campi-Azevedo AC, 2019, EMERG INFECT DIS, V25, P1511, DOI 10.3201/eid2508.181432
   Campi-Azevedo AC, 2016, HUM VACC IMMUNOTHER, V12, P491, DOI 10.1080/21645515.2015.1082693
   Christian KA, 2017, HEALTH SECUR, V15, P453, DOI 10.1089/hs.2017.0004
   Costa GB, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11111029
   Costa GB, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0575-6
   COSTA Z.G.A., 2005, EST CAR EP FEBR AM B
   Cutts FT, 2016, VACCINE, V34, P4103, DOI 10.1016/j.vaccine.2016.06.053
   Dimech W, 2016, VACCINE, V34, P4110, DOI 10.1016/j.vaccine.2016.06.002
   Domingo C, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0128-8
   Douam F, 2018, TRENDS MICROBIOL, V26, P913, DOI 10.1016/j.tim.2018.05.012
   Estofolete CF, 2018, BRAZ J MICROBIOL, V49, P683, DOI 10.1016/j.bjm.2018.02.003
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Ferreira CD, 2018, EXPERT REV VACCINES, V17, P79, DOI 10.1080/14760584.2018.1406800
   Figueiredo PO, 2018, ECOHEALTH, V15, P864, DOI 10.1007/s10393-018-1364-z
   Gardner CL, 2010, CLIN LAB MED, V30, P237, DOI 10.1016/j.cll.2010.01.001
   IBF, 2018, BIOM MAT ATL
   IBGE, 2010, CENS DEM
   Lindenbach B.D, 2013, FIELDS VIROL
   LIRAa, 2019, LEV IND RAP AED AEG
   Luiza-Silva M, 2011, J INFECT DIS, V204, P873, DOI 10.1093/infdis/jir439
   Machado VW, 2013, REV SOC BRAS MED TRO, V46, P166, DOI 10.1590/0037-8682-0007-2012
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   Romano APM, 2011, EPIDEMIOL SERV SAUDE, V20, P101, DOI 10.5123/S1679-49742011000100011
   Ministerio Da Saude, 2018, 27 MIN SAUD
   Ministerio Da Saude, 2019, 18 MIN SAUD
   Miyaji KT, 2017, REV INST MED TROP SP, V59, DOI [10.1590/S1678-9946201759002, 10.1590/s1678-9946201759002]
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Moura LC, 2016, REV VOZES VALES PUBL, V120
   Muyanja E, 2014, J CLIN INVEST, V124, P3147, DOI 10.1172/JCI75429
   Silva NIO, 2020, VIROL J, V17, DOI 10.1186/s12985-019-1277-7
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760180278
   Ribeiro M, 2009, REV SOC BRAS MED TRO, V42, P523, DOI 10.1590/S0037-86822009000500009
   SES/MG, 2019, DAD COB VAC MIN GERA
   SES/MG, 2019, FEBR AM SILV MIN GER
   SES/MG, 2018, B EPID MON CAS DENG
   Soper FL, 1942, FEBRE AMARELA PANAM
   Staples JE, 2020, NPJ VACCINES, V5, DOI 10.1038/s41541-020-0205-6
   SVS, 2003, EP FEB AM SIL REG BA
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   Tuboi SH, 2007, T ROY SOC TROP MED H, V101, P169, DOI 10.1016/j.trstmh.2006.04.001
   Vasconcelos PFC, 2018, MEM I OSWALDO CRUZ, V113, P135, DOI 10.1590/0074-02760170347
   Vasconcelos Pedro Fernando da Costa, 2003, Rev. Soc. Bras. Med. Trop., V36, P275, DOI 10.1590/S0037-86822003000200012
   Watson AM, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040077
   WHO, 2013, POSITION PAPER, V88, P269
   WHO, 2007, GUID PLAQ RED NEUTR
   WHO, 2019, YELL FEV FACT SHEETS
   WHO, 2017, GLOB STRAT EL YELL F
   WHO. World health organization, 2020, YELL FEV INT TRAV HL
   Zimmermann P, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00084-18
NR 52
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD SEP 29
PY 2020
VL 38
IS 42
BP 6592
EP 6599
DI 10.1016/j.vaccine.2020.07.077
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA NU1TY
UT WOS:000573425200015
PM 32788140
DA 2020-12-09
ER

PT J
AU Rezende, IM
   Pereira, LS
   Fradico, JRB
   Xavier, MANP
   Alves, PA
   Campi-Azevedo, AC
   Speziali, E
   dos Santos, LZM
   Albuquerque, NS
   Penido, I
   Santos, TA
   Bom, APDA
   da Silva, AMV
   Fernandes, CB
   Calzavara, CE
   Kroon, EG
   Martins, OA
   Teixeira-Carvalho, A
   Drumond, BP
AF Rezende, Izabela Mauricio
   Pereira, Leonardo Soares
   Fradico, Jordana Rodrigues Barbosa
   Xavier, Marcelo Antonio Pascoal
   Alves, Pedro Augusto
   Campi-Azevedo, Ana Carolina
   Speziali, Elaine
   dos Santos, Livia Zignago Moreira
   Albuquerque, Natalia Soares
   Penido, Indiara
   Santos, Tayrine Araujo
   Bom, Ana Paula Dinis Ano
   da Silva, Andrea Marques Vieira
   Fernandes, Camilla Bayma
   Calzavara, Carlos Eduardo
   Kroon, Erna Geessien
   Martins-Filho, Olindo Assis
   Teixeira-Carvalho, Andrea
   Drumond, Betania Paiva
TI Late-Relapsing Hepatitis after Yellow Fever
SO VIRUSES-BASEL
LA English
DT Article
DE yellow fever virus; yellow fever; liver damage; viral persistence;
   hepatitis; liver biopsy; persistent infection; relapsing hepatitis;
   emerging virus; flavivirus
ID VIRUS; ASSAY
AB One patient presented hyporexia, asthenia, adynamia, and jaundice two months after acute yellow fever (YF) onset; plus laboratory tests indicating hepatic cytolysis and a rebound of alanine and aspartate transaminases, and total and direct bilirubin levels. Laboratory tests discarded autoimmune hepatitis, inflammatory or metabolic liver disease, and new infections caused by hepatotropic agents. Anti-YFV IgM, IgG and neutralizing antibodies were detected in different times, but no viremia. A liver biopsy was collected three months after YF onset and tested positive for YFV antigens and wild-type YFV-RNA (364 RNA-copies/gram/liver). Transaminases and bilirubin levels remained elevated for five months, and the arresting of symptoms persisted for six months after the acute YF onset. Several serum chemokines, cytokines, and growth factors were measured. A similar immune response profile was observed in the earlier phases of the disease, followed by more pronounced changes in the later stages, when transaminases levels returned to normal. The results indicated viral persistence in the liver and continual liver cell damage three months after YF onset and reinforced the need for extended follow-ups of YF patients. Further studies to investigate the role of possible viral persistence and the immune response causing relapsing hepatitis following YF are also necessary.
C1 [Rezende, Izabela Mauricio; Kroon, Erna Geessien; Drumond, Betania Paiva] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
   [Pereira, Leonardo Soares; dos Santos, Livia Zignago Moreira; Albuquerque, Natalia Soares; Penido, Indiara; Santos, Tayrine Araujo] Eduardo Menezes Hosp, BR-30622020 Belo Horizonte, MG, Brazil.
   [Fradico, Jordana Rodrigues Barbosa; Campi-Azevedo, Ana Carolina; Speziali, Elaine; Martins-Filho, Olindo Assis; Teixeira-Carvalho, Andrea] Fundacao Oswaldo Cruz FIOCRUZ, Grp Integrado Pesquisas Biomarcadores, Inst Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil.
   [Xavier, Marcelo Antonio Pascoal] Univ Fed Minas Gerais, Dept Anat Patol & Med Legal, Fac Menincina, BR-31270901 Belo Horizonte, MG, Brazil.
   [Xavier, Marcelo Antonio Pascoal; Alves, Pedro Augusto] Fundacao Oswaldo Cruz FIOCRUZ, Inst Rene Rachou, Imunologia Doencas Virais, BR-30190002 Belo Horizonte, MG, Brazil.
   [Bom, Ana Paula Dinis Ano; da Silva, Andrea Marques Vieira; Fernandes, Camilla Bayma] Fundacao Oswaldo Cruz FIOCRUZ, Lab Tecnol Imunol, Biomanguinhos, BR-21040900 Rio De Janeiro, Brazil.
   [Calzavara, Carlos Eduardo] Fundacao Oswaldo Cruz FIOCRUZ, Inst Rene Rachou, Imunol Celular & Mol, BR-30190002 Belo Horizonte, MG, Brazil.
RP Drumond, BP (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
EM izabelamauriciorezende@gmail.com; leosoaresgallo@yahoo.com.br;
   jordanafradico@gmail.com; mpascoal@medicina.ufmg.br;
   pedroaugustoalves@yahoo.com.br; campiazevedo@gmail.com;
   fariaspeziali@gmail.com; lizms@msn.com; albuquerque.natalia@gmail.com;
   indypenido@hotmail.com; tayrine.araujo@fhemig.mg.gov.br;
   adinis@bio.fiocruz.br; amarques@bio.fiocruz.br;
   camilla.bayma@bio.fiocruz.br; calzavara@gmail.com; ernagkroon@gmail.com;
   oamfilho@gmail.com; atcteixeira@gmail.com; betaniadrumond@gmail.com
RI Alves, Pedro/T-7203-2019; Rezende, Izabela Mauricio/AAL-5766-2020;
   Kroon, Erna/B-3631-2015
OI Alves, Pedro/0000-0002-9659-5621; Rezende, Izabela
   Mauricio/0000-0003-2616-6300; Kroon, Erna/0000-0003-2721-3826;
   Martins-Filho, Olindo Assis/0000-0002-5494-4889; Pereira,
   Leonardo/0000-0002-5426-0655
FU Fundacao Oswaldo Cruz/Secretaria de Saude de Minas Gerais/Secretaria de
   Planejamento de Minas Gerais/Fundacao de Amparo a Pesquisa do Estado de
   Minas Gerais (FIOCRUZ/SES-MG/SPLAG-MG/FAPEMIG); National Council for
   Scientific and Technological Development (CNPq)National Council for
   Scientific and Technological Development (CNPq) [307423/2015-8,
   440911/2016-8]; Brazilian Federal Agency for Support and Evaluation of
   Graduate Education (CAPES)CAPES [001, 88881130799/2016-01]; Department
   for Science and Technology/Brazilian Ministry of Health (DECIT/MS);
   Minas Gerais State Agency for Research (FAPEMIG)Minas Gerais State
   Research Foundation (FAPEMIG) [APQ-01989-18, APQ-04178-17]
FX This work was supported by the Fundacao Oswaldo Cruz/Secretaria de Saude
   de Minas Gerais/Secretaria de Planejamento de Minas Gerais/Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais
   (FIOCRUZ/SES-MG/SPLAG-MG/FAPEMIG) under grant yellow fever; National
   Council for Scientific and Technological Development (CNPq) under Grant
   307423/2015-8 and 440911/2016-8; Brazilian Federal Agency for Support
   and Evaluation of Graduate Education (CAPES) under grants PRINT/CAPES,
   001, and 88881130799/2016-01; Department for Science and
   Technology/Brazilian Ministry of Health (DECIT/MS); and Minas Gerais
   State Agency for Research (FAPEMIG) under grants APQ-01989-18 and
   APQ-04178-17. E.G.K, O.A.M.-F., A.T.-C, and B.P.D. are CNPq researchers.
CR Alm E, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1226-z
   Denis B, 2019, EMERG INFECT DIS, V25, P1248, DOI 10.3201/eid2506.190069
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   FRANCIS TI, 1972, B WORLD HEALTH ORGAN, V46, P659
   Kallas EG, 2019, LANCET INFECT DIS, V19, P750, DOI 10.1016/S1473-3099(19)30125-2
   Kar PK, 2009, INDIAN J MED RES, V129, P335
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   OUDART JL, 1970, B WORLD HEALTH ORGAN, V42, P95
   Patel P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-58
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Waggoner JJ, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.00827-18
   Wieten RW, 2016, VACCINE, V34, P1247, DOI 10.1016/j.vaccine.2016.01.037
NR 13
TC 1
Z9 2
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD FEB
PY 2020
VL 12
IS 2
AR 222
DI 10.3390/v12020222
PG 9
WC Virology
SC Virology
GA KW6DX
UT WOS:000521256600063
PM 32079143
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Silva, NIO
   Sacchetto, L
   de Rezende, IM
   Trindade, GD
   LaBeaud, AD
   de Thoisy, B
   Drumond, BP
AF Oliveira Silva, Natalia Ingrid
   Sacchetto, Livia
   de Rezende, Izabela Mauricio
   Trindade, Giliane de Souza
   LaBeaud, Angelle Desiree
   de Thoisy, Benoit
   Drumond, Betania Paiva
TI Recent sylvatic yellow fever virus transmission in Brazil: the news from
   an old disease
SO VIROLOGY JOURNAL
LA English
DT Review
DE Yellow fever virus; Yellow fever; Arbovirus; Flavivirus; Non-human
   primate; Epizootic; Outbreak; Epidemiology; Vector; Pathogenesis
ID ALOUATTA-GUARIBA-CLAMITANS; HOWLER MONKEYS; NONHUMAN-PRIMATES; VECTOR
   COMPETENCE; ESPIRITO-SANTO; AEDES-AEGYPTI; STATE; MOSQUITOS; OUTBREAK;
   RHESUS
AB Yellow fever (YF) is an acute viral disease, affecting humans and non-human primates (NHP), caused by the yellow fever virus (YFV). Despite the existence of a safe vaccine, YF continues to cause morbidity and mortality in thousands of people in Africa and South America. Since 2016, massive YF outbreaks have taken place in Brazil, reaching YF-free zones, causing thousands of deaths of humans and NHP. Here we reviewed the main epidemiological aspects, new clinical findings in humans, and issues regarding YFV infection in vectors and NHP in Brazil. The 2016-2019 YF epidemics have been considered the most significant outbreaks of the last 70 years in the country, and the number of human cases was 2.8 times higher than total cases in the previous 36 years. A new YFV lineage was associated with the recent outbreaks, with persistent circulation in Southeast Brazil until 2019. Due to the high number of infected patients, it was possible to evaluate severity and death predictors and new clinical features of YF. Haemagogus janthinomys and Haemagogus leucocelaenus were considered the primary vectors during the outbreaks, and no human case suggested the occurrence of the urban transmission cycle. YFV was detected in a variety of NHP specimens presenting viscerotropic disease, similar to that described experimentally. Further studies regarding NHP sensitivity to YFV, YF pathogenesis, and the duration of the immune response in NHP could contribute to YF surveillance, control, and future strategies for NHP conservation.
C1 [Oliveira Silva, Natalia Ingrid; Sacchetto, Livia; de Rezende, Izabela Mauricio; Trindade, Giliane de Souza; Drumond, Betania Paiva] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
   [LaBeaud, Angelle Desiree] Stanford Univ, Sch Med, Dept Pediat, Div Infect Dis, Stanford, CA 94305 USA.
   [de Thoisy, Benoit] Inst Pasteur Guyane, Lab Interact Virus Hotes, Cayenne, French Guiana, France.
RP Drumond, BP (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
EM betaniadrumond@gmail.com
RI Silva, Natalia/AAL-6048-2020; Sacchetto, Livia/B-8841-2019; Rezende,
   Izabela Mauricio/AAL-5766-2020
OI Silva, Natalia/0000-0003-3449-8313; Sacchetto,
   Livia/0000-0001-9716-6899; Rezende, Izabela Mauricio/0000-0003-2616-6300
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas
   Gerais State Research Foundation (FAPEMIG) [APQ-01574-17]; European
   (ERDF/FEDER) funds; Agence Nationale de la Recherche (CEBA)French
   National Research Agency (ANR) [ANR-10-LABEX-25-01]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)/BRAZILCAPES [0001];
   CNPqNational Council for Scientific and Technological Development
   (CNPq); National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq)
FX This study was developed in the context of projects supported by
   different agencies. BPD acknowledges Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais (FAPEMIG) (APQ-01574-17), GST acknowledges
   Decit/SCTIE/MoH, BPD and GST acknowledge Secretaria de Estado de Saude
   de Minas Gerais (SES-MG)/Secretaria de Estado de Planejamento de Minas
   Gerais (SEPLAG-MG)/Fundacao Oswaldo Cruz (FIOCRUZ)/FAPEMIG (grant Yellow
   fever) and National Council for Scientific and Technological Development
   (research fellowships). BdT acknowledges the RESERVOIRS program
   supported by European (ERDF/FEDER) funds and assistance from
   Collectivite Territoriale de la Guyane and Direction Regionale pour la
   Recherche et la Technologie, and the Laboratoire d'Excellence CEBA
   "Investissement d'Avenir" and managed by the Agence Nationale de la
   Recherche (CEBA, Ref. ANR-10-LABEX-25-01). LS and IMR acknowledge
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)/BRAZIL (grant 0001-graduate scholarship) and NIOS acknowledge
   CNPq-(grant graduate scholarship). The funders had no role in study
   design, data collection, and analysis, decision to publish, or
   preparation of the manuscript.
CR Agostini I, 2008, PRIMATES, V49, P304, DOI 10.1007/s10329-008-0106-1
   Alencar J, 2005, J MED ENTOMOL, V42, P981, DOI 10.1603/0022-2585(2005)042[0981:FPOHJD]2.0.CO;2
   Alencar J, 2016, REV SOC BRAS MED TRO, V49, P351, DOI 10.1590/0037-8682-0438-2015
   Auguste AJ, 2015, EMERG INFECT DIS, V21, P99, DOI 10.3201/eid2101.140814
   Barbosa CM, 2018, EMERG INFECT DIS, V24, P176, DOI 10.3201/eid2401.171310
   de Almeida MAB, 2012, AM J PRIMATOL, V74, P68, DOI 10.1002/ajp.21010
   BATES B C, 1970, Primates, V11, P271, DOI 10.1007/BF01793893
   BEARCROFT WGC, 1957, J PATHOL BACTERIOL, V74, P295, DOI 10.1002/path.1700740207
   Bicca-Marques JC, 2010, TROP CONSERV SCI, V3, P78, DOI 10.1177/194008291000300107
   Casadio LVB, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760190033
   Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Burke A. W., 1937, AM J TROP MED HYG, Vs1-17, P313, DOI [10.4269/ajtmh.1937.s1-17.313, DOI 10.4269/AJTMH.1937.S1-17.313]
   Caldas IR, 2014, VACCINE, V32, P4977, DOI 10.1016/j.vaccine.2014.07.021
   Campi-Azevedo AC, 2016, HUM VACC IMMUNOTHER, V12, P491, DOI 10.1080/21645515.2015.1082693
   Cardoso JD, 2010, EMERG INFECT DIS, V16, P1918, DOI 10.3201/eid1612.100608
   CAUSEY OR, 1950, AM J TROP MED, V30, P301
   COES-PR, 2019, COES PR B EP 015 30, P1
   COES-PR, 2019, COES PR B EP N 017 0, P1
   COLLIAS NICHOLAS, 1952, PROC AMER PHIL SOC, V96, P143
   Costa-Pereira C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006462
   Fernandes NCCD, 2017, EMERG INFECT DIS, V23, P2038, DOI 10.3201/eid2312.170685
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Cunha MS, 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2
   DAVIES CR, 1991, FUNCT ECOL, V5, P655, DOI 10.2307/2389485
   Davis N C, 1930, J Exp Med, V52, P405
   Davis NC, 1930, AM J HYG, V11, P321
   Davis NC, 1929, J EXP MED, V50, P81, DOI 10.1084/jem.50.1.81
   Davis NC, 1931, J EXP MED, V51, P703
   de Rezende IM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006538
   de Thoisy B, 2001, AM J PRIMATOL, V54, P1, DOI 10.1002/ajp.1008
   Degallier Nicolas, 1992, Ciencia e Cultura (Sao Paulo), V44, P143
   Delatorre E, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01079
   Denis B, 2019, EMERG INFECT DIS, V25, P1248, DOI 10.3201/eid2506.190069
   deThoisy B, 1997, FOLIA PRIMATOL, V68, P357, DOI 10.1159/000157266
   dos Santos TP, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0194-y
   Douam F, 2018, TRENDS MICROBIOL, VXX, P1
   Duarte MHL, 2012, APPL ANIM BEHAV SCI, V137, P127, DOI 10.1016/j.applanim.2011.11.013
   Dunn J, 2016, NEW WORLD MONKEYS
   Engelmann F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003295
   ESPINOZA VJC, 2009, INT J CLIMATOL, V29, P1574, DOI DOI 10.1002/J0C.1791
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Favoretto S., 2016, 1 DETECTION ZIKA VIR
   Figueiredo PO, 2018, ECOHEALTH, V15, P864, DOI 10.1007/s10393-018-1364-z
   Forattini OP, 2002, CULICIDOLOGIA MED
   Franco O, 1969, HIST FEBRE AMARELA B, P1
   G1BR, 2018, MAC SAO VIT FALT INF
   Galindo P, 1973, NONHUM PRIMATES MED
   GERMAIN M, 1978, MED MALADIES INFECT, V8, P69, DOI 10.1016/S0399-077X(78)80035-3
   Gomes AD, 2007, REV SOC BRAS MED TRO, V40, P487, DOI 10.1590/S0037-86822007000400025
   Gomez MM, 2018, J GEN VIROL, V99, P536, DOI 10.1099/jgv.0.001033
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Herve J, 1983, REV FUND SESP, V28, P11
   Ho YL, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz040
   Holzmann I, 2010, AM J PRIMATOL, V72, P475, DOI 10.1002/ajp.20796
   Hudson NP, 1929, J EXP MED, V50, P583, DOI 10.1084/jem.50.5.583
   IEC, 2018, I EV CHAG DET VIR FE
   Johnson BW, 2002, T ROY SOC TROP MED H, V96, P611, DOI 10.1016/S0035-9203(02)90326-3
   Kallas EG, 2019, LANCET INFECT DIS, V19, P750, DOI 10.1016/S1473-3099(19)30125-2
   Klitting R, 2018, GENES-BASEL, V9, DOI 10.3390/genes9060291
   KUMM HW, 1950, AM J TROP MED, V30, P733
   Laemmert Hugo W., 1945, AM J TROP MED HYG, Vs1-25, P231, DOI [10.4269/ajtmh.1945.s1-25.231, DOI 10.4269/AJTMH.1945.S1-25.231]
   LAEMMERT HW, 1950, AM J TROP MED, V30, P723
   LAEMMERT HW, 1949, AM J TROP MED, V29, P555
   LAEMMERT HW, 1946, AM J TROP MED, V26, P33
   Leal SG, 2016, REV SOC BRAS MED TRO, V49, P29, DOI 10.1590/0037-8682-0363-2015
   Lindenbach B.D, 2013, FIELDS VIROL
   Lourenco-De-Oliveira R, 2004, T ROY SOC TROP MED H, V98, P43, DOI 10.1016/S0035-9203(03)00006-3
   Lourenco-de-Oliveira R, 2002, MEM I OSWALDO CRUZ, V97, P437, DOI 10.1590/S0074-02762002000300031
   Maguire HCF, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3764
   Marcondes C, 2010, REV BIOMED
   Marinho PES, 2019, EMERG INFECT DIS, V25, P1567, DOI [10.3201/eid2508/181479, 10.3201/eid2508.181479]
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   MILLER BR, 1988, T ROY SOC TROP MED H, V82, P476, DOI 10.1016/0035-9203(88)90168-X
   Mir D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07873-7
   Mittermeier R. A., 1988, ECOL BEHAV NEOTROP P, V2, P348
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Monath TP, 2005, EXPERT REV VACCINES, V4, P553, DOI 10.1586/14760584.4.4.553
   MONATH TP, 1981, AM J TROP MED HYG, V30, P431, DOI 10.4269/ajtmh.1981.30.431
   Monath TP, 1989, ARBOVIRUSES EPIDEMIO, V5, P139
   Moreno ES, 2013, REV INST MED TROP SP, V55, P45, DOI 10.1590/S0036-46652013000100008
   MS-BR, 2017, OR IND DOS UN VAC FE
   MS-BR, 2019, GUIA VIG SAUD, P1
   MS-BR, 2017, GUIA VIG EP PRIM NAO
   MS-BR, 2014, MAN VIG EP EV ADV PO, P1
   MS-BR, 2017, CTR OP EM SAUD PUBL, P1
   MS-BR, 2017, GUIA VIG SAUD
   MS-BR, 2017, MON PER SAZ FEBR AM, V2018
   MS-BR, 2019, MON FEBR AM BRAS 201, P1
   Mucci LF, 2016, J AM MOSQUITO CONTR, V32, P329, DOI 10.2987/16-6587.1
   Ott-Joslin J.E., 1986, P674
   Paglia A.P., 2012, LISTA ANOTADA MAMIFE
   PAHO, 2005, CONTR YELL FEV, P1
   PAHO-WHO, 2018, LAB DIAGN YELL FEV V, P1
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P204, DOI 10.4269/ajtmh.1981.30.204
   Pinheiro GG, 2019, INSECTS, V10, DOI 10.3390/insects10050136
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760180278
   Prata A, 1976, YELLOW FEVER, V2000, P183
   QGIS Development Team, 2016, WELC QGIS PROJ QGIS
   Quaresma JAS, 2013, REV MED VIROL, V23, P305, DOI 10.1002/rmv.1752
   RA Mittermeier, 2013, HDB MAMMALS WORLD, V3, P951
   Ribeiro AF, 2019, AM J TROP MED HYG, V101, P180, DOI 10.4269/ajtmh.18-0882
   Rifakis PM, 2006, ANN NY ACAD SCI, V1081, P57, DOI 10.1196/annals.1373.005
   Roig C, 2009, Mem. Inst. Investig. Cienc. Salud, V7, P40
   Sallis ESV, 2003, J VET DIAGN INVEST, V15, P574, DOI 10.1177/104063870301500611
   de Abreu FVS, 2019, AM J PRIMATOL, V81, DOI 10.1002/ajp.23000
   de Abreu FVS, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760190076
   de Abreu FVS, 2019, EMERG MICROBES INFEC, V8, P218, DOI 10.1080/22221751.2019.1568180
   Selemane I, 2019, TRAVEL MED INFECT DI, V28, P46, DOI 10.1016/j.tmaid.2018.12.008
   SES-MG, 2016, EV ADV POS VACC ASS, V2018, P1
   SES-MG, 2018, FEBR AM MIN GER B EP, P1
   SES-MG, 2019, SES MG B EP 19 02 20, P1
   SES-MG, 2017, AT SIT EP FEBR AM SI, V2017, P1
   SES-MG, 2018, SES MG B EP 20 06 20
   SES-RJ, 2018, INF EP FEBR AM
   SES-SC, 2018, SES PR B EP FEBR AM, P1
   SESAB-BA, 2019, SESAB BA B EP FEBR A, V1, P1
   SESAB-BA, 2018, SESAB BA B EP FEBR A, V2, P1
   Soper FL, 1933, AM J HYG, V18, P555, DOI 10.1093/oxfordjournals.aje.a117967
   Soper FL, 1938, YELLOW FEVER AM 1938, Va, P1942
   Stokes A, 1928, J AMER MED ASSOC, V90, P253, DOI 10.1001/jama.1928.02690310005002
   Strier KB, 2019, PRIMATES, V60, P21, DOI 10.1007/s10329-018-0701-8
   Taufflieb R, 1971, ORSTOM EMP, V9, P351
   TAYLOR R M, 1955, Bull World Health Organ, V12, P711
   Teixeira B, 2015, WILDLIFE RES, V42, P579, DOI 10.1071/WR14148
   Terzian ACB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34423-6
   Tuboi SH, 2007, T ROY SOC TROP MED H, V101, P169, DOI 10.1016/j.trstmh.2006.04.001
   VARGASMENDEZ O, 1953, AM J TROP MED HYG, V2, P850, DOI 10.4269/ajtmh.1953.2.850
   Vasconcelos Pedro Fernando da Costa, 2003, Rev. Soc. Bras. Med. Trop., V36, P275, DOI 10.1590/S0037-86822003000200012
   Vasconcelos PFC, 2004, EMERG INFECT DIS, V10, P1578, DOI 10.3201/eid1009.040197
   Whitman Loring, 1938, AM J TROP MED HYG, Vs1-18, P135, DOI [10.4269/ajtmh.1938.s1-18.135, DOI 10.4269/AJTMH.1938.S1-18.135]
   WHO, 2014, REP 2014, P1
   WHO, 2013, WEEKL EP REC REL EP, P269
   WHO, 1989, GUID EV PLASM FALC A, P1
   WOODALL JP, 1968, ANN TROP MED PARASIT, V62, P528, DOI 10.1080/00034983.1968.11686594
   World Health Organization (WHO), 2008, DRUG RES TUB S E AS, P1
NR 137
TC 14
Z9 14
U1 1
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1743-422X
J9 VIROL J
JI Virol. J.
PD JAN 23
PY 2020
VL 17
IS 1
AR 9
DI 10.1186/s12985-019-1277-7
PG 12
WC Virology
SC Virology
GA KK2WS
UT WOS:000512609100001
PM 31973727
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU de Rezende, IM
   Alves, PA
   Arruda, MS
   Goncalves, AP
   Oliveira, GFG
   Pereira, LS
   Dutra, MRT
   Campi-Azevedo, AC
   Valim, V
   Tourinho, R
   de Oliveira, JG
   Calzavara, CE
   Said, RFD
   Kroon, EG
   Martins, OA
   Teixeira-Carvalho, A
   Drumond, BP
AF de Rezende, Izabela Mauricio
   Alves, Pedro Augusto
   Arruda, Matheus Soares
   Goncalves, Andreza Parreiras
   Oliveira, Gabriela Fernanda Garcia
   Pereira, Leonardo Soares
   Dutra, Maria Rita Teixeira
   Campi-Azevedo, Ana Carolina
   Valim, Valeria
   Tourinho, Renata
   de Oliveira, Jaquelline Germano
   Calzavara, Carlos Eduardo
   Said, Rodrigo Fabiano do Carmo
   Kroon, Erna Geessien
   Martins-Filho, Olindo Assis
   Teixeira-Carvalho, Andrea
   Drumond, Betania Paiva
TI Yellow Fever Virus Genotyping Tool and Investigation of Suspected
   Adverse Events Following Yellow Fever Vaccination
SO VACCINES
LA English
DT Article
DE yellow fever virus; YFV-17DD; adverse event; arbovirus; yellow fever;
   vaccination; immunisation; vaccine; genotyping; wild-type virus
ID PCR
AB The yellow fever (YF) vaccine consists of an attenuated virus, and despite its relative safety, some adverse events following YF vaccination have been described. At the end of 2016, Brazil experienced the most massive sylvatic yellow fever outbreak over the last 70 years and an intense campaign of YF vaccination occurred in Minas Gerais state in Southeast Brazil from 2016 to 2018. The present study aimed to develop a genotyping tool and investigate 21 cases of suspected adverse events following YF vaccination. Initial in silico analyses were performed using partial NS5 nucleotide sequences to verify the discriminatory potential between wild-type and vaccine viruses. Samples from patients were screened for the presence of the YFV RNA, using 5 ' UTR as the target, and then used for amplification of partial NS5 gene amplification, sequencing, and phylogenetic analysis. Genotyping indicated that 17 suspected cases were infected by the wild-type yellow fever virus, but four cases remained inconclusive. The genotyping tool was efficient in distinguishing the vaccine from wild-type virus, and it has the potential to be used for the differentiation of all yellow fever virus genotypes.
C1 [de Rezende, Izabela Mauricio; Arruda, Matheus Soares; Oliveira, Gabriela Fernanda Garcia; Pereira, Leonardo Soares; Kroon, Erna Geessien; Drumond, Betania Paiva] Univ Fed Minas Gerais, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Alves, Pedro Augusto; Goncalves, Andreza Parreiras; Campi-Azevedo, Ana Carolina; de Oliveira, Jaquelline Germano; Calzavara, Carlos Eduardo; Martins-Filho, Olindo Assis; Teixeira-Carvalho, Andrea] Fundacao Oswaldo Cruz, Inst Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil.
   [Pereira, Leonardo Soares; Dutra, Maria Rita Teixeira] Fundacao Hosp Estado Minas Gerais, Hosp Eduardo de Menezes, BR-30622020 Belo Horizonte, MG, Brazil.
   [Valim, Valeria] Univ Fed Espirito Santo, Empresa Brasileira Serv Hosp, Hosp Univ Cassiano Antonio Moraes, BR-29075910 Vitoria, ES, Brazil.
   [Tourinho, Renata] Fundacao Oswaldo Cruz, Biomanguinhos, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Said, Rodrigo Fabiano do Carmo] Secretaria Estado Saude Minas Gerais, BR-31630900 Belo Horizonte, MG, Brazil.
   [Said, Rodrigo Fabiano do Carmo] Secretaria Vigilancia Saude, Minist Saude, Dept Vigilancia Doencas Transmissiveis, BR-70058900 Brasilia, DF, Brazil.
RP Drumond, BP (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
EM izabelamauriciorezende@gmail.com; pedroaugustoalves@yahoo.com.br;
   matheusmtsa@hotmail.com; andreza.parreiras@hotmail.com;
   gabrielafernandag@gmail.com; leosoaresgallo@yahoo.com.br;
   mariaritatdutra@gmail.com; campiazevedo@gmail.com; val.valim@gmail.com;
   renata.tourinho@bio.fiocruz.br; jaquelline.oliveira@fiocruz.br;
   calzavara@gmail.com; rodrigo.said@saude.gov.br; ernagkroon@gmail.com;
   oamfilho@gmail.com; atcteixeira@gmail.com; betaniadrumond@gmail.com
RI Rezende, Izabela Mauricio/AAL-5766-2020; Alves, Pedro/T-7203-2019;
   Kroon, Erna/B-3631-2015
OI Rezende, Izabela Mauricio/0000-0003-2616-6300; Alves,
   Pedro/0000-0002-9659-5621; Pereira, Leonardo/0000-0002-5426-0655;
   OLIVEIRA, JAQUELLINE/0000-0002-0487-8748; Kroon,
   Erna/0000-0003-2721-3826; Martins-Filho, Olindo
   Assis/0000-0002-5494-4889
FU Fundacao Oswaldo Cruz/Secretaria de Saude de Minas Gerais/Secretaria de
   Planejamento de Minas Gerais/Fundacao de Amparo a Pesquisa do Estado de
   Minas Gerais (FIOCRUZ/SES-MG/SPLAG-MG/FAPEMIG)
   [Fiocruz-VPPIS-004-FIO-18]; National Council for Scientific and
   Technological Development (CNPq)National Council for Scientific and
   Technological Development (CNPq) [440911/2016-8]; Department for Science
   and Technology/Brazilian Ministry of Health (DECIT/MS);  [APQ-01989-18];
    [APQ-04178-17]
FX Financial support was provided by Fundacao Oswaldo Cruz
   (Fiocruz-VPPIS-004-FIO-18), Fundacao Oswaldo Cruz/Secretaria de Saude de
   Minas Gerais/Secretaria de Planejamento de Minas Gerais/Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais
   (FIOCRUZ/SES-MG/SPLAG-MG/FAPEMIG) (grant yellow fever); National Council
   for Scientific and Technological Development (CNPq) (440911/2016-8,
   research fellowship); Department for Science and Technology/Brazilian
   Ministry of Health (DECIT/MS), FAPEMIG (APQ-01989-18, APQ-04178-17).
   E.G.K, O.A.M.-F., A.T.C, and B.P.D. are CNPq researcher fellowships.
CR [Anonymous], 2010, NEW YORK TIMES  1007, VZ, P1, DOI DOI 10.1109/IEEESTD.2010.5514475
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Caldas IR, 2014, VACCINE, V32, P4977, DOI 10.1016/j.vaccine.2014.07.021
   Campi-Azevedo AC, 2016, HUM VACC IMMUNOTHER, V12, P491, DOI 10.1080/21645515.2015.1082693
   Costa-Pereira C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006462
   Vasconcelos PFD, 2010, REV SAUDE PUBL, V44, P1144, DOI 10.1590/S0034-89102010005000046
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Fischer C, 2017, EMERG INFECT DIS, V23, P1867, DOI 10.3201/eid2311.171131
   Holford NC, 2008, ANN NY ACAD SCI, V1137, P108, DOI 10.1196/annals.1448.006
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Ministerio da Saude (BR), 2014, MAN VIG EP EV ADV PO
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Monath TP, 2005, EXPERT REV VACCINES, V4, P553, DOI 10.1586/14760584.4.4.553
   Patel P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-58
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   Porudominsky R, 2018, REV PANAM SALUD PUBL, V42, DOI [10.26633/RPSP.2018.75, 10.26633/rpsp.2018.75]
   Rambaut A., 2015, TREEANNOTATOR
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Soper F.L., 1942, PAN AM J PUBLIC HLTH, P1207
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   Vincent AT, 2017, J MICROBIOL METH, V138, P60, DOI 10.1016/j.mimet.2016.02.016
   WHO, 2013, WEEKL EP REC VACC VA
   World Health Organization, 2008, DET INV SER ADV EV F
   World Health Organization (WHO), 2017, EL YELL FEV EP 2026
NR 29
TC 1
Z9 1
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-393X
J9 VACCINES-BASEL
JI Vaccines
PD DEC
PY 2019
VL 7
IS 4
AR 206
DI 10.3390/vaccines7040206
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA KA3PC
UT WOS:000505709700001
PM 31817103
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Costa, GB
   Marinho, PES
   Vilela, APP
   Saraiva-Silva, AT
   Crispim, APC
   Borges, IA
   Dutra, AGS
   Lobato, ZIP
   dos Reis, JKP
   de Oliveira, DB
   Drumond, BP
   Kroon, EG
   Trindade, GD
AF Costa, Galileu Barbosa
   Silva Marinho, Paula Eillany
   Pessoa Vilela, Ana Paula
   Saraiva-Silva, Ana Teresa
   Correia Crispim, Ana Paula
   Borges, Iara Apolinario
   Stoffella Dutra, Ana Gabriella
   Portela Lobato, Zelia Ines
   Pimenta dos Reis, Jenner Karlison
   de Oliveira, Danilo Bretas
   Drumond, Betania Paiva
   Kroon, Erna Geessien
   Trindade, Giliane de Souza
TI Silent Circulation of the Saint Louis Encephalitis Virus among Humans
   and Equids, Southeast Brazil
SO VIRUSES-BASEL
LA English
DT Article
DE Saint Louis encephalitis virus; seroprevalence; epidemiology;
   asymptomatic cases; public health burden
ID INFECTION; ARBOVIRUSES; STRAINS
AB Saint Louis encephalitis virus (SLEV) is a mosquito-borne flavivirus that occurs throughout the Americas, and is considered a public health threat. In Brazil, SLEV has been detected from human cases associated with dengue-like disease, but no neurological symptoms were reported. Furthermore, the epidemiology of SLEV in human populations is still poorly explored in the country. We reported serological and molecular detection of SLEV in a healthy population of equids and humans from rural areas in Southeast Brazil. A plaque reduction neutralization test was applied, and neutralizing antibodies were detected in 11 individuals (4.6%) and 60 horses (21.5%). A qPCR targeting the 5'UTR region and reverse transcription-PCR (RT-PCR) targeting the non-structural protein (NS5) gene were performed and three individuals tested positive in both assays. Subsequent phylogenetic analysis confirmed SLEV circulation and its findings suggest the occurrence of an asymptomatic or subclinical presence in human and animal cases, correlating with the risks for outbreaks and consequently burden of SLEV infections to public health. Preventive strategies should include improved surveillance in regions with a high probability of SLEV occurrence, improvement in diagnostic methods, and evaluation of exposure/risk factors that can favor SLEV emergence.
C1 [Costa, Galileu Barbosa; Silva Marinho, Paula Eillany; Pessoa Vilela, Ana Paula; Saraiva-Silva, Ana Teresa; Correia Crispim, Ana Paula; Borges, Iara Apolinario; Stoffella Dutra, Ana Gabriella; Drumond, Betania Paiva; Kroon, Erna Geessien; Trindade, Giliane de Souza] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Ave Presidente Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Portela Lobato, Zelia Ines] Univ Fed Minas Gerais, Dept Med Vet Prevent, Lab Pesquisa Virol Anim, Escola Vet, BR-31270901 Belo Horizonte, MG, Brazil.
   [Pimenta dos Reis, Jenner Karlison] Univ Fed Minas Gerais, Dept Med Vet Prevent, Lab Retroviroses, Escola Vet, BR-31270901 Belo Horizonte, MG, Brazil.
   [de Oliveira, Danilo Bretas] Univ Fed Vales Jequitinhonha & Mucuri, Fac Med, BR-39100000 Diamantina, Brazil.
   [Costa, Galileu Barbosa] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.
RP Costa, GB; Trindade, GD (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Ave Presidente Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.; Costa, GB (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.
EM galileu@wustl.edu; ei_lanny@hotmail.com; pessoavilela58@gmail.com;
   anateresasaraivasilva@gmail.com; anapbio2@gmail.com;
   borges2805@gmail.com; anagstoffella@gmail.com; ziplobato@gmail.com;
   jennerkpr@gmail.com; danilobretas@yahoo.com.br;
   betaniadrumond@gmail.com; ernagkroon@gmail.com; gitrindade@yahoo.com.br
RI Reis, Jenner/AAJ-9164-2020; Kroon, Erna/B-3631-2015
OI Reis, Jenner/0000-0003-0395-358X; Pessoa Vilela, Ana
   Paula/0000-0001-9030-0688; Barbosa Costa, Galileu/0000-0001-7360-6722;
   Kroon, Erna/0000-0003-2721-3826
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [440593/2016-6]; Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES)CAPES; Departamento de Ciencia e Tecnologia
   (DECIT); Secretaria de Ciencia, Tecnologia, Inovacao e Insumos
   Estrategicos em Saude (SCTIE); Ministerio da Saude; Fundacao de Amparo a
   Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas Gerais State Research
   Foundation (FAPEMIG); Pro-Reitoria de Pesquisa/UFMG (PRPq)
FX We thank colleagues from the Laboratorio de Virus (ICB-UFMG) for their
   excellent technical support. Financial support was provided by the
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
   grant number 440593/2016-6, Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES), Departamento de Ciencia e Tecnologia (DECIT),
   Secretaria de Ciencia, Tecnologia, Inovacao e Insumos Estrategicos em
   Saude (SCTIE), Ministerio da Saude, Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais (FAPEMIG), and Pro-Reitoria de Pesquisa/UFMG
   (PRPq). Z.I.P. Lobato, J. K. P. Reis, E.G. Kroon, B.P. Drumond and G.S.
   Trindade are researchers from CNPq.
CR Diaz LA, 2006, EMERG INFECT DIS, V12, P1752, DOI 10.3201/eid1211.060486
   Diaz LA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001489
   Terzian ACB, 2011, VECTOR-BORNE ZOONOT, V11, P291, DOI 10.1089/vbz.2009.0200
   Borges IA, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00402
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Centers for Disease Control and Prevention, SAINT LOUIS ENC
   Companhia de Tecnologia da InformacAo do Estado de Minas Gerais Brasil, CLIM VEG REL
   Costa GB, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0575-6
   Heinen LBD, 2015, REV INST MED TROP SP, V57, P215, DOI 10.1590/S0036-46652015000300006
   de Rezende IM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006538
   Diaz A, 2018, EMERG INFECT DIS, V24, P2150, DOI 10.3201/eid2412.180372
   Diaz LA, 2003, ENTOMOLVECT, V10, P551
   Rivarola ME, 2017, VIROLOGY, V505, P181, DOI 10.1016/j.virol.2017.02.023
   Instituto Estadual de Florestas (IEF), COB VEG MIN GER
   Johnson BW, 2009, CLIN VACCINE IMMUNOL, V16, P1052, DOI 10.1128/CVI.00095-09
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   MONATH TP, 1980, AM J TROP MED HYG, V29, P948, DOI 10.4269/ajtmh.1980.29.948
   Mondini A, 2007, J CLIN VIROL, V40, P84, DOI 10.1016/j.jcv.2007.06.007
   Mondini A, 2007, EMERG INFECT DIS, V13, P176, DOI 10.3201/eid1301.060905
   Figueiredo LTM, 2014, REV SOC BRAS MED TRO, V47, P541, DOI 10.1590/0037-8682-0197-2014
   Pauvolid-Correa A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002706
   Piersen TC, 2013, FIELDS VIROLOGY, P747
   Pupo M, 2006, EMERG INFECT DIS, V12, P1022, DOI 10.3201/eid1206.051235
   Reisen William K, 2003, Adv Virus Res, V61, P139, DOI 10.1016/S0065-3527(03)61004-3
   Romano-Lieber NS, 2000, REV SAUDE PUBL, V34, P236, DOI 10.1590/S0034-89102000000300005
   Rosa R, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002537
   Silva JR, 2014, REV SOC BRAS MED TRO, V47, P414, DOI 10.1590/0037-8682-0117-2014
   Spinsanti L, 2007, T ROY SOC TROP MED H, V101, P1248, DOI 10.1016/j.trstmh.2007.08.011
   SPINSANTI Lorena Ivana, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P59, DOI 10.1590/S0036-46652002000200001
   TAVARES-NETO J, 1986, Memorias do Instituto Oswaldo Cruz, V81, P351, DOI 10.1590/S0074-02761986000400001
   Vasconcelos P., 1998, OVERVIEW ARBOVIROLOG, P72
   VASCONCELOS PFD, 1991, REV INST MED TROP SP, V33, P465, DOI 10.1590/S0036-46651991000600007
NR 32
TC 2
Z9 2
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2019
VL 11
IS 11
AR 1029
DI 10.3390/v11111029
PG 10
WC Virology
SC Virology
GA JV3UX
UT WOS:000502292300057
PM 31694207
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Figueiredo, PD
   de Oliveira, DB
   Figueiredo, LB
   Costa, GB
   Alves, PA
   Guedes, MIMC
   Barbosa-Stancioli, EF
   Drumond, BP
   Abrahao, JS
   Kroon, EG
   Trindade, GD
AF Figueiredo, Poliana de Oliveira
   de Oliveira, Danilo Bretas
   Figueiredo, Leandra Barcelos
   Costa, Galileu Barbosa
   Alves, Pedro Augusto
   Maldonado Coelho Guedes, Maria Isabel
   Barbosa-Stancioli, Edel Figueiredo
   Drumond, Betania Paiva
   Abrahao, Jonatas Santos
   Kroon, Erna Geessien
   Trindade, Giliane de Souza
TI Molecular detection and phylogeny of bovine viral diarrhea virus 1 among
   cattle herds from Northeast, Southeast, and Midwest regions, Brazil
SO BRAZILIAN JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE BVDV; 5' UTR; Brazilian cattle; Economic burden; Veterinary pathogen
ID GENETIC DIVERSITY; BEEF-CATTLE; HOBI-LIKE; BVDV; INFECTION; PESTIVIRUS;
   PATHOGENESIS; PREVALENCE; FREQUENCY
AB We examined the circulating BVDV species and genotypes among cattle herds from Northeast, Southeast, and Midwest regions in Brazil. A total of 77 animals tested positive through standard PCR. Phylogenetic analyses revealed the presence of BVDV-1a, highlighting the need for better surveillance strategies to prevent BVDV spread in the country.
C1 [Figueiredo, Poliana de Oliveira; de Oliveira, Danilo Bretas; Figueiredo, Leandra Barcelos; Costa, Galileu Barbosa; Alves, Pedro Augusto; Drumond, Betania Paiva; Abrahao, Jonatas Santos; Kroon, Erna Geessien; Trindade, Giliane de Souza] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
   [de Oliveira, Danilo Bretas] Univ Fed Vales Jequitinhonha & Mucuri, Fac Med, Diamantina, MG, Brazil.
   [Alves, Pedro Augusto] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Imunol Doencas Virais, Belo Horizonte, MG, Brazil.
   [Maldonado Coelho Guedes, Maria Isabel] Univ Fed Minas Gerais, Escola Vet, Dept Med Vet Prevent, Lab Pesquisa Virol Anim, Belo Horizonte, MG, Brazil.
   [Barbosa-Stancioli, Edel Figueiredo] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virol Basica & Aplicada, Belo Horizonte, MG, Brazil.
RP Figueiredo, PD; Trindade, GD (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
EM polianaofigueiredo@yahoo.com.br; gitrindade@yahoo.com.br
RI Barbosa-Stancioli, Edel F/J-7230-2012; Alves, Pedro/T-7203-2019; Kroon,
   Erna/V-5444-2019
OI Barbosa-Stancioli, Edel F/0000-0001-6584-4333; Alves,
   Pedro/0000-0002-9659-5621; Barbosa Costa, Galileu/0000-0001-7360-6722
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG)
FX This work has received financial support from Brazilian agencies CAPES,
   CNPq, and FAPEMIG.
CR Alves PA, 2016, COMP IMMUNOL MICROB, V49, P70, DOI 10.1016/j.cimid.2016.09.005
   Bachofen C, 2008, VET MICROBIOL, V131, P93, DOI 10.1016/j.vetmic.2008.02.023
   Bachofen C, 2013, J VIROL METHODS, V190, P1, DOI 10.1016/j.jviromet.2013.03.015
   Bianchi E, 2011, PESQUI VET BRASIL, V31, P649, DOI 10.1590/S0100-736X2011000800003
   Brodersen BW, 2014, VET PATHOL, V51, P453, DOI 10.1177/0300985813520250
   Chaves N.P., 2012, Arq. Inst. Biol., V79, P495
   Cortez A, 2006, PESQUI VET BRASIL, V26, P211, DOI 10.1590/S0100-736X2006000400005
   de Brito WMED, 2004, GOIAS REV PATOL TROP, V33, P45
   Matos ACD, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10030120
   Fernandes LG, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1412-5
   Flores E.F., 2003, BIOLOGICO SAO PAULO, V65, P3
   Fulton RW, 2003, VACCINE, V21, P2980, DOI 10.1016/S0264-410X(03)00118-X
   Giammarioli M, 2015, VIRUS GENES, V50, P147, DOI 10.1007/s11262-014-1132-2
   Guarino H, 2008, PREV VET MED, V85, P34, DOI 10.1016/j.prevetmed.2007.12.012
   Hassig M, 2015, SCHWEIZ ARCH TIERH, V157, P441, DOI 10.17236/sat00029
   Headley SA, 2018, J VET DIAGN INVEST, V30, P249, DOI 10.1177/1040638717739945
   Houe H, 1999, VET MICROBIOL, V64, P89, DOI 10.1016/S0378-1135(98)00262-4
   Jackova A, 2008, VET RES COMMUN, V32, P7, DOI 10.1007/s11259-007-9012-z
   Jones LR, 2001, VET MICROBIOL, V81, P367, DOI 10.1016/S0378-1135(01)00367-4
   Laguardia-Nascimento M, 2017, ARCH VIROL, V162, P2797, DOI 10.1007/s00705-017-3407-0
   Laguardia-Nascimento M, 2016, J VET DIAGN INVEST, V28, P377, DOI 10.1177/1040638716645836
   Lanyon SR, 2014, VET J, V199, P201, DOI 10.1016/j.tvjl.2013.07.024
   Luzzago C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/147145
   Maya L, 2016, ARCH VIROL, V161, P529, DOI 10.1007/s00705-015-2688-4
   Moennig V, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7010029
   Nagai M, 2008, VIRUS GENES, V36, P135, DOI 10.1007/s11262-007-0190-0
   Otonel RAA, 2014, TROP ANIM HEALTH PRO, V46, P87, DOI 10.1007/s11250-013-0451-y
   Pinior B, 2017, PREV VET MED, V137, P77, DOI 10.1016/j.prevetmed.2016.12.014
   Ribeiro MB, 1987, B EPABA, V11
   Richter V, 2017, VET J, V220, P80, DOI 10.1016/j.tvjl.2017.01.005
   Richtzenhain L. J., 1999, Arquivos do Instituto Biologico (Sao Paulo), V66, P107
   Ridpath JF, 1998, MOL CELL PROBE, V12, P101, DOI 10.1006/mcpr.1998.0158
   Ridpath JF, 2010, VET CLIN N AM-FOOD A, V26, P105, DOI 10.1016/j.cvfa.2009.10.007
   SAMARA S. I., 2004, BRAZ J VET RES ANIM, V41, P396, DOI DOI 10.1590/S1413-
   Silveira S, 2018, TRANSBOUND EMERG DIS, V65, pe113, DOI 10.1111/tbed.12689
   Silveira S, 2017, TRANSBOUND EMERG DIS, V64, P613, DOI 10.1111/tbed.12427
   Stahl K, 2007, VET RES, V38, P517, DOI 10.1051/vetres:2007012
   Tago D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157450
   Talafha AQ, 2009, TROP ANIM HEALTH PRO, V41, P499, DOI 10.1007/s11250-008-9214-6
   VanderWaal K, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170808
   vanRijn PA, 1997, VIROLOGY, V237, P337, DOI 10.1006/viro.1997.8792
   Weber MN, 2014, VIRUS RES, V191, P117, DOI 10.1016/j.virusres.2014.07.035
   Yesilbag K, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060128
   2008, VET REC, V162, P211, DOI DOI 10.1136/VR.162.7.211
   2009, VIROLOGY, V385, P351, DOI DOI 10.1016/J.VIROL.2008.12.004
NR 45
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1517-8382
EI 1678-4405
J9 BRAZ J MICROBIOL
JI Braz. J. Microbiol.
PD APR
PY 2019
VL 50
IS 2
BP 571
EP 577
DI 10.1007/s42770-019-00064-8
PG 7
WC Microbiology
SC Microbiology
GA HW9TN
UT WOS:000467033700029
PM 30879262
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Andrade, ACDP
   Boratto, PVD
   Rodrigues, RAL
   Bastos, TM
   Azevedo, BL
   Dornas, FP
   Oliveira, DB
   Drumond, BP
   Kroon, EG
   Abrahao, JS
AF dos Santos Pereira Andrade, Ana Claudia
   de Miranda Boratto, Paulo Victor
   Lima Rodrigues, Rodrigo Araujo
   Bastos, Talita Machado
   Azevedo, Bruna Luiza
   Dornas, Fabio Pio
   Oliveira, Danilo Bretas
   Drumond, Betania Paiva
   Kroon, Erna Geessien
   Abrahao, Jonatas Santos
TI New Isolates of Pandoraviruses: Contribution to the Study of Replication
   Cycle Steps
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE pandoravirus; giant virus; replication cycle; viral morphogenesis; viral
   release; virus diversity
ID GIANT VIRUSES; DNA VIRUSES; ENDOCYTOBIONT; ACANTHAMOEBA; AMEBAS; ORIGIN
AB Giant viruses are complex members of the virosphere, exhibiting outstanding structural and genomic features. Among these viruses, the pandoraviruses are some of the most intriguing members, exhibiting giant particles and genomes presenting at up to 2.5 Mb, with many genes having no known function. In this work, we analyzed, by virological and microscopic methods, the replication cycle steps of three new pandoravirus isolates from samples collected in different regions of Brazil. Our data indicate that all analyzed pandoravirus isolates can deeply modify the Acanthamoeba cytoplasmic environment, recruiting mitochondria and membranes into and around the electron-lucent viral factories. We also observed that the viral factories start forming before the complete degradation of the cellular nucleus. Various patterns of pandoravirus particle morphogenesis were observed, and the assembly of the particles seemed to be started either by the apex or by the opposite side. On the basis of the counting of viral particles during the infection time course, we observed that pandoravirus particles could undergo exocytosis after their morphogenesis in a process that involved intense recruitment of membranes that wrapped the just-formed particles. The treatment of infected cells with brefeldin affected particle exocytosis in two of the three analyzed strains, indicating biological variability among isolates. Despite such particle exocytosis, the lysis of host cells also contributed to viral release. This work reinforces knowledge of and reveals important steps in the replication cycle of pandoraviruses.
   IMPORTANCE The emerging Pandoraviridae family is composed of some of the most complex viruses known to date. Only a few pandoravirus isolates have been described until now, and many aspects of their life cycle remain to be elucidated. A comprehensive description of the replication cycle is pivotal to a better understanding of the biology of the virus. For this report, we describe new pandoraviruses and used different methods to better characterize the steps of the replication cycle of this new group of viruses. Our results provide new information about the diversity and biology of these giant viruses.
C1 [dos Santos Pereira Andrade, Ana Claudia; de Miranda Boratto, Paulo Victor; Lima Rodrigues, Rodrigo Araujo; Bastos, Talita Machado; Azevedo, Bruna Luiza; Drumond, Betania Paiva; Kroon, Erna Geessien; Abrahao, Jonatas Santos] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Dornas, Fabio Pio; Oliveira, Danilo Bretas] Univ Fed Vales Jequitinhonha & Mucuri, Diamantina, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Kroon, Erna/V-5444-2019; Dornas, Fabio/AAI-3582-2020
OI Dornas, Fabio/0000-0001-7926-5551; de Azevedo, Bruna
   Luiza/0000-0003-2348-9649; Araujo Lima Rodrigues,
   Rodrigo/0000-0001-7148-4012
CR Abergel C, 2015, FEMS MICROBIOL REV, V39, P779, DOI 10.1093/femsre/fuv037
   Abrahao J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03168-1
   Aherfi S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01486
   Aherfi S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00349
   Andrade ACDP, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0930-x
   Andreani J, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8110300
   Antwerpen MH, 2015, MICROBIOL RESOUR ANN, V3, DOI 10.1128/genomeA.00136-15
   Atoni E, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010030
   Bajrai LH, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8110278
   Boyer M, 2009, P NATL ACAD SCI USA, V106, P21848, DOI 10.1073/pnas.0911354106
   Brinkman NE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195350
   Dornas FP, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01086
   Andrade ACDP, 2017, J VIROL, V91, DOI 10.1128/JVI.01335-17
   Silva LKD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22398-3
   Filee J, 2010, INTERVIROLOGY, V53, P354, DOI 10.1159/000312920
   Hingamp P, 2013, ISME J, V7, P1678, DOI 10.1038/ismej.2013.59
   Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009
   Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001
   Kerepesi C, 2017, ARCH VIROL, V162, P1671, DOI 10.1007/s00705-017-3286-4
   KORN ED, 1967, J CELL BIOL, V34, P219, DOI 10.1083/jcb.34.1.219
   La Scola B, 2003, SCIENCE, V299, P2033
   Legendre M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04698-4
   Legendre M, 2015, P NATL ACAD SCI USA, V112, pE5327, DOI 10.1073/pnas.1510795112
   Legendre M, 2014, P NATL ACAD SCI USA, V111, P4274, DOI 10.1073/pnas.1320670111
   Rodrigues RAL, 2018, J VIROL, V92, DOI 10.1128/JVI.00372-18
   Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164
   Mutsafi Y, 2010, P NATL ACAD SCI USA, V107, P5978, DOI 10.1073/pnas.0912737107
   Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058
   Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181
   Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Reteno DG, 2015, J VIROL, V89, P6585, DOI 10.1128/JVI.00115-15
   Scheid P, 2008, PARASITOL RES, V102, P945, DOI 10.1007/s00436-007-0858-3
   Scheid P, 2016, CURR OPIN MICROBIOL, V31, P58, DOI 10.1016/j.mib.2016.02.005
   Scheid P, 2014, PARASITOL RES, V113, P2407, DOI 10.1007/s00436-014-3932-7
   Schulz F, 2017, SCIENCE, V356, P82, DOI 10.1126/science.aal4657
   Suarez C, 2015, CELL MICROBIOL, V17, P1683, DOI 10.1111/cmi.12468
   Suarez C, 2013, CELL MICROBIOL, V15, P1883, DOI 10.1111/cmi.12156
   Temmam S, 2017, TRANSBOUND EMERG DIS, V64, P1159, DOI 10.1111/tbed.12481
   Temmam S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139810
   Verneau J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00428
   Yutin N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-223
NR 42
TC 6
Z9 6
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD MAR
PY 2019
VL 93
IS 5
AR e01942-18
DI 10.1128/JVI.01942-18
PG 12
WC Virology
SC Virology
GA HL8VZ
UT WOS:000459022000028
PM 30541841
OA Green Published, Bronze
DA 2020-12-09
ER

PT J
AU Cardoso, FD
   de Rezende, IM
   Barros, ELT
   Sacchetto, L
   Garces, TCDS
   Silva, NIO
   Alves, PA
   Soares, JO
   Kroon, EG
   Pereira, ACTD
   Drumond, BP
   Ferreira, GP
AF Cardoso, Felipe Daniel
   de Rezende, Izabela Mauricio
   Teixeira Barros, Emanuela Lima
   Sacchetto, Livia
   de Carvalho Souza Garces, Tereza Cristina
   Oliveira Silva, Natalia Ingrid
   Alves, Pedro Augusto
   Soares, Jefferson Oliveira
   Kroon, Erna Geessien
   Toledo da Cunha Pereira, Anna Carolina
   Drumond, Betania Paiva
   Ferreira, Gustavo Portela
TI Circulation of Chikungunya virus East-Central-South Africa genotype
   during an outbreak in 2016-17 in Piaui State, Northeast Brazil
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Article
DE Chikungunya virus; Brazil; ECSA genotype; Arbovirus; Togavirus;
   Alphavirus; Molecular surveillance; Epidemiology; E1 gene
ID REUNION ISLAND; INFECTION; SEROPREVALENCE
AB Chikungunya virus (CHIKV) is an arbovirus that emerged in the Americas in 2013. Infection with CHIKV is symptomatic in most of the cases and patients can develop chronic arthralgia that lasts from months to years in over 40% of the cases. The East-Central-South Africa (ECSA) genotype was introduced in Brazil in 2014. in Bahia State. Here we report the circulation of the CHIKV ECSA genotype in Piaui State. Northeast Brazil. during the years 2016-2017. The phylogenetic analysis revealed a single introduction of this lineage probably in 2015 and its maintenance at least until 2017. This analysis has also demonstrated the proximity of this genotype with isolates from neighboring Stales. and its partial nucleotide sequence of the viral E1 gene revealed a synapomorphy synonyms. This finding highlights the spread of the ECSA genotype in Brazil and supports its circulation in the Brazilian Northeast.
C1 [Cardoso, Felipe Daniel; Teixeira Barros, Emanuela Lima; de Carvalho Souza Garces, Tereza Cristina; Soares, Jefferson Oliveira; Toledo da Cunha Pereira, Anna Carolina; Ferreira, Gustavo Portela] Univ Fed Piaui, Campus Ministro Reis Velloso,Av Sao Sebastiao 281, BR-64202020 Parnaiba, Piaui, Brazil.
   [de Rezende, Izabela Mauricio; Sacchetto, Livia; Oliveira Silva, Natalia Ingrid; Kroon, Erna Geessien; Drumond, Betania Paiva] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Alves, Pedro Augusto] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
RP Ferreira, GP (corresponding author), Univ Fed Piaui, Campus Ministro Reis Velloso,Av Sao Sebastiao 281, BR-64202020 Parnaiba, Piaui, Brazil.
EM gtvpf@ufpi.edu.br
RI Rezende, Izabela Mauricio/AAL-5766-2020; Silva, Natalia/AAL-6048-2020;
   Sacchetto, Livia/B-8841-2019; Alves, Pedro/T-7203-2019; Kroon,
   Erna/B-3631-2015; S Oliveira, Jefferson/G-2729-2015
OI Rezende, Izabela Mauricio/0000-0003-2616-6300; Silva,
   Natalia/0000-0003-3449-8313; Sacchetto, Livia/0000-0001-9716-6899;
   Alves, Pedro/0000-0002-9659-5621; Kroon, Erna/0000-0003-2721-3826;
   Barros, Emanuela Lima Teixeira/0000-0003-2048-4922; Cardoso, Felipe
   Daniel/0000-0001-8700-524X; S Oliveira, Jefferson/0000-0003-4192-8238
FU Piaui Research Foundation - FAPEPI; Prefeitura Municipal de Parnaiba;
   Brazilian National Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq) [456707/2014-0];
   Coordination for the Improvement of Higher Education Personnel
   CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX This study was supported by grants from Piaui Research Foundation -
   FAPEPI, Prefeitura Municipal de Parnaiba and from Brazilian National
   Research Council (CNPq) 456707/2014-0. ELTB, TCCSG, IMR and LS. were
   supported by graduate fellowships from the Coordination for the
   Improvement of Higher Education Personnel CAPES. NIOS was supported by a
   graduate fellowship from CNPq. EGK and BPD are fellows of CNPq. The
   funding agencies had no role in data collection, data analysis, data
   interpretation, and writing of this manuscript.
CR Ayu SM, 2010, AM J TROP MED HYG, V83, P1245, DOI 10.4269/ajtmh.2010.10-0279
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   BEAST Developers, TRACER
   BEAST Developers, TREEANNOTATOR
   Brasil Ministerio da Saude, 2017, B EPIDEMIOL, V48, P1, DOI DOI 10.5588/IJTLD.11.0170
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2018, B EPIDEMIOLOGICO, V49, P1
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2017, B EPIDEMIOL, V47, P1
   Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630
   Crosby L, 2016, INT J INFECT DIS, V48, P78, DOI 10.1016/j.ijid.2016.05.010
   Cunha MS, 2017, EMERG INFECT DIS, V23, P1737, DOI 10.3201/eid2310.161855
   Cunha MD, 2017, J CLIN VIROL, V97, P44, DOI 10.1016/j.jcv.2017.10.015
   da Costa AC, 2017, EMERG INFECT DIS, V23, P1742, DOI 10.3201/eid2310.170307
   Tanabe ELD, 2018, REV INST MED TROP SP, V60, DOI [10.1590/s1678-9946201860019, 10.1590/S1678-9946201860019]
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Feldstein LR, 2017, EMERG INFECT DIS, V23, P673, DOI 10.3201/eid2304.161562
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kumar CVMN, 2007, INDIAN J MED RES, V126, P534
   Lemant J, 2008, CRIT CARE MED, V36, P2536, DOI 10.1097/CCM.0b013e318183f2d2
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Machado LC, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007332
   Mehta R, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1978
   Ministerio da Saude (BR), 2016, B EPIDEMIOL, V47, P1
   Nakkhara P, 2013, T ROY SOC TROP MED H, V107, P789, DOI 10.1093/trstmh/trt083
   Paixao ES, 2018, T ROY SOC TROP MED H, V112, P301, DOI 10.1093/trstmh/try063
   Porter Kevin R., 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P408
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083
   Queyriaux B, 2008, LANCET INFECT DIS, V8, P2, DOI 10.1016/S1473-3099(07)70294-3
   Rambaut A, FIGTREE
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333
   Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066
   Souza TML, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39406-9
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Tang BL, 2012, CELL MICROBIOL, V14, P1354, DOI 10.1111/j.1462-5822.2012.01825.x
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
NR 42
TC 1
Z9 1
U1 0
U2 2
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PY 2019
VL 61
AR e57
DI 10.1590/S1678-9946201961057
PG 9
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JC9QN
UT WOS:000489611000005
PM 31618377
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Figueiredo, PO
   Silva, ATS
   Oliveira, JS
   Marinho, PE
   Rocha, FT
   Domingos, GP
   Poblete, PCP
   Oliveira, LBS
   Duarte, DC
   Bonjardim, CA
   Abrahao, JS
   Kroon, EG
   Drumond, BP
   Oliveira, DB
   Trindade, GS
AF Figueiredo, P. O.
   Silva, A. T. S.
   Oliveira, J. S.
   Marinho, P. E.
   Rocha, F. T.
   Domingos, G. P.
   Poblete, P. C. P.
   Oliveira, L. B. S.
   Duarte, D. C.
   Bonjardim, C. A.
   Abrahao, J. S.
   Kroon, E. G.
   Drumond, B. P.
   Oliveira, D. B.
   Trindade, G. S.
TI Detection and Molecular Characterization of Yellow Fever Virus, 2017,
   Brazil
SO ECOHEALTH
LA English
DT Article
DE Yellow fever virus; Non-human primates; Emerging infectious diseases;
   Zoonotic virus; Arboviruses; Outbreak
ID NONHUMAN-PRIMATES; OUTBREAK; STATE; RNA
AB At the end of 2016, Brazil experienced an unprecedented yellow fever (YF) outbreak. Clinical, molecular and ecological aspects of human and non-human primate (NHP) samples collected at the beginning of the outbreak are described in this study. Spatial distribution analyses demonstrated a strong overlap between human and NHP cases. Through molecular analyses, we showed that the outbreak had a sylvatic origin, caused by the South American genotype 1 YFV, which has already been shown to circulate in Brazil. As expected, the clusters of cases were identified in regions with a low vaccination coverage. Our findings highlight the importance of the synchronization of animal surveillance and health services to identify emerging YF cases, thereby promoting a better response to the vulnerable population.
C1 [Figueiredo, P. O.; Silva, A. T. S.; Oliveira, J. S.; Marinho, P. E.; Bonjardim, C. A.; Abrahao, J. S.; Kroon, E. G.; Drumond, B. P.; Trindade, G. S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Av Antonio Carlos 6627,Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
   [Rocha, F. T.; Domingos, G. P.; Oliveira, D. B.] Univ Fed Vales Jequitinhonha & Mucuri, Fac Med, Ctr Integrado Pesquisa Saude, Campus JK,Rodovia MGT 367,KM 583,5000, BR-39100000 Diamantina, MG, Brazil.
   [Poblete, P. C. P.; Duarte, D. C.] Zoovet Consultoria LTDA, Ave Amazonas 2474, BR-30180001 Belo Horizonte, MG, Brazil.
   [Oliveira, L. B. S.] Pontificia Univ Catolica Minas Gerais, Rua Dom Jose Gaspar,702, BR-30535000 Belo Horizonte, MG, Brazil.
RP Figueiredo, PO (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Av Antonio Carlos 6627,Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM polianaofigueiredo@yahoo.com.br
RI Kroon, Erna/V-5444-2019
FU Brazilian agency CAPESCAPES; Brazilian agency CNPqNational Council for
   Scientific and Technological Development (CNPq); MCTIC/FNDCT-CNPq/
   MEC-CAPES/ MS-Decit [14/2016]
FX We are thankful to Zoovet Clinica e Consultoria LTDA and Bicho do Mato
   Meio Ambiente, which provided NHP samples from Conceicao do Mato Dentro,
   Minas Gerais, Brazil. We thank Galileu Barbosa Costa for the critical
   review of this work and Grant M. Williams for English review. We also
   thank colleagues from the Laboratorio de Virus (ICB-UFMG) for their
   excellent technical support. This work has received financial support
   from Brazilian agencies CAPES and CNPq in accordance with the
   MCTIC/FNDCT-CNPq/ MEC-CAPES/ MS-Decit/ No 14/2016 - Prevencao e Combate
   ao virus Zika.
CR [Anonymous], 2017, MIN SAUD AN FIM SURT
   [Anonymous], 2017, COBERTURA VACINAL FE
   [Anonymous], 2005, MAN VIG EP EM PRIM N
   [Anonymous], 2017, AT INV CAS SUSP FEBR
   Barbosa CM, 2018, EMERG INFECT DIS, V24, P176, DOI 10.3201/eid2401.171310
   de Almeida MAB, 2012, AM J PRIMATOL, V74, P68, DOI 10.1002/ajp.21010
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Carrington CVF, 2013, INFECT GENET EVOL, V13, P198, DOI 10.1016/j.meegid.2012.08.015
   Costa ZGA, 2011, REV PAN AMAZ SAUDE, V2, P11, DOI DOI 10.5123/S2176-62232011000100002
   Fernandes NCCD, 2017, EMERG INFECT DIS, V23, P2038, DOI 10.3201/eid2312.170685
   Dierssen U, 2008, J CLIN VIROL, V42, P58, DOI 10.1016/j.jcv.2007.11.016
   Engelmann F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003295
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Jorge TR, 2017, ACTA TROP, V166, P114, DOI 10.1016/j.actatropica.2016.09.030
   Kuno G, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070185
   Leal SG, 2016, REV SOC BRAS MED TRO, V49, P29, DOI 10.1590/0037-8682-0363-2015
   Leo YS, 2009, EMERG INFECT DIS, V15, P836, DOI 10.3201/eid1505.081390
   Ministerio da Saude, 2017, INF ESP FEBR AM BRAS
   Mir D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07873-7
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026
   Moreno ES, 2013, REV INST MED TROP SP, V55, P45, DOI 10.1590/S0036-46652013000100008
   Patel P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-58
   Pessanha JEM, 2009, YELLOW FEVER VISION, V19
   Plowright RK, 2017, NAT REV MICROBIOL, V15, P502, DOI 10.1038/nrmicro.2017.45
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   [WHO World Health Organization], 2017, YELL FEV VACC REC AM
   World Health Organization, 2008, DET INV SER ADV EV F
NR 32
TC 5
Z9 5
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1612-9202
EI 1612-9210
J9 ECOHEALTH
JI EcoHealth
PD DEC
PY 2018
VL 15
IS 4
BP 864
EP 870
DI 10.1007/s10393-018-1364-z
PG 7
WC Biodiversity Conservation; Ecology; Environmental Sciences
SC Biodiversity & Conservation; Environmental Sciences & Ecology
GA HC1VP
UT WOS:000451591600016
PM 30117000
DA 2020-12-09
ER

PT J
AU Costa, GB
   de Almeida, LR
   Cerqueira, AGR
   Mesquita, WU
   de Oliveira, JS
   Miranda, JB
   Saraiva-Silva, AT
   Abrahao, JS
   Drumond, BP
   Kroon, EG
   Pereira, PLL
   Soares, DFD
   Trindade, GD
AF Costa, Galileu Barbosa
   de Almeida, Lara Ribeiro
   Ribeiro Cerqueira, Aline Gabriele
   Mesquita, Wander Ulisses
   de Oliveira, Jaqueline Silva
   Miranda, Julia Bahia
   Saraiva-Silva, Ana Teresa
   Abrahao, Jonatas Santos
   Drumond, Betania Paiva
   Kroon, Erna Geessien
   Lithg Pereira, Pedro Lucio
   de Magalhaes Soares, Danielle Ferreira
   Trindade, Giliane de Souza
TI Vaccinia Virus among Domestic Dogs and Wild Coatis, Brazil, 2013-2015
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID MOLECULAR EVIDENCE; INFECTION; HUMANS; CATTLE; PAULO
AB To determine their potential role as a source of human infection, we tested domestic dogs (urban) and wild coatis (wild) in Brazil for vaccinia virus. Our findings of positive neutralizing antibodies and quantitative PCR results for 35/184 dogs and 13/90 coatis highlight a potential public health risk.
C1 [Costa, Galileu Barbosa] Univ Fed Minas Gerais, Inst Ciencias Biol, Microbiol Dept, Lab Virus,Microbiol, Belo Horizonte, MG, Brazil.
   [de Almeida, Lara Ribeiro; Ribeiro Cerqueira, Aline Gabriele; de Oliveira, Jaqueline Silva; Miranda, Julia Bahia; Saraiva-Silva, Ana Teresa; Abrahao, Jonatas Santos; Drumond, Betania Paiva; Kroon, Erna Geessien; Lithg Pereira, Pedro Lucio; de Magalhaes Soares, Danielle Ferreira; Trindade, Giliane de Souza] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Mesquita, Wander Ulisses] Univ Fed Ouro Preto, Ouro Preto, Brazil.
RP Costa, GB; Trindade, GD (corresponding author), Univ Fed Minas Gerais, Microbiol, Ave Presidente Antonio Carlos 6627,Campus Pamulha, BR-3127090 Belo Horizonte, MG, Brazil.
EM galileuk1@gmail.com; giliane@icb.ufmg.br
RI Costa, Galileu Barbosa/M-5768-2019; Kroon, Erna/V-5444-2019
OI Barbosa Costa, Galileu/0000-0001-7360-6722
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Coordenacao
   de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Pro-Reitoria de
   Pesquisa/Universidade Federal de Minas Gerais; Fundacao de Amparo a
   Pesquisa do Estado de Minas GeraisMinas Gerais State Research Foundation
   (FAPEMIG)
FX Financial support was provided by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico, Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior, Fundacao de Amparo a Pesquisa do Estado de
   Minas Gerais, and Pro-Reitoria de Pesquisa/Universidade Federal de Minas
   Gerais. J.S.A., E.G.K., and G.S.T. are researchers from Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico.
CR A, DFD, V5, P43, DOI DOI 10.1002/CPMC.13
   Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Costa GB, 2017, EMERG INFECT DIS, V23, P360, DOI 10.3201/eid2302.161341
   de Oliveira JS, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110340
   Essbauer S, 2010, VET MICROBIOL, V140, P229, DOI 10.1016/j.vetmic.2009.08.026
   Gallardo-Romero NF, 2016, J WILDLIFE DIS, V52, P609, DOI 10.7589/2015-10-291
   Geessien Kroon E, 2016, CURR PROTOC MICROBIO, V42, DOI 10.1002/cpmc.13
   Dutra LAL, 2017, ARCH VIROL, V162, P439, DOI 10.1007/s00705-016-3121-3
   Miranda JB, 2017, EMERG INFECT DIS, V23, P931, DOI 10.3201/eid2306.161643
   Peres MG, 2016, EMERG INFECT DIS, V22, P271, DOI 10.3201/eid2202.140747
   Peres MG, 2013, ARCH VIROL, V158, P2433, DOI 10.1007/s00705-013-1740-5
   PERES MG, 2018, VIRUSES-BASEL, V10, DOI DOI 10.3390/V10020051
   Shchelkunov SN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003756
   Smith KC, 1999, J SMALL ANIM PRACT, V40, P495, DOI 10.1111/j.1748-5827.1999.tb03003.x
   von Bomhard W, 2011, VET DERMATOL, V22, P111, DOI 10.1111/j.1365-3164.2010.00923.x
NR 16
TC 3
Z9 3
U1 0
U2 0
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD DEC
PY 2018
VL 24
IS 12
BP 2338
EP 2342
DI 10.3201/eid2412.171584
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA HA9JM
UT WOS:000450617500025
PM 30457519
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Terzian, ACB
   Zini, N
   Sacchetto, L
   Rocha, RF
   Parra, MCP
   Del Sarto, JL
   Dias, ACF
   Coutinho, F
   Rayra, J
   da Silva, RA
   Costa, VV
   Fernandes, NCCDA
   Ressio, R
   Diaz-Delgado, J
   Guerra, J
   Cunha, MS
   Catao-Dias, JL
   Bittar, C
   Reis, AFN
   dos Santos, INP
   Ferreira, ACM
   Cruz, LEAA
   Rahal, P
   Ullmann, L
   Malossi, C
   de Araujo, JP
   Widen, S
   de Rezende, IM
   Mello, E
   Pacca, CC
   Kroon, EG
   Trindade, G
   Drumond, B
   Chiaravalloti-Neto, F
   Vasilakis, N
   Teixeira, MM
   Nogueira, ML
AF Terzian, Ana Carolina B.
   Zini, Nathalia
   Sacchetto, Livia
   Rocha, Rebeca Froes
   Pereira Parra, Maisa Carla
   Del Sarto, Juliana Lemos
   Fialho Dias, Ana Carolina
   Coutinho, Felipe
   Rayra, Jessica
   da Silva, Rafael Alves
   Costa, Vivian Vasconcelos
   Couto De Azevedo Fernandes, Natalia Coelho
   Ressio, Rodrigo
   Diaz-Delgado, Josue
   Guerra, Juliana
   Cunha, Mariana S.
   Catao-Dias, Jose Luiz
   Bittar, Cintia
   Negri Reis, Andreia Francesli
   Penha dos Santos, Izalco Nuremberg
   Marascalchi Ferreira, Andreia Cristina
   Arao Antonio Cruz, Lilian Elisa
   Rahal, Paula
   Ullmann, Leila
   Malossi, Camila
   de Araujo, Joao Pessoa, Jr.
   Widen, Steven
   de Rezende, Izabela Mauricio
   Mello, Erica
   Pacca, Carolina Colombelli
   Kroon, Erna Geessien
   Trindade, Giliane
   Drumond, Betania
   Chiaravalloti-Neto, Francisco
   Vasilakis, Nikos
   Teixeira, Mauro M.
   Nogueira, Mauricio Lacerda
TI Evidence of natural Zika virus infection in neotropical non-human
   primates in Brazil
SO SCIENTIFIC REPORTS
LA English
DT Article
ID YELLOW-FEVER; CALLITHRIX-JACCHUS; MODEL; IDENTIFICATION; TRANSMISSION;
   CHIKUNGUNYA; EMERGENCE; OUTBREAK; VIREMIA
AB In Africa, Old World Primates are involved in the maintenance of sylvatic circulation of ZIKV. However, in Brazil, the hosts for the sylvatic cycle remain unknown. We hypothesized that free-living NHPs might play a role in urban/periurban ZIKV dynamics, thus we undertook an NH P ZIKV investigation in two cities in Brazil. We identified ZIKV-positive NHPs and sequences obtained were phylogenetically related to the American lineage of ZIKV. Additionally, we inoculated four C. penicillata with ZIKV and our results demonstrated that marmosets had a sustained viremia. The natural and experimental infection of NHPs with ZIKV, support the hypothesis that NHPs may be a vertebrate host in the maintainance of ZIKV transmission/circulation in urban tropical settings. Further studies are needed to understand the role they may play in maintaining the urban cycle of the ZIKV and how they may be a conduit in establishing an enzootic transmission cycle in tropical Latin America.
C1 [Terzian, Ana Carolina B.; Zini, Nathalia; Pereira Parra, Maisa Carla; da Silva, Rafael Alves; Nogueira, Mauricio Lacerda] Sao Jose do Rio Preto Sch Med FAMERP, Ave Brigadeiro Faria Lima 5416, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
   [Sacchetto, Livia; de Rezende, Izabela Mauricio; Kroon, Erna Geessien; Trindade, Giliane; Drumond, Betania] Univ Fed Minas Gerais, Lab Virus, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Rocha, Rebeca Froes; Del Sarto, Juliana Lemos; Fialho Dias, Ana Carolina; Coutinho, Felipe; Rayra, Jessica; Costa, Vivian Vasconcelos; Teixeira, Mauro M.] Univ Fed Minas Gerais, Ctr Drug Res & Dev, Inst Ciencias Biol, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Couto De Azevedo Fernandes, Natalia Coelho; Ressio, Rodrigo; Diaz-Delgado, Josue; Guerra, Juliana; Cunha, Mariana S.] IAL, Ave Dr Arnaldo,351-7 Andar,Sala 706, BR-01246000 Sao Paulo, SP, Brazil.
   [Catao-Dias, Jose Luiz] Univ Sao Paulo, FMVZ, LAPOCM, Lab Wildlife Comparat Pathol,Dept Pathol,Sch Vet, Ave Orlando Marques de Paiva 87, BR-05508270 Sao Paulo, SP, Brazil.
   [Bittar, Cintia; Rahal, Paula] Sao Paulo State Univ, Inst Biosci Letters & Exact Sci, Dept Biol, Sao Jose Rio Preto IBILCE,UNESP, Rua Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Negri Reis, Andreia Francesli; Penha dos Santos, Izalco Nuremberg; Marascalchi Ferreira, Andreia Cristina; Arao Antonio Cruz, Lilian Elisa] Epidemiol Surveillance Dept Sao Jose Do Rio Preto, Ave Romeu Strazzi 199, BR-15084010 Sao Jose Do Rio Preto, SP, Brazil.
   [Ullmann, Leila; Malossi, Camila; de Araujo, Joao Pessoa, Jr.] Sao Paulo State Univ Unesp, Inst Biotechnol, Alameda Tecomarias S-N, BR-18607440 Botucatu, SP, Brazil.
   [Widen, Steven] Univ Texas Med Branch, Dept Biochem & Mol Biol, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Mello, Erica] Belo Horizonte Council, Ctr Controle Zoonoses, Rua Edna Quintel 173, BR-31270705 Belo Horizonte, MG, Brazil.
   [Pacca, Carolina Colombelli] Faceres Med Sch, Ave Anisio Haddad 6751, BR-15090305 Sao Jose Do Rio Preto, SP, Brazil.
   [Chiaravalloti-Neto, Francisco] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Ave Dr Arnaldo 715, BR-01246904 Sao Paulo, SP, Brazil.
   [Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Ctr Trop Dis, Inst Human Infect & Immun, 301 Univ Blvd, Galveston, TX 77555 USA.
RP Nogueira, ML (corresponding author), Sao Jose do Rio Preto Sch Med FAMERP, Ave Brigadeiro Faria Lima 5416, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
EM mnogueira@famerp.br
RI Bittar, Cintia/A-5042-2015; Sacchetto, Livia/B-8841-2019; CATAO-DIAS,
   JOSE LUIZ/C-4897-2012; Costa, Vivian VVC/I-2499-2018; Vasilakis,
   Nikos/ABE-7318-2020; Kroon, Erna/V-5444-2019; Fernandes,
   Natalia/H-4537-2012; Neto, Francisco Chiaravalloti/F-8006-2012; Rahal,
   Paula/D-3871-2012; Teixeira, Mauro M/A-4587-2008; Rezende, Izabela
   Mauricio/AAL-5766-2020; Guerra, Juliana Mariotti/H-5310-2012; Nogueira,
   Mauricio L/B-7599-2012
OI Bittar, Cintia/0000-0002-2048-4589; Sacchetto,
   Livia/0000-0001-9716-6899; CATAO-DIAS, JOSE LUIZ/0000-0003-2999-3395;
   Costa, Vivian VVC/0000-0002-0175-642X; Fernandes,
   Natalia/0000-0003-4754-4200; Neto, Francisco
   Chiaravalloti/0000-0003-2686-8740; Rahal, Paula/0000-0001-5693-6148;
   Teixeira, Mauro M/0000-0002-6944-3008; Rezende, Izabela
   Mauricio/0000-0003-2616-6300; Guerra, Juliana
   Mariotti/0000-0002-0326-7187; Nogueira, Mauricio L/0000-0003-1102-2419;
   Dantas Malossi, Camila/0000-0002-3841-2479; Reis,
   AlessanRSS/0000-0001-8486-7469
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2013/21719-3, 2016/15021-1, 2015/12295-0,
   2014/23159-8]; CNPqNational Council for Scientific and Technological
   Development (CNPq) [440593/2016-6]; INCT-Dengue; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES/Finance)
   [001]; NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [1U01AI115577]; NATIONAL INSTITUTE OF
   ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [U01AI115577,
   U01AI115577, U01AI115577, U01AI115577] Funding Source: NIH RePORTER
FX We thank colleagues from Laboratorio de Virus and the team from
   Laboratorio de Zoonoses/Prefeitura de Belo Horizonte/MG. We thank Dr.
   Scott Weaver for critical reviewing of the manuscript. This work is
   supported by the Sao Paulo Research Foundation (FAPESP) via grants
   2013/21719-3 and 2016/15021-1 (MLN) and fellowships 2015/12295-0 (ACBT)
   and 2014/23159-8 (LSU). Additional support was provided by the FAPESP
   Zika Network, FAPEMIG (APQ01574-17), and CNPq (440593/2016-6) and
   INCT-Dengue. IMR and LS received fellowships from Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES/Finance Code
   001). MLN and GST are CNPq Research Fellows. NV Zika work is supported
   by NIH grant 1U01AI115577 (NV).
CR Andrade EHP, 2016, AM J TROP MED HYG, V94, P1080, DOI 10.4269/ajtmh.15-0892
   [Anonymous], 2018, JORNAL BRASIL DESINF
   Ausubel F.M., 2003, CURRENT PROTOCOLS MO
   Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   Baylis SA, 2017, TRANSFUSION, V57, P748, DOI 10.1111/trf.14026
   Terzian ACB, 2011, VECTOR-BORNE ZOONOT, V11, P291, DOI 10.1089/vbz.2009.0200
   BrazilGovNews, 2017, BRAZILGOVNEWS
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carrion R, 2012, CURR OPIN VIROL, V2, P357, DOI 10.1016/j.coviro.2012.02.007
   CHIU CY, 2017, SCI REP UK, V7
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Colombo TE, 2016, ACTA TROP, V164, P84, DOI 10.1016/j.actatropica.2016.09.004
   CONCEA, 2015, NORM CONCEA PROD MAN, P209
   Consoli RAGB, 1998, PRINCIPAIS MOSQUITOS
   Fernandes NCCD, 2017, EMERG INFECT DIS, V23, P2038, DOI 10.3201/eid2312.170685
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Mota MTD, 2016, BRAZ J MICROBIOL, V47, P38, DOI 10.1016/j.bjm.2016.10.008
   De Oliveira-Filho E. F, 2018, TRANSBOUND EMERG DIS, P1
   de Rezende IM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006538
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Dos Santos Marina Nogueira, 2014, Revista de Etologia, V13, P37
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Elias Colombo T, 2017, CLIN LAB VIROLOGICAL
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Favoretto S., 2016, BIORXIV, DOI [10.1101/049395., DOI 10.1101/049395]
   Ferreira MS, 2014, IMMUNOL LETT, V158, P126, DOI 10.1016/j.imlet.2013.12.008
   Fischer C, 2018, EMERG INFECT DIS, V24, P888, DOI 10.3201/eid2405.171747
   Forattini O. P, 2002, CULICIDOLOGIA MED, V2
   Fragaszy D. M., 2004, COMPLETE CAPUCHIN BI
   Garcia CC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001171
   Gubler DJ, 2017, J INFECT DIS, V216, pS860, DOI 10.1093/infdis/jix451
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P300, DOI 10.1016/0035-9203(77)90104-3
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Machado DC, 2012, INTERVIROLOGY, V55, P475, DOI 10.1159/000337166
   Mansfield K, 2003, COMPARATIVE MED, V53, P383
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Ministerio da Saude, 2017, INF ESP FEBR AM BRAS
   Mondini A, 2007, EMERG INFECT DIS, V13, P176, DOI 10.3201/eid1301.060905
   Moreira-Soto A, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00523-17, 10.1128/msphere.00523-17]
   Nei M, 2000, MOL EVOLUTION PHYLOG
   Omatsu T, 2012, J MED PRIMATOL, V41, P289, DOI 10.1111/j.1600-0684.2012.00552.x
   Omatsu T, 2011, J GEN VIROL, V92, P2272, DOI 10.1099/vir.0.031229-0
   Osuna CE, 2017, NAT MED, V23, P264, DOI 10.1038/nm0217-264b
   Rylands AB, 2008, IUCN RED LIST THREAT
   SEFEROVIC M, 2018, SCI REP UK, V8
   Terzian ACB, 2017, EMERG INFECT DIS, V23, P1891, DOI 10.3201/eid2311.170078
   Vanchiere JA, 2018, AM J TROP MED HYG, V98, P173, DOI 10.4269/ajtmh.17-0322
   Vasilakis N, 2008, AM J TROP MED HYG, V79, P128, DOI 10.4269/ajtmh.2008.79.128
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   WHO, 2017, DIS OUTBREAK NEWS
NR 64
TC 27
Z9 27
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 30
PY 2018
VL 8
AR 16034
DI 10.1038/s41598-018-34423-6
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GY6SV
UT WOS:000448727000004
PM 30375482
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Sacchetto, L
   Zauli, DAG
   Costa, GB
   Guagliardo, SAJ
   Alvim, LB
   Marinho, FLD
   Abrahao, JS
   Trindade, GD
   Kroon, EG
   Mateo, ECC
   Drumond, BP
AF Sacchetto, Livia
   Gomes Zauli, Danielle Alves
   Costa, Galileu Barbosa
   Guagliardo, Sarah Anne J.
   Alvim, Luige Biciati
   de Oliveira Marinho, Feliciana Lage
   Abrahao, Jonatas Santos
   Trindade, Giliane de Souza
   Kroon, Erna Geessien
   Cueva Mateo, Elvis Cristian
   Drumond, Betania Paiva
TI Screening for Zika virus RNA in sera of suspected cases: a retrospective
   cross-sectional study
SO VIROLOGY JOURNAL
LA English
DT Article
DE Zika virus; Cross-sectional study; Epidemiology; Brazil; Dengue virus;
   Chikungunya virus
ID CASE SERIES; BRAZIL; INFECTION; OUTBREAK
AB Background: Zika virus (ZIKV) became a global human health concern owing to its rapid spread worldwide and its association with congenital and neurological disorders. The current epidemiological profile of arboviruses in Brazil is characterized by widespread co-circulation of Dengue virus, Chikungunya virus, and ZIKV throughout the country. These viruses cause acute diseases frequently with overlapping symptoms, which could result in an inaccurate diagnosis based solely on clinical and epidemiological grounds. Here we conducted a screening for ZIKV RNA in serum samples from patients across Brazil with suspected ZIKV infection.
   Methods: Using RT-qPCR, we investigated ZIKV RNA in 3001 serum samples. Samples were passively acquired through a private laboratory network, between December 2015 and August 2016, from 27 Brazilian Federative Units. We performed descriptive statistics on demographic variables including sex, age, and geographic location.
   Results: ZIKV was detected in 11.4% (95%CI = 10.3-12.6%) of the sera. ZIKV RNA was detected in sera collected throughout the country, but during the analyzed period, RNA was more frequently detected in samples from the Southeast, Midwest, and North regions (3.9 to 5.8 times higher) when compared to the Northeast and South regions.
   Conclusions: These data reinforce the importance of laboratory diagnosis, surveillance systems, and further epidemiological studies to understand the dynamics of outbreaks and diseases associated with ZIKV and other arboviruses.
C1 [Sacchetto, Livia; Costa, Galileu Barbosa; Abrahao, Jonatas Santos; Trindade, Giliane de Souza; Kroon, Erna Geessien; Drumond, Betania Paiva] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Bloco F4,Sala 258,Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Gomes Zauli, Danielle Alves; Alvim, Luige Biciati; de Oliveira Marinho, Feliciana Lage; Cueva Mateo, Elvis Cristian] Inst Hermes Pardini, Vespasiano, MG, Brazil.
   [Costa, Galileu Barbosa; Guagliardo, Sarah Anne J.] US Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Atlanta, GA USA.
   [Guagliardo, Sarah Anne J.] US Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA.
   [Drumond, Betania Paiva] Univ Fed Juiz de Fora, Programa Posgrad Ciencias Biol, Juiz De Fora, MG, Brazil.
RP Drumond, BP (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Bloco F4,Sala 258,Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.; Drumond, BP (corresponding author), Univ Fed Juiz de Fora, Programa Posgrad Ciencias Biol, Juiz De Fora, MG, Brazil.
EM betaniadrumond@ufmg.br
RI Kroon, Erna/V-5444-2019; Costa, Galileu Barbosa/M-5768-2019; Sacchetto,
   Livia/B-8841-2019
OI Sacchetto, Livia/0000-0001-9716-6899; Barbosa Costa,
   Galileu/0000-0001-7360-6722
FU Hermes Pardini Institute; Fundacao de Amparo a Pesquisa do Estado de
   Minas Gerais (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG)
   [APQ-01703-14]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES)CAPES; Pro-Reitoria de Pesquisa da Universidade Federal
   de Minas Gerais;  [MCTIC/FNDCT-CNPq/ MEC-CAPES/MS-Decit-14/2016]
FX The study was supported by Hermes Pardini Institute, Fundacao de Amparo
   a Pesquisa do Estado de Minas Gerais (FAPEMIG) [APQ-01703-14],
   MCTIC/FNDCT-CNPq/ MEC-CAPES/MS-Decit-14/2016, Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Pro-Reitoria
   de Pesquisa da Universidade Federal de Minas Gerais. Livia Sacchetto is
   fellow from CAPES. Giliane de Souza Trindade, Jonatas Santos Abrahao and
   Erna Geessien Kroon are CNPq researchers.
CR Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bioclin QUIBASA, 2017, BIOG ZIK VIR PCR
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005334
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Centers for Disease Control and Prevention, 2016, CHIK
   Centers for Disease Control and Prevention, 2017, ZIK VIR
   Centres for Disease Control and Prevention, DENGUE
   Colombo TE, 2017, J CLIN VIROL, V96, P20, DOI 10.1016/j.jcv.2017.09.002
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Lourenco J, 2017, ELIFE, V6, DOI [10.7554/elife.29820, 10.7554/eLife.29820]
   Ministerio da Saude Brasil, 2016, PROC SER AD VIG FEBR
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pan American Health Organization, 2016, ZIK VIR
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2018, B EPIDEMIOLOGICO, V49
   Secretaria de Vigilancia em Saude Ministerio da Saude Brasil, 2017, B EPIDEMIOLOGICO, V48
   Secretaria de Vigilancia em Saude Ministerio da Saude Brasil, 2017, B EP
   Secretaria de Vigilancia em Saude Ministerio da Saude Brasil, 2016, B EPIDEMIOLOGICO, V47
   Smith DR, 2017, CRIT REV MICROBIOL, V43, P405, DOI [10.1080/1040841x.2016.1230974, 10.1080/1040841X.2016.1230974]
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 25
TC 0
Z9 0
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD OCT 11
PY 2018
VL 15
AR 155
DI 10.1186/s12985-018-1070-z
PG 8
WC Virology
SC Virology
GA GW9EK
UT WOS:000447284700001
PM 30305112
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Amaral, CD
   Costa, GB
   de Souza, WM
   Alves, PA
   Borges, IA
   Tolardo, AL
   Romeiro, MF
   Drumond, BP
   Abrahao, JS
   Kroon, EG
   Paglia, AP
   Figueiredo, LTM
   Trindade, GD
AF Amaral, Carolina Dourado
   Costa, Galileu Barbosa
   de Souza, William Marciel
   Alves, Pedro Augusto
   Borges, Iara Apolinario
   Tolardo, Aline Lavado
   Romeiro, Marilia Farignoli
   Drumond, Betania Paiva
   Abrahao, Jonatas Santos
   Kroon, Erna Geessien
   Paglia, Adriano Pereira
   Moraes Figueiredo, Luiz Tadeu
   Trindade, Giliane de Souza
TI Silent Orthohantavirus Circulation Among Humans and Small Mammals from
   Central Minas Gerais, Brazil
SO ECOHEALTH
LA English
DT Article
DE Orthohantavirus; Juquitiba virus; Rural population; Serosurvey; Small
   mammals; Disease ecology; Ecoepidemiology
ID HANTAVIRUS PULMONARY SYNDROME; SEROLOGICAL EVIDENCE; EMERGING PATHOGENS;
   SOUTHERN BRAZIL; ANDES-VIRUS; SAO-PAULO; INFECTION; STATE; RODENTS;
   AMERICA
AB New World orthohantaviruses are emerging RNA viruses that cause hantavirus cardiopulmonary syndrome (HCPS). These viruses are a burden to public health around the world with a lethality rate of around 60%. In South America, rodents of Sigmodontinae subfamily are the main reservoirs of orthohantaviruses. We described a serosurvey for orthohantaviruses circulation in an apparently healthy human population and small mammals from rural areas in Central Minas Gerais State, Brazil. A total of 240 individuals and 50 small mammals (26 rodents belonging to 10 different species and 24 marsupials from 4 different species) were sampled during 2012-2013. The seroprevalence rates of IgG/IgM antibodies in humans were 7.1 and 1.6%, respectively. Only one rodent, an Oligoryzomys nigripes captured in peridomestic area, tested positive for IgG antibodies and viral RNA. Our findings suggest a silent circulation of orthohantaviruses in a region of intensive agriculture production. The detection of seropositive humans in an area with a lack of previous HCPS reports highlights potential oligosymptomatic cases and the need for surveillance strategies that could reduce the risk of future outbreaks.
C1 [Amaral, Carolina Dourado; Costa, Galileu Barbosa; Borges, Iara Apolinario; Drumond, Betania Paiva; Abrahao, Jonatas Santos; Kroon, Erna Geessien; Trindade, Giliane de Souza] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Ave Presidente Antonio Carlos, BR-31270901 Belo Horizonte, MG, Brazil.
   [de Souza, William Marciel; Tolardo, Aline Lavado; Romeiro, Marilia Farignoli; Moraes Figueiredo, Luiz Tadeu] Univ Sao Paulo, Fac Med Ribeirao Preto, Ctr Pesquisa Virol, Sao Paulo, Brazil.
   [Alves, Pedro Augusto] Inst Rene Rachou, Lab Imunol Doencas Virais, Fiocruz, MG, Brazil.
   [Paglia, Adriano Pereira] Univ Fed Minas Gerais, Lab Ecol & Conservacao, Belo Horizonte, MG, Brazil.
RP Costa, GB; Trindade, GD (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Ave Presidente Antonio Carlos, BR-31270901 Belo Horizonte, MG, Brazil.
EM galileuk1@gmail.com; giliane@icb.ufmg.br
RI de Souza, William Marciel/D-3044-2017; Paglia, Adriano P/A-7965-2012;
   Kroon, Erna/V-5444-2019; Costa, Galileu Barbosa/M-5768-2019; Alves,
   Pedro/T-7203-2019
OI de Souza, William Marciel/0000-0002-0025-8293; Paglia, Adriano
   P/0000-0001-9957-5506; Alves, Pedro/0000-0002-9659-5621; Barbosa Costa,
   Galileu/0000-0001-7360-6722
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Pro-Reitoria
   de Pesquisa/UFMG (PRPq)
FX We are thankful to colleagues from the Laboratorio de Virus (ICB-UFMG)
   and Centro de Pesquisa em Virologia, Faculdade de Medicina de Ribeirao
   Preto, for their excellent technical support. Financial support was
   provided by the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais (FAPEMIG), and Pro-Reitoria de Pesquisa/UFMG (PRPq). J.S.
   Abrahao, E.G. Kroon, A. Paglia, L.T. Figueiredo, and G.S. Trindade are
   researchers from CNPq.
CR Araujo J, 2011, ARCH VIROL, V156, P1269, DOI 10.1007/s00705-011-0968-1
   Badra SJ, 2012, REV SOC BRAS MED TRO, V45, P468, DOI [10.1590/S0037-86822012005000005, 10.1590/s0037-86822012005000005]
   Borba L. d., 2013, CASE REPORTS, V2013
   Carver S, 2015, BIOSCIENCE, V65, P651, DOI 10.1093/biosci/biv047
   Costa GB, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0575-6
   Cruz CD, 2012, EMERG INFECT DIS, V18, P750, DOI 10.3201/eid1805.111111
   Vieira CJD, 2016, REV SOC BRAS MED TRO, V49, P348, DOI 10.1590/0037-8682-0026-2016
   de Oliveira RC, 2014, EMERG INFECT DIS, V20, P1568, DOI 10.3201/eid2009.131472
   de Oliveira RC, 2014, VIRUSES-BASEL, V6, P1929, DOI 10.3390/v6051929
   de Oliveira SV, 2015, EMERG THEMES EPIDEMI, V12, DOI 10.1186/s12982-015-0036-5
   de Oliveira SV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085137
   de Souza WM, 2011, REV SOC BRAS MED TRO, V44, P131, DOI 10.1590/s0037-86822011005000013
   Elliot R. M., 2013, FIELDS VIROLOGY, P1244
   Figueiredo LTM, 2008, BRAZ J MED BIOL RES, V41, P596, DOI 10.1590/S0100-879X2008000700008
   Figueiredo LTM, 2009, EMERG INFECT DIS, V15, P561, DOI 10.3201/eid1504.080289
   Firth C, 2012, J VIROL, V86, P13756, DOI 10.1128/JVI.02341-12
   Galeno H, 2002, EMERG INFECT DIS, V8, P657, DOI 10.3201/eid0807.010277
   Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1
   Guo WP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003159
   Guterres A, 2013, INFECT GENET EVOL, V18, P262, DOI 10.1016/j.meegid.2013.05.027
   Hjelle B, 2010, VIRUSES-BASEL, V2, P2559, DOI 10.3390/v2122559
   Holmes R, 2000, EMERG INFECT DIS, V6, P560, DOI 10.3201/eid0605.000523
   Instituto Brasileiro de Geografia e Estatistica-IBGE, 2017, EST POP 2017
   Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09
   Kruger DH, 2015, J CLIN VIROL, V64, P128, DOI 10.1016/j.jcv.2014.08.033
   Gimaque JBL, 2012, MEM I OSWALDO CRUZ, V107, P135, DOI 10.1590/S0074-02762012000100019
   Limongi JE, 2009, EMERG INFECT DIS, V15, P1981, DOI 10.3201/eid1512.090229
   Machado AM, 2013, VIRUSES-BASEL, V5, P2272, DOI 10.3390/v5092272
   Mattar S, 2004, EMERG INFECT DIS, V10, P2263, DOI 10.3201/eid1012.040821
   Medeiros DBA, 2010, MEM I OSWALDO CRUZ, V105, P665, DOI 10.1590/S0074-02762010000500011
   Mendes WS, 2004, EMERG INFECT DIS, V10, P1496, DOI 10.3201/eid1008.040002
   Menezes Filho HR, 2016, EPIDEMIOLIA SERVICOS, V25, P1, DOI [10.5123/S1679-49742016002100003, DOI 10.5123/S1679-49742016002100003]
   MILLS JN, 1995, J MAMMAL, V76, P716, DOI 10.2307/1382742
   Miranda JB, 2017, EMERG INFECT DIS, V23, P931, DOI 10.3201/eid2306.161643
   Montgomery JM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001840
   Figueiredo LTM, 2009, AM J TROP MED HYG, V81, P273, DOI 10.4269/ajtmh.2009.81.273
   Muhire BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108277
   Munoz-Zanzi C, 2015, VIRUSES-BASEL, V7, P2006, DOI 10.3390/v7042006
   Cuong NV, 2015, VECTOR-BORNE ZOONOT, V15, P65, DOI 10.1089/vbz.2014.1603
   Oliveira RC, 2009, ACTA TROP, V112, P212, DOI 10.1016/j.actatropica.2009.07.029
   Ore RMC, 2012, VECTOR-BORNE ZOONOT, V12, P683, DOI 10.1089/vbz.2011.0820
   Pereira GW, 2012, REV SOC BRAS MED TRO, V45, P117, DOI 10.1590/S0037-86822012000100022
   Pini N, 2003, EMERG INFECT DIS, V9, P1070
   Raboni SM, 2009, J GEN VIROL, V90, P2166, DOI 10.1099/vir.0.011585-0
   Rivas YJ, 2003, ANN TROP MED PARASIT, V97, P61, DOI 10.1179/000349803125002788
   Santos IO, 2013, REV SOC BRAS MED TRO, V46, P30, DOI 10.1590/S0037-86822012005000002
   Secretaria de Vigilancia em Saude Ministerio da Saude Brasil, 2017, CAS CONF HANT BRAS G
   da Rosa EST, 2011, EMERG INFECT DIS, V17, P1527, DOI 10.3201/eid1708.101547
   Trindade GD, 2014, REV SOC BRAS MED TRO, V47, P778, DOI 10.1590/0037-8682-0033-2014
   Vaheri A, 2013, NAT REV MICROBIOL, V11, P539, DOI 10.1038/nrmicro3066
   Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609
NR 51
TC 4
Z9 4
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1612-9202
EI 1612-9210
J9 ECOHEALTH
JI EcoHealth
PD SEP
PY 2018
VL 15
IS 3
BP 577
EP 589
DI 10.1007/s10393-018-1353-2
PG 13
WC Biodiversity Conservation; Ecology; Environmental Sciences
SC Biodiversity & Conservation; Environmental Sciences & Ecology
GA GX8MH
UT WOS:000448039100010
PM 30105563
DA 2020-12-09
ER

PT J
AU Faria, NR
   Kraemer, MUG
   Hill, SC
   de Jesus, JG
   Aguiar, RS
   Iani, FCM
   Xavier, J
   Quick, J
   du Plessis, L
   Dellicour, S
   Theze, J
   Carvalho, RDO
   Baele, G
   Wu, CH
   Silveira, PP
   Arruda, MB
   Pereira, MA
   Pereira, GC
   Lourenco, J
   Obolski, U
   Abade, L
   Vasylyeva, TI
   Giovanetti, M
   Yi, D
   Weiss, DJ
   Wint, GRW
   Shearer, FM
   Funk, S
   Nikolay, B
   Fonseca, V
   Adelino, TER
   Oliveira, MAA
   Silva, MVF
   Sacchetto, L
   Figueiredo, PO
   Rezende, IM
   Mello, EM
   Said, RFC
   Santos, DA
   Ferraz, ML
   Brito, MG
   Santana, LF
   Menezes, MT
   Brindeiro, RM
   Tanuri, A
   dos Santos, FCP
   Cunha, MS
   Nogueira, JS
   Rocco, IM
   da Costa, AC
   Komninakis, SCV
   Azevedo, V
   Chieppe, AO
   Araujo, ESM
   Mendonca, MCL
   dos Santos, CC
   dos Santos, CD
   Mares-Guia, AM
   Nogueira, RMR
   Sequeira, PC
   Abreu, RG
   Garcia, MHO
   Abreu, AL
   Okumoto, O
   Kroon, EG
   de Albuquerque, CFC
   Lewandowski, K
   Pullan, ST
   Carroll, M
   de Oliveira, T
   Sabino, EC
   Souza, RP
   Suchard, MA
   Lemey, P
   Trindade, GS
   Drumond, BP
   Filippis, AMB
   Loman, NJ
   Cauchemez, S
   Alcantara, LCJ
   Pybus, OG
AF Faria, N. R.
   Kraemer, M. U. G.
   Hill, S. C.
   de Jesus, J. Goes
   Aguiar, R. S.
   Iani, F. C. M.
   Xavier, J.
   Quick, J.
   du Plessis, L.
   Dellicour, S.
   Theze, J.
   Carvalho, R. D. O.
   Baele, G.
   Wu, C. -H.
   Silveira, P. P.
   Arruda, M. B.
   Pereira, M. A.
   Pereira, G. C.
   Lourenco, J.
   Obolski, U.
   Abade, L.
   Vasylyeva, T. I.
   Giovanetti, M.
   Yi, D.
   Weiss, D. J.
   Wint, G. R. W.
   Shearer, F. M.
   Funk, S.
   Nikolay, B.
   Fonseca, V.
   Adelino, T. E. R.
   Oliveira, M. A. A.
   Silva, M. V. F.
   Sacchetto, L.
   Figueiredo, P. O.
   Rezende, I. M.
   Mello, E. M.
   Said, R. F. C.
   Santos, D. A.
   Ferraz, M. L.
   Brito, M. G.
   Santana, L. F.
   Menezes, M. T.
   Brindeiro, R. M.
   Tanuri, A.
   dos Santos, F. C. P.
   Cunha, M. S.
   Nogueira, J. S.
   Rocco, I. M.
   da Costa, A. C.
   Komninakis, S. C. V.
   Azevedo, V.
   Chieppe, A. O.
   Araujo, E. S. M.
   Mendonca, M. C. L.
   dos Santos, C. C.
   dos Santos, C. D.
   Mares-Guia, A. M.
   Nogueira, R. M. R.
   Sequeira, P. C.
   Abreu, R. G.
   Garcia, M. H. O.
   Abreu, A. L.
   Okumoto, O.
   Kroon, E. G.
   de Albuquerque, C. F. C.
   Lewandowski, K.
   Pullan, S. T.
   Carroll, M.
   de Oliveira, T.
   Sabino, E. C.
   Souza, R. P.
   Suchard, M. A.
   Lemey, P.
   Trindade, G. S.
   Drumond, B. P.
   Filippis, A. M. B.
   Loman, N. J.
   Cauchemez, S.
   Alcantara, L. C. J.
   Pybus, O. G.
TI Genomic and epidemiological monitoring of yellow fever virus
   transmission potential
SO SCIENCE
LA English
DT Article
ID SPREAD; BRAZIL; ANGOLA
AB The yellow fever virus (YFV) epidemic in Brazil is the largest in decades. The recent discovery of YFV in Brazilian Aedes species mosquitos highlights a need to monitor the risk of reestablishment of urban YFV transmission in the Americas. We use a suite of epidemiological, spatial, and genomic approaches to characterize YFV transmission. We show that the age and sex distribution of human cases is characteristic of sylvatic transmission. Analysis of YFV cases combined with genomes generated locally reveals an early phase of sylvatic YFV transmission and spatial expansion toward previously YFV-free areas, followed by a rise in viral spillover to humans in late 2016. Our results establish a framework for monitoring YFV transmission in real time that will contribute to a global strategy to eliminate future YFV epidemics.
C1 [Faria, N. R.; Kraemer, M. U. G.; Hill, S. C.; du Plessis, L.; Theze, J.; Lourenco, J.; Obolski, U.; Abade, L.; Vasylyeva, T. I.; Wint, G. R. W.; Pybus, O. G.] Univ Oxford, Dept Zool, Oxford, England.
   [Kraemer, M. U. G.] Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA USA.
   [Kraemer, M. U. G.] Harvard Med Sch, Dept Pediat, Boston, MA USA.
   [de Jesus, J. Goes; Xavier, J.; Giovanetti, M.; Araujo, E. S. M.; Mendonca, M. C. L.; dos Santos, C. C.; dos Santos, C. D.; Mares-Guia, A. M.; Nogueira, R. M. R.; Sequeira, P. C.; de Oliveira, T.; Filippis, A. M. B.; Alcantara, L. C. J.] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Aguiar, R. S.; Silveira, P. P.; Arruda, M. B.; Menezes, M. T.; Brindeiro, R. M.; Tanuri, A.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Mol Virol Lab, Rio De Janeiro, Brazil.
   [Iani, F. C. M.; Pereira, M. A.; Pereira, G. C.; Adelino, T. E. R.; Oliveira, M. A. A.; Silva, M. V. F.] FUNED, Inst Octavio Magalhaes, Lab Cent Saude Publ, Belo Horizonte, MG, Brazil.
   [Iani, F. C. M.; Carvalho, R. D. O.; Giovanetti, M.; Fonseca, V.; Sacchetto, L.; Figueiredo, P. O.; Rezende, I. M.; Mello, E. M.; Azevedo, V.; Kroon, E. G.; Trindade, G. S.; Drumond, B. P.; Alcantara, L. C. J.] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Quick, J.; Loman, N. J.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Dellicour, S.; Baele, G.; Lemey, P.] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst, Leuven, Belgium.
   [Wu, C. -H.] Univ Oxford, Dept Stat, Oxford, England.
   [Abade, L.] Univ Oxford, Global Hlth Network, Oxford, England.
   [Yi, D.] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA.
   [Weiss, D. J.; Shearer, F. M.] Univ Oxford, Nuffield Dept Med, Big Data Inst, Malaria Atlas Project, Oxford, England.
   [Funk, S.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.
   [Nikolay, B.; Cauchemez, S.] Inst Pasteur, Math Modelling Infect Dis, Paris, France.
   [Nikolay, B.; Cauchemez, S.] Inst Pasteur, Ctr Bioinformat, Paris, France.
   [Nikolay, B.; Cauchemez, S.] Inst Pasteur, CNRS, Genom Evolut Modelisat & Sante UMR2000, Paris, France.
   [Fonseca, V.; de Oliveira, T.] Univ KwaZulu Natal, KwaZulu Natal Res Innovat & Sequencing Platform K, Sch Lab Med & Med Sci, Durban, South Africa.
   [Said, R. F. C.; Santos, D. A.; Ferraz, M. L.; Brito, M. G.; Santana, L. F.] Secretaria Estado Saude Minas Gerais, Belo Horizonte, MG, Brazil.
   [dos Santos, F. C. P.; Cunha, M. S.; Nogueira, J. S.; Rocco, I. M.; Souza, R. P.] Adolfo Lutz Inst, Nucleo Doencas Transmissao Vetorial, Sao Paulo, Brazil.
   [da Costa, A. C.; Sabino, E. C.] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.
   [da Costa, A. C.; Sabino, E. C.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Komninakis, S. C. V.] Univ Fed Sao Paulo, Retrovirol Lab, Sao Paulo, Brazil.
   [Komninakis, S. C. V.] Sch Med ABC FMABC, Clin Immunol Lab, Santo Andre, SP, Brazil.
   [Chieppe, A. O.] Coordenacao Vigilancia Epidemiol Estado Rio de Ja, Rio De Janeiro, Brazil.
   [Abreu, R. G.; Garcia, M. H. O.] Minist Saude, Dept Vigilancia Doencas Transmissiveis, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Abreu, A. L.; Okumoto, O.] Minist Saude, Secretaria Vigilancia Saude, Coordenacao Geral Labs Saude Publ, Brasilia, DF, Brazil.
   [de Albuquerque, C. F. C.] OMS, OPAS, Brasilia, DF, Brazil.
   [Lewandowski, K.; Pullan, S. T.] Publ Hlth England, Natl Infect Serv, Salisbury, Wilts, England.
   [Carroll, M.] Publ Hlth England, NIHR HPRU Emerging & Zoonot Infect, London, England.
   [de Oliveira, T.] Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa.
   [Suchard, M. A.] Univ Calif Los Angeles, Dept Biostat, Fielding Sch Publ Hlth, Los Angeles, CA USA.
   [Suchard, M. A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath & Human Genet, Los Angeles, CA 90095 USA.
RP Faria, NR; Pybus, OG (corresponding author), Univ Oxford, Dept Zool, Oxford, England.; Alcantara, LCJ (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Alcantara, LCJ (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
EM nuno.faria@zoo.ox.ac.uk; luiz.alcantara@ioc.fiocruz.br;
   oliver.pybus@zoo.ox.ac.uk
RI Sabino, Ester Cerdeira/F-7750-2010; Azevedo, Vasco A.C/F-4315-2011;
   Giovanetti, Marta/AAK-7408-2020; Faria, Nuno R/I-2975-2012; Pybus,
   Oliver G/B-2640-2012; Sacchetto, Livia/B-8841-2019; Funk,
   Stefan/B-7629-2015; Kroon, Erna/V-5444-2019; Azevedo, Vasco
   A/B-1556-2019; Dellicour, Simon/AAE-9054-2020; Fonseca,
   Vagner/R-5813-2019; Loman, Nicholas/Z-1573-2019; Rezende, Izabela
   Mauricio/AAL-5766-2020; da-Costa, Antonio Charlys/G-1548-2010;
   Komninakis, Shirley V/B-2915-2010; Aguiar, Renato S/G-3542-2015; Baele,
   Guy/R-8157-2017; du Plessis, Louis/K-1667-2013
OI Sabino, Ester Cerdeira/0000-0003-2623-5126; Azevedo, Vasco
   A.C/0000-0002-4775-2280; Faria, Nuno R/0000-0001-8839-2798; Pybus,
   Oliver G/0000-0002-8797-2667; Sacchetto, Livia/0000-0001-9716-6899;
   Funk, Stefan/0000-0002-2012-0080; Azevedo, Vasco A/0000-0002-4775-2280;
   Dellicour, Simon/0000-0001-9558-1052; Fonseca,
   Vagner/0000-0001-5521-6448; Rezende, Izabela
   Mauricio/0000-0003-2616-6300; da-Costa, Antonio
   Charlys/0000-0001-5516-5177; Komninakis, Shirley V/0000-0001-7784-3418;
   Aguiar, Renato S/0000-0001-5180-3717; Xavier,
   Joilson/0000-0003-3916-2018; Funk, Sebastian/0000-0002-2842-3406;
   Vasylyeva, Tetyana/0000-0002-9736-7022; Alcantara,
   Luiz/0000-0002-6769-9931; Baele, Guy/0000-0002-1915-7732; du Plessis,
   Louis/0000-0003-0352-6289; Hill, Sarah/0000-0002-2995-2596; Pullan,
   Steven/0000-0002-8983-599X; Theze, Julien/0000-0001-8188-9494; De Jesus,
   Jaqueline/0000-0002-5404-272X; Iani, Felipe/0000-0002-3629-8529; Wu,
   Chieh-Hsi/0000-0001-9386-725X; Pereira de Souza,
   Renato/0000-0003-1315-7085; Carvalho, Rodrigo/0000-0003-0216-7173
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [400354/2016-0]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [2016/01735-2, 2017/00021-9]; Sir Henry Dale Fellowship
   [204311/Z/16/Z]; internal GCRF grant [005073]; John Fell Research Fund
   [005166]; ERCEuropean Research Council (ERC) [614725-PATHPHYLODYN];
   Oxford Martin School; Branco Weiss Fellowship; National Institute of
   Child Health and Human DevelopmentUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH Eunice
   Kennedy Shriver National Institute of Child Health & Human Development
   (NICHD) [T32HD040128]; National Library of Medicine of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Library of
   Medicine (NLM) [R01LM010812, R01LM011965]; Fonds Wetenschappelijk
   Onderzoek (FWO, Flanders, Belgium)FWO; Interne Fondsen KU
   Leuven/Internal Funds KU Leuven; EU's Horizon 2020 Programme through
   ZIKAlliance [734548]; Investissement d'Avenir programFrench National
   Research Agency (ANR); Laboratoire d'Excellence Integrative Biology of
   Emerging Infectious Diseases program [ANR-10-LABX-62-IBEID]; Models of
   Infectious Disease Agent Study of the National Institute of General
   Medical Sciences; AXA Research Fund; Association Robert Debre; European
   Research CouncilEuropean Research Council (ERC) [725422-ReservoirDOCS];
   Wellcome TrustWellcome Trust [206298/Z/17/Z]; Research Foundation,
   Flanders (Fonds voor Wetenschappelijk Onderzoek, Vlaanderen)FWO
   [G066215N, G0D5117N, G0B9317N]; EUNICE KENNEDY SHRIVER NATIONAL
   INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Eunice Kennedy Shriver National Institute of Child Health & Human
   Development (NICHD) [T32HD040128, T32HD040128, T32HD040128, T32HD040128,
   T32HD040128, T32HD040128, T32HD040128] Funding Source: NIH RePORTER;
   EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN
   DEVELOPMENTUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [T32HD040128,
   T32HD040128, T32HD040128, T32HD040128, T32HD040128, T32HD040128,
   T32HD040128, T32HD040128, T32HD040128] Funding Source: NIH RePORTER;
   NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Library of
   Medicine (NLM) [R01LM010812, R01LM010812, R01LM011965, R01LM010812,
   R01LM011965, R01LM010812, R01LM010812, R01LM011965, R01LM011965,
   R01LM010812, R01LM010812, R01LM010812] Funding Source: NIH RePORTER
FX This work was supported in part by CNPq 400354/2016-0 and FAPESP
   2016/01735-2. N.R.F. is supported by a Sir Henry Dale Fellowship
   (204311/Z/16/Z), internal GCRF grant 005073, and John Fell Research Fund
   grant 005166. This research received funding from the ERC (grant
   agreement 614725-PATHPHYLODYN) and from the Oxford Martin School.
   M.U.G.K. acknowledges funding from a Branco Weiss Fellowship,
   administered by ETH Zurich, a Training Grant from the National Institute
   of Child Health and Human Development (T32HD040128), and the National
   Library of Medicine of the National Institutes of Health (R01LM010812
   and R01LM011965). S.D. is funded by the Fonds Wetenschappelijk Onderzoek
   (FWO, Flanders, Belgium). G.B. acknowledges support from the Interne
   Fondsen KU Leuven/Internal Funds KU Leuven. A.C.d.C. is funded by FAPESP
   2017/00021-9. B.B.N. and S.C. are supported by the EU's Horizon 2020
   Programme through ZIKAlliance (grant 734548), the Investissement
   d'Avenir program, the Laboratoire d'Excellence Integrative Biology of
   Emerging Infectious Diseases program (grant ANR-10-LABX-62-IBEID), the
   Models of Infectious Disease Agent Study of the National Institute of
   General Medical Sciences, the AXA Research Fund, and the Association
   Robert Debre. P.L. and M.A.S. acknowledge funding from the European
   Research Council (grant agreement 725422-ReservoirDOCS) and from the
   Wellcome Trust Collaborative Award 206298/Z/17/Z. P.L. acknowledges
   support from the Research Foundation, Flanders (Fonds voor
   Wetenschappelijk Onderzoek, Vlaanderen, G066215N, G0D5117N, and
   G0B9317N).
CR Auguste AJ, 2015, EMERG INFECT DIS, V21, P99, DOI 10.3201/eid2101.140814
   Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   Brasil, 2017, B EPIDEMIOLOGICO, V48
   Camara FP, 2011, REV SOC BRAS MED TRO, V44, P297, DOI [10.1590/S0037-86822011005000024, 10.1590/s0037-86822011005000024]
   Cardoso JD, 2010, EMERG INFECT DIS, V16, P1918, DOI 10.3201/eid1612.100608
   CHANG GJJ, 1995, J VIROL, V69, P5773, DOI 10.1128/JVI.69.9.5773-5780.1995
   Consoli RAGB, 1994, PRINCIPAIS MOSQUITOS
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   do Nascimento Rafaela Almeida, 2013, Neotropical Biology and Conservation, V8, P79, DOI 10.4013/nbc.2013.82.03
   Dudas G, 2018, ELIFE, V7, DOI [10.7554/eLife.31257, 10.7554/eLife.37324, 10.7554/elife.37324]
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Estrada A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600946
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Flacio E, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1577-3
   FRANCO Odair, 1969, HIST FEBRE AMARELA B
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gill MS, 2016, SYST BIOL, V65, P1041, DOI 10.1093/sysbio/syw050
   Grobbelaar AA, 2016, EMERG INFECT DIS, V22, P1854, DOI 10.3201/eid2210.160818
   Jung L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129789
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067
   Lourenco-De-Oliveira R, 2004, T ROY SOC TROP MED H, V98, P43, DOI 10.1016/S0035-9203(03)00006-3
   Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026
   Mutebi JP, 2001, J VIROL, V75, P6999, DOI 10.1128/JVI.75.15.6999-7008.2001
   NASIDI A, 1989, T ROY SOC TROP MED H, V83, P401, DOI 10.1016/0035-9203(89)90518-X
   Nunes MRT, 2012, J VIROL, V86, P13263, DOI 10.1128/JVI.00565-12
   PAHO, 2009, OUTBR YELL FEV PAR
   Pan American Health Organization/World Health Organization, 2018, EP UPD YELL FEV 16 F
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Ribeiro M, 2009, REV SOC BRAS MED TRO, V42, P523, DOI 10.1590/S0037-86822009000500009
   Rodrigues Faria Nuno, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.c97507e3e48efb946401755d468c28b2
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2015, B EPIDEMIOLOGICO, V46
   Segura M. N. O., 2007, ATLAS CULICIDEOS AMA, V167
   Shearer FM, 2018, LANCET GLOB HEALTH, V6, pE270, DOI 10.1016/S2214-109X(18)30024-X
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   Stephens PR, 2017, ECOLOGY, V98, P1476, DOI 10.1002/ecy.1799
   Theiler M, 1937, J EXP MED, V65, P767, DOI 10.1084/jem.65.6.767
   Thiberville SD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002004
   Tuboi SH, 2007, T ROY SOC TROP MED H, V101, P169, DOI 10.1016/j.trstmh.2006.04.001
   Vainio J., 1998, YELLOW FEVER
   Vasconcelos P F, 2001, Cad Saude Publica, V17 Suppl, P155, DOI 10.1590/S0102-311X2001000700025
   Vasconcelos PFC, 2004, EMERG INFECT DIS, V10, P1578, DOI 10.3201/eid1009.040197
   Vasconcelos PFC, 2001, J MED VIROL, V65, P598, DOI 10.1002/jmv.2078
   Vaughan TG, 2014, BIOINFORMATICS, V30, P2272, DOI 10.1093/bioinformatics/btu201
   von Lindern JJ, 2006, J GEN VIROL, V87, P895, DOI 10.1099/vir.0.81236-0
   Wang E, 1996, VIROLOGY, V225, P274, DOI 10.1006/viro.1996.0601
NR 49
TC 82
Z9 83
U1 0
U2 14
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD AUG 31
PY 2018
VL 361
IS 6405
BP 894
EP +
DI 10.1126/science.aat7115
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GS3UB
UT WOS:000443547000033
PM 30139911
OA Bronze, Green Accepted
DA 2020-12-09
ER

PT J
AU Eiras, AE
   Pires, SF
   Staunton, KM
   Paixao, KS
   Resende, MC
   Silva, HA
   Rocha, IG
   Oliveira, BA
   Peres, AM
   Drumond, BP
   Ritchie, SA
AF Eiras, Alvaro E.
   Pires, Simone F.
   Staunton, Kyran M.
   Paixao, Kelly S.
   Resende, Marcelo C.
   Silva, Hilcielly A.
   Rocha, Isadora G.
   Oliveira, Bruna A.
   Peres, Anderson M.
   Drumond, Betania P.
   Ritchie, Scott A.
TI A high-risk Zika and dengue transmission hub: virus detections in
   mosquitoes at a Brazilian university campus
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Dengue virus; Zika virus; GAT; Dissemination premises
ID GRAVID AEDES TRAP; ANTIGEN
AB Background: Zika virus (ZIKV) and dengue virus (DENV) are mosquito-borne flaviviruses prevalent throughout tropical regions. Currently, management of ZIKV and DENV centers on control of the primary vector Aedes aegypti. This vector is highly anthropophilic and is therefore prevalent throughout densely urbanised landscapes. A new passive trap for gravid Ae. aegypti (Gravid Aedes Trap - GAT) was developed for mosquito surveillance. Here the different killing agents and the level of transmission of arboviruses that may occur in mosquitoes sampled by GATs are assessed for the first time.
   Methods: Gravid Aedes traps (GATs) were deployed at the Federal University of Minas Gerais campus, in Belo Horizonte, Brazil to sample Ae. aegypti. Three different killing agents were evaluated within the GATs: sticky cards, long-lasting insecticide-impregnated nets (LLINs) and canola oil. Traps were monitored weekly for 14 weeks then mosquito specimens were identified to the species level and Ae. aegypti catches were pooled and submitted to qRT-PCR assays for to DENV and ZIKV virus detection, followed by Bayesian phylogenetic analysis of the ZIKV. Additionally, comparisons of means were performed on transformed weekly catch data (P = 0.05, t-tests) with the stats package of the R statistical software.
   Results: In total, 1506 female Ae. aegypti were captured using GATs, with traps using sticky cards catching more mosquito than those using either LLINs or canola oil. Both ZIKV and DENV were detected in Ae. aegypti females captured over several weeks suggesting that this highly populated university campus may have served as a significant transmission hub. The infection rate for ZIKV was present in seven (8.5%) pools from four weeks while DENV was detected in four (4.9%) pools from four weeks. Phylogenetic analysis of ZIKV classified the strain as Asian genotype.
   Conclusions: The Federal University of Minas Gerais and similar organizations must strongly consider monitoring Ae. aegypti populations and reinforcing personal protection of staff and students during seasons of high mosquito activity.
C1 [Eiras, Alvaro E.; Pires, Simone F.; Paixao, Kelly S.; Resende, Marcelo C.; Silva, Hilcielly A.; Rocha, Isadora G.; Oliveira, Bruna A.; Peres, Anderson M.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Parasitol, Belo Horizonte, MG, Brazil.
   [Staunton, Kyran M.; Ritchie, Scott A.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Cairns, Australia.
   [Staunton, Kyran M.; Ritchie, Scott A.] James Cook Univ, Australian Inst Trop Hlth & Med, Cairns, Australia.
   [Drumond, Betania P.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
RP Eiras, AE (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Parasitol, Belo Horizonte, MG, Brazil.
EM alvaro@icb.ufmg.br
RI Staunton, Kyran/W-2263-2019; Eiras, Alvaro/Z-6023-2019
OI Staunton, Kyran/0000-0001-6812-3320; Eiras, Alvaro/0000-0002-3045-0673
FU CAPES/MEC-CNPq/MCTI-DECIT/SCTIE/MS [440358/2016-7]; FAPEMIGMinas Gerais
   State Research Foundation (FAPEMIG) [23129-02/2015]; National Health and
   Medical Research Council of AustraliaNational Health and Medical
   Research Council of Australia [1044698]
FX The research received funding support from the
   CAPES/MEC-CNPq/MCTI-DECIT/SCTIE/MS (Grant #440358/2016-7) and FAPEMIG
   (Grant# 23129-02/2015) and National Health and Medical Research Council
   of Australia (Senior Research Fellowship 1044698).
CR Andrade Filho A, 2016, EXPERIENCIA BELO HOR
   Avsic Zupanc Tatjana, 2016, Zdr Varst, V55, P228
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gks1195, 10.1093/nar/gkt1030, 10.1093/nar/gkr1202]
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Christophers R, 1960, AEDES AEGYPTI L YELL
   de Resende MC, 2012, MEM I OSWALDO CRUZ, V107, P294, DOI 10.1590/S0074-02762012000300002
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Drummond AJ, BAYESIAN EVOLUTIONAR
   Eiras AE, 2014, J MED ENTOMOL, V51, P200, DOI 10.1603/ME13104
   Focosi D, 2016, CLIN INFECT DIS, V63, P227, DOI 10.1093/cid/ciw210
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Grange L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00280
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0000
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hanna JN, 2001, MED J AUSTRALIA, V174, P178, DOI 10.5694/j.1326-5377.2001.tb143213.x
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Heringer L, 2016, J MED ENTOMOL, V53, P873, DOI 10.1093/jme/tjw051
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108
   Kollars TM, 2017, RES REP TROP MED, V8, P1, DOI [10.2147/RRTM.S123456, 10.2147/rrtm.s123456]
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Leparc-Goffart I, 2009, J CLIN VIROL, V45, P61, DOI 10.1016/j.jcv.2009.02.010
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Rajapakse Senaka, 2011, J Emerg Trauma Shock, V4, P120, DOI 10.4103/0974-2700.76835
   Rambaut A, TREE FIGURE DRAWING
   Reiter P, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P481, DOI 10.1079/9781845939649.0481
   Ritchie SA, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P455, DOI 10.1079/9781845939649.0455
   Ritchie SA, 2014, J MED ENTOMOL, V51, P210, DOI 10.1603/ME13105
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Tan CH, 2011, VECTOR-BORNE ZOONOT, V11, P789, DOI 10.1089/vbz.2010.0028
   Voge NV, 2013, AM J TROP MED HYG, V88, P260, DOI 10.4269/ajtmh.2012.12-0477
   Whitehead SS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005584
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
NR 40
TC 4
Z9 5
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JUN 22
PY 2018
VL 11
AR 359
DI 10.1186/s13071-018-2883-8
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GK1WS
UT WOS:000435914600001
PM 29929561
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-12-09
ER

PT J
AU de Rezende, IM
   Sacchetto, L
   de Mello, EM
   Alves, PA
   Iani, FCD
   Adelino, TER
   Duarte, MM
   Cury, ALF
   Bernardes, AFL
   Santos, TA
   Pereira, LS
   Dutra, MRT
   Ramalho, DB
   de Thoisy, B
   Kroon, EG
   Trindade, GD
   Drumond, BP
AF de Rezende, Izabela Mauricio
   Sacchetto, Livia
   de Mello, Erica Munhoz
   Alves, Pedro Augusto
   de Melo Iani, Felipe Campos
   Ribeiro Adelino, Talita Emile
   Duarte, Myrian Morato
   Furtado Cury, Ana Luisa
   Leal Bernardes, Andre Felipe
   Santos, Tayrine Araujo
   Pereira, Leonardo Soares
   Teixeira Dutra, Maria Rita
   Ramalho, Dario Brock
   de Thoisy, Benoit
   Kroon, Erna Geessien
   Trindade, Giliane de Souza
   Drumond, Betania Paiva
TI Persistence of Yellow fever virus outside the Amazon Basin, causing
   epidemics in Southeast Brazil, from 2016 to 2018
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID PHYML
AB Background
   Yellow fever (YF) is endemic in the Brazilian Amazon Basin, and sporadic outbreaks take place outside the endemic area in Brazil. Since 2016, YF epidemics have been occurring in Southeast Brazil, with more than 1,900 human cases and more than 1,600 epizooties of non-human primates (NHPs) reported until April 2018. Previous studies have demonstrated that Yellow fever virus (YFV) causing outbreaks in 2017 formed a monophyletic group.
   Methodology/Principal findings
   Aiming to decipher the origin of the YFV responsible for the recent epidemics, we obtained nucleotide sequences of YFV detected in humans (n = 6) and NHPs (n = 10) from Minas Gerais state during 2017 +/- 2018. Next, we performed evolutionary analyses and discussed the results in the light of epidemiological records (official numbers of YFV cases at each Brazilian Federative unit, reported by the Brazilian Ministry of Health). Nucleotide sequences of YFV from Southeast Brazil from 2016 to 2018 were highly conserved and formed a monophyletic lineage (BR-YFV_2016/18) within the genotype South America I. Different clusters were observed within lineage BR-YFV_2016/18, one containing the majority of isolates (from humans and NHPs), indicating the sylvatic transmission of YFV. We also detected a cluster characterized by two synapomorphies (amino acid substitutions) that contained YFV only associated with NHP what should be further investigated. The topology of lineage BRYFV_2016/18 was congruent with epidemiological and temporal patterns of the ongoing epidemic. YFV isolates detected in 2016, in Sao Paulo state were located in the most basal position of the lineage, followed by the isolates from Minas Gerais and Esp oA rito Santo obtained in 2017 and 2018. The most recent common ancestor of the lineage BRYFV_2016/18 dated to 2015 (95% credible intervals = 2014 +/- 2016), in a period that was coincident with the reemergence of YFV in the Midwest region of Brazil.
   Conclusions
   The results demonstrated a single introduction of YFV in the Southeast region and the silent viral circulation before the onset of the outbreaks in 2016. Evolutionary analyses combined with epidemiological records supported the idea that BR- YFV_2016/18 was probably introduced from the Midwest into the Southeast region, possibly in Sao Paulo state. The persistence of YFV in the Southeast region, causing epidemics from 2016 to 2018, suggests that this region presents suitable ecological and climatic conditions for YFV maintenance during the epidemic and interepidemic seasons. This fact poses risks for the establishing of YF enzootic cycles and epidemics, outside the Amazon Basin in Brazil. YF surveillance and studies of viral dynamics deserve particular attention, especially in Midwest, Southeast and neighbor regions which are the main areas historically associated with YF outbreaks outside the Amazon Basin. YFV persistence in Southeast Brazil should be carefully considered in the context of public health, especially for public health decision-makers and researchers.
C1 [de Rezende, Izabela Mauricio; Sacchetto, Livia; Kroon, Erna Geessien; Trindade, Giliane de Souza; Drumond, Betania Paiva] Univ Fed Minas Gerais, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
   [de Mello, Erica Munhoz] Ctr Controle Zoonoses Prefeitura Belo Horizonte, Belo Horizonte, MG, Brazil.
   [Alves, Pedro Augusto] Fundacao Oswaldo Cruz, Inst Rene Rachou, Lab Imunol Doencas Virais, Belo Horizonte, MG, Brazil.
   [de Melo Iani, Felipe Campos; Ribeiro Adelino, Talita Emile; Duarte, Myrian Morato; Furtado Cury, Ana Luisa; Leal Bernardes, Andre Felipe] Fundacao Ezequiel Dias LACEN MG, Serv Virol & Riquetsioses, Belo Horizonte, MG, Brazil.
   [Santos, Tayrine Araujo; Pereira, Leonardo Soares; Teixeira Dutra, Maria Rita; Ramalho, Dario Brock] Fundacao Hosp Estado Minas Gerais, Hosp Eduardo Menezes, Belo Horizonte, MG, Brazil.
   [de Thoisy, Benoit] Inst Pasteur, Lab Interact Virus Hotes, Cayenne, French Guiana.
RP Drumond, BP (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
EM betaniadrumond@ufmg.br
RI Kroon, Erna/V-5444-2019; Sacchetto, Livia/B-8841-2019; Rezende, Izabela
   Mauricio/AAL-5766-2020; Alves, Pedro/T-7203-2019
OI Sacchetto, Livia/0000-0001-9716-6899; Rezende, Izabela
   Mauricio/0000-0003-2616-6300; Alves, Pedro/0000-0002-9659-5621; Pereira,
   Leonardo/0000-0002-5426-0655; Iani, Felipe/0000-0002-3629-8529
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas
   Gerais State Research Foundation (FAPEMIG) [APQ01574-17]; Pro-Reitoria
   de Pesquisa da Universidade Federal de Minas Gerais (PRPq-UFMG); GdST
   [440593/2016-6]; EGK [440911/2016-8]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); CNPqNational Council
   for Scientific and Technological Development (CNPq); ERDF from European
   Commission; Institut Pasteur de La Guyane; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
FX This work was supported by grant APQ01574-17, received by BPD from
   Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG;
   http://www.fapemig.br) and from Pro-Reitoria de Pesquisa da Universidade
   Federal de Minas Gerais (PRPq-UFMG; https://www.ufmg.br/prpq). Grants
   440593/2016-6 and 440911/2016-8 were received by GdST and EGK,
   respectively, by Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq; http://www.cnpq.br). GdST and EGK are fellowships
   from CNPq. BdT received grant (Project RESERVOIRS) from ERDF from
   European Commission and Institut Pasteur de La Guyane. IMdR and LS
   received scholarships from Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES; www.capes.gov.br). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Araujo FAA, 2011, EPIDEMIOL SERV SAUDE, V20, P527, DOI 10.5123/S1679-49742011000400012
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   Vasconcelos PFD, 2010, REV SAUDE PUBL, V44, P1144, DOI 10.1590/S0034-89102010005000046
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Gomez MM, 2018, J GEN VIROL, V99, P536, DOI 10.1099/jgv.0.001033
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   IBGE, 2018, I BRAS GEOGR EST
   Jorge TR, 2017, ACTA TROP, V166, P114, DOI 10.1016/j.actatropica.2016.09.030
   Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3
   Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149
   Ministe A rio da Sau A de, 2018, FEBR AM MIN SAUD AT
   Ministerio da Saude, 2001, DATASUS FEBR AM
   Ministerio da Saude, 2018, MON PER SAZ FEBR AM, V16
   Ministerio da Saude, 2018, MON PER SAZ FEB AM, V11, P11
   Ministerio da Saude, 2007, DATASUS FEBRE AMAREL
   Ministerio da Saude, 2015, REEM FEBR AM SILV BR, V46
   Ministerio da Saude, 2017, EM EP FEBR AM BRAS P, V48
   Ministerio do Meio Ambiente-MMA, 2018, DOWNL DAD GEOGR
   Mir D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07873-7
   Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026
   QGIS Development Team (YEAR), 2009, QGIS GEOGR INF SYST
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Secretaria Estadual de Saude / SES-MG, 2018, INF FEBR AM
   Secretaria Estadual de Saude / SES-MG, 2017, COB VAC FEBR AM MIN
   Secretaria Estadual de Saude / SES-MG, 2018, INF EP FEBR AM 17 04, P12
   Secretaria Estadual de Saude / SES-MG, 2017, B EP FEBR AM MIN GER, V20
   Secretaria Estadual de Saude / SES-MG, 2018, INF EP FEBR AM 05 01
   Secretaria Estadual de Saude / SES-SP, 2017, B EP EP, P6
   Shearer FM, 2018, LANCET GLOB HEALTH, V6, pE270, DOI 10.1016/S2214-109X(18)30024-X
   Stucky Brian J, 2012, J Biomol Tech, V23, P90, DOI 10.7171/jbt.12-2303-004
   Vasconcelos Pedro Fernando da Costa, 2003, Rev. Soc. Bras. Med. Trop., V36, P275, DOI 10.1590/S0037-86822003000200012
NR 32
TC 26
Z9 26
U1 1
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2018
VL 12
IS 6
AR e0006538
DI 10.1371/journal.pntd.0006538
PG 12
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GL8CX
UT WOS:000437442000027
PM 29864115
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Assis, ASF
   Fumian, TM
   Miagostovich, MP
   Drumond, BP
   Silva, MLDE
AF Ferreira Assis, Andressa Silvino
   Fumian, Tulio Machado
   Miagostovich, Marize Pereira
   Drumond, Betania Paiva
   da Rosa e Silva, Maria Luzia
TI Adenovirus and rotavirus recovery from a treated effluent through an
   optimized skimmed-milk flocculation method
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article
DE Treated effluent; Water contamination; Organic flocculation; Enteric
   virus; Internal control; Quantitative PCR
ID RIO-DE-JANEIRO; WATER TREATMENT PLANTS; HUMAN ENTERIC VIRUSES; GROUP-A
   ROTAVIRUS; REAL-TIME PCR; WASTE-WATER; MOLECULAR CHARACTERIZATION;
   ENVIRONMENTAL SURVEILLANCE; GASTROENTERITIS OUTBREAK; QUANTITATIVE
   DETECTION
AB Sewage treatment may be insufficient for the complete removal of enteric viruses, such as human adenoviruses (HAdV) and group A rotavirus (RVA). The differences in the efficiency of the treatment methodologies used may interfere with the detection of these viruses. The objective of this study was to optimize a skimmed-milk flocculation technique for the recovery of HAdV and RVA in the samples of treated effluent. The treated effluent collected at the wastewater treatment plant (WWTP) was processed via four protocols including modifications in the initial centrifugation step and the final concentration of skimmed-milk. The viral load and recovery rate were determined by quantitative PCR TaqMan (R) System. The highest recovery rates of HAdV, RVA, and bacteriophage PP7 (internal control process) were obtained when the concentration of skimmed-milk was doubled and no centrifugation step was used for the sample clarification. The optimized protocol was assessed in a field study conducted with 24 treated effluent samples collected bi-monthly during 2015. HAdV and RVA were detected in 50.0% (12/24) and 33.3% (08/24) of the samples tested, respectively, throughout the year, without seasonal variation (p > 0.05). This study corroborates the use of the organic flocculation method for virus recovery in environmental samples with the adaptation of the protocols to different aquatic matrices.
C1 [Ferreira Assis, Andressa Silvino; Drumond, Betania Paiva; da Rosa e Silva, Maria Luzia] Univ Fed Juiz de Fora, Inst Biol Sci, Dept Parasitol Microbiol & Immunol, Lab Virol, Juiz De Fora, MG, Brazil.
   [Fumian, Tulio Machado; Miagostovich, Marize Pereira] Inst Oswaldo Cruz, Lab Comparat & Environm Virol, Rio De Janeiro, RJ, Brazil.
   [Drumond, Betania Paiva] Univ Fed Minas Gerais, Inst Biol Sci, Lab Virus, Dept Microbiol, Belo Horizonte, MG, Brazil.
RP Assis, ASF; Drumond, BP (corresponding author), Univ Fed Juiz de Fora, Inst Biol Sci, Dept Parasitol Microbiol & Immunol, Lab Virol, Juiz De Fora, MG, Brazil.; Drumond, BP (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Lab Virus, Dept Microbiol, Belo Horizonte, MG, Brazil.
EM andressasilvino@yahoo.com.br; betaniadrumond@ufmg.br
FU CAPES scholarshipCAPES
FX The author ASFA was a holder of a CAPES scholarship.
CR Adefisoye MA, 2016, FOOD ENVIRON VIROL, V8, P262, DOI 10.1007/s12560-016-9246-4
   Assis ASF, 2017, SCI TOTAL ENVIRON, V583, P163, DOI 10.1016/j.scitotenv.2017.01.045
   Assis ASF, 2013, J PEDIAT-BRAZIL, V89, P470, DOI 10.1016/j.jped.2013.02.019
   Aw TG, 2010, J APPL MICROBIOL, V109, P716, DOI 10.1111/j.1365-2672.2010.04701.x
   Berk AJ, 2013, FIELDS VIROLOGY, V2, P1704
   Bofill-Mas S, 2006, APPL ENVIRON MICROB, V72, P7894, DOI 10.1128/AEM.00965-06
   Bosch A, 2008, CURR OPIN BIOTECH, V19, P295, DOI 10.1016/j.copbio.2008.04.006
   Braeye T, 2015, EPIDEMIOL INFECT, V143, P711, DOI 10.1017/S0950268814001629
   Calgua B, 2008, J VIROL METHODS, V153, P79, DOI 10.1016/j.jviromet.2008.08.003
   Calgua B, 2013, WATER RES, V47, P2797, DOI 10.1016/j.watres.2013.02.043
   Calgua B, 2013, J VIROL METHODS, V187, P215, DOI 10.1016/j.jviromet.2012.10.012
   Carducci A, 2008, WATER SCI TECHNOL, V58, P893, DOI 10.2166/wst.2008.437
   Estes M. K. A. G., 2013, FIELDS VIROLOGY, P1347
   Farthing M, 2013, J CLIN GASTROENTEROL, V47, P12, DOI 10.1097/MCG.0b013e31826df662
   Assis ASF, 2015, ENVIRON SCI POLLUT R, V22, P6886, DOI 10.1007/s11356-014-3874-8
   Ferreira FFM, 2009, WATER SCI TECHNOL, V60, P633, DOI 10.2166/wst.2009.413
   Fioretti JM, 2018, FOOD ENVIRON VIROL, V10, P1, DOI 10.1007/s12560-017-9308-2
   Fong TT, 2010, APPL ENVIRON MICROB, V76, P715, DOI 10.1128/AEM.01316-09
   Fumian TM, 2013, J WATER HEALTH, V11, P110, DOI 10.2166/wh.2012.123
   Fumian TM, 2011, WATER RES, V45, P5755, DOI 10.1016/j.watres.2011.08.039
   Gibson KE, 2014, CURR OPIN VIROL, V4, P50, DOI 10.1016/j.coviro.2013.12.005
   Girones R, 2010, WATER RES, V44, P4325, DOI 10.1016/j.watres.2010.06.030
   Hassine-Zaafrane M, 2015, J APPL MICROBIOL, V119, P1443, DOI 10.1111/jam.12920
   Hata A, 2013, J APPL MICROBIOL, V114, P545, DOI 10.1111/jam.12051
   Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382
   Katayama H, 2008, WATER RES, V42, P1441, DOI 10.1016/j.watres.2007.10.029
   Kitajima M, 2014, SCI TOTAL ENVIRON, V488, P290, DOI 10.1016/j.scitotenv.2014.04.087
   Kiulia NM, 2015, PATHOGENS, V4, P229, DOI 10.3390/pathogens4020229
   Mellou K, 2014, EPIDEMIOL INFECT, V142, P40, DOI 10.1017/S0950268813000939
   Myrmel M, 2015, FOOD ENVIRON VIROL, V7, P213, DOI 10.1007/s12560-015-9200-x
   Naidoo S, 2014, INT J ENV RES PUB HE, V11, P249, DOI 10.3390/ijerph110100249
   Okoh AI, 2010, INT J ENV RES PUB HE, V7, P2620, DOI 10.3390/ijerph7062620
   Parshionikar S, 2010, APPL ENVIRON MICROB, V76, P4318, DOI 10.1128/AEM.02800-09
   Petrinca AR, 2009, J APPL MICROBIOL, V106, P1608, DOI 10.1111/j.1365-2672.2008.04128.x
   Pina S, 1998, APPL ENVIRON MICROB, V64, P4485
   Prado T, 2014, BRAZ J MICROBIOL, V45, P343, DOI 10.1590/S1517-83822014000100049
   Prado T, 2013, MEM I OSWALDO CRUZ, V108, P77, DOI 10.1590/S0074-02762013000100013
   Prado T, 2011, WATER RES, V45, P1287, DOI 10.1016/j.watres.2010.10.012
   Raboni SM, 2014, MEM I OSWALDO CRUZ, V109, P428, DOI 10.1590/0074-0276140066
   Rajal VB, 2007, WATER RES, V41, P4287, DOI 10.1016/j.watres.2007.06.002
   Rajal VB, 2007, WATER RES, V41, P1411, DOI 10.1016/j.watres.2006.12.034
   Rames E, 2017, FOOD ENVIRON VIROL, V9, P354, DOI 10.1007/s12560-017-9294-4
   Rock C, 2010, APPL ENVIRON MICROB, V76, P8102, DOI 10.1128/AEM.02339-09
   Portes SAR, 2016, MEM I OSWALDO CRUZ, V111, P403, DOI 10.1590/0074-02760160030
   Rosario K, 2009, ENVIRON MICROBIOL, V11, P2806, DOI 10.1111/j.1462-2920.2009.01964.x
   Sanchez G, 2012, FOOD ENVIRON VIROL, V4, P21, DOI 10.1007/s12560-011-9074-5
   Sdiri-Loulizi K, 2010, J APPL MICROBIOL, V109, P1093, DOI 10.1111/j.1365-2672.2010.04772.x
   Stals A, 2011, FOOD MICROBIOL, V28, P52, DOI 10.1016/j.fm.2010.08.004
   Templeton MR, 2008, CRIT REV ENV SCI TEC, V38, P137, DOI 10.1080/10643380601174764
   UFJF-Federal University of Juiz de Fora, 2016, HIST AV TEMP RAINF 2
   Vieira CB, 2016, FOOD ENVIRON VIROL, V8, P57, DOI 10.1007/s12560-016-9226-8
   Reis TAV, 2016, BRAZ J MICROBIOL, V47, P243, DOI 10.1016/j.bjm.2015.11.011
   Von Sperling M, 2014, INTRO WATER TREATMEN
   Zeng SQ, 2008, J VIROL METHODS, V153, P238, DOI 10.1016/j.jviromet.2008.08.004
NR 54
TC 5
Z9 6
U1 1
U2 9
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD JUN
PY 2018
VL 25
IS 17
BP 17025
EP 17032
DI 10.1007/s11356-018-1873-x
PG 8
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA GK2LJ
UT WOS:000435961300070
PM 29633189
DA 2020-12-09
ER

PT J
AU Pereira, ACTD
   de Siqueira, TR
   Prado, AAD
   da Silva, CAV
   Moraes, TDS
   Aleixo, AA
   de Magalhaes, JC
   de Souza, GAP
   Drumond, BP
   Ferreira, GP
   Silva, BDM
   Magalhaes, CLD
   Santos, LL
   Ferreira, JMS
   Malaquias, LCC
   Coelho, LFL
AF Toledo da Cunha Pereira, Anna Carolina
   de Siqueira, Tatiane Ribeiro
   de Oliveira Prado, Andressa Anunciacao
   Veiga da Silva, Camila Almeida
   Silva Moraes, Thais de Fatima
   Aleixo, Alan Alex
   de Magalhaes, Jose Carlos
   Pires de Souza, Gabriel Augusto
   Drumond, Betania Paiva
   Ferreira, Gustavo Portela
   Silva, Breno de Mello
   de Brito Magalhaes, Cintia Lopes
   Santos, Luciana Lara
   Siqueira Ferreira, Jaqueline Maria
   Cotta Malaquias, Luiz Cosme
   Leomil Coelho, Luiz Felipe
TI High prevalence of dengue antibodies and the arginine variant of the Fc
   gamma RIIa polymorphism in asymptomatic individuals in a population of
   Minas Gerais State, Southeast Brazil
SO IMMUNOGENETICS
LA English
DT Article
DE Dengue; FcR gamma RIIa; Asymptomatic patients; SNPs
ID SINGLE AMINO-ACID; RECEPTOR-II; ASSOCIATION; INFECTION; PROMOTER;
   ADMIXTURE
AB Dengue is the most prevalent arthropod-borne viral illness in humans worldwide. Single-nucleotide polymorphisms (SNPs) in genes involved in the immune response, such as dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN), IgG Fc receptor II-A (Fc gamma RIIa), vitamin D receptor (VDR), and tumor necrosis factor alpha (TNF-alpha), were previously reported to be associated with susceptibility to dengue disease in different human populations. Therefore, due to the relevant association of host immune and genetic status with disease susceptibility/severity of dengue, this work aims to verify the frequency of anti-dengue virus antibodies and some dengue-associated risk SNPs in a population in Minas Gerais State, Southeast Brazil. A total of 1560 individuals were genotyped for polymorphisms in DC-SIGN (rs4804803), Fc gamma RIIa (rs1801274), VDR (rs7975232), and TNF-alpha (rs1800629). The presence of anti-dengue antibodies (IgM and/or IgG) in these samples was also assayed. Anti-dengue antibodies were detected at an overall frequency of 16.86%, indicating a virus infection in asymptomatic individuals. The genotypic frequencies of all SNPs studied did not differ between the asymptomatic and control groups. Regarding the allelic frequencies of the four SNPs analyzed, a higher frequency was detected of the G allele of Fc gamma RIIa/rs1801274 in the asymptomatic individuals when compared to that in the control group (p = 0.03). Therefore, the results showed a high prevalence of asymptomatic individuals in Minas Gerais State, with a potential association between the presence of the G allele of Fc gamma RIIa/rs1801274 and protection against symptomatic disease.
C1 [Toledo da Cunha Pereira, Anna Carolina; Ferreira, Gustavo Portela] Univ Fed Piaui, Lab Bioquim & Biol Microrganismos & Plantas, Campus Minist Reis Velloso, Parnaiba, PI, Brazil.
   [de Siqueira, Tatiane Ribeiro; Drumond, Betania Paiva] Univ Fed Juiz de Fora, Lab Virol, Dept Parasitol Microbiol & Imunol, Juiz De Fora, Brazil.
   [de Oliveira Prado, Andressa Anunciacao; Veiga da Silva, Camila Almeida; Pires de Souza, Gabriel Augusto; Cotta Malaquias, Luiz Cosme; Leomil Coelho, Luiz Felipe] Univ Fed Alfenas, Lab Vacinas, Inst Ciencias Biomed, Rua Gabriel Monteiro,700 Ctr, BR-37130000 Alfenas, MG, Brazil.
   [Silva Moraes, Thais de Fatima; de Magalhaes, Jose Carlos] Univ Fed Sao Joao del Rei, Dept Quim Biotecnol & Engn Bioproc, Ouro Branco, MG, Brazil.
   [Aleixo, Alan Alex; Santos, Luciana Lara] Univ Fed Sao Joao Del Rei, Campus Ctr Oeste Dona Lindu, Divinopolis, Brazil.
   [Drumond, Betania Paiva] Univ Fed Minas Gerais, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
   [Silva, Breno de Mello; de Brito Magalhaes, Cintia Lopes] Univ Fed Ouro Preto, NUPEB, Nucleo Pesquisas Ciencias Biol, Ouro Preto, MG, Brazil.
   [Silva, Breno de Mello; de Brito Magalhaes, Cintia Lopes] Univ Fed Ouro Preto, Dept Ciencias Biol, Ouro Preto, MG, Brazil.
RP Coelho, LFL (corresponding author), Univ Fed Alfenas, Lab Vacinas, Inst Ciencias Biomed, Rua Gabriel Monteiro,700 Ctr, BR-37130000 Alfenas, MG, Brazil.
EM coelho@unifal-mg.edu.br
RI Santos, Luciana L/C-9688-2013; silva, breno/W-5122-2018; Coelho, Luiz
   FL/G-5853-2012; DE SOUZA, GABRIEL/AAL-6131-2020
OI Santos, Luciana L/0000-0001-6186-4062; silva, breno/0000-0003-2472-8111;
   DE SOUZA, GABRIEL/0000-0002-2479-4429; Coelho, Luiz
   Felipe/0000-0003-4289-384X
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [404005/2012-8]; FAPEMIGMinas Gerais State Research Foundation (FAPEMIG)
   [CBB APQ 01703/14]; CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPEMIGMinas Gerais State Research
   Foundation (FAPEMIG); CAPESCAPES
FX The authors thank CNPq (grant number 404005/2012-8) and FAPEMIG (grant
   number CBB APQ 01703/14) for the financial support. A.A.O.P. received
   fellowships from CNPq. C.A.V.S., T.F.S.M., and A.A.A. received
   fellowships from FAPEMIG. T.R.S received fellowships from CAPES.
CR Alagarasu K, 2013, INFECT GENET EVOL, V17, P239, DOI 10.1016/j.meegid.2013.04.024
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Carabali M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1058-x
   CLARK MR, 1991, EUR J IMMUNOL, V21, P1911, DOI 10.1002/eji.1830210820
   de Oliveira LF, 2014, VIRAL IMMUNOL, V27, P245, DOI 10.1089/vim.2013.0119
   Dettogni RS, 2015, HUM IMMUNOL, V76, P717, DOI 10.1016/j.humimm.2015.09.026
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Friberg H, 2011, SCI REP-UK, V1, DOI 10.1038/srep00051
   Gao XY, 2011, GENET EPIDEMIOL, V35, P154, DOI 10.1002/gepi.20563
   Garcia G, 2010, AM J TROP MED HYG, V82, P1153, DOI 10.4269/ajtmh.2010.09-0353
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Halstead SB, 2015, F1000RES, V4, pF1000, DOI DOI 10.12688/F1000RESEARCH.7024.1
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Jamjoom GA, 2016, SEROEPIDEMIOLOGY ASY, P5, DOI [10.4137/VRT.S34187, DOI 10.4137/VRT.S34187]
   Kehdy FSG, 2015, P NATL ACAD SCI USA, V112, P8696, DOI 10.1073/pnas.1504447112
   Lok SM, 2016, TRENDS MICROBIOL, V24, P284, DOI 10.1016/j.tim.2015.12.004
   Loke H, 2002, AM J TROP MED HYG, V67, P102, DOI 10.4269/ajtmh.2002.67.102
   Malavige GN, 2013, J CLIN VIROL, V58, P605, DOI 10.1016/j.jcv.2013.10.023
   dos Santos ACM, 2017, IMMUNOL INVEST, V46, P201, DOI 10.1080/08820139.2016.1248560
   Mohsin SN, 2015, AM J TROP MED HYG, V93, P691, DOI 10.4269/ajtmh.15-0199
   Noecker CA, 2014, ACTA TROP, V138, P15, DOI 10.1016/j.actatropica.2014.05.021
   Ranjit S, 2011, PEDIATR CRIT CARE ME, V12, P90, DOI 10.1097/PCC.0b013e3181e911a7
   Garcia-Trejo AR, 2011, ACTA TROP, V120, P67, DOI 10.1016/j.actatropica.2011.06.002
   Sakuntabhai A, 2005, NAT GENET, V37, P507, DOI 10.1038/ng1550
   Santos HC, 2016, EUR J HUM GENET, V24, P725, DOI 10.1038/ejhg.2015.187
   Suarez-Kurtz G, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00191
   Taioli E, 2004, MUTAT RES-REV MUTAT, V567, P63, DOI 10.1016/j.mrrev.2004.06.001
   Vikram K, 2016, ACTA TROP, V153, P21, DOI 10.1016/j.actatropica.2015.09.025
   Wang L, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000934
   WARMERDAM PAM, 1991, J IMMUNOL, V147, P1338
   Yacoub Sophie, 2016, F1000Res, V5, DOI 10.12688/f1000research.6233.1
   Yacoub S, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0147-9
NR 33
TC 1
Z9 1
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0093-7711
EI 1432-1211
J9 IMMUNOGENETICS
JI Immunogenetics
PD JUN
PY 2018
VL 70
IS 6
BP 355
EP 362
DI 10.1007/s00251-017-1046-y
PG 8
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA GF4CY
UT WOS:000431909100002
PM 29164277
DA 2020-12-09
ER

PT J
AU Pinheiro, TM
   Mota, MTD
   Watanabe, ASA
   Biselli-Perico, JM
   Drumond, BP
   Ribeiro, MR
   Vedovello, D
   Araujo, JP
   Pimenta, PFP
   Chaves, BA
   da Silva, MMC
   Batista, ICA
   Papa, MP
   Meuren, LM
   Lucas, CGD
   Matassoli, FL
   Gil, LHVG
   Bozzi, A
   Calzavara-Silva, CE
   de Arruda, LB
   de Souza, DD
   Teixeira, MM
   Vasilakis, N
   Nogueira, ML
AF Pinheiro, Tauyne Menegaldo
   de Oliveira Mota, Manlio Tasso
   Aranha Watanabe, Aripuana Sakurada
   Biselli-Perico, Joice Matos
   Drumond, Betania Paiva
   Ribeiro, Milene Rocha
   Vedovello, Danila
   Araujo, Joao Pessoa, Jr.
   Paolucci Pimenta, Paulo Filemon
   Chaves, Barbara Aparecida
   Carneiro da Silva, Mayara Marques
   Andrade Batista, Izabella Cristina
   Papa, Michelle Premazzi
   Meuren, Lana Monteiro
   de Oliveira Lucas, Carolina Goncalves
   Matassoli, Flavio Lemos
   Vega Gonzales Gil, Laura Helena
   Bozzi, Adriana
   Calzavara-Silva, Carlos Eduardo
   de Arruda, Luciana Barros
   de Souza, Danielle da Gloria
   Teixeira, Mauro Martins
   Vasilakis, Nikos
   Nogueira, Mauricio Lacerda
TI Viral immunogenicity determines epidemiological fitness in a cohort of
   DENV-1 infection in Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DENGUE VIRUS; POPULATION-DYNAMICS; CO-CIRCULATION; IDENTIFICATION;
   REPLACEMENT; MOSQUITOS; SEVERITY; DISEASE; CLADE; FEVER
AB The dynamics of dengue virus (DENV) circulation depends on serotype, genotype and lineage replacement and turnover. In Sao Jose do Rio Preto, Brazil, we observed that the L6 lineage of DENV-1 (genotype V) remained the dominant circulating lineage even after the introduction of the L1 lineage. We investigated viral fitness and immunogenicity of the L1 and L6 lineages and which factors interfered with the dynamics of DENV epidemics. The results showed a more efficient replicative fitness of L1 over L6 in mosquitoes and in human and non-human primate cell lines. Infections by the L6 lineage were associated with reduced antigenicity, weak B and T cell stimulation and weak host immune system interactions, which were associated with higher viremia. Our data, therefore, demonstrate that reduced viral immunogenicity and consequent greater viremia determined the increased epidemiological fitness of DENV-1 L6 lineage in Sao Jose do Rio Preto.
C1 [Pinheiro, Tauyne Menegaldo; de Oliveira Mota, Manlio Tasso; Aranha Watanabe, Aripuana Sakurada; Biselli-Perico, Joice Matos; Ribeiro, Milene Rocha; Vedovello, Danila; Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto, Lab Pesquisa Virol, Dept Doencas Dermatol Infecciosas & Parasitarias, Sao Jose Do Rio Preto, SP, Brazil.
   [Drumond, Betania Paiva] Univ Fed Minas Gerais, Lab Virus, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Araujo, Joao Pessoa, Jr.] Univ Estadual Paulista Julio de Mesquita, Inst Biociencias, Lab Virol, Dept Microbiol & Imunol, Botucatu, SP, Brazil.
   [Paolucci Pimenta, Paulo Filemon; Chaves, Barbara Aparecida] Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Entomol Med, Belo Horizonte, MG, Brazil.
   [Chaves, Barbara Aparecida] Univ Estado Amazonas, Programa Posgrad Med Trop, Manaus, AM, Brazil.
   [Chaves, Barbara Aparecida] Fundacao Med Trop Dr Heitor Vieira Dourado FMT HV, Manaus, AM, Brazil.
   [Carneiro da Silva, Mayara Marques; Vega Gonzales Gil, Laura Helena] Fiocruz MS, Dept Virol, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Andrade Batista, Izabella Cristina; Bozzi, Adriana; Calzavara-Silva, Carlos Eduardo] Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Imunol Celular & Mol, Belo Horizonte, MG, Brazil.
   [Papa, Michelle Premazzi; Meuren, Lana Monteiro; de Oliveira Lucas, Carolina Goncalves; Matassoli, Flavio Lemos; de Arruda, Luciana Barros] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Dept Virol, Lab Genet & Imunol Infeccoes Virais, Rio De Janeiro, RJ, Brazil.
   [de Souza, Danielle da Gloria] Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Teixeira, Mauro Martins] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Inst Ciencias Biol, Lab Imunofarmacol, Belo Horizonte, MG, Brazil.
   [Vasilakis, Nikos] Univ Texas Med Branch, Ctr Trop Dis, Inst Human Infect & Immun, Dept Pathol,Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.
   [Aranha Watanabe, Aripuana Sakurada] Univ Fed Juiz de Fora, Lab Virol, Dept Parasitol Microbiol & Imunol, Juiz De Fora, MG, Brazil.
   [Biselli-Perico, Joice Matos] Univ Estadual Paulista, Dept Biol, Inst Biociencias Letras & Ciencias Exatas, Sao Jose Do Rio Preto, SP, Brazil.
RP Nogueira, ML (corresponding author), Fac Med Sao Jose do Rio Preto, Lab Pesquisa Virol, Dept Doencas Dermatol Infecciosas & Parasitarias, Sao Jose Do Rio Preto, SP, Brazil.
EM mauriciolnogueira@gmail.com
RI Bozzi, Adriana/M-6795-2013; Araujo, Joao Pessoa/C-2444-2012; Nogueira,
   Mauricio L/B-7599-2012; Bozzi, Adriana/ABE-3750-2020; Teixeira, Mauro
   M/A-4587-2008; Araujo, JP/Q-3043-2019; de Oliveira Mota, Manlio
   Tasso/E-2619-2013; Vasilakis, Nikos/ABE-7318-2020; Arruda, Luciana
   B/N-9086-2013; Biselli, Joice Matos/B-6913-2014; Pimenta,
   Paulo/AAH-1502-2020; Vedovello, Danila/M-5757-2014
OI Bozzi, Adriana/0000-0002-8242-5584; Araujo, Joao
   Pessoa/0000-0002-9153-1485; Nogueira, Mauricio L/0000-0003-1102-2419;
   Teixeira, Mauro M/0000-0002-6944-3008; Araujo, JP/0000-0002-9153-1485;
   CALZAVARA-SILVA, CARLOS/0000-0002-1406-6401; ,
   Aripuana/0000-0003-0875-2269; Matos Biselli, Joice/0000-0001-5105-9537;
   Vedovello, Danila/0000-0001-8585-8206; Chaves,
   Barbara/0000-0003-2079-6096
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/11733-6,
   2013/21719-3, 2015/22750-7]; INCT-Dengue/CNPq; NIH/NIAIDUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U01 AI115577]
FX Viral This work is funded by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP), Grants # 2012/11733-6 and 2013/21719-3 to MLN and
   2015/22750-7 to TMP and by INCT-Dengue/CNPq. MLN and MMT are CNPq
   Fellows. NV is supported by a NIH/NIAID Grant # U01 AI115577. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abu Choudhury M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107264
   Azeredo EL, 2010, IMMUNOLOGY, V130, P202, DOI 10.1111/j.1365-2567.2009.03224.x
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bidet K, 2014, BIOCHEM J, V462, P215, DOI 10.1042/BJ20140456
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897
   Chaturvedi UC, 2000, FEMS IMMUNOL MED MIC, V28, P183, DOI 10.1111/j.1574-695X.2000.tb01474.x
   Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562
   Christenbury JG, 2010, J VIROL METHODS, V169, P202, DOI 10.1016/j.jviromet.2010.06.013
   Chutinimitkul S, 2005, J VIROL METHODS, V129, P8, DOI 10.1016/j.jviromet.2005.05.006
   Cologna R, 2005, J VIROL, V79, P853, DOI 10.1128/JVI.79.2.853-859.2005
   Cunha MD, 2016, INFECT GENET EVOL, V43, P130, DOI 10.1016/j.meegid.2016.05.021
   dos Santos FB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-387
   Drummond A.J., 2002, BEAST BAYESIAN EVOLU
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drumond BP, 2012, ARCH VIROL, V157, P2061, DOI 10.1007/s00705-012-1393-9
   Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280
   Goncalves CM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-320
   Goncalvez AP, 2002, VIROLOGY, V303, P110, DOI 10.1006/viro.2002.1686
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Ho LJ, 2005, J IMMUNOL, V174, P8163, DOI 10.4049/jimmunol.174.12.8163
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   Horstick O, 2015, PATHOG GLOB HEALTH, V109, P19, DOI 10.1179/2047773215Y.0000000003
   Jain A, 2013, J CLIN IMMUNOL, V33, P613, DOI 10.1007/s10875-012-9855-0
   Katzelnick LC, 2016, P NATL ACAD SCI USA, V113, P728, DOI 10.1073/pnas.1522136113
   Lambeth CR, 2005, J CLIN MICROBIOL, V43, P3267, DOI 10.1128/JCM.43.7.3267-3272.2005
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046
   Machado DC, 2012, INTERVIROLOGY, V55, P475, DOI 10.1159/000337166
   Manakkadan A, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-37
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Mendez JA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-226
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084
   Quiner CA, 2014, J VIROL, V88, P13125, DOI 10.1128/JVI.01822-14
   Raghwani J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002064
   Rambaut A, 2002, TREEANOTATOR V1 8 1
   Rambaut A., 2003, TRACER MCMC TRACE AN
   Sariol CA, 2018, TRENDS MICROBIOL, V26, P186, DOI 10.1016/j.tim.2017.10.004
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Vedovello D, 2015, ARCH VIROL, V160, P1189, DOI 10.1007/s00705-015-2378-2
   Villabona-Arenas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062649
   Wargo AR, 2012, CURR OPIN VIROL, V2, P538, DOI 10.1016/j.coviro.2012.07.007
   Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005
NR 44
TC 8
Z9 8
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2018
VL 12
IS 5
AR e0006525
DI 10.1371/journal.pntd.0006525
PG 25
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GH9WW
UT WOS:000434021900060
PM 29813061
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Sedda, L
   Vilela, APP
   Aguiar, ERGR
   Gaspar, CHP
   Goncalves, ANA
   Olmo, RP
   Silva, ATS
   da Silveira, LD
   Eiras, AE
   Drumond, BP
   Kroon, EG
   Marques, JT
AF Sedda, Luigi
   Pessoa Vilela, Ana Paula
   Guimaraes Rocha Aguiar, Eric Roberto
   Pessoa Gaspar, Caio Henrique
   Aquime Goncalves, Andre Nicolau
   Olmo, Roenick Proveti
   Saraiva Silva, Ana Teresa
   da Silveira, Lizia de Cassia
   Eiras, Alvaro Eduardo
   Drumond, Betania Paiva
   Kroon, Erna Geessien
   Marques, Joao Trindade
TI The spatial and temporal scales of local dengue virus transmission in
   natural settings: a retrospective analysis
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; Dengue virus serotypes 1 and 3;
   Bivariate point-process; Kriging; Geostatistical additive models; Urban
   dengue
ID AEDES-ALBOPICTUS DIPTERA; RIO-DE-JANEIRO; POLYMERASE-CHAIN-REACTION;
   AEGYPTI MOSQUITOS; LARVAL INDEXES; SEROTYPES 1; SAO-PAULO; CULICIDAE;
   VECTOR; SURVEILLANCE
AB Background: Dengue is a vector-borne disease caused by the dengue virus (DENV). Despite the crucial role of Aedes mosquitoes in DENV transmission, pure vector indices poorly correlate with human infections. Therefore there is great need for a better understanding of the spatial and temporal scales of DENV transmission between mosquitoes and humans. Here, we have systematically monitored the circulation of DENV in individual Aedes spp. mosquitoes and human patients from Caratinga, a dengue endemic city in the state of Minas Gerais, in Southeast Brazil. From these data, we have developed a novel stochastic point process pattern algorithm to identify the spatial and temporal association between DENV infected mosquitoes and human patients.
   Methods: The algorithm comprises of: (i) parameterization of the variogram for the incidence of each DENV serotype in mosquitoes; (ii) identification of the spatial and temporal ranges and variances of DENV incidence in mosquitoes in the proximity of humans infected with dengue; and (iii) analysis of the association between a set of environmental variables and DENV incidence in mosquitoes in the proximity of humans infected with dengue using a spatio-temporal additive, geostatistical linear model.
   Results: DENV serotypes 1 and 3 were the most common virus serotypes detected in both mosquitoes and humans. Using the data on each virus serotype separately, our spatio-temporal analyses indicated that infected humans were located in areas with the highest DENV incidence in mosquitoes, when incidence is calculated within 2.5-3 km and 50 days (credible interval 30-70 days) before onset of symptoms in humans. These measurements are in agreement with expected distances covered by mosquitoes and humans and the time for virus incubation. Finally, DENV incidence in mosquitoes found in the vicinity of infected humans correlated well with the low wind speed, higher air temperature and northerly winds that were more likely to favor vector survival and dispersal in Caratinga.
   Conclusions: We have proposed a new way of modeling bivariate point pattern on the transmission of arthropodborne pathogens between vector and host when the location of infection in the latter is known. This strategy avoids some of the strong and unrealistic assumptions made by other point-process models. Regarding virus transmission in Caratinga, our model showed a strong and significant association between high DENV incidence in mosquitoes and the onset of symptoms in humans at specific spatial and temporal windows. Together, our results indicate that vector surveillance must be a priority for dengue control. Nevertheless, localized vector control at distances lower than 2.5 km around premises with infected vectors in densely populated areas are not likely to be effective.
C1 [Sedda, Luigi] Univ Lancaster, CHICAS, Furness Bldg, Lancaster LA1 4YG, England.
   [Pessoa Vilela, Ana Paula; Guimaraes Rocha Aguiar, Eric Roberto; Aquime Goncalves, Andre Nicolau; Olmo, Roenick Proveti; Saraiva Silva, Ana Teresa; da Silveira, Lizia de Cassia; Marques, Joao Trindade] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, BR-30270901 Belo Horizonte, MG, Brazil.
   [Pessoa Vilela, Ana Paula; Pessoa Gaspar, Caio Henrique; Drumond, Betania Paiva; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, BR-30270901 Belo Horizonte, MG, Brazil.
   [Guimaraes Rocha Aguiar, Eric Roberto] Univ Fed Bahia, Inst Ciencias Saude, BR-40110100 Salvador, BA, Brazil.
   [Eiras, Alvaro Eduardo] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, BR-30270901 Belo Horizonte, MG, Brazil.
RP Marques, JT (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, BR-30270901 Belo Horizonte, MG, Brazil.
EM jtm@ufmg.br
RI Aguiar, Eric/T-5076-2019; Marques, Joao T/F-7683-2012; Aguiar, Eric
   RGR/L-7989-2018; Vilela, Ana Paula Pessoa/Q-7538-2018; Kroon,
   Erna/V-5444-2019; Sedda, Luigi/ABD-8784-2020; Eiras, Alvaro/Z-6023-2019;
   Olmo, Roenick/AAF-6412-2020
OI Aguiar, Eric/0000-0002-8143-5756; Marques, Joao T/0000-0002-3457-3320;
   Aguiar, Eric RGR/0000-0002-8143-5756; Vilela, Ana Paula
   Pessoa/0000-0001-9030-0688; Eiras, Alvaro/0000-0002-3045-0673; Sedda,
   Luigi/0000-0002-9271-6596
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG)
FX This work was supported with grants from CAPES, CNPq and FAPEMIG to EGK
   and JTM. EGK and JTM are researchers from CNPq.
CR Azil AH, 2014, J VECTOR ECOL, V39, P153, DOI 10.1111/j.1948-7134.2014.12082.x
   Barmak DH, 2016, PHYSICA A, V447, P129, DOI 10.1016/j.physa.2015.12.015
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Cecilio SG, 2015, J VECTOR ECOL, V40, P71, DOI 10.1111/jvec.12134
   Chadee DD, 2009, ACTA TROP, V112, P174, DOI 10.1016/j.actatropica.2009.07.017
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chen CF, 2010, VECTOR-BORNE ZOONOT, V10, P1017, DOI 10.1089/vbz.2008.0069
   Cheong YL, 2013, INT J ENV RES PUB HE, V10, P6319, DOI 10.3390/ijerph10126319
   Chow VTK, 1998, AM J TROP MED HYG, V58, P578, DOI 10.4269/ajtmh.1998.58.578
   Consoli RAGB, 1994, PRINCIPAIS MOSQUITOS
   Costa ACC, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0219-6
   Cressie N., 2015, STAT SPATIAL DATA
   Cummins B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002500
   Taranto MFD, 2015, TROP MED INT HEALTH, V20, P77, DOI 10.1111/tmi.12402
   de Bronzoni RV Morais, 2005, J CLIN MICROBIOL, V43, P7
   de Castro MG, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-3
   de Thoisy B, 2009, VECTOR-BORNE ZOONOT, V9, P157, DOI 10.1089/vbz.2007.0280
   Degener CM, 2015, MEM I OSWALDO CRUZ, V110, P517, DOI 10.1590/0074-02760140374
   Depradine CA, 2004, INT J ENVIRON HEAL R, V14, P429, DOI 10.1080/09603120400012868
   Diallo M, 2003, EMERG INFECT DIS, V9, P362, DOI 10.3201/eid0903.020219
   Diggle P J, 2013, STAT ANAL SPATIAL SP
   Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2
   Drumond BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059422
   Eiras AE, 2009, CAD SAUDE PUBLICA, V25, pS45, DOI 10.1590/S0102-311X2009001300005
   Estallo EL, 2014, ACTA TROP, V136, P129, DOI 10.1016/j.actatropica.2014.04.024
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Favaro EA, 2006, J VECTOR ECOL, V31, P285, DOI 10.3376/1081-1710(2006)31[285:PSOASA]2.0.CO;2
   de Figueiredo MLG, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-60
   Gaye A, 2014, TROP MED INT HEALTH, V19, P1355, DOI 10.1111/tmi.12373
   Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326
   Heringer M, 2015, T ROY SOC TROP MED H, V109, P268, DOI 10.1093/trstmh/trv006
   Higa Yukiko, 2011, Tropical Medicine and Health, V39, P17, DOI 10.2149/tmh.2011-S04
   Cuong HQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001322
   Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005
   Honorio NA, 2009, CAD SAUDE PUBLICA, V25, P1203, DOI 10.1590/S0102-311X2009000600003
   Kan CC, 2008, AM J TROP MED HYG, V79, P344, DOI 10.4269/ajtmh.2008.79.344
   Karl S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-447
   Khalid B, 2015, INT J BIOMETEOROL, V59, P267, DOI 10.1007/s00484-014-0840-6
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Le Goff G, 2011, PARASITE, V18, P277, DOI 10.1051/parasite/2011183277
   Maciel-de-Freitas R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065252
   Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508
   Mendez-Galvan J, 2014, SOUTHWEST ENTOMOL, V39, P307, DOI 10.3958/059.039.0208
   Mercado-Hernandez R, 2003, J AM MOSQUITO CONTR, V19, P15
   Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Mwangangi JM, 2012, PARASITOL RES, V110, P61, DOI 10.1007/s00436-011-2449-6
   Naish S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092524
   Nino L, 2008, BIOMEDICA, V28, P578, DOI 10.7705/biomedica.v28i4.64
   de Melo DPO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042125
   Pepin KM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0659-y
   Pepin KM, 2013, EMERG INFECT DIS, V19, P542, DOI 10.3201/eid1904.120117
   Pepin KM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-28
   Pinheiro J. C, 2012, NLME PACKAGE LINEAR, V6
   Piovezan R, 2013, J VECTOR ECOL, V38, P317, DOI 10.1111/j.1948-7134.2013.12046.x
   Racloz V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001648
   Richards SL, 2012, J MED ENTOMOL, V49, P942, DOI 10.1603/ME11293
   Rosa-Freitas Maria Goreti, 2006, Rev Panam Salud Publica, V20, P256, DOI 10.1590/S1020-49892006000900006
   Sanchez L, 2006, EMERG INFECT DIS, V12, P800
   Schlather M., 2012, ADV CHALLENGES SPACE, P25, DOI DOI 10.1007/978-3-642-17086-7_2
   Sedda L, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1024-5
   Simoes TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064773
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Sun CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088025
   Taber ED, 2017, J VECTOR ECOL, V42, P3, DOI 10.1111/jvec.12234
   Talagala T, 2015, EPIDEMIOL BIOSTAT PU, V12, DOI 10.2427/11522
   Telle O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146539
   Urdaneta Ludmel, 2005, Infection Genetics and Evolution, V5, P177, DOI 10.1016/j.meegid.2004.09.004
   Vargas WP, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2097-3
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920
   Viennet E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-379
   Vikram K, 2015, J VECTOR DIS, V52, P129
   Vilela APP, 2010, EMERG INFECT DIS, V16, P989, DOI 10.3201/eid1606.091000
   Villabona-Arenas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062649
   Wang CG, 2014, ASIA-PAC J PUBLIC HE, V26, P48, DOI 10.1177/1010539513490195
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   Wen TH, 2015, APPL GEOGR, V62, P256, DOI 10.1016/j.apgeog.2015.05.003
   Whitehorn J, 2015, J INFECT DIS, V212, P1182, DOI 10.1093/infdis/jiv173
   Wijayanti SPM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004964
   Wong GKL, 2017, BUILD ENVIRON, V112, P63, DOI 10.1016/j.buildenv.2016.11.028
   Wong GKL, 2016, SCI TOTAL ENVIRON, V573, P222, DOI 10.1016/j.scitotenv.2016.08.102
   WORLD HEALTH ORGANIZATION (WHO); Special Programme for Research and Training in Tropical Diseases (TDR), 2009, DENG GUID DIAGN TREA
   ZIMMERMAN DL, 1993, MATH GEOL, V25, P453, DOI 10.1007/BF00894779
NR 88
TC 5
Z9 5
U1 0
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD FEB 2
PY 2018
VL 11
AR 79
DI 10.1186/s13071-018-2662-6
PG 14
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FU9CY
UT WOS:000424154800001
PM 29394906
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-12-09
ER

PT J
AU Boratto, PVM
   Dornas, FP
   da Silva, LCF
   Rodrigues, RAL
   Oliveira, GP
   Cortines, JR
   Drumond, BP
   Abrahao, JS
AF Miranda Boratto, Paulo Victor
   Dornas, Fabio Pio
   Ferreira da Silva, Lorena Christine
   Lima Rodrigues, Rodrigo Araujo
   Oliveira, Graziele Pereira
   Cortines, Juliana Reis
   Drumond, Betania Paiva
   Abrahao, Jonatas Santos
TI Analyses of the Kroon Virus Major Capsid Gene and Its Transcript
   Highlight a Distinct Pattern of Gene Evolution and Splicing among
   Mimiviruses
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE KV; mimivirus; Megavirales; giant virus; isolation; capsid; splicing
ID GIANT; MIMIVIRIDAE; LINEAGE; ORIGIN
AB The inclusion of Mimiviridae members in the putative monophyletic nucleocytoplasmic large DNA virus (NCLDV) group is based on genomic and phylogenomic patterns. This shows that, along with other viral families, they share a set of genes known as core or "hallmark genes," including the gene for the major capsid protein (MCP). Although previous studies have suggested that the maturation of mimivirus MCP transcripts is dependent on splicing, there is little information about the processing of this transcript in other mimivirus isolates. Here we report the characterization of a new mimivirus isolate, called Kroon virus (KV) mimivirus. Analysis of the structure, synteny, and phylogenetic relationships of the MCP genes in many mimivirus isolates revealed a remarkable variation at position and types of intronic and exonic regions, even for mimiviruses belonging to the same lineage. In addition, sequencing of KV and Acanthamoeba polyphaga mimivirus (APMV) MCP transcripts has shown that inside the family, even related giant viruses may present different ways to process the MCP mRNA. These results contribute to the understanding of the genetic organization and evolution of the MCP gene in mimiviruses.
   IMPORTANCE Mimivirus isolates have been obtained by prospecting studies since 2003. Based on genomic and phylogenomic studies of conserved genes, these viruses have been clustered together with members of six other viral families. Although the major capsid protein (MCP) gene is an important member of the so-called "hallmark genes," there is little information about the processing and structure of this gene in many mimivirus isolates. In this work, we have analyzed the structure, synteny, and phylogenetic relationships of the MCP genes in many mimivirus isolates; these genes showed remarkable variation at position and types of intronic and exonic regions, even for mimiviruses belonging to the same lineage. These results contribute to the understanding of the genetic organization and evolution of the MCP gene in mimiviruses.
C1 [Miranda Boratto, Paulo Victor; Dornas, Fabio Pio; Ferreira da Silva, Lorena Christine; Lima Rodrigues, Rodrigo Araujo; Oliveira, Graziele Pereira; Drumond, Betania Paiva; Abrahao, Jonatas Santos] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
   [Cortines, Juliana Reis] Inst Microbiol Paulo de Goes, Dept Virol, Ctr Ciencias Saude, Rio De Janeiro, RJ, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Cortines, Juliana/V-3997-2019; Dornas, Fabio/AAI-3582-2020
OI Dornas, Fabio/0000-0001-7926-5551; Araujo Lima Rodrigues,
   Rodrigo/0000-0001-7148-4012; Cortines, Juliana/0000-0003-2481-9267
CR Andrade KR, 2015, ARCH VIROL, V160, P477, DOI 10.1007/s00705-014-2257-2
   Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108
   Assis FL, 2015, VIRUSES-BASEL, V7, P3483, DOI 10.3390/v7072782
   Azza S, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-39
   Boratto PVM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01256
   Brighenti LS, 2011, ACTA SCI-BIOL SCI, V33, P7
   Campos RK, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-95
   Colson Philippe, 2011, Genome Biol Evol, V3, P737, DOI 10.1093/gbe/evr048
   Dornas FP, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01086
   Dornas FP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087811
   Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009
   Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001
   Khalil JYB, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00026
   Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-1
   Koonin EV, 2010, INTERVIROLOGY, V53, P284, DOI 10.1159/000312913
   La Scola B, 2003, SCIENCE, V299, P2033
   Legendre M, 2014, P NATL ACAD SCI USA, V111, P4274, DOI 10.1073/pnas.1320670111
   Legendre M, 2010, GENOME RES, V20, P664, DOI 10.1101/gr.102582.109
   LWOFF A, 1957, J GEN MICROBIOL, V17, P239, DOI 10.1099/00221287-17-2-239
   Moreira D, 2009, NAT REV MICROBIOL, V7, P306, DOI 10.1038/nrmicro2108
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Renesto P, 2006, J VIROL, V80, P11678, DOI 10.1128/JVI.00940-06
   Yoosuf N, 2014, VIROLOGY, V452, P125, DOI 10.1016/j.virol.2013.12.032
   Yoosuf N, 2012, GENOME BIOL EVOL, V4, P1324, DOI 10.1093/gbe/evs109
   Yutin N, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-106
NR 25
TC 5
Z9 5
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JAN
PY 2018
VL 92
IS 2
AR e01782-17
DI 10.1128/JVI.01782-17
PG 11
WC Virology
SC Virology
GA FR4NJ
UT WOS:000419042000029
PM 29118120
OA Green Published, Bronze
DA 2020-12-09
ER

PT J
AU Oliveira, GP
   Rodrigues, RAL
   Lima, MT
   Drumond, BP
   Abrahao, JS
AF Oliveira, Graziele Pereira
   Lima Rodrigues, Rodrigo Araujo
   Lima, Mauricio Teixeira
   Drumond, Betania Paiva
   Abrahao, Jonatas Santos
TI Poxvirus Host Range Genes and Virus-Host Spectrum: A Critical Review
SO VIRUSES-BASEL
LA English
DT Review
DE Poxviridae; network; host range genes; horizontal gene transfer;
   evolution
ID CONDITIONAL-LETHAL MUTANTS; SHOPE FIBROMA VIRUS; VACCINIA-VIRUS;
   RABBITPOX VIRUS; MYXOMA-VIRUS; PROTEIN-KINASE; PET RATS; E3L GENE;
   IN-VIVO; EVOLUTION
AB The Poxviridae family is comprised of double-stranded DNA viruses belonging to nucleocytoplasmic large DNA viruses (NCLDV). Among the NCLDV, poxviruses exhibit the widest known host range, which is likely observed because this viral family has been more heavily investigated. However, relative to each member of the Poxviridae family, the spectrum of the host is variable, where certain viruses can infect a large range of hosts, while others are restricted to only one host species. It has been suggested that the variability in host spectrum among poxviruses is linked with the presence or absence of some host range genes. Would it be possible to extrapolate the restriction of viral replication in a specific cell lineage to an animal, a far more complex organism? In this study, we compare and discuss the relationship between the host range of poxvirus species and the abundance/diversity of host range genes. We analyzed the sequences of 38 previously identified and putative homologs of poxvirus host range genes, and updated these data with deposited sequences of new poxvirus genomes. Overall, the term host range genes might not be the most appropriate for these genes, since no correlation between them and the viruses' host spectrum was observed, and a change in nomenclature should be considered. Finally, we analyzed the evolutionary history of these genes, and reaffirmed the occurrence of horizontal gene transfer (HGT) for certain elements, as previously suggested. Considering the data presented in this study, it is not possible to associate the diversity of host range factors with the amount of hosts of known poxviruses, and this traditional nomenclature creates misunderstandings.
C1 [Oliveira, Graziele Pereira; Lima Rodrigues, Rodrigo Araujo; Lima, Mauricio Teixeira; Drumond, Betania Paiva; Abrahao, Jonatas Santos] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
EM graziufmg@yahoo.com.br; rodriguesral07@gmail.com; maurili15@hotmail.com;
   betaniadrumond@gmail.com; jonatas.abrahao@gmail.com
OI Teixeira Lima, Mauricio/0000-0002-0830-3909; Araujo Lima Rodrigues,
   Rodrigo/0000-0001-7148-4012
CR Abrahao JS, 2010, J CLIN VIROL, V48, P69, DOI 10.1016/j.jcv.2010.02.001
   Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Abrahao JS, 2015, EMERG INFECT DIS, V21, P695, DOI 10.3201/eid2104.140351
   Afonso CL, 1999, J VIROL, V73, P533, DOI 10.1128/JVI.73.1.533-552.1999
   Alejo A, 2006, P NATL ACAD SCI USA, V103, P5995, DOI 10.1073/pnas.0510462103
   ALI AN, 1994, VIROLOGY, V202, P305, DOI 10.1006/viro.1994.1347
   Alzhanova D, 2010, MICROBES INFECT, V12, P900, DOI 10.1016/j.micinf.2010.07.007
   Assis FL, 2013, EMERG INFECT DIS, V19, P2045, DOI 10.3201/eid1912.120937
   Baker KS, 2013, VIROLOGY, V441, P95, DOI 10.1016/j.virol.2013.03.014
   Balamurugan V, 2013, INDIAN J VIROL, V24, P295, DOI 10.1007/s13337-013-0145-0
   Barrett JW, 2007, VIROLOGY, V361, P123, DOI 10.1016/j.virol.2006.11.015
   Barry M, 1997, PARASITOLOGY, V115, pS89, DOI 10.1017/S0031182097001820
   BEATTIE E, 1995, VIROLOGY, V210, P254, DOI 10.1006/viro.1995.1342
   BOWMAN KF, 1981, JAMA-J AM MED ASSOC, V246, P2813, DOI 10.1001/jama.246.24.2813
   Boyer M, 2010, INTERVIROLOGY, V53, P310, DOI 10.1159/000312916
   Bratke KA, 2013, INFECT GENET EVOL, V14, P406, DOI 10.1016/j.meegid.2012.12.002
   Bratke KA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-67
   Campe H, 2009, EMERG INFECT DIS, V15, P777, DOI 10.3201/eid1505.090159
   Castrucci MR, 2014, INFLUENZA OTHER RESP, V8, P367, DOI 10.1111/irv.12221
   Chan WNM, 2013, VACCINE, V31, P4252, DOI 10.1016/j.vaccine.2013.05.056
   CHANG HW, 1993, VIROLOGY, V194, P537, DOI 10.1006/viro.1993.1292
   CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825
   Chang SJ, 2009, J VIROL, V83, P4140, DOI 10.1128/JVI.01835-08
   CHEN W, 1993, VIROLOGY, V196, P682, DOI 10.1006/viro.1993.1525
   Chen XY, 2013, LANCET INFECT DIS, V13, P877, DOI 10.1016/S1473-3099(13)70109-9
   Craig AWB, 1996, J BIOL CHEM, V271, P24526, DOI 10.1074/jbc.271.40.24526
   Damon I. K., 2014, FIELDS VIROLOGY, V2, P2160
   DAVIES MV, 1992, J VIROL, V66, P1943, DOI 10.1128/JVI.66.4.1943-1950.1992
   DAVIES MV, 1993, J VIROL, V67, P1688, DOI 10.1128/JVI.67.3.1688-1692.1993
   Douglas AE, 2007, PROTEIN SCI, V16, P695, DOI 10.1110/ps.062720107
   Essbauer S, 2010, VET MICROBIOL, V140, P229, DOI 10.1016/j.vetmic.2009.08.026
   FENNER F, 1958, VIROLOGY, V5, P502, DOI 10.1016/0042-6822(58)90042-4
   FENNER F, 1966, VIROLOGY, V28, P600, DOI 10.1016/0042-6822(66)90245-5
   Fenner F, 2000, FEMS MICROBIOL REV, V24, P123, DOI 10.1111/j.1574-6976.2000.tb00536.x
   Fenner F, 1988, SMALLPOX ITS ERADICA, P1371
   Friederichs S, 2015, J GEN VIROL, V96, P1446, DOI 10.1099/vir.0.000080
   Garcia-Arriaza J, 2014, J VIROL, V88, P3527, DOI 10.1128/JVI.03418-13
   Geessien Kroon Erna, 2016, Curr Protoc Microbiol, V42, DOI 10.1002/cpmc.13
   GEMMELL A, 1959, VIROLOGY, V8, P381, DOI 10.1016/0042-6822(59)90037-6
   Gjessing MC, 2015, J VIROL, V89, P9348, DOI 10.1128/JVI.01174-15
   Gunther T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03997-y
   Haller SL, 2014, INFECT GENET EVOL, V21, P15, DOI 10.1016/j.meegid.2013.10.014
   Henderson DA, 2011, VACCINE, V29, pD7, DOI 10.1016/j.vaccine.2011.06.080
   Herrera E, 1998, J VIROL, V72, P294, DOI 10.1128/JVI.72.1.294-302.1998
   Hughes AL, 2005, MOL PHYLOGENET EVOL, V35, P186, DOI 10.1016/j.ympev.2004.12.008
   Hughes AL, 2002, J MOL EVOL, V54, P90, DOI 10.1007/s00239-001-0021-1
   Hughes AL, 2010, INFECT GENET EVOL, V10, P50, DOI 10.1016/j.meegid.2009.10.001
   Hutson CL, 2007, AM J TROP MED HYG, V76, P757, DOI 10.4269/ajtmh.2007.76.757
   Hutson CL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004013
   Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001
   Johnston JB, 2005, IMMUNITY, V23, P587, DOI 10.1016/j.immuni.2005.10.003
   KawagishiKobayashi M, 1997, MOL CELL BIOL, V17, P4146, DOI 10.1128/MCB.17.7.4146
   Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-29
   KOTWAL GJ, 1990, SCIENCE, V250, P827, DOI 10.1126/science.2237434
   KOTWAL GJ, 1988, VIROLOGY, V167, P524, DOI 10.1016/0042-6822(88)90115-8
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Langland JO, 2006, J VIROL, V80, P10083, DOI 10.1128/JVI.00607-06
   Langland JO, 2002, VIROLOGY, V299, P133, DOI 10.1006/viro.2002.1479
   Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413
   Lefkowitz EJ, 2006, VIRUS RES, V117, P105, DOI 10.1016/j.virusres.2006.01.016
   Legendre M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-99
   Legrand FA, 2004, J VIROL, V78, P2770, DOI 10.1128/JVI.78.6.2770-2779.2004
   Leung AKC, 2017, RECENT PATENTS INFLA, V11, P22, DOI 10.2174/1872213X11666170518114456
   Liszewski MK, 2009, J IMMUNOL, V183, P3150, DOI 10.4049/jimmunol.0901366
   Liu J, 2012, J VIROL, V86, P5371, DOI 10.1128/JVI.06933-11
   Mauldin MR, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050101
   MAYR A, 1970, ARCH GES VIRUSFORSCH, V31, P51, DOI 10.1007/BF01241665
   MCCLAIN ME, 1965, VIROLOGY, V25, P516, DOI 10.1016/0042-6822(65)90079-6
   McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099
   McLysaght A, 2003, P NATL ACAD SCI USA, V100, P15655, DOI 10.1073/pnas.2136653100
   Mendez-Rios JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034604
   Meng XZ, 2008, VIROLOGY, V372, P372, DOI 10.1016/j.virol.2007.10.023
   Franco-Luiz APM, 2016, EMERG INFECT DIS, V22, P2174, DOI 10.3201/eid2212.160447
   Moss B, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010199
   Ninove L, 2009, EMERG INFECT DIS, V15, P781, DOI 10.3201/eid1505.090235
   Nolen LD, 2016, EMERG INFECT DIS, V22, P1014, DOI 10.3201/eid2206.150579
   O'Dea MA, 2016, J GEN VIROL, V97, P2363, DOI 10.1099/jgv.0.000538
   Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500
   Odom MR, 2009, VIRUS RES, V144, P233, DOI 10.1016/j.virusres.2009.05.006
   Ojha H, 2014, MOL IMMUNOL, V61, P89, DOI 10.1016/j.molimm.2014.06.004
   Oliveira G, 2016, PARAPOXVIRUS MOL DET, P881
   Reynolds MG, 2010, AM J TROP MED HYG, V82, P746, DOI 10.4269/ajtmh.2010.09-0716
   Rivas C, 1998, VIROLOGY, V243, P406, DOI 10.1006/viro.1998.9072
   Rodger G, 2002, J GEN VIROL, V83, P323, DOI 10.1099/0022-1317-83-2-323
   SAMBROOK JF, 1966, VIROLOGY, V28, P592, DOI 10.1016/0042-6822(66)90244-3
   Senkevich TG, 1997, VIROLOGY, V233, P19, DOI 10.1006/viro.1997.8607
   Shchelkunov SN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003756
   Sigal LJ, 2016, ADV IMMUNOL, V129, P251, DOI 10.1016/bs.ai.2015.10.001
   Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200
   SMITH CA, 1991, BIOCHEM BIOPH RES CO, V176, P335, DOI 10.1016/0006-291X(91)90929-2
   SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731
   Smithson C, 2017, VIRUS GENES, V53, P883, DOI 10.1007/s11262-017-1501-8
   SPEHNER D, 1988, J VIROL, V62, P1297, DOI 10.1128/JVI.62.4.1297-1304.1988
   Stanford MM, 2005, TRENDS IMMUNOL, V26, P339, DOI 10.1016/j.it.2005.04.001
   Stern RJ, 1997, VIROLOGY, V233, P118, DOI 10.1006/viro.1997.8556
   Theves C, 2014, CLIN MICROBIOL INFEC, V20, P210, DOI 10.1111/1469-0691.12536
   Theze J, 2015, VIRUSES-BASEL, V7, P1960, DOI 10.3390/v7041960
   Theze J, 2013, J VIROL, V87, P7992, DOI 10.1128/JVI.00453-13
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Trindade GD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120328
   Tu SL, 2017, VIRUS GENES, V53, P856, DOI 10.1007/s11262-017-1485-4
   Tulman ER, 2004, J VIROL, V78, P353, DOI 10.1128/JVI.78.1.353-366.2004
   UPTON C, 1986, MOL CELL BIOL, V6, P265, DOI 10.1128/MCB.6.1.265
   Villarreal LP, 2000, VIROLOGY, V272, P1, DOI 10.1006/viro.2000.0381
   Werden SJ, 2008, ADV VIRUS RES, V71, P135, DOI 10.1016/S0065-3527(08)00003-1
   Wong CK, 2011, J VIROL, V85, P7900, DOI 10.1128/JVI.00645-11
   Zhao GY, 2011, J VIROL, V85, P10230, DOI 10.1128/JVI.00637-11
NR 107
TC 2
Z9 2
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2017
VL 9
IS 11
AR 331
DI 10.3390/v9110331
PG 17
WC Virology
SC Virology
GA FO4KB
UT WOS:000416810300021
PM 29112165
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Vedovello, D
   Ullmman, LS
   Biselli-Perico, JM
   Colombo, TE
   Pinheiro, TM
   Bronzoni, RV
   Mondini, A
   Terzian, ACB
   Araujo, JP
   Chiavanotti-Neto, F
   Teixeira, MM
   Vasilakis, N
   Drumond, BP
   Rahal, P
   Nogueira, ML
AF Vedovello, Danila
   Ullmman, Leila Sabrina
   Biselli-Perico, Joice M.
   Colombo, Tatiana E.
   Pinheiro, Tauyne M.
   Bronzoni, Roberta V.
   Mondini, Adriano
   Terzian, Ana Carolina B.
   Araujo, Joao P., Jr.
   Chiavanotti-Neto, Francisco
   Teixeira, Mauro M.
   Vasilakis, Nikos
   Drumond, Betania P.
   Rahal, Paula
   Nogueira, Mauricio L.
TI DENGUE VIRUS: THE CIRCULATION OF FOUR SEROTYPES IN AN ENDEMIC REGION,
   DURING NINE SEASONS: SINGULARITIES ON EPIDEMIC DYNAMICS AND GENETIC
   DIVERSITY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Vedovello, Danila] UFABC, Sao Bernardo Do Campo, Brazil.
   [Ullmman, Leila Sabrina; Araujo, Joao P., Jr.] UNESP, Botucatu, SP, Brazil.
   [Biselli-Perico, Joice M.; Rahal, Paula] UNESP, Sao Jose Do Rio Preto, Brazil.
   [Colombo, Tatiana E.; Pinheiro, Tauyne M.; Terzian, Ana Carolina B.; Nogueira, Mauricio L.] FAMERP, Sao Jose Do Rio Preto, Brazil.
   [Bronzoni, Roberta V.] UFMT, Sinop, Brazil.
   [Mondini, Adriano] UNESP, Araraquara, Brazil.
   [Chiavanotti-Neto, Francisco] FSP USP, Sao Paulo, Brazil.
   [Teixeira, Mauro M.; Drumond, Betania P.] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Vasilakis, Nikos] Univ Texas Med Branch, Galveston, TX 77555 USA.
RI Teixeira, Mauro M/A-4587-2008; Nogueira, Mauricio L/B-7599-2012;
   Biselli, Joice Matos/B-6913-2014; Rahal, Paula/D-3871-2012; Araujo, Joao
   Pessoa/C-2444-2012; Vasilakis, Nikos/ABE-7318-2020
OI Teixeira, Mauro M/0000-0002-6944-3008; Nogueira, Mauricio
   L/0000-0003-1102-2419; Rahal, Paula/0000-0001-5693-6148; Araujo, Joao
   Pessoa/0000-0002-9153-1485; 
NR 0
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 91
BP 31
EP 31
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851501091
DA 2020-12-09
ER

PT J
AU de Oliveira, JS
   Figueiredo, PD
   Costa, GB
   de Assis, FL
   Drumond, BP
   da Fonseca, FG
   Nogueira, ML
   Kroon, EG
   Trindade, GD
AF de Oliveira, Jaqueline Silva
   Figueiredo, Poliana de Oliveira
   Costa, Galileu Barbosa
   de Assis, Felipe Lopes
   Drumond, Betania Paiva
   da Fonseca, Flavio Guimaraes
   Nogueira, Mauricio Lacerda
   Kroon, Erna Geessien
   Trindade, Giliane de Souza
TI Vaccinia Virus Natural Infections in Brazil: The Good, the Bad, and the
   Ugly
SO VIRUSES-BASEL
LA English
DT Review
DE orthopoxvirus; smallpox vaccine; vaccinia virus; zoonosis; public
   health; ecology; host range; natural infections
ID SAO-PAULO STATE; BOVINE VACCINIA; HYDROCHOERUS-HYDROCHAERIS; MOLECULAR
   CHARACTERIZATION; CLINICAL DESCRIPTION; ECZEMA VACCINATUM; MAHARASHTRA
   STATE; SMALLPOX VACCINE; VARIOLA MINOR; OUTBREAK
AB The orthopoxviruses (OPV) comprise several emerging viruses with great importance to human and veterinary medicine, including vaccinia virus (VACV), which causes outbreaks of bovine vaccinia (BV) in South America. Historically, VACV is the most comprehensively studied virus, however, its origin and natural hosts remain unknown. VACV was the primary component of the smallpox vaccine, largely used during the smallpox eradication campaign. After smallpox was declared eradicated, the vaccination that conferred immunity to OPV was discontinued, favoring a new contingent of susceptible individuals to OPV. VACV infections occur naturally after direct contact with infected dairy cattle, in recently vaccinated individuals, or through alternative routes of exposure. In Brazil, VACV outbreaks are frequently reported in rural areas, affecting mainly farm animals and humans. Recent studies have shown the role of wildlife in the VACV transmission chain, exploring the role of wild rodents as reservoirs that facilitate VACV spread throughout rural areas. Furthermore, VACV circulation in urban environments and the significance of this with respect to public health, have also been explored. In this review, we discuss the history, epidemiological, ecological and clinical aspects of natural VACV infections in Brazil, also highlighting alternative routes of VACV transmission, the factors involved in susceptibility to infection, and the natural history of the disease in humans and animals, and the potential for dissemination to urban environments.
C1 [de Oliveira, Jaqueline Silva; Figueiredo, Poliana de Oliveira; Costa, Galileu Barbosa; Drumond, Betania Paiva; Kroon, Erna Geessien; Trindade, Giliane de Souza] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
   [de Assis, Felipe Lopes] US FDA, Silver Spring, MD 20993 USA.
   [da Fonseca, Flavio Guimaraes] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Virol Basica & Aplicada, BR-31270901 Belo Horizonte, MG, Brazil.
   [Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto, Lab Pesquisas Virol, Dept Doencas Infecciosas Parasitarias, BR-15090000 Sao Paulo, Brazil.
RP Costa, GB; Trindade, GD (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
EM jaquelinebmedica@hotmail.com; polianaofigueiredo@yahoo.com.br;
   galileuk1@gmail.com; felipelopesassis@gmail.com;
   betaniadrumond@gmail.com; fdafonseca@icb.ufmg.br; mnogueira@famerp.br;
   ernagkroon@gmail.com; giliane@icb.ufmg.br
RI Nogueira, Mauricio L/B-7599-2012; Kroon, Erna/V-5444-2019; Costa,
   Galileu Barbosa/M-5768-2019
OI Nogueira, Mauricio L/0000-0003-1102-2419; Barbosa Costa,
   Galileu/0000-0001-7360-6722
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Pro-Reitoria
   de Pesquisa/UFMG (PRPq)
FX We are thankful colleagues from the Laboratorio de Virus (ICB-UFMG) for
   their excellent technical support. We are also grateful to Joel Barratt
   for English reviewing process and for appropriate and constructive
   suggestions on the manuscript. Financial support was provided by the
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),
   Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), and
   Pro-Reitoria de Pesquisa/UFMG (PRPq). F.G. da Fonseca, M.L. Nogueira,
   E.G. Kroon, and G.S. Trindade are researchers from CNPq.
CR Abrahao JS, 2017, EQUINE VET J, V49, P221, DOI 10.1111/evj.12571
   Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Abrahao JS, 2010, J CLIN VIROL, V48, P69, DOI 10.1016/j.jcv.2010.02.001
   Abrahao JS, 2009, FOODBORNE PATHOG DIS, V6, P1141, DOI 10.1089/fpd.2009.0324
   Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Abrahao JS, 2009, ARCH VIROL, V154, P1551, DOI 10.1007/s00705-009-0470-1
   Abrahao JS, 2015, EMERG INFECT DIS, V21, P695, DOI 10.3201/eid2104.140351
   Abrahao JS, 2010, J MED VIROL, V82, P692, DOI 10.1002/jmv.21617
   Alves PA, 2016, COMP IMMUNOL MICROB, V49, P70, DOI 10.1016/j.cimid.2016.09.005
   Assis FL, 2013, EMERG INFECT DIS, V19, P2045, DOI 10.3201/eid1912.120937
   Assis FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050413
   Barbosa AV, 2014, J INFECT DEV COUNTR, V8, P1646, DOI 10.3855/jidc.5216
   Batista V. H., 2009, VIRUS REV RES, DOI 10.17525/vrr.v14i1.27
   BAXBY D, 1971, ARCH GES VIRUSFORSCH, V35, P70, DOI 10.1007/BF01249754
   Baxby D, 1981, JENNERS SMALLPOX VAC
   BEHBEHANI AM, 1983, MICROBIOL REV, V47, P455, DOI 10.1128/MMBR.47.4.455-509.1983
   Bhanuprakash V, 2010, TRANSBOUND EMERG DIS, V57, P375, DOI 10.1111/j.1865-1682.2010.01158.x
   Campos RK, 2011, ARCH VIROL, V156, P275, DOI 10.1007/s00705-010-0857-z
   CHANDRA R, 1986, ACTA VIROL, V30, P390
   Costa GB, 2015, EMERG INFECT DIS, V21, P2244, DOI 10.3201/eid2112.141249
   Costa GB, 2017, EMERG INFECT DIS, V23, P360, DOI 10.3201/eid2302.161341
   Costa GB, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0575-6
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   da Fonseca FG, 2011, FUTURE VIROL, V6, P697, DOI 10.2217/FVL.11.46
   Damaso CR, 2018, LANCET INFECT DIS, V18, pE55, DOI 10.1016/S1473-3099(17)30445-0
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Damon I., 2013, POXVIRUSES, p[2160, 2184]
   de Oliveira JS, 2017, VACCINE, V35, P3281, DOI 10.1016/j.vaccine.2017.04.048
   DEQUADRO.CC, 1972, B WORLD HEALTH ORGAN, V46, P165
   DiGiacomo R. F., 1994, BIOL LAB RABBIT
   Downie A. W., 1939, IMMUNOLOGICAL RELATI
   Downie A. W., 1939, STUDY LESIONS PRODUC
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Duggan AT, 2016, CURR BIOL, V26, P3407, DOI 10.1016/j.cub.2016.10.061
   DUMBELL K, 1993, ARCH VIROL, V128, P257, DOI 10.1007/BF01309438
   Eddy S R, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P114
   Essbauer S, 2007, ZOONOSES PUBLIC HLTH, V54, P118, DOI 10.1111/j.1863-2378.2007.01035.x
   Fassbender P, 2016, EMERG INFECT DIS, V22, P553, DOI 10.3201/eid2203.151158
   FENNER F, 1958, VIROLOGY, V5, P502, DOI 10.1016/0042-6822(58)90042-4
   Fenner F, 1988, SMALLPOX ITS ERADICA
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Geessien Kroon Erna, 2016, Curr Protoc Microbiol, V42, DOI 10.1002/cpmc.13
   Goyal T, 2013, J DERMATOL, V52, P1224, DOI [10.1111/ijd.12120, DOI 10.1111/IJD.12120]
   Guedes MIMC, 2013, TRANSBOUND EMERG DIS, V60, P552, DOI 10.1111/j.1865-1682.2012.01372.x
   Gurav YK, 2011, PREV VET MED, V100, P242, DOI 10.1016/j.prevetmed.2011.03.008
   Henderson DA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0113
   Henderson DA, 2009, SMALLPOX DEATH DIS I
   Hughes CM, 2011, EMERG INFECT DIS, V17, P730, DOI 10.3201/eid1704.101010
   Kolhapure RM, 1997, INDIAN J MED RES, V106, P441
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Kugelman JR, 2014, EMERG INFECT DIS, V20, P232, DOI 10.3201/eid2002.130118
   Laguardia-Nascimento M, 2017, ARCH VIROL, V162, P2797, DOI 10.1007/s00705-017-3407-0
   Laguardia-Nascimento M, 2016, J VET DIAGN INVEST, V28, P377, DOI 10.1177/1040638716645836
   Dutra LAL, 2017, ARCH VIROL, V162, P439, DOI 10.1007/s00705-016-3121-3
   Lederman E, 2009, VACCINE, V27, P375, DOI 10.1016/j.vaccine.2008.11.019
   Lederman ER, 2012, J INFECT DIS, V206, P1372, DOI 10.1093/infdis/jis510
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   de Oliveira TML, 2015, FOODBORNE PATHOG DIS, V12, P898, DOI 10.1089/fpd.2015.1974
   de Oliveira TML, 2010, FOODBORNE PATHOG DIS, V7, P1491, DOI 10.1089/fpd.2010.0597
   Marques JT, 2001, VIRUS GENES, V23, P291, DOI 10.1023/A:1012521322845
   Medaglia MLG, 2015, J VIROL, V89, P11909, DOI 10.1128/JVI.01833-15
   Megid J, 2008, AM J TROP MED HYG, V79, P647, DOI 10.4269/ajtmh.2008.79.647
   Megid J, 2012, EMERG INFECT DIS, V18, P189, DOI 10.3201/eid1801.110692
   Ferraz KMPMD, 2010, POPUL ECOL, V52, P263, DOI 10.1007/s10144-009-0181-1
   Ministerio da Agricultura Pecuaria e Abastecimento (MAPA), 2015, DAD REB BOV BAB BRAS
   Miranda JB, 2017, EMERG INFECT DIS, V23, P931, DOI 10.3201/eid2306.161643
   Moojen V., 1996, VIROSES CONFUNDIVEIS
   Franco-Luiz APM, 2016, EMERG INFECT DIS, V22, P2174, DOI 10.3201/eid2212.160447
   Franco-Luiz APM, 2016, COMP IMMUNOL MICROB, V46, P16, DOI 10.1016/j.cimid.2016.03.003
   Franco-Luiz APM, 2014, EMERG INFECT DIS, V20, P1576, DOI 10.3201/eid2009.140154
   Mota BEF, 2010, ARCH VIROL, V155, P1139, DOI 10.1007/s00705-010-0675-3
   Moussatche N, 2008, J INFECT DEV COUNTR, V2, P156, DOI 10.3855/jidc.258
   Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004
   Nalca A, 2010, DRUG DES DEV THER, V4, P71
   Nedunchelliyan S, 1992, Indian J Public Health, V36, P57
   Oliveira DB, 2013, AM J TROP MED HYG, V89, P1142, DOI 10.4269/ajtmh.13-0369
   Oliveira GP, 2014, AM J TROP MED HYG, V90, P1021, DOI 10.4269/ajtmh.13-0621
   Olson VA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9090242
   Peres MG, 2016, EMERG INFECT DIS, V22, P271, DOI 10.3201/eid2202.140747
   Peres MG, 2013, ARCH VIROL, V158, P2433, DOI 10.1007/s00705-013-1740-5
   Quenelle DC, 2007, ANTIMICROB AGENTS CH, V51, P4118, DOI 10.1128/AAC.00762-07
   Quiner CA, 2017, INT J HEALTH GEOGR, V16, DOI 10.1186/s12942-017-0100-1
   Quixabeira-Santos JC, 2011, EMERG INFECT DIS, V17, P726, DOI 10.3201/eid1704.101581
   Rehfeld IS, 2017, J DAIRY SCI, V100, P7051, DOI 10.3168/jds.2017-12560
   Rehfeld IS, 2013, RES VET SCI, V95, P752, DOI 10.1016/j.rvsc.2013.05.005
   Rehfeld IS, 2017, RES VET SCI, V114, P233, DOI 10.1016/j.rvsc.2017.03.022
   Rehfeld IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127350
   Rivetti AV, 2013, VET MICROBIOL, V162, P103, DOI 10.1016/j.vetmic.2012.09.005
   RODRIGUESDASILVA G, 1963, PUBLIC HEALTH REP, V78, P165, DOI 10.2307/4591745
   Sanchez-Sampedro L, 2015, VIRUSES-BASEL, V7, P1726, DOI 10.3390/v7041726
   Sant'ana F. F, 2013, PESQUI VET BRASIL, P860, DOI [10.1590/S0100-736X2013000700006, DOI 10.1590/S0100-736X2013000700006]
   Schatzmayr G. H, 2005, VIRUS REV RES, V10, DOI 10.17525/vrrjournal.v10i2.249
   Schatzmayr HG, 2009, REV SOC BRAS MED TRO, V42, P672, DOI 10.1590/S0037-86822009000600012
   Shchelkunov SN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003756
   Shchelkunov SN, 2011, VACCINE, V29, pD49, DOI 10.1016/j.vaccine.2011.05.037
   Gomes JAS, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/974067
   Silva L., 2008, VIROSES EMERGENTES B, P132
   Silva P, 1985, BRAS MED VET ZOOTEC, V38, P323
   Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007
   Singh RK, 2012, INDIAN J VIROL, V23, P1, DOI 10.1007/s13337-012-0068-1
   Singh R. K, 2006, INDIA REV SCI TECH, V25, P981, DOI 10.20506/rst.25.3.1708
   Theves C, 2014, CLIN MICROBIOL INFEC, V20, P210, DOI 10.1111/1469-0691.12536
   THOMPSON JD, 1994, COMPUT APPL BIOSCI, V10, P19
   Trindade G, 2014, J VACCINES VACCIN, V5, DOI [10.4172/2157-7560.1000i101, DOI 10.4172/2157-7560.1000I101]
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GD, 2008, J VIROL METHODS, V152, P63, DOI 10.1016/j.jviromet.2008.05.028
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
   Trindade GD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120328
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2009, CLIN INFECT DIS, V48, pE37, DOI 10.1086/595856
   Usme-Ciro JA, 2017, EMERG INFECT DIS, V23, P649, DOI 10.3201/eid2304.161041
   Venkatesan G, 2010, VET ITAL, V46, P439
   Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668
   Wertheimer ER, 2012, VACCINE, V30, P985, DOI 10.1016/j.vaccine.2011.12.049
   Young GE, 2011, EMERG INFECT DIS, V17, P718, DOI 10.3201/eid1704.101316
   Zafar A, 2007, EMERG INFECT DIS, V13, P902, DOI 10.3201/eid1306.061068
NR 119
TC 15
Z9 15
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2017
VL 9
IS 11
AR 340
DI 10.3390/v9110340
PG 21
WC Virology
SC Virology
GA FO4KB
UT WOS:000416810300030
PM 29140260
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Costa, GB
   Lavergne, A
   Darcissac, E
   Lacoste, V
   Drumond, BP
   Abrahao, JS
   Kroon, EG
   de Thoisy, B
   Trindade, GD
AF Costa, Galileu Barbosa
   Lavergne, Anne
   Darcissac, Edith
   Lacoste, Vincent
   Drumond, Betania Paiva
   Abrahao, Jonatas Santos
   Kroon, Erna Geessien
   de Thoisy, Benoit
   Trindade, Giliane de Souza
TI Absence of vaccinia virus detection in a remote region of the Northern
   Amazon forests, 2005-2015
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID MOLECULAR CHARACTERIZATION; ZOONOTIC OUTBREAK; CATTLE; ORTHOPOXVIRUS;
   STATE; SPREAD; HUMANS; PAULO
AB Vaccinia virus (VACV) circulates in Brazil and other South America countries and is responsible for a zoonotic disease that usually affects dairy cattle and humans, causing economic losses and impacting animal and human health. Furthermore, it has been detected in wild areas in the Brazilian Amazon. To better understand the natural history of VACV, we investigated its circulation in wildlife from French Guiana, a remote region in the Northern Amazon forest. ELISA and plaque reduction neutralization tests were performed to detect anti-orthopoxvirus antibodies. Real-time and standard PCR targeting C11R, A56R and A26L were applied to detect VACV DNA in serum, saliva and tissue samples. No evidence of VACV infection was found in any of the samples tested. These findings provide additional information on the VACV epidemiological puzzle. The virus could nevertheless be circulating at low levels that were not detected in areas where no humans or cattle are present.
C1 [Costa, Galileu Barbosa; Drumond, Betania Paiva; Abrahao, Jonatas Santos; Kroon, Erna Geessien; Trindade, Giliane de Souza] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Ave Presidente Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Lavergne, Anne; Darcissac, Edith; Lacoste, Vincent; de Thoisy, Benoit] Inst Pasteur, Lab Interact Virus Hotes, 23 Ave Pasteur,BP 6010, Cayenne 97306, French Guiana.
RP Costa, GB; Trindade, GD (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Ave Presidente Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM galileuk1@gmail.com; gitrindade@yahoo.com.br
RI Kroon, Erna/V-5444-2019; Costa, Galileu Barbosa/M-5768-2019; Kroon, Erna
   Geessien/B-3631-2015; LACOSTE, Vincent/V-2321-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; LACOSTE,
   Vincent/0000-0002-3173-4053; Barbosa Costa, Galileu/0000-0001-7360-6722
FU CAROLIA; RESERVOIRS through ERDF funds; European CommissionEuropean
   CommissionEuropean Commission Joint Research Centre
   [REGPOT-CT-2011-285837-STRonGer]; "Investissements d'Avenir' grantFrench
   National Research Agency (ANR)
FX This study was funded by two European projects, CAROLIA and RESERVOIRS,
   through ERDF funds and a European Commission
   "REGPOT-CT-2011-285837-STRonGer'' grant within the FP7. This work also
   benefited from an "Investissements d'Avenir' grant managed by Agence
   Nationale de la Recherche, France (CEBA, ref. ANR-10-LABX-25-01).
CR Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   de Assis FL, 2013, EMERG INFECT DIS, V19, P2017, DOI 10.3201/eid1912.130589
   de Thoisy B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004378
   de Thoisy B, 2009, VECTOR-BORNE ZOONOT, V9, P157, DOI 10.1089/vbz.2007.0280
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Geessien Kroon E, 2016, CURR PROTOC MICROBIO, V42
   Guedes MIMC, 2013, TRANSBOUND EMERG DIS, V60, P552, DOI 10.1111/j.1865-1682.2012.01372.x
   Hansen MC, 2013, SCIENCE, V342, P850, DOI 10.1126/science.1244693
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Dutra LAL, 2017, ARCH VIROL, V162, P439, DOI 10.1007/s00705-016-3121-3
   Medaglia MLG, 2015, J VIROL, V89, P11909, DOI 10.1128/JVI.01833-15
   Medaglia MLG, 2009, EMERG INFECT DIS, V15, P1142, DOI 10.3201/eid1507.081702
   Franco-Luiz APM, 2016, EMERG INFECT DIS, V22, P2174, DOI 10.3201/eid2212.160447
   Franco-Luiz APM, 2016, COMP IMMUNOL MICROB, V46, P16, DOI 10.1016/j.cimid.2016.03.003
   Franco-Luiz APM, 2014, EMERG INFECT DIS, V20, P1576, DOI 10.3201/eid2009.140154
   Mota BEF, 2010, ARCH VIROL, V155, P1139, DOI 10.1007/s00705-010-0675-3
   Oliveira DB, 2013, AM J TROP MED HYG, V89, P1142, DOI 10.4269/ajtmh.13-0369
   Oliveira G, 2015, VIRUSES-BASEL, V7, P1218, DOI 10.3390/v7031218
   Peres MG, 2016, EMERG INFECT DIS, V22, P271, DOI 10.3201/eid2202.140747
   Peres MG, 2013, ARCH VIROL, V158, P2433, DOI 10.1007/s00705-013-1740-5
   Quixabeira-Santos JC, 2011, EMERG INFECT DIS, V17, P726, DOI 10.3201/eid1704.101581
   Trindade GD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120328
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Usme-Ciro JA, 2017, EMERG INFECT DIS, V23, P649, DOI 10.3201/eid2304.161041
NR 26
TC 2
Z9 2
U1 0
U2 2
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD AUG
PY 2017
VL 162
IS 8
BP 2369
EP 2373
DI 10.1007/s00705-017-3353-x
PG 5
WC Virology
SC Virology
GA FA5QE
UT WOS:000405497700022
PM 28389806
DA 2020-12-09
ER

PT J
AU de Oliveira, JS
   Costa, GB
   Luiz, APMF
   Leite, JA
   Bonjardim, CA
   Abrahao, JS
   Drumond, BP
   Kroon, EG
   Trindade, GD
AF de Oliveira, Jaqueline Silva
   Costa, Galileu Barbosa
   Moreira Franco Luiz, Ana Paula
   Leite, Juliana Almeida
   Bonjardim, Claudio Antonio
   Abrahao, Jonatas Santos
   Drumond, Betania Paiva
   Kroon, Erna Geessien
   Trindade, Giliane de Souza
TI Cross-sectional study involving healthcare professionals in a Vaccinia
   virus endemic area
SO VACCINE
LA English
DT Article
DE Orthopoxvirus; Vaccinia virus; Healthcare professionals; Knowledge;
   Unpreparedness serological survey
ID SMALLPOX VACCINE; ORTHOPOXVIRUS; MONKEYPOX; CATTLE; SEROPREVALENCE
AB Orthopoxviruses (OPV) are emerging viruses with great importance in human and veterinary medicine, such as Vaccinia virus (VACV), which causes outbreaks of bovine vaccinia (BV) in South America. The clinical aspects of BV are similar to other vesicular infections, complicating the clinical diagnosis. This crosssectional study evaluated the knowledge of Healthcare Professionals about BV and revealed their unpreparedness about BV in a VACV hyper-endemic area in Brazil, highlighting the public health issues associated with VACV infections. This study presents an opportunity to discuss the importance of vaccination for healthcare professionals who work in areas of VACV circulation and brings an educational measure on VACV infections for health professionals around the world. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [de Oliveira, Jaqueline Silva; Costa, Galileu Barbosa; Moreira Franco Luiz, Ana Paula; Bonjardim, Claudio Antonio; Abrahao, Jonatas Santos; Drumond, Betania Paiva; Kroon, Erna Geessien; Trindade, Giliane de Souza] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
   [Leite, Juliana Almeida] Oswaldo Cruz Fdn FIOCRUZ, Inst Oswaldo Cruz, Resp Virus Lab, Rio De Janeiro, Brazil.
   [Leite, Juliana Almeida] WHO, Pan Amer Hlth Org, Washington, DC USA.
RP Costa, GB (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Presidente Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM galileuk1@gmail.com; gitrindade@yahoo.com.br
RI Kroon, Erna/V-5444-2019; Costa, Galileu Barbosa/M-5768-2019
OI Barbosa Costa, Galileu/0000-0001-7360-6722
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG)
FX We thank colleagues from Laboratorio de Virus (ICB/UFMG) for their
   excellent technical support. We also thank Hugo Jose Valencia Rivero for
   helping to review the educative material translation for Spanish, and
   Susan Realegeno from NCEZID/CDC for manuscript language reviewing. We
   are grateful for the assistance of Mirtes Ribeiro, Antonio Moreira,
   Mariana Sobral Pedrosa and Serro Health Secretary. Financial support was
   provided by the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais (FAPEMIG). CA Bonjardim, EG Kroon, JS Abrahao, and GS Trindade
   are researchers from CNPq.
CR Assis FL, 2012, EMERG INFECT DIS, V18, P2035, DOI 10.3201/eid1812.120145
   Bass J, 2013, INT HEALTH, V5, P237, DOI 10.1093/inthealth/iht029
   Costa GB, 2015, EMERG INFECT DIS, V21, P2244, DOI 10.3201/eid2112.141249
   Costa GB, 2017, EMERG INFECT DIS, V23, P360, DOI 10.3201/eid2302.161341
   Costa GB, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0575-6
   de Sant'Ana FJF, 2013, PESQUI VET BRASIL, V33, P860, DOI 10.1590/S0100-736X2013000700006
   Fenner F, 1988, SMALLPOX ITS ERADICA
   Geessien Kroon Erna, 2016, Curr Protoc Microbiol, V42, DOI 10.1002/cpmc.13
   Isaacs Stuart N, 2012, Methods Mol Biol, V890, P1, DOI 10.1007/978-1-61779-876-4_1
   Kennedy RB, 2009, VACCINE, V27, P3319, DOI 10.1016/j.vaccine.2009.01.086
   Kroon EG, 2011, ANTIVIR RES, V92, P150, DOI 10.1016/j.antiviral.2011.08.018
   Dutra LAL, 2017, ARCH VIROL, V162, P439, DOI 10.1007/s00705-016-3121-3
   Franco-Luiz APM, 2016, EMERG INFECT DIS, V22, P2174, DOI 10.3201/eid2212.160447
   Franco-Luiz APM, 2014, EMERG INFECT DIS, V20, P1576, DOI 10.3201/eid2009.140154
   Mota BEF, 2010, ARCH VIROL, V155, P1139, DOI 10.1007/s00705-010-0675-3
   NeffJM Lane JM, 2002, JAMA-J AM MED ASSOC, V288, P1901
   Pereira Oliveira Graziele, 2014, Am J Trop Med Hyg, V90, P1021, DOI 10.4269/ajtmh.13-0621
   Peres MG, 2016, EMERG INFECT DIS, V22, P271, DOI 10.3201/eid2202.140747
   Petersen BW, 2016, MMWR-MORBID MORTAL W, V65, P257, DOI 10.15585/mmwr.mm6510a2
   Reynolds MG, 2013, AM J TROP MED HYG, V88, P982, DOI 10.4269/ajtmh.12-0758
   Roess AA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001356
   Tan XL, 2012, CLIN VACCINE IMMUNOL, V19, P418, DOI 10.1128/CVI.05521-11
   Trindade GS, 2009, CLIN INFECT DIS, V48, pE37, DOI 10.1086/595856
   Usme-Ciro JA, 2017, EMERG INFECT DIS, V23, P649, DOI 10.3201/eid2304.161041
   Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668
   Zafar A, 2007, EMERG INFECT DIS, V13, P902, DOI 10.3201/eid1306.061068
NR 26
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 5
PY 2017
VL 35
IS 25
BP 3281
EP 3285
DI 10.1016/j.vaccine.2017.04.048
PG 5
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA EX3LS
UT WOS:000403134200001
PM 28495317
OA Bronze
DA 2020-12-09
ER

PT J
AU Miranda, JB
   Borges, IA
   Campos, SPS
   Vieira, FN
   de Azara, TMF
   Marques, FA
   Costa, GB
   Luis, APMF
   de Oliveira, JS
   Ferreira, PCP
   Bonjardim, CA
   da Silva, SLM
   Eiras, AE
   Abrahao, JS
   Kroon, EG
   Drumond, BP
   Paglia, AP
   Trindade, GD
AF Miranda, Julia B.
   Borges, Iara A.
   Campos, Samantha P. S.
   Vieira, Flavia N.
   de Azara, Tatiana M. F.
   Marques, Fernanda A.
   Costa, Galileu B.
   Luis, Ana Paula M. F.
   de Oliveira, Jaqueline S.
   Ferreira, Paulo Cesar P.
   Bonjardim, Claudio Antonio
   da Silva, Silvio L. M.
   Eiras, Alvaro E.
   Abrahao, Jonatas S.
   Kroon, Erna G.
   Drumond, Betania P.
   Paglia, Adriano P.
   Trindade, Giliane de S.
TI Serologic and Molecular Evidence of Vaccinia Virus Circulation among
   Small Mammals from Different Biomes, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID RIO-DE-JANEIRO; ORTHOPOXVIRUS; POXVIRUS; OUTBREAK; HUMANS; STATE;
   CATTLE; GUIDELINES; INFECTION; STRAINS
AB Vaccinia virus (VACV) is a zoonotic agent that causes a disease called bovine vaccinia, which is detected mainly in milking cattle and humans in close contact with these animals. Even though many aspects of VACV infection have been described, much is still unknown about its circulation in the environment and its natural hosts/reservoirs. To investigate the presence of Orthopoxvirus antibodies or VACV DNA, we captured small rodents and marsupials in 3 areas of Minas Gerais state, Brazil, and tested their samples in a laboratory. A total of 336 animals were tested; positivity ranged from 18.1% to 25.5% in the 3 studied regions located in different biomes, including the Atlantic Forest and the Cerrado. Analysis of nucleotide sequences indicated co-circulation of VACV groups I and II. Our findings reinforce the possible role played by rodents and marsupials in VACV maintenance and its transmission chain.
C1 [Miranda, Julia B.; Borges, Iara A.; Campos, Samantha P. S.; Vieira, Flavia N.; de Azara, Tatiana M. F.; Marques, Fernanda A.; Costa, Galileu B.; Luis, Ana Paula M. F.; de Oliveira, Jaqueline S.; Ferreira, Paulo Cesar P.; Bonjardim, Claudio Antonio; Eiras, Alvaro E.; Abrahao, Jonatas S.; Kroon, Erna G.; Drumond, Betania P.; Paglia, Adriano P.; Trindade, Giliane de S.] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [da Silva, Silvio L. M.] Inst Fed Educ Ciencia & Tecnol Sudeste Minas Gera, Rio Pomba, Brazil.
RP Trindade, GD (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Virus, Sala 258,Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM gitrindade@yahoo.com.br
RI Azara, Tatiana/AAR-1604-2020; Costa, Galileu Barbosa/M-5768-2019;
   Miranda, Julia/N-6480-2019; Kroon, Erna/V-5444-2019; Eiras,
   Alvaro/Z-6023-2019; Paglia, Adriano P/A-7965-2012
OI Eiras, Alvaro/0000-0002-3045-0673; Paglia, Adriano
   P/0000-0001-9957-5506; Barbosa Costa, Galileu/0000-0001-7360-6722
FU Departamento de Microbiologia; CNPqNational Council for Scientific and
   Technological Development (CNPq); CAPESCAPES; PRPq-UFMG; FAPEMIGMinas
   Gerais State Research Foundation (FAPEMIG); MAPA
FX Financial support was provided by Departamento de Microbiologia, CNPq,
   CAPES, PRPq-UFMG, FAPEMIG, and MAPA. G.S.T., E.G.K., A.E.E., J.S.A., and
   A.P. are researchers from CNPq.
CR Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Abrahao JS, 2009, ARCH VIROL, V154, P1551, DOI 10.1007/s00705-009-0470-1
   Abrahao JS, 2010, J MED VIROL, V82, P692, DOI 10.1002/jmv.21617
   Assis FL, 2012, EMERG INFECT DIS, V18, P2035, DOI 10.3201/eid1812.120145
   Barbosa AV, 2014, J INFECT DEV COUNTR, V8, P1646, DOI 10.3855/jidc.5216
   Batagelj V, 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368
   Brum MCS, 2010, J VET DIAGN INVEST, V22, P143
   BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991
   Campos RK, 2011, ARCH VIROL, V156, P275, DOI 10.1007/s00705-010-0857-z
   Chaudhri G, 2006, J VIROL, V80, P6339, DOI 10.1128/JVI.00116-06
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   de Assis FL, 2012, EMERG INFECT DIS, V18, P698, DOI 10.3201/eid1804.111800
   Diniz S, 2001, ARQUIVO BRASILEIRO M, V53, P1
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Essbauer S, 2010, VET MICROBIOL, V140, P229, DOI 10.1016/j.vetmic.2009.08.026
   Fenner F, 1989, THE ORTHOPOXVIRUSES, P317
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Geessien Kroon Erna, 2016, Curr Protoc Microbiol, V42, DOI 10.1002/cpmc.13
   McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099
   MILLS JN, 1995, J MAMMAL, V76, P716, DOI 10.2307/1382742
   Moss B., 2013, FIELDS VIROLOGY, V2, P2129
   Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480
   Oliveira DB, 2013, AM J TROP MED HYG, V89, P1142, DOI 10.4269/ajtmh.13-0369
   Oliveira G, 2015, VIRUSES-BASEL, V7, P1218, DOI 10.3390/v7031218
   Paglia AP, 2012, OCCASIONAL PAPERS CO, V6, P76
   Peres MG, 2016, EMERG INFECT DIS, V22, P271, DOI 10.3201/eid2202.140747
   Peres MG, 2013, ARCH VIROL, V158, P2433, DOI 10.1007/s00705-013-1740-5
   Rehfeld IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127350
   Reynolds MG, 2010, AM J TROP MED HYG, V82, P746, DOI 10.4269/ajtmh.2010.09-0716
   Schatzmayr HG, 2011, VACCINE, V29, pD65, DOI 10.1016/j.vaccine.2011.09.105
   Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1
   Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043
   Ferreira JMS, 2008, J GEN VIROL, V89, P2986, DOI 10.1099/vir.0.2008/003947-0
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2009, CLIN INFECT DIS, V48, pE37, DOI 10.1086/595856
   Trindade GS, 2004, J GEN VIROL, V85, P2015, DOI 10.1099/vir.0.79840-0
   Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668
NR 40
TC 13
Z9 13
U1 0
U2 4
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUN
PY 2017
VL 23
IS 6
BP 931
EP 938
DI 10.3201/eid2306.161643
PG 8
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EW1OB
UT WOS:000402259100006
PM 28518030
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Dutra, KR
   Drumond, BP
   de Rezende, IM
   Nogueira, ML
   Lopes, DD
   Silva, CEC
   Ferreira, JMS
   dos Santos, LL
AF Dutra, Karina Rocha
   Drumond, Betania Paiva
   de Rezende, Izabela Mauricio
   Nogueira, Mauricio Lacerda
   Lopes, Debora de Oliveira
   Calzavara Silva, Carlos Eduardo
   Siqueira Ferreira, Jaqueline Maria
   dos Santos, Luciana Lara
TI Molecular surveillance of dengue in Minas Gerais provides insights on
   dengue virus 1 and 4 circulation in Brazil
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE phylogenetic analysis; dengue virus; evolution; dynamics; genotype;
   lineage
ID POPULATION-DYNAMICS; CO-CIRCULATION; PHYLOGENETIC ANALYSIS; GENOTYPE-I;
   EVOLUTION; REPLACEMENT; DIVERSITY; SEROTYPES; LINEAGES; REVEALS
AB Dengue, caused by any of the four types of Dengue virus (DENV) is the most important arbovirus in the world. In this study we performed a molecular surveillance of dengue during the greatest dengue outbreak that took place in Divinopolis, Minas Gerais state, Southeast Brazil, in 2013. Samples from 100 patients with clinical symptoms of dengue were studied and 26 were positive. The capsid/premembrane (CprM) and envelope gene sequences of some samples were amplified and sequenced. Molecular analyses demonstrated that two DENV-1 lineages, belonging to genotype V were introduced and co-circulated in Divinopolis. When compared to each other, those lineages presented high genetic diversity and showed unique amino acids substitutions in the envelope protein, including in domains I, II, and III. DENV-4 strains from Divinopolis clustered within genotype IIb and the most recent common ancestor was probably introduced into the city three years before the 2013 epidemic. Here we demonstrated for the first time the circulation of DENV-4 and the co-circulation of two DENV-1 lineages in Midwest region of Minas Gerais, Brazil. Moreover our analysis indicated the introduction of five DENV-1 lineages, genotype V into Brazil, in different times. J. Med. Virol. 89:966-973, 2017. (c) 2016 Wiley Periodicals, Inc.
C1 [Dutra, Karina Rocha; Lopes, Debora de Oliveira; Siqueira Ferreira, Jaqueline Maria; dos Santos, Luciana Lara] Univ Fed Sao Joao Del Rei UFSJ, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
   [Drumond, Betania Paiva; de Rezende, Izabela Mauricio] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Drumond, Betania Paiva; de Rezende, Izabela Mauricio] Univ Fed Juiz de Fora UFJF, Inst Ciencias Biol, Juiz De Fora, MG, Brazil.
   [Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto FAMERP, Sao Paulo, Brazil.
   [Calzavara Silva, Carlos Eduardo] Fiocruz MS, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
RP dos Santos, LL (corresponding author), Univ Fed Sao Joao del Rei, Lab Biol Mol, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.
EM llaramg@hotmail.com
RI Santos, Luciana L/C-9688-2013; Rezende, Izabela Mauricio/AAL-5766-2020;
   Ferreira, Jaqueline/E-4630-2018; lopes, debora/L-3601-2016; Nogueira,
   Mauricio L/B-7599-2012
OI Santos, Luciana L/0000-0001-6186-4062; Rezende, Izabela
   Mauricio/0000-0003-2616-6300; Ferreira, Jaqueline/0000-0002-1779-1975;
   lopes, debora/0000-0002-8559-8552; Nogueira, Mauricio
   L/0000-0003-1102-2419; CALZAVARA-SILVA, CARLOS/0000-0002-1406-6401
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [475329/2013-9]; Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG)
   [APQ-01703-14]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2013/21719-3]
FX Grant sponsor: Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq); Grant number: 475329/2013-9; Grant sponsor: Fundacao
   de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Grant number:
   APQ-01703-14; Grant sponsor: Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP); Grant number: 2013/21719-3
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Martins VDA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100535
   Amancio FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129046
   Andrade EHP, 2016, AM J TROP MED HYG, V94, P1080, DOI 10.4269/ajtmh.15-0892
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Braga Jcd, 2014, J TROP MED, V2014, P1
   Campos RD, 2013, J CLIN VIROL, V56, P86, DOI 10.1016/j.jcv.2012.10.006
   Cao-Lormeau VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029555
   Carneiro AR, 2012, MEM I OSWALDO CRUZ, V107, P805, DOI 10.1590/S0074-02762012000600016
   Center for Disease Control and Prevention, 2016, ENT EC
   Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562
   Christenbury JG, 2010, J VIROL METHODS, V169, P202, DOI 10.1016/j.jviromet.2010.06.013
   Cunha MD, 2016, INFECT GENET EVOL, V43, P130, DOI 10.1016/j.meegid.2016.05.021
   Taranto MFD, 2015, TROP MED INT HEALTH, V20, P77, DOI 10.1111/tmi.12402
   de Bruycker-Nogueira F, 2015, INFECT GENET EVOL, V34, P126, DOI 10.1016/j.meegid.2015.07.007
   de Melo FL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000390
   dos Santos FB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-387
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Drumond BP, 2016, BRAZ J MICROBIOL, V47, P251, DOI 10.1016/j.bjm.2015.11.016
   Drumond BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059422
   Drumond BP, 2012, ARCH VIROL, V157, P2061, DOI 10.1007/s00705-012-1393-9
   Figueiredo LB, 2008, EMERG INFECT DIS, V14, P314, DOI 10.3201/eid1402.070278
   Figueiredo LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104516
   Figueiredo Luiz Tadeu Moraes, 1999, Revista da Sociedade Brasileira de Medicina Tropical, V32, P613, DOI 10.1590/S0037-86821999000600002
   Foster JE, 2003, VIROLOGY, V306, P126, DOI 10.1016/S0042-6822(02)00033-8
   de Araujo JMG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001784
   Goncalvez AP, 2002, VIROLOGY, V303, P110, DOI 10.1006/viro.2002.1686
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Klungthong C, 2008, J VIROL METHODS, V154, P175, DOI 10.1016/j.jviromet.2008.07.021
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Ministerio Da Saude, 2010, 1182010 CGPNCDDEVEPS
   Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161
   Rambaut A, 2015, TREEANNOTATOR VERSIO
   Rambaut A, 2014, FIGTREE VERSION 1 4
   Rambaut A., 2014, TRACER VERSION 1 6
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   Ross TM, 2010, CLIN LAB MED, V30, P149, DOI 10.1016/j.cll.2009.10.007
   Rossi SL, 2012, VIROLOGY, V423, P58, DOI 10.1016/j.virol.2011.11.018
   Secretaria de Vigilancia em SaudeMinisterio da Saude, 2016, SEMANA EPIDEMIOLOGIC, V7
   Secretaria de Vigilancia em SaudeMinisterio da Saude, 2015, SEMANA EPIDEMIOLOGIC, V52
   Secretaria de Vigilancia em SaudeMinisterio da Saude, 2014, SEMANA EPIDEMIOLOGIC, V53
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Teoh BT, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-213
   Vilela APP, 2010, EMERG INFECT DIS, V16, P989, DOI 10.3201/eid1606.091000
   Villabona-Arenas CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002620
   Villabona-Arenas CJ, 2011, INFECT GENET EVOL, V11, P878, DOI 10.1016/j.meegid.2011.02.007
   World Health Organization, 2016, DENG GUID DIAGN TREA
   Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548
NR 54
TC 3
Z9 3
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD JUN
PY 2017
VL 89
IS 6
BP 966
EP 973
DI 10.1002/jmv.24729
PG 8
WC Virology
SC Virology
GA ER6DA
UT WOS:000398893900005
PM 27926790
DA 2020-12-09
ER

PT J
AU Assis, ASF
   Otenio, MH
   Drumond, BP
   Fumian, TM
   Miagostovich, MP
   Silva, MLDE
AF Assis, Andressa S. F.
   Otenio, Marcelo Henrique
   Drumond, Betania P.
   Fumian, Tulio M.
   Miagostovich, Marize P.
   da Rosa e Silva, Maria Luzia
TI Optimization of the skimmed-milk flocculation method for recovery of
   adenovirus from sludge
SO SCIENCE OF THE TOTAL ENVIRONMENT
LA English
DT Article
DE Sewage sludge; Wastewater treatment plant; Organic flocculation; Human
   adenovirus; Internal control; Quantitative PCR
ID WATER TREATMENT PLANTS; TREATED WASTE-WATER; ENTERIC VIRUSES;
   SEWAGE-SLUDGE; ORGANIC FLOCCULATION; QUANTITATIVE SURVEY; PATHOGENIC
   VIRUSES; PCR; QUANTIFICATION; INDICATORS
AB Return of treated sludge to the environment poses concerns and has stimulated the development of studies on viral monitoring in this matrix, in order to assess its potential risks for public health. Human adenovirus (HAdV) has been identified as a putative viral marker of faecal contamination due to its stability and resistance to the sewage treatment process. The aim of this study was to optimize the organic flocculation procedure in order to establish an appropriate methodology for HAdV recovery from sewage sludge samples. Four protocols (A-D) have been proposed, with changes in the initial sample dilution, in the stirring time and in the final concentration of skimmed-milk. A single sludge sample was obtained in Wastewater Treatment Plant (WWTP) and divided into aliquots. In each protocol, three aliquots were inoculated with HAdV and bacteriophage PP7 and a non-inoculated one was used as negative control. Viral load and recovery rate were determihed by quantitative PCR. HAdV recovery rate varied between the protocols tested (p = 0.016) and the best result was obtained through the protocol C. In order to confirm this result a field study with activated, thickened and digested sludge samples was carried out. Different types of sludge were obtained in two WWTPs and processed using protocol C. HAdV was detected in all samples, with a similar or higher viral load than those obtained with other concentration techniques already applied to sludge. Protocol C proved to be really efficient, with the advantage of showing low cost and practicability in routine laboratories. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Assis, Andressa S. F.; Drumond, Betania P.; da Rosa e Silva, Maria Luzia] Univ Fed Juiz de Fora, Inst Biol Sci, Dept Microbiol, Virol Lab, Juiz De Fora, MG, Brazil.
   [Otenio, Marcelo Henrique] Embrapa Daily Cattle, Brazilian Agr Res Corp, Juiz De Fora, MG, Brazil.
   [Fumian, Tulio M.; Miagostovich, Marize P.] Inst Oswaldo Cruz, Lab Comparat & Environm Virol, Rio De Janeiro, RJ, Brazil.
   [Drumond, Betania P.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, Virus Lab, Belo Horizonte, MG, Brazil.
RP Assis, ASF (corresponding author), Univ Fed Juiz de Fora, Inst Biol Sci, Dept Microbiol, Virol Lab, Juiz De Fora, MG, Brazil.
EM andressasilvino@yahoo.com.br
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E-26/102.845/2012]; CAPESCAPES
FX The authors thank the staff of CESAMA (Water and Wastewater Sanitation
   Company - Juiz de Fora - MG) and of CEDAE (Water and Wastewater
   Sanitation Company - Rio de Janeiro - RJ) for kindly providing sewage
   sludge samples. This project was partially supported by FAPERJ
   (E-26/102.845/2012). ASFA received scholarship from CAPES.
CR Albinana-Gimenez N, 2009, WATER RES, V43, P2011, DOI 10.1016/j.watres.2009.01.025
   Bofill-Mas S, 2006, APPL ENVIRON MICROB, V72, P7894, DOI 10.1128/AEM.00965-06
   Braeye T, 2015, EPIDEMIOL INFECT, V143, P711, DOI 10.1017/S0950268814001629
   Calgua B, 2008, J VIROL METHODS, V153, P79, DOI 10.1016/j.jviromet.2008.08.003
   Calgua B, 2013, WATER RES, V47, P2797, DOI 10.1016/j.watres.2013.02.043
   Calgua B, 2013, J VIROL METHODS, V187, P215, DOI 10.1016/j.jviromet.2012.10.012
   FERREIRA JD, 2014, REV PAN-AMAZ SAUDE, V5, P47, DOI DOI 10.5123/S2176-62232014000300006
   Fong TT, 2005, MICROBIOL MOL BIOL R, V69, P357, DOI 10.1128/MMBR.69.2.357-371.2005
   Fumian TM, 2010, J VIROL METHODS, V170, P42, DOI 10.1016/j.jviromet.2010.08.017
   Fumian TM, 2013, J WATER HEALTH, V11, P110, DOI 10.2166/wh.2012.123
   Gall AM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004867
   Girones R, 2010, WATER RES, V44, P4325, DOI 10.1016/j.watres.2010.06.030
   Guzman C, 2007, J VIROL METHODS, V144, P41, DOI 10.1016/j.jviromet.2007.03.017
   Hernroth BE, 2002, APPL ENVIRON MICROB, V68, P4523, DOI 10.1128/AEM.68.9.4523-4533.2002
   Katayama H, 2008, WATER RES, V42, P1441, DOI 10.1016/j.watres.2007.10.029
   KATZENELSON E, 1976, APPL ENVIRON MICROB, V32, P638, DOI 10.1128/AEM.32.4.638-639.1976
   Keeley A.A., 2003, MOVEMENT LONGEVITY V
   LEWIS GD, 1988, APPL ENVIRON MICROB, V54, P1983, DOI 10.1128/AEM.54.8.1983-1988.1988
   Melgaco FG, 2016, INT J FOOD MICROBIOL, V217, P14, DOI 10.1016/j.ijfoodmicro.2015.10.005
   Monpoeho S, 2004, APPL ENVIRON MICROB, V70, P5434, DOI 10.1128/AEM.70.9.5434-5440.2004
   Morales-Morales HA, 2003, APPL ENVIRON MICROB, V69, P4098, DOI 10.1128/AEM.69.7.4098-4102.2003
   Myrmel M, 2015, FOOD ENVIRON VIROL, V7, P213, DOI 10.1007/s12560-015-9200-x
   Okoh AI, 2010, INT J ENV RES PUB HE, V7, P2620, DOI 10.3390/ijerph7062620
   Prado T, 2014, BRAZ J MICROBIOL, V45, P343, DOI 10.1590/S1517-83822014000100049
   Prado T, 2013, MEM I OSWALDO CRUZ, V108, P77, DOI 10.1590/S0074-02762013000100013
   Prado T, 2011, WATER RES, V45, P1287, DOI 10.1016/j.watres.2010.10.012
   Pusch D, 2005, ARCH VIROL, V150, P929, DOI 10.1007/s00705-004-0467-8
   Rajal VB, 2007, WATER RES, V41, P1411, DOI 10.1016/j.watres.2006.12.034
   Rock C, 2010, APPL ENVIRON MICROB, V76, P8102, DOI 10.1128/AEM.02339-09
   Rodriguez-Manzano J, 2014, FOOD ENVIRON VIROL, V6, P31, DOI 10.1007/s12560-013-9133-1
   Sano D, 2003, WATER RES, V37, P3490, DOI 10.1016/S0043-1354(03)00208-2
   Schlindwein AD, 2010, WATER SCI TECHNOL, V61, P537, DOI 10.2166/wst.2010.845
   Sidhu JPS, 2009, ENVIRON INT, V35, P187, DOI 10.1016/j.envint.2008.07.006
   Singh RP, 2008, WASTE MANAGE, V28, P347, DOI 10.1016/j.wasman.2006.12.010
   Staggemeier R, 2015, AGR WATER MANAGE, V152, P135, DOI 10.1016/j.agwat.2015.01.010
   Staggemeier R, 2015, J VIROL METHODS, V213, P65, DOI 10.1016/j.jviromet.2014.11.019
   Stals A, 2011, FOOD MICROBIOL, V28, P52, DOI 10.1016/j.fm.2010.08.004
   Templeton MR, 2008, CRIT REV ENV SCI TEC, V38, P137, DOI 10.1080/10643380601174764
   Viau E, 2009, APPL ENVIRON MICROB, V75, P164, DOI 10.1128/AEM.01331-08
   Wang HL, 2008, ENVIRON SCI POLLUT R, V15, P308, DOI 10.1007/s11356-008-0012-5
   Wong K, 2010, APPL ENVIRON MICROB, V76, P6441, DOI 10.1128/AEM.02685-09
NR 41
TC 3
Z9 3
U1 1
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0048-9697
EI 1879-1026
J9 SCI TOTAL ENVIRON
JI Sci. Total Environ.
PD APR 1
PY 2017
VL 583
BP 163
EP 168
DI 10.1016/j.scitotenv.2017.01.045
PG 6
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA EL3YK
UT WOS:000394556400018
PM 28094048
DA 2020-12-09
ER

PT J
AU Oliveira, GP
   Andrade, ACDP
   Rodrigues, RAL
   Arantes, TS
   Boratto, PVM
   Silva, LKD
   Dornas, FP
   Trindade, GD
   Drumond, BP
   La Scola, B
   Kroon, EG
   Abrahao, JS
AF Oliveira, Graziele Pereira
   dos Santos Pereira Andrade, Ana Cludia
   Lima Rodrigues, Rodrigo Araujo
   Arantes, Thalita Souza
   Miranda Boratto, Paulo Victor
   dos Santos Silva, Ludmila Karen
   Dornas, Fabio Pio
   Trindade, Giliane de Souza
   Drumond, Betania Paiva
   La Scola, Bernard
   Kroon, Erna Geessien
   Abrahao, Jonatas Santos
TI Promoter Motifs in NCLDVs: An Evolutionary Perspective
SO VIRUSES-BASEL
LA English
DT Review
DE megavirales; NCLDV; giant viruses; promoter; transcription; evolution;
   MEGA-box
ID SWINE-FEVER-VIRUS; MAJOR CAPSID PROTEIN; RNA-POLYMERASE-II; GENOME-WIDE
   ANALYSIS; FROG VIRUS-3; GIANT VIRUSES; DNA VIRUSES; TRANSCRIPTION
   INITIATION; MACROMOLECULAR-SYNTHESIS; MUTATIONAL ANALYSIS
AB For many years, gene expression in the three cellular domains has been studied in an attempt to discover sequences associated with the regulation of the transcription process. Some specific transcriptional features were described in viruses, although few studies have been devoted to understanding the evolutionary aspects related to the spread of promoter motifs through related viral families. The discovery of giant viruses and the proposition of the new viral order Megavirales that comprise a monophyletic group, named nucleo-cytoplasmic large DNA viruses (NCLDV), raised new questions in the field. Some putative promoter sequences have already been described for some NCLDV members, bringing new insights into the evolutionary history of these complex microorganisms. In this review, we summarize the main aspects of the transcription regulation process in the three domains of life, followed by a systematic description of what is currently known about promoter regions in several NCLDVs. We also discuss how the analysis of the promoter sequences could bring new ideas about the giant viruses' evolution. Finally, considering a possible common ancestor for the NCLDV group, we discussed possible promoters' evolutionary scenarios and propose the term "MEGA-box"to designate an ancestor promoter motif ('TATATAAAATTGA') that could be evolved gradually by nucleotides gain and loss and point mutations.
C1 [Oliveira, Graziele Pereira; dos Santos Pereira Andrade, Ana Cludia; Lima Rodrigues, Rodrigo Araujo; Arantes, Thalita Souza; Miranda Boratto, Paulo Victor; dos Santos Silva, Ludmila Karen; Dornas, Fabio Pio; Trindade, Giliane de Souza; Drumond, Betania Paiva; Kroon, Erna Geessien; Abrahao, Jonatas Santos] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
   [La Scola, Bernard] Aix Marseille Univ, URMITE, CNRS IRD INSERM U1095 UM63 7278 198, Fac Med, 27 Blvd Jean Moulin, F-13385 Marseille 05, France.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, BR-31270901 Belo Horizonte, MG, Brazil.
EM graziufmg@yahoo.com.br; ana.andrade2008@hotmail.com;
   rodriguesral07@gmail.com; tsarantes@gmail.com; pvboratto@gmail.com;
   ludmilakaren@gmail.com; fabiopiod154@gmail.com; gitrindade@yahoo.com.br;
   betaniadrumond@gmail.com; bernard.la-scola@univ-amu.fr;
   ernagkroon@gmail.com; jonatas.abrahao@gmail.com
RI Dornas, Fabio/AAI-3582-2020; Kroon, Erna/V-5444-2019; Kroon, Erna
   Geessien/B-3631-2015
OI Dornas, Fabio/0000-0001-7926-5551; Kroon, Erna
   Geessien/0000-0003-2721-3826; Araujo Lima Rodrigues,
   Rodrigo/0000-0001-7148-4012
CR Abergel C, 2007, J VIROL, V81, P12406, DOI 10.1128/JVI.01107-07
   Aravind L, 1999, NUCLEIC ACIDS RES, V27, P4658, DOI 10.1093/nar/27.23.4658
   Asgari S, 2007, J GEN VIROL, V88, P1120, DOI 10.1099/vir.0.82651-0
   BALDICK CJ, 1992, J VIROL, V66, P4710, DOI 10.1128/JVI.66.8.4710-4719.1992
   BAROUDY BM, 1980, J BIOL CHEM, V255, P4372
   BAROUDY BM, 1982, NUCLEIC ACIDS RES, V10, P5673, DOI 10.1093/nar/10.18.5673
   BARRAY S, 1987, ANN INST PASTEUR VIR, V138, P253, DOI 10.1016/S0769-2617(87)80009-6
   BECKMAN W, 1988, J VIROL, V62, P1271, DOI 10.1128/JVI.62.4.1271-1277.1988
   Bell SD, 1998, P NATL ACAD SCI USA, V95, P15218, DOI 10.1073/pnas.95.26.15218
   Bell SD, 2001, CURR OPIN MICROBIOL, V4, P208, DOI 10.1016/S1369-5274(00)00190-9
   Benamar S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00003
   Bigot Y, 1997, J GEN VIROL, V78, P1139, DOI 10.1099/0022-1317-78-5-1139
   Boyer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015530
   Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787
   Browning DF, 2016, NAT REV MICROBIOL, V14, P638, DOI 10.1038/nrmicro.2016.103
   Broyles SS, 1999, J BIOL CHEM, V274, P35662, DOI 10.1074/jbc.274.50.35662
   Broyles SS, 2010, FUTURE VIROL, V5, P639, DOI 10.2217/FVL.10.51
   BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0
   Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789
   Cheng XW, 2005, J INVERTEBR PATHOL, V89, P193, DOI 10.1016/j.jip.2005.06.011
   Cheng XW, 2000, J GEN VIROL, V81, P3083, DOI 10.1099/0022-1317-81-12-3083
   Chinchar VG, 2009, CURR TOP MICROBIOL, V328, P123
   Chinchar VG, 2011, VIRUSES-BASEL, V3, P1959, DOI 10.3390/v3101959
   Chuchird N, 2002, VIROLOGY, V295, P289, DOI 10.1006/viro.2002.1408
   Claverie JM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-110
   Colson P, 2013, ARCH VIROL, V158, P2517, DOI 10.1007/s00705-013-1768-6
   Colson P, 2012, INTERVIROLOGY, V55, P321, DOI 10.1159/000336562
   Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606
   D'Costa SM, 2004, ARCH VIROL, V149, P723, DOI 10.1007/s00705-003-0232-4
   D'Costa SM, 2001, ARCH VIROL, V146, P2165, DOI 10.1007/s007050170027
   Damon I. K., 2014, FIELDS VIROLOGY, V2, P2160
   DARAI G, 1985, VIROLOGY, V146, P292, DOI 10.1016/0042-6822(85)90012-1
   Darcy TJ, 1999, J BACTERIOL, V181, P4424, DOI 10.1128/JB.181.14.4424-4429.1999
   DAVISON AJ, 1989, J MOL BIOL, V210, P749, DOI 10.1016/0022-2836(89)90107-1
   Dixon LK, 2013, VIRUS RES, V173, P3, DOI 10.1016/j.virusres.2012.10.020
   Dizman YA, 2012, VIRUS RES, V167, P353, DOI 10.1016/j.virusres.2012.05.025
   Durzynska J, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0400-7
   Elde NC, 2012, CELL, V150, P831, DOI 10.1016/j.cell.2012.05.049
   Federici B. A., 2005, VIRUS TAXONOMY, P261
   Filee J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00593
   Fischer MG, 2010, P NATL ACAD SCI USA, V107, P19508, DOI 10.1073/pnas.1007615107
   Fitzgerald LA, 2008, VIROLOGY, V380, P388, DOI 10.1016/j.virol.2008.07.025
   Fitzgerald LA, 2007, VIROLOGY, V358, P459, DOI 10.1016/j.virol.2006.08.034
   Fitzgerald LA, 2007, VIROLOGY, V358, P472, DOI 10.1016/j.virol.2006.08.033
   Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449
   Garcia-Escudero R, 2000, J VIROL, V74, P8176, DOI 10.1128/JVI.74.17.8176-8182.2000
   GOORHA R, 1977, J VIROL, V21, P802, DOI 10.1128/JVI.21.2.802-805.1977
   GOORHA R, 1978, VIROLOGY, V84, P32, DOI 10.1016/0042-6822(78)90216-7
   GOORHA R, 1981, J VIROL, V37, P496, DOI 10.1128/JVI.37.1.496-499.1981
   GRAVES MV, 1992, VIROLOGY, V188, P198, DOI 10.1016/0042-6822(92)90750-J
   Haberle V, 2016, SEMIN CELL DEV BIOL, V57, P11, DOI 10.1016/j.semcdb.2016.01.014
   HANGGI M, 1986, EMBO J, V5, P1071, DOI 10.1002/j.1460-2075.1986.tb04324.x
   HANSEN SK, 1995, CELL, V82, P565, DOI 10.1016/0092-8674(95)90029-2
   Hausner W, 1996, J BIOL CHEM, V271, P30144, DOI 10.1074/jbc.271.47.30144
   Huang YH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-224
   Hughes AL, 2005, MOL PHYLOGENET EVOL, V35, P186, DOI 10.1016/j.ympev.2004.12.008
   Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001
   Jakob NJ, 2001, VIROLOGY, V286, P182, DOI 10.1006/viro.2001.0963
   Kang M, 2004, VIROLOGY, V326, P150, DOI 10.1016/j.virol.2004.05.023
   Kawasaki T, 2004, VIROLOGY, V318, P214, DOI 10.1016/j.virol.2003.09.015
   KECK JG, 1990, CELL, V61, P801, DOI 10.1016/0092-8674(90)90190-P
   Knutson BA, 2008, VIRUS GENES, V36, P307, DOI 10.1007/s11262-008-0207-3
   Knutson BA, 2006, J VIROL, V80, P6784, DOI 10.1128/JVI.02705-05
   Koonin EV, 2015, ANN NY ACAD SCI, V1341, P10, DOI 10.1111/nyas.12728
   KUZNAR J, 1980, VIROLOGY, V101, P169, DOI 10.1016/0042-6822(80)90493-6
   Kyrpides NC, 1999, P NATL ACAD SCI USA, V96, P8545, DOI 10.1073/pnas.96.15.8545
   La Scola B., 2003, SCIENCE, P299
   Lacadie SA, 2016, FEBS J, V283, P4214, DOI 10.1111/febs.13747
   Lee DJ, 2012, ANNU REV MICROBIOL, V66, P125, DOI 10.1146/annurev-micro-092611-150012
   Legendre M, 2015, P NATL ACAD SCI USA, V112, pE5327, DOI 10.1073/pnas.1510795112
   Legendre M, 2014, P NATL ACAD SCI USA, V111, P4274, DOI 10.1073/pnas.1320670111
   Legendre M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-99
   Legendre M, 2010, GENOME RES, V20, P664, DOI 10.1101/gr.102582.109
   Levasseur A, 2016, GENOME BIOL EVOL, V8, P2333, DOI 10.1093/gbe/evw153
   Rodrigues RAL, 2015, J VIROL, V89, P11812, DOI 10.1128/JVI.01976-15
   LWOFF A, 1957, J GEN MICROBIOL, V17, P239, DOI 10.1099/00221287-17-2-239
   Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623
   McLysaght A, 2003, P NATL ACAD SCI USA, V100, P15655, DOI 10.1073/pnas.2136653100
   Moreira David, 2005, Science, V308, P1114
   Moss B, 1996, P NATL ACAD SCI USA, V93, P11341, DOI 10.1073/pnas.93.21.11341
   Moss B., 2014, FIELDS VIROLOGY, V2, P2129
   Moss B, 2013, VACCINE, V31, P4220, DOI 10.1016/j.vaccine.2013.03.042
   Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595
   Nalcacioglu R, 2003, VIROLOGY, V317, P321, DOI 10.1016/j.virol.2003.08.007
   Nalcacioglu R, 2007, J GEN VIROL, V88, P2488, DOI 10.1099/vir.0.82947-0
   Nasir A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-156
   Pallister J, 2005, ARCH VIROL, V150, P1911, DOI 10.1007/s00705-005-0532-y
   PALMER JR, 1995, J BACTERIOL, V177, P1844, DOI 10.1128/jb.177.7.1844-1849.1995
   Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181
   Piegu B, 2015, MOL PHYLOGENET EVOL, V84, P44, DOI 10.1016/j.ympev.2014.12.013
   Portugal R, 2015, J GEN VIROL, V96, P408, DOI 10.1099/vir.0.070508-0
   Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485
   REITER WD, 1990, P NATL ACAD SCI USA, V87, P9509, DOI 10.1073/pnas.87.24.9509
   Ren B, 1998, EMBO J, V17, P1076, DOI 10.1093/emboj/17.4.1076
   Reteno DG, 2015, J VIROL, V89, P6585, DOI 10.1128/JVI.00115-15
   Rodriguez JM, 2013, VIRUS RES, V173, P15, DOI 10.1016/j.virusres.2012.09.014
   Rodriguez JM, 1996, J VIROL, V70, P8584
   Sabin LR, 2013, MOL CELL, V49, P783, DOI 10.1016/j.molcel.2013.02.010
   SALAS J, 1988, VIROLOGY, V164, P280, DOI 10.1016/0042-6822(88)90646-0
   Salem TZ, 2008, ARCH VIROL, V153, P149, DOI 10.1007/s00705-007-1081-3
   Scheid P, 2016, CURR OPIN MICROBIOL, V31, P58, DOI 10.1016/j.mib.2016.02.005
   Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022
   Sharma V, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00722
   Sharma V, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00423
   Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520
   SOGO JM, 1984, VIROLOGY, V133, P271, DOI 10.1016/0042-6822(84)90394-5
   Stasiak K, 2003, J GEN VIROL, V84, P2999, DOI 10.1099/vir.0.19290-0
   Sugimoto I, 2000, VIROLOGY, V277, P119, DOI 10.1006/viro.2000.0590
   Suhre K, 2005, P NATL ACAD SCI USA, V102, P14689, DOI 10.1073/pnas.0506465102
   Suzan-Monti M, 2006, VIRUS RES, V117, P145, DOI 10.1016/j.virusres.2005.07.011
   Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736
   Tidona CA, 1997, ARCH VIROL, P49
   Tulman ER, 2009, CURR TOP MICROBIOL, V328, P43
   Van Etten JL, 2003, ANNU REV GENET, V37, P153, DOI 10.1146/annurev.genet.37.110801.143915
   Van Etten JL, 1999, ANNU REV MICROBIOL, V53, P447, DOI 10.1146/annurev.micro.53.1.447
   Van Etten JL, 2002, ARCH VIROL, V147, P1479, DOI 10.1007/s00705-002-0822-6
   Vannini A, 2010, CELL, V143, P59, DOI 10.1016/j.cell.2010.09.002
   WEISS SB, 1959, J AM CHEM SOC, V81, P4118, DOI 10.1021/ja01524a087
   Werner F, 2011, NAT REV MICROBIOL, V9, P85, DOI 10.1038/nrmicro2507
   Whelan S., 2014, FIELDS VIROLOGY, V2, P2160
   Williams T, 2005, ADV VIRUS RES, V65, P173, DOI 10.1016/S0065-3527(05)65006-3
   WILLIS DB, 1987, VIROLOGY, V161, P1, DOI 10.1016/0042-6822(87)90164-4
   WILLIS DB, 1985, J VIROL, V56, P495, DOI 10.1128/JVI.56.2.495-501.1985
   Wilson WH, 2009, CURR TOP MICROBIOL, V328, P1
   Wilson WH, 2005, SCIENCE, V309, P1090, DOI 10.1126/science.1113109
   Xiao C, 2009, PLOS BIOL, V7, P958, DOI 10.1371/journal.pbio.1000092
   Yamada T, 1997, VIROLOGY, V230, P361, DOI 10.1006/viro.1997.8486
   Yang ZL, 2012, J BIOL CHEM, V287, P31050, DOI 10.1074/jbc.M112.390054
   Yang ZL, 2011, J VIROL, V85, P9899, DOI 10.1128/JVI.05446-11
   Yang Z, 2011, J VIROL, V85, P5897, DOI 10.1128/JVI.00428-11
   YATES PR, 1995, BIOCHEM SOC T, V23, pS139, DOI 10.1042/bst023139s
   Yutin N, 2014, VIROLOGY, V466, P38, DOI 10.1016/j.virol.2014.06.032
   Zauberman N, 2008, PLOS BIOL, V6, P1104, DOI 10.1371/journal.pbio.0060114
   Zhao KJ, 2003, VIRUS GENES, V27, P93, DOI 10.1023/A:1025132720885
NR 134
TC 10
Z9 10
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JAN
PY 2017
VL 9
IS 1
AR 16
DI 10.3390/v9010016
PG 20
WC Virology
SC Virology
GA EO1RS
UT WOS:000396476200015
PM 28117683
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Rodrigues, RAL
   Abrahao, JS
   Drumond, BP
   Kroon, EG
AF Lima Rodrigues, Rodrigo Araujo
   Abrahao, Jonatas Santos
   Drumond, Betania Paiva
   Kroon, Erna Geessien
TI Giants among larges: how gigantism impacts giant virus entry into
   amoebae
SO CURRENT OPINION IN MICROBIOLOGY
LA English
DT Review
ID ACANTHAMOEBA-CASTELLANII; LEGIONELLA-PNEUMOPHILA; AMOEBAL ENCYSTMENT;
   DNA VIRUSES; PANDORAVIRUSES; SURVIVAL; CELLS
AB The proposed order Megavirales comprises the nucleocytoplasmic large DNA viruses (NCLDV), infecting a wide range of hosts. Over time, they co-evolved with different host cells, developing various strategies to penetrate them. Mimiviruses and other giant viruses enter cells through phagocytosis, while Marseillevirus and other large viruses explore endocytosis and macropinocytosis. These differing strategies might reflect the evolution of those viruses. Various scenarios have been proposed for the origin and evolution of these viruses, presenting one of the most enigmatic issues to surround these microorganisms. In this context, we believe that giant viruses evolved independently by massive gene/size gain, exploring the phagocytic pathway of entry into amoebas. In response to gigantism, hosts developed mechanisms to evade these parasites.
C1 [Lima Rodrigues, Rodrigo Araujo; Abrahao, Jonatas Santos; Drumond, Betania Paiva; Kroon, Erna Geessien] Univ Fed Minas Gerais, Brasil UFMG, ICB, Lab Virus,Dept Microbiol, BR-486 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Brasil UFMG, ICB, Lab Virus,Dept Microbiol, BR-486 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Kroon, Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826; Araujo Lima Rodrigues,
   Rodrigo/0000-0001-7148-4012
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Fundacao de
   Amparo a Pesquisa do Estado de Minas GeraisMinas Gerais State Research
   Foundation (FAPEMIG)
FX Scholarships were provided by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, and Fundacao de Amparo a Pesquisa do Estado de
   Minas Gerais.
CR Abergel C, 2015, FEMS MICROBIOL REV, V39, P779, DOI 10.1093/femsre/fuv037
   Aherfi S, 2014, VIROLOGY, V466, P27, DOI 10.1016/j.virol.2014.07.014
   Arantes TS, 2016, J VIROL
   Benamar S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00003
   Berk SG, 1998, APPL ENVIRON MICROB, V64, P279
   Boratto P, 2015, J VIROL, V89, P2962, DOI 10.1128/JVI.03177-14
   Boyer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015530
   Boyer M, 2009, P NATL ACAD SCI USA, V106, P21848, DOI 10.1073/pnas.0911354106
   Colson P, 2013, ARCH VIROL, V158, P2517, DOI 10.1007/s00705-013-1768-6
   Colson P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018935
   Silva LKD, 2016, CURR OPIN MICROBIOL, V31, P9, DOI 10.1016/j.mib.2016.01.003
   Filee J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00593
   Ghigo E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000087
   Hussain M, 2009, ARCH VIROL, V154, P1737, DOI 10.1007/s00705-009-0512-8
   KILVINGTON S, 1990, J APPL BACTERIOL, V68, P519, DOI 10.1111/j.1365-2672.1990.tb02904.x
   Koonin EV, 2015, ANN NY ACAD SCI, V1341, P10, DOI 10.1111/nyas.12728
   KORN ED, 1967, J CELL BIOL, V34, P219, DOI 10.1083/jcb.34.1.219
   La Scola B., 2003, SCIENCE, P299
   La Scola B, 2014, MICROB PATHOGENESIS, V77, P131, DOI 10.1016/j.micpath.2014.09.005
   Legendre M, 2015, P NATL ACAD SCI USA, V112, pE5327, DOI 10.1073/pnas.1510795112
   Legendre M, 2014, P NATL ACAD SCI USA, V111, P4274, DOI 10.1073/pnas.1320670111
   Leitsch D, 2010, EUKARYOT CELL, V9, P611, DOI 10.1128/EC.00300-09
   Rodrigues RAL, 2015, J VIROL, V89, P11812, DOI 10.1128/JVI.01976-15
   Lloyd D, 2014, EXP PARASITOL, V145, pS20, DOI 10.1016/j.exppara.2014.03.026
   Moon EK, 2008, EUKARYOT CELL, V7, P1513, DOI 10.1128/EC.00068-08
   Moss B., 2013, FIELDS VIROLOGY, V2, P2129
   Moss B, 2012, VIRUSES-BASEL, V4, P688, DOI 10.3390/v4050688
   Mutsafi Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003367
   Mutsafi Y, 2010, P NATL ACAD SCI USA, V107, P5978, DOI 10.1073/pnas.0912737107
   Nasir A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-156
   Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181
   Raoult D, 2010, INTERVIROLOGY, V53, P321, DOI 10.1159/000312917
   Reteno DG, 2015, J VIROL, V89, P6585, DOI 10.1128/JVI.00115-15
   Sanchez EG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002754
   Scheid P, 2014, PARASITOL RES, V113, P2407, DOI 10.1007/s00436-014-3932-7
   Schmitz-Esser S, 2008, APPL ENVIRON MICROB, V74, P5822, DOI 10.1128/AEM.01093-08
   Sharma V, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00722
   Sharma V, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00423
   Siddiqui R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-6
   Steenbergen JN, 2004, INFECT IMMUN, V72, P3478, DOI 10.1128/IAI.72.6.3478-3488.2004
   Wang SW, 2014, J VIROL, V88, P13047, DOI 10.1128/JVI.01744-14
   Wheat WH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003405
   Wilson WH, 2009, CURR TOP MICROBIOL, V328, P1
   Xiao C, 2009, PLOS BIOL, V7, P958, DOI 10.1371/journal.pbio.1000092
   Zauberman N, 2008, PLOS BIOL, V6, P1104, DOI 10.1371/journal.pbio.0060114
NR 45
TC 11
Z9 11
U1 0
U2 13
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1369-5274
EI 1879-0364
J9 CURR OPIN MICROBIOL
JI Curr. Opin. Microbiol.
PD JUN
PY 2016
VL 31
BP 88
EP 93
DI 10.1016/j.mib.2016.03.009
PG 6
WC Microbiology
SC Microbiology
GA DP4GK
UT WOS:000378454200014
PM 27039270
DA 2020-12-09
ER

PT J
AU Assis, F
   Trindade, G
   Drumond, B
   Frace, M
   Sammons, S
   Emerson, G
   Li, Y
   Carroll, D
   Batra, D
   Abrahao, J
   Kroon, E
AF Assis, Felipe
   Trindade, Giliane
   Drumond, Betania
   Frace, Mike
   Sammons, Scott
   Emerson, Ginny
   Li, Yu
   Carroll, Darin
   Batra, Dhwani
   Abrahao, Jonatas
   Kroon, Erna
TI Genome Sequence of Vaccinia virus Strain Lister-Butantan, a Lister
   Vaccine Variant Used during a Smallpox Eradication Campaign in Brazil
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
AB Here, we report the 187.8-kb genome sequence of Vaccinia virus Lister-Butantan, which was used in Brazil during the WHO smallpox eradication campaign. Its genome showed an average similarity of 98.18% with the original Lister isolate, highlighting the low divergence among related Vaccinia virus vaccine strains, even after several passages in animals and cell culture.
C1 [Assis, Felipe; Trindade, Giliane; Drumond, Betania; Abrahao, Jonatas; Kroon, Erna] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Virus, Belo Horizonte, MG, Brazil.
   [Frace, Mike; Sammons, Scott; Emerson, Ginny; Li, Yu; Carroll, Darin; Batra, Dhwani] Ctr Dis Control & Prevent, NCEZID, Atlanta, GA USA.
RP Abrahao, J (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Virus, Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Kroon, Erna/V-5444-2019; Kroon, Erna/B-3631-2015
OI Kroon, Erna/0000-0003-2721-3826
CR Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610
   Fenner F, 1988, SMALLPOX ITS ERADICA
   Garcel A, 2007, J GEN VIROL, V88, P1906, DOI 10.1099/vir.0.82708-0
   Jacobs BL, 2009, ANTIVIR RES, V84, P1, DOI 10.1016/j.antiviral.2009.06.006
   Medaglia MLG, 2015, J VIROL, V89, P11909, DOI 10.1128/JVI.01833-15
   Morikawa S, 2005, J VIROL, V79, P11873, DOI 10.1128/JVI.79.18.11873-11891.2005
NR 6
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD MAY-JUN
PY 2016
VL 4
IS 3
AR e00536-16
DI 10.1128/genomeA.00536-16
PG 2
WC Microbiology
SC Microbiology
GA VI1DQ
UT WOS:000460660100183
PM 27340056
OA Green Published, Other Gold
DA 2020-12-09
ER

PT J
AU Drumond, BP
   Fagundes, LGD
   Rocha, RP
   Fumagalli, MJ
   Araki, CS
   Colombo, TE
   Nogueira, ML
   Castilho, TE
   da Silveira, NJF
   Malaquias, LCC
   Coelho, LFL
AF Drumond, Betania Paiva
   da Silva Fagundes, Luiz Gustavo
   Rocha, Raissa Prado
   Fumagalli, Marcilio Jorge
   Araki, Carlos Shigueru
   Colombo, Tatiana Elisa
   Nogueira, Mauricio Lacerda
   Castilho, Thiago Elias
   Freitas da Silveira, Nelson Jose
   Cotta Malaquias, Luiz Cosme
   Leomil Coelho, Luiz Felipe
TI Phylogenetic analysis of Dengue virus 1 isolated from South Minas
   Gerais, Brazil
SO BRAZILIAN JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE Dengu virus-1; Alfenas; Minas Gerais; Phylogenetic analysis
ID ENVELOPE PROTEIN; POPULATION-DYNAMICS; BINDING; DNA; CIRCULATION;
   SEQUENCES
AB Dengue is a major worldwide public health problem, especially in the tropical and subtropical regions of the world. Primary infection with a single Dengue virus serotype causes a mild, self-limiting febrile illness called dengue fever. However, a subset of patients who experience secondary infection with a different serotype can progress to a more severe form of the disease, called dengue hemorrhagic fever. The four Dengue virus serotypes (1-4) are antigenically and genetically distinct and each serotype is composed of multiple genotypes. In this study we isolated one Dengue virus 1 serotype, named BR/Alfenas/2012, from a patient with dengue hemorrhagic fever in Alfenas, South Minas Gerais, Brazil and molecular identification was performed based on the analysis of NS5 gene. Swiss mice were infected with this isolate to verify its potential to induce histopathological alterations characteristic of dengue. Liver histopathological analysis of infected animals showed the presence of inflammatory infiltrates, hepatic steatosis, as well as edema, hemorrhage and necrosis focal points. Phylogenetic and evolutionary analyses based on the envelope gene provided evidence that the isolate BR/Alfenas/2012 belongs to genotype V, lineage I and it is probably derived from isolates of Rio de Janeiro, Brazil. The isolate BR/Alfenas/2012 showed two unique amino acids substitutions (SER222THRE and PHE306SER) when compared to other Brazilian isolates from the same genotype/lineage. Molecular models were generated for the envelope protein indicating that the amino acid alteration PHE 306 SER could contribute to a different folding in this region located within the domain III. Further genetic and animal model studies using BR/Alfenas/2012 and other isolates belonging to the same lineage/genotype could help determine the relation of these genetic alterations and dengue hemorrhagic fever in a susceptible population. (C) 2015 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda
C1 [Drumond, Betania Paiva; Cotta Malaquias, Luiz Cosme; Leomil Coelho, Luiz Felipe] Univ Fed Juiz De Fora, Inst Ciencias Biol, Virol Lab, Juiz De Fora, MG, Brazil.
   [da Silva Fagundes, Luiz Gustavo; Rocha, Raissa Prado; Fumagalli, Marcilio Jorge] Univ Fed Alfenas, Inst Ciencias Biomed, Lab Vacinas, Rua Gabriel Monteiro,700 Ctr, Alfenas, MG, Brazil.
   [Araki, Carlos Shigueru; Colombo, Tatiana Elisa; Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto, Dept Doencas Infecciosas & Parasitarias, Lab Pesquisas Virol, Sao Paulo, Brazil.
   [Castilho, Thiago Elias; Freitas da Silveira, Nelson Jose] Univ Fed Alfenas, Lab Bioinformat, Alfenas, MG, Brazil.
RP Coelho, LFL (corresponding author), Univ Fed Alfenas, Inst Ciencias Biomed, Lab Vacinas, Rua Gabriel Monteiro,700 Ctr, Alfenas, MG, Brazil.
EM coelho@unifal-mg.edu.br
RI Nogueira, Mauricio L/B-7599-2012; Rocha, Raissa/ABF-1480-2020;
   Fumagalli, Marcilio/ABE-1183-2020; Coelho, Luiz FL/G-5853-2012;
   Silveira, Nelson J F/R-3418-2016
OI Nogueira, Mauricio L/0000-0003-1102-2419; Fumagalli,
   Marcilio/0000-0002-0207-5423; Silveira, Nelson J F/0000-0001-9257-7322;
   Coelho, Luiz Felipe/0000-0003-4289-384X
FU National Counsel of Technological and Scientific Development
   (CNPq)/BrazilNational Council for Scientific and Technological
   Development (CNPq) [404005/2012-8]
FX The authors thank National Counsel of Technological and Scientific
   Development (CNPq)/Brazil for the financial support (grant number
   404005/2012-8).
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Amancio FF, 2014, J INFECT PUBLIC HEAL, V7, P547, DOI 10.1016/j.jiph.2014.07.016
   [Anonymous], 2006, Wkly Epidemiol Rec, V81, P362
   Barth OM, 2006, MEM I OSWALDO CRUZ, V101, P905, DOI 10.1590/S0074-02762006000800014
   Burke D, 2001, FIELDS VIROLOGY, V4, P1043
   Carneiro AR, 2012, MEM I OSWALDO CRUZ, V107, P805, DOI 10.1590/S0074-02762012000600016
   Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562
   Chen YP, 1996, J VIROL, V70, P8765, DOI 10.1128/JVI.70.12.8765-8772.1996
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   dos Santos FB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-387
   Drummond A.J., 2002, BEAST BAYESIAN EVOLU
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drumond BP, 2012, ARCH VIROL, V157, P2061, DOI 10.1007/s00705-012-1393-9
   FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359
   Figueiredo LTM, 2000, MICROBES INFECT, V2, P1643, DOI 10.1016/S1286-4579(00)01320-4
   Goncalvez AP, 2002, VIROLOGY, V303, P110, DOI 10.1006/viro.2002.1686
   Huerta V, 2008, VIRUS RES, V137, P225, DOI 10.1016/j.virusres.2008.07.022
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Klungthong C, 2008, J VIROL METHODS, V154, P175, DOI 10.1016/j.jviromet.2008.07.021
   Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16
   Mandl CW, 2000, J VIROL, V74, P9601, DOI 10.1128/JVI.74.20.9601-9609.2000
   MEGRET F, 1992, VIROLOGY, V187, P480, DOI 10.1016/0042-6822(92)90450-4
   Nayak V, 2009, J VIROL, V83, P4338, DOI 10.1128/JVI.02574-08
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   Paes MV, 2009, LAB INVEST, V89, P1140, DOI 10.1038/labinvest.2009.83
   Paes MV, 2005, VIROLOGY, V338, P236, DOI 10.1016/j.virol.2005.04.042
   de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185
   Rambaut A, 2006, FIGTREE TREE FIGURE
   Rambaut A, 2002, TREEANOTATOR V1 8 1
   Rambaut A, 2002, LOGCOMBINER V1 8 1
   Rambaut A., 2003, TRACER MCMC TRACE AN
   Stiasny K, 2011, AMINO ACIDS, V41, P1159, DOI 10.1007/s00726-009-0370-4
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Villabona-Arenas CJ, 2013, PLOS ONE, V8
   Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/cpps.20, 10.1002/0471140864.ps0209s50, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]
   Wilder-Smith A, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.17273
NR 42
TC 8
Z9 8
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1517-8382
EI 1678-4405
J9 BRAZ J MICROBIOL
JI Braz. J. Microbiol.
PD JAN-MAR
PY 2016
VL 47
IS 1
BP 251
EP 258
DI 10.1016/j.bjm.2015.11.016
PG 8
WC Microbiology
SC Microbiology
GA DG4TE
UT WOS:000372064700033
PM 26887252
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Vieira, CJDP
   da Silva, DJF
   Barreto, ES
   Siqueira, CEH
   Colombo, TE
   Ozanic, K
   Schmidt, DJ
   Drumond, BP
   Mondini, A
   Nogueira, ML
   Bronzoni, RVD
AF da Silva Pessoa Vieira, Carla Julia
   Ferreira da Silva, David Jose
   Barreto, Eriana Serpa
   Hassegawa Siqueira, Carlos Eduardo
   Colombo, Tatiana Elias
   Ozanic, Katia
   Schmidt, Diane Johnson
   Drumond, Betania Paiva
   Mondini, Adriano
   Nogueira, Mauricio Lacerda
   de Morais Bronzoni, Roberta Vieira
TI Detection of Mayaro virus infections during a dengue outbreak in Mato
   Grosso, Brazil
SO ACTA TROPICA
LA English
DT Article
DE Arboviruses; Febrile illness; RT-PCR
ID LOUIS ENCEPHALITIS-VIRUS; OROPOUCHE FEVER; NESTED PCR; TRANSMISSION;
   ARBOVIRUSES; REEMERGENCE; MANAUS; CITY
AB Arboviruses are common agents of human febrile illness worldwide. In dengue-endemic areas illness due to other arboviruses have been misdiagnosed as dengue based only on clinical-epidemiological data. In this study we investigated the presence of Brazilian arboviruses in sera of 200 patients presenting acute febrile illness, during a dengue outbreak in Sinop, MT, Brazil. The results showed that 38 samples were positive to Dengue virus (DENV) type 1, two samples to DENV type 4, and six to Mayaro virus. These results indicate that arboviruses others than DENV are circulating in Sinop and the surrounding region, which are going undiagnosed. In addition, molecular and evolutionary analyses indicate that two MAYV genotypes are co-circulating in Mato Grosso, Brazil. Thus, a strong surveillance program must be implemented to evaluate and monitor the distribution and the true importance of non-dengue arboviruses in the etiology of acute febrile illnesses. (C) 2015 Elsevier B.V. All rights reserved.
C1 [da Silva Pessoa Vieira, Carla Julia; Ferreira da Silva, David Jose; Barreto, Eriana Serpa; de Morais Bronzoni, Roberta Vieira] Univ Fed Mato Grosso, Inst Ciencias Saude, Sinop, MT, Brazil.
   [Hassegawa Siqueira, Carlos Eduardo] Lab Municipal Anal, Sinop, MT, Brazil.
   [Colombo, Tatiana Elias; Ozanic, Katia; Nogueira, Mauricio Lacerda] Fac Med Sao Jose Rio Preto, Sao Jose Do Rio Preto, SP, Brazil.
   [Schmidt, Diane Johnson] Tufts Univ, Grafton, MA USA.
   [Drumond, Betania Paiva] Univ Fed Juiz Fora, Juiz De Fora, MG, Brazil.
   [Mondini, Adriano] Univ Estadual Paulista, Araraquara, SP, Brazil.
RP Bronzoni, RVD (corresponding author), Univ Fed Mato Grosso, Inst Ciencias Saude, Sinop, MT, Brazil.
EM robertabronzoni@gmail.com
RI Silva, David J F/M-5317-2015; Mondini, Adriano/AAB-4358-2020; da Silva,
   David Jose Ferreira/I-8082-2019; Mondini, Adriano/F-7446-2012; Vieira,
   Carla Julia S P/Y-9722-2018; Nogueira, Mauricio L/B-7599-2012
OI Silva, David J F/0000-0003-1037-2097; Mondini,
   Adriano/0000-0002-5557-9721; da Silva, David Jose
   Ferreira/0000-0003-1037-2097; Mondini, Adriano/0000-0002-5557-9721;
   Vieira, Carla Julia S P/0000-0003-3880-6758; Nogueira, Mauricio
   L/0000-0003-1102-2419
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [478876/2010-6]
FX The authors gratefully acknowledge the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) for financial support
   (478876/2010-6).
CR Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   Terzian ACB, 2011, VECTOR-BORNE ZOONOT, V11, P291, DOI 10.1089/vbz.2009.0200
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Bronzoni RVM, 2004, T ROY SOC TROP MED H, V98, P456, DOI 10.1016/j.trstmh.2003.09.002
   CALISHER CH, 1994, CLIN MICROBIOL REV, V7, P89, DOI 10.1128/CMR.7.1.89-116.1994
   Azevedo RDD, 2007, EMERG INFECT DIS, V13, P912
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Drummond A.J., 2002, BEAST BAYESIAN EVOLU
   Fonseca B.A.L., 2005, TRATADO INFECTOLOGIA, P343
   Fortini S., 2013, FLORESTAS BRASIL RES, P25
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Ministerio da Saude, 2013, DENG NOT REG SIST IN
   Mondini A, 2007, EMERG INFECT DIS, V13, P176, DOI 10.3201/eid1301.060905
   Figueiredo LTM, 2007, REV SOC BRAS MED TRO, V40, P224, DOI 10.1590/S0037-86822007000200016
   Figueiredo LTM, 2012, REV SOC BRAS MED TRO, V45, P285, DOI 10.1590/S0037-86822012000300001
   Moreli ML, 2002, J MED VIROL, V66, P139, DOI 10.1002/jmv.2122
   Moreno ES, 2011, REV SOC BRAS MED TRO, V44, P290, DOI [10.1590/s0037-86822011005000041, 10.1590/S0037-86822011005000041]
   Maia FGM, 2014, INT J INFECT DIS, V26, P96, DOI 10.1016/j.ijid.2014.05.018
   Mourao MPG, 2009, EMERG INFECT DIS, V15, P2063, DOI 10.3201/eid1512.090917
   Pinheiro F.P., 1988, ARBOVIRUSES EPIDEMIO, P137
   de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185
   Powers AM, 2006, AM J TROP MED HYG, V75, P461, DOI 10.4269/ajtmh.2006.75.461
   Rambaut A, 2006, FIGTREE TREE FIGURE
   Rambaut A., 2003, TRACER MCMC TRACE AN
   Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1
   Saeed MF, 2000, J GEN VIROL, V81, P743, DOI 10.1099/0022-1317-81-3-743
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Terzian ACB, 2009, EMERG INFECT DIS, V15, P348, DOI 10.3201/eid1502.080401
   Vasconcelos HB, 2011, EMERG INFECT DIS, V17, P800, DOI 10.3201/eid1705.101333
   Vasconcelos P., 1998, OVERVIEW ARBOVIROLOG, P72
   Vasconcelos P F, 2001, Cad Saude Publica, V17 Suppl, P155, DOI 10.1590/S0102-311X2001000700025
   Vasconcelos PFC, 1998, OVERVIEW ARBOVIROLOG, P19
   Vasconcelos PFC, 2005, TRATADO INFECTOLOGIA, V1, P289
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 36
TC 35
Z9 35
U1 0
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD JUL
PY 2015
VL 147
BP 12
EP 16
DI 10.1016/j.actatropica.2015.03.020
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA CJ4ZJ
UT WOS:000355496900003
PM 25817238
DA 2020-12-09
ER

PT J
AU Vedovello, D
   Drumond, BP
   Marques, RE
   Ullmann, LS
   Favaro, EA
   Terzian, ACB
   Figueiredo, LTM
   Teixeira, MM
   Araujo, JP
   Nogueira, ML
AF Vedovello, Danila
   Drumond, Betania Paiva
   Marques, Rafael Elias
   Ullmann, Leila Sabrina
   Favaro, Eliane Aparecida
   Bernardes Terzian, Ana Carolina
   Moraes Figueiredo, Luiz Tadeu
   Teixeira, Mauro Martins
   Araujo Junior, Joao Pessoa
   Nogueira, Mauricio Lacerda
TI First genome sequence of St. Louis encephalitis virus (SLEV) isolated
   from a human in Brazil
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID WEST-NILE VIRUS; MIGRATORY BIRDS; EPIDEMIOLOGY; STRAINS
AB St. Louis encephalitis virus (SLEV), a member of the family Flaviviridae, genus Flavivirus, is a causative agent of encephalitis in the Americas. In Brazil, sporadic cases of SLEV infection have been reported since 1953, but the first outbreak of SLEV in Brazil was identified only in 2007, concomitant with an outbreak of dengue virus (DENV) serotype 3. This finding, along with other reports, indicates that SLEV circulation in Brazil is largely unknown, and there may be epidemiological implications of the co-circulation of SLEV, DENV and other flaviviruses in Brazil. Here, we describe the first complete genome sequence of an SLEV strain isolated from a human patient in Brazil, strain BeH 355964. Phylogenetic analysis was performed to determine the genotype of BeH 355964 using the full-length genome and envelope (E) gene sequences separately. Both analyses showed that BeH 355964 could be classified as genotype V. Although the number of single gene sequences available is greater (such as for the E gene), the phylogenetic tree based on the complete genome sequence was better supported and provided further information about the virus.
C1 [Vedovello, Danila; Favaro, Eliane Aparecida; Bernardes Terzian, Ana Carolina; Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto FAMERP, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
   [Drumond, Betania Paiva] Univ Fed Juiz de Fora, Juiz De Fora, MG, Brazil.
   [Marques, Rafael Elias; Teixeira, Mauro Martins] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Ullmann, Leila Sabrina; Araujo Junior, Joao Pessoa] Univ Estadual Paulista, Botucatu, SP, Brazil.
   [Moraes Figueiredo, Luiz Tadeu] Univ Sao Paulo, BR-14049 Ribeirao Preto, Brazil.
RP Nogueira, ML (corresponding author), Fac Med Sao Jose do Rio Preto FAMERP, Ave Brigadeiro Faria Lima 5416, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
EM mnogueira@famerp.br
RI Araujo, JP/Q-3043-2019; Marques, Rafael Elias/R-4890-2016; Teixeira,
   Mauro M/A-4587-2008; Araujo, Joao Pessoa/C-2444-2012; Nogueira, Mauricio
   L/B-7599-2012; Vedovello, Danila/M-5757-2014
OI Araujo, JP/0000-0002-9153-1485; Marques, Rafael
   Elias/0000-0002-6949-0947; Teixeira, Mauro M/0000-0002-6944-3008;
   Araujo, Joao Pessoa/0000-0002-9153-1485; Nogueira, Mauricio
   L/0000-0003-1102-2419; Vedovello, Danila/0000-0001-8585-8206
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2012/11733-6]; CAPESCAPES; CNPqNational Council for Scientific and
   Technological Development (CNPq)
FX Financial support to MLN by FAPESP (Grant No. 2012/11733-6) CAPES and
   CNPq.
CR Diaz LA, 2006, EMERG INFECT DIS, V12, P1752, DOI 10.3201/eid1211.060486
   Auguste AJ, 2009, INFECT GENET EVOL, V9, P709, DOI 10.1016/j.meegid.2008.07.006
   Baillie GJ, 2008, MOL PHYLOGENET EVOL, V47, P717, DOI 10.1016/j.ympev.2008.02.015
   Bernard KA, 2001, VIRAL IMMUNOL, V14, P319, DOI 10.1089/08828240152716574
   Terzian ACB, 2011, VECTOR-BORNE ZOONOT, V11, P291, DOI 10.1089/vbz.2009.0200
   BOWEN GS, 1980, AM J TROP MED HYG, V29, P1411, DOI 10.4269/ajtmh.1980.29.1411
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Chamberlain RW, 1980, ST LOUIS ENCEPHALITI, P3
   Clark DC, 2012, ARCH VIROL, V157, P1423, DOI 10.1007/s00705-012-1337-4
   dos Santos CLS, 2006, MEM I OSWALDO CRUZ, V101, P57, DOI 10.1590/S0074-02762006000100011
   Felices V, 2014, EMERG INFECT DIS, V20, P730, DOI 10.3201/eid2004.131735
   Figueiredo LTM, 2000, MICROBES INFECT, V2, P1643, DOI 10.1016/S1286-4579(00)01320-4
   King AM, 2012, 9 REPORT INT COMMITT
   Kopp A, 2013, MBIO, V4, DOI 10.1128/mBio.00322-13
   Kramer LD, 2001, ARCH VIROL, V146, P2341, DOI 10.1007/s007050170007
   Lindenbach BD, 2001, FIELDS VIROLOGY, VII, P991, DOI DOI 10.1016/J.JMB.2013.11.024
   LUBY JP, 1969, ANNU REV MED, V20, P329, DOI 10.1146/annurev.me.20.020169.001553
   Mancini F, 2013, NEW MICROBIOL, V36, P433
   May FJ, 2008, J GEN VIROL, V89, P1901, DOI 10.1099/vir.0.2008/000190-0
   METTLER NE, 1971, ACTA VIROL, V15, P148
   Mishra N, 2012, COMP IMMUNOL MICROB, V35, P591, DOI 10.1016/j.cimid.2012.08.002
   MONATH TP, 1980, AM J TROP MED HYG, V29, P948, DOI 10.4269/ajtmh.1980.29.948
   MONATH TP, 1987, AM J TROP MED HYG, V37, pS40, DOI 10.4269/ajtmh.1987.37.40S
   Mondini A, 2007, EMERG INFECT DIS, V13, P176, DOI 10.3201/eid1301.060905
   Ottendorfer CL, 2009, EMERG INFECT DIS, V15, P604, DOI 10.3201/eid1504.081094
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P145, DOI 10.4269/ajtmh.1981.30.145
   Rappole JH, 2000, EMERG INFECT DIS, V6, P319, DOI 10.3201/eid0604.000401
   Rocco Iray M., 2005, Rev. Inst. Med. trop. S. Paulo, V47, P281, DOI 10.1590/S0036-46652005000500008
   Rodrigues SG, 2010, J GEN VIROL, V91, P2420, DOI 10.1099/vir.0.019117-0
   Rosa R, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002537
   Sambrook J, 2012, MOL CLONING LAB MANU
   SPINSANTI Lorena Ivana, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P59, DOI 10.1590/S0036-46652002000200001
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Tompkins D, 2013, WEST PAC SURVEILL RE, V4, P16, DOI [10.5365/wpsar.2013.4.3.002, 10.5365/WPSAR.2013.4.3.002]
   Travassos da Rosa APA, 1998, OVERWIEW ARBOVIROLOG, P19
   TRENT DW, 1987, VIROLOGY, V156, P293, DOI 10.1016/0042-6822(87)90409-0
   Valinotto LE, 2012, J CLIN VIROL, V54, P349, DOI 10.1016/j.jcv.2012.04.005
   VASCONCELOS PFD, 1991, REV INST MED TROP SP, V33, P465, DOI 10.1590/S0036-46651991000600007
NR 39
TC 6
Z9 6
U1 0
U2 8
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD MAY
PY 2015
VL 160
IS 5
BP 1189
EP 1195
DI 10.1007/s00705-015-2378-2
PG 7
WC Virology
SC Virology
GA CF8FB
UT WOS:000352790400006
PM 25740285
DA 2020-12-09
ER

PT J
AU Taranto, MFD
   Pessanha, JEM
   dos Santos, M
   Andrade, ACDP
   Camargos, VN
   Alves, SN
   Oliveira, CD
   Taranto, AG
   dos Santos, LL
   de Magalhaes, JC
   Kroon, EG
   Figueiredo, LB
   Drumond, BP
   Ferreira, JMS
AF da Rocha Taranto, Martinelle Ferreira
   Marques Pessanha, Jose Eduardo
   dos Santos, Michelli
   dos Santos Pereira Andrade, Ana Claudia
   Camargos, Vidyleison Neves
   Alves, Stenio Nunes
   Oliveira, Claudia Di Lorenzo
   Taranto, Alex Gutterres
   dos Santos, Luciana Lara
   de Magalhaes, Jose Carlos
   Kroon, Erna Geessien
   Figueiredo, Leandra Barcelos
   Drumond, Betania Paiva
   Siqueira Ferreira, Jaqueline Maria
TI Dengue outbreaks in Divinopolis, south-eastern Brazil and the geographic
   and climatic distribution of Aedes albopictus and Aedes aegypti in
   2011-2012
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article
DE Aedes albopictus; Aedes aegypti; dengue; entomological index; ovitraps;
   Aedes albopictus; Aedes aegypti; dengue; indice entomologique; pieges a
   OEufs; Aedes albopictus; Aedes aegypti; dengue; indice entomologico;
   ovitrampas
ID RIO-DE-JANEIRO; DIPTERA; CULICIDAE; VIRUS; TEMPERATURE; DYNAMICS;
   HISTORY; TRANSMISSION; REEMERGENCE; MOSQUITOS
AB ObjectiveTo entomologically monitor Aedes spp. and correlate the presence of these vectors with the recent epidemic of dengue in Divinopolis, Minas Gerais State, Brazil.
   MethodsOvitraps were installed at 44 points in the city, covering six urban areas, from May 2011 to May 2012. After collection, the eggs were incubated until hatching. In the 4th stage of development, the larvae were classified as Ae.aegypti or Ae.albopictus.
   ResultsIn total, 25633 Aedes spp. eggs were collected. February was the month with the highest incidence, with 5635 eggs collected and a hatching rate of 46.7%. Ae.aegypti eggs had the highest hatching rate, at 72.3%, whereas Ae.albopictus eggs had 27.7%. Climate and population density influenced the number of eggs found. Indicators of vector presence were positively correlated with the occurrence of dengue cases.
   ConclusionThese data reinforce the need for entomological studies, highlight the relevance of Ae.albopictus as a possible disease vector and demonstrate its adaptation. Ae.albopictus, most commonly found in forested areas, comprised a substantial proportion of the urban mosquito population.
   ObjectifSurveiller entomologiquement Aedes spp. et correler la presence de ces vecteurs avec l'epidemie recente de dengue a Divinopolis, dans l'Etat de Minas Gerais, au Bresil.
   MethodesDes pieges a OEufs ont ete installes a 44 points de la ville, couvrant 6 zones urbaines, de mai 2011 a mai 2012. Apres la collecte, les OEufs ont ete incubes jusqu'a l'eclosion. Au 4(eme) stade de developpement, les larves ont ete classees comme Ae. aegypti ou Ae. albopictus.
   ResultatsAu total, 25 633 OEufs d'Aedes spp. ont ete collectes. Fevrier etait le mois avec l'incidence la plus elevee, avec 5635 OEufs collectes et un taux d'eclosion de 46,7%. Les OEufs d'Ae. aegypti avaient le taux d'eclosion le plus eleve de 72,3% par rapport a 27,7% pour les OEufs d'Ae. albopictus. Le climat et la densite de population influencaient le nombre d'OEufs trouves. Les indicateurs de la presence de vecteurs etaient positivement correles a la survenue des cas de dengue.
   ConclusionCes donnees renforcent la necessite d'etudes entomologiques, mettent en evidence la pertinence de Ae. albopictus comme un possible vecteur de la maladie et demontrent son adaptation. Ae. albopictus, plus souvent retrouve dans les zones boisees, comprend une proportion importante de la population de moustiques urbains.
   ObjetivoRealizar una monitorizacion entomologica de Aedes spp. y correlacionar la presencia de estos vectores con la epidemia reciente de dengue en Divinopolis, Estado de Minas Gerais, Brasil.
   MetodosSe instalaron ovitrampas en 44 puntos de la ciudad, cubriendo 6 areas urbanas, entre Mayo del 2011 y Mayo del 2012. Tras su recoleccion, los huevos se incubaron hasta que eclosionaron. En el 4to estadio de desarrollo, las larvas se clasificaron como Ae. aegypti o Ae. albopictus.
   ResultadosEn total se recolectaron 25,633 huevos de Aedes spp. Febrero fue el mes con la mayor incidencia: se recolectaron 5,635 huevos con una tasa de eclosion del 46.7%. Los huevos de Ae. aegypti tenian la mayor tasa de eclosion (72.3%) que los de Ae. albopictus (27.7%). El clima y la densidad poblacional influian sobre el numero de huevos encontrados. Los indicadores de presencia vectorial estaban positivamente correlacionados con los casos de dengue.
   ConclusionEstos datos refuerzan la necesidad de estudios entomologicos, subrayan la relevancia de Ae. albopictus como un posible vector de enfermedad y demuestran su adaptacion. Ae. albopictus, comunmente encontrado en areas forestales, es tambien una parte sustancial de la poblacion urbana de mosquitos.
C1 [da Rocha Taranto, Martinelle Ferreira; dos Santos, Michelli; dos Santos Pereira Andrade, Ana Claudia; Camargos, Vidyleison Neves; Alves, Stenio Nunes; Oliveira, Claudia Di Lorenzo; Taranto, Alex Gutterres; dos Santos, Luciana Lara; Siqueira Ferreira, Jaqueline Maria] Univ Fed Sao Joao del Rei, Campus Ctr Oeste Dona Lindu, BR-35501293 Divinopolis, MG, Brazil.
   [Marques Pessanha, Jose Eduardo] Secretaria Municipal Saude Belo Horizonte, Belo Horizonte, MG, Brazil.
   [Marques Pessanha, Jose Eduardo] Univ Fed Minas Gerais, Observ Saude Urbana, Belo Horizonte, MG, Brazil.
   [de Magalhaes, Jose Carlos] Univ Fed Sao Joao del Rei, Dept Quim Biotecnol & Engn Bioproc, Ouro Branco, Brazil.
   [dos Santos Pereira Andrade, Ana Claudia; Kroon, Erna Geessien; Figueiredo, Leandra Barcelos] Univ Fed Minas Gerais, Virus Lab, Belo Horizonte, MG, Brazil.
   [Drumond, Betania Paiva] Univ Fed Juiz de Fora, Virol Lab, Juiz De Fora, Brazil.
RP Ferreira, JMS (corresponding author), Univ Fed Sao Joao del Rei, Microbiol Lab, Campus Ctr Oeste Dona Lindu, Rua Sebastiao Goncalves Coelho 400, BR-35501293 Divinopolis, MG, Brazil.
EM jaque@ufsj.edu.br
RI Santos, Luciana L/C-9688-2013; Camargos, Vidyleison/AAN-2202-2020;
   Oliveira, Claudia/O-2326-2019; Kroon, Erna Geessien/B-3631-2015; Santos,
   Michelli dos/Q-2341-2019; Taranto, Alex G/F-8618-2012; Kroon,
   Erna/V-5444-2019; Alves, Stenio Nunes/B-6031-2013; Ferreira,
   Jaqueline/E-4630-2018
OI Santos, Luciana L/0000-0001-6186-4062; Camargos,
   Vidyleison/0000-0002-7926-0950; Oliveira, Claudia/0000-0001-8533-8155;
   Kroon, Erna Geessien/0000-0003-2721-3826; Santos, Michelli
   dos/0000-0003-0257-6620; Taranto, Alex G/0000-0002-6086-1043; Alves,
   Stenio Nunes/0000-0002-4103-2266; Ferreira,
   Jaqueline/0000-0002-1779-1975; Taranto, Martinelle/0000-0001-5556-4506
FU FAPEMIGMinas Gerais State Research Foundation (FAPEMIG); PRONEX
   CNPq/FAPEMIGNational Council for Scientific and Technological
   Development (CNPq)Minas Gerais State Research Foundation (FAPEMIG)
   [550106/2010-3]; CapesCAPES
FX We thank Adriana Aparecida Gomes, Wanderson Teixeira and the health
   agents of the Secretaria Municipal de Saude/Prefeitura Municipal de
   Divinopolis, MG, for their contributions to this work. We are grateful
   for financial support from FAPEMIG, PRONEX CNPq/FAPEMIG 550106/2010-3
   and Capes.
CR Alencar CHM, 2008, REV APS, V11, P459
   Barreto Maurício L., 2008, Estud. av., V22, P53, DOI 10.1590/S0103-40142008000300005
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P113
   Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   Camara FP, 2007, REV SOC BRAS MED TRO, V40, P192, DOI 10.1590/S0037-86822007000200009
   Chadee DD, 2009, ACTA TROP, V111, P279, DOI 10.1016/j.actatropica.2009.05.012
   Chen SC, 2012, SCI TOTAL ENVIRON, V431, P385, DOI 10.1016/j.scitotenv.2012.05.012
   Coelho GE, 2008, MEM I OSWALDO CRUZ, V103, P535, DOI 10.1590/S0074-02762008000600004
   Consoli RAGB, 1994, PRINCIPAIS MOSQUITOS
   de Carvalho-Leandro D, 2010, REV BRAS ENTOMOL, V54, P701, DOI 10.1590/S0085-56262010000400025
   de Figueiredo MLG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-152
   Decker KD, 2012, JNP-J NURSE PRACT, V8, P389, DOI 10.1016/j.nurpra.2011.09.004
   Degallier N, 2003, REV SAUDE PUBL, V37, P386, DOI 10.1590/s0034-89102003000300019
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Erickson RA, 2010, ECOL MODEL, V221, P2899, DOI 10.1016/j.ecolmodel.2010.08.036
   Farnesi LC, 2009, MEM I OSWALDO CRUZ, V104, P124, DOI 10.1590/S0074-02762009000100020
   FAY R. W., 1965, MOSQUITO NEWS, V25, P276
   Gomes AC, 1998, INF EPIDEMIOL SUS, V7, P49, DOI DOI 10.5123/S0104-16731998000300006
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Honorio NA, 2009, CAD SAUDE PUBLICA, V25, P1203, DOI 10.1590/S0102-311X2009000600003
   Khormi HM, 2011, SCI TOTAL ENVIRON, V409, P4713, DOI 10.1016/j.scitotenv.2011.08.028
   Kobayashi M, 2002, J MED ENTOMOL, V39, P4, DOI 10.1603/0022-2585-39.1.4
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Le Goff G, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-207
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Martinez-Cerdeno V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030178
   Ministerio da Saude: FUNASA-FundacAo Nacional de Saude, 2001, DENG INSTR PESS COMB, P84
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007
   NOGUEIRA RMR, 1991, MEM I OSWALDO CRUZ, V86, P269, DOI 10.1590/S0074-02761991000200018
   Nunes LS, 2011, BIOTA AMAZONIA, V1, P26
   Padmanabha H, 2012, J INSECT PHYSIOL, V58, P1597, DOI 10.1016/j.jinsphys.2012.09.015
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   PEDRO Antonio, 1923, Brasil-Medico, V1, P173
   Pessanha José Eduardo Marques, 2011, Rev. Soc. Bras. Med. Trop., V44, P103, DOI 10.1590/S0037-86822011000100023
   Ponce G, 2004, REV SALUD PUBLICA NU, V5, P1
   Prophiro JS, 2011, REV SOC BRAS MED TRO, V44, P300, DOI [10.1590/s0037-86822011005000025, 10.1590/S0037-86822011005000025]
   REITER P, 1991, J AM MOSQUITO CONTR, V7, P52
   Reiter Paul, 1997, P425
   Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72
   Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   SEMUSA, 2010, B EP
   SEMUSA, 2001, B EP
   Silva HHG, 1999, REV SOC BRAS MED TRO, V32, P349, DOI DOI 10.1590/S0037-86821999000400003
   Simard F, 2005, J MED ENTOMOL, V42, P726, DOI 10.1603/0022-2585(2005)042[0726:GDABSP]2.0.CO;2
   SINAN, 2014, SYST REP NOT COND
   Thenmozhi V, 2007, JPN J INFECT DIS, V60, P245
   Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001
NR 51
TC 9
Z9 9
U1 1
U2 41
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD JAN
PY 2015
VL 20
IS 1
BP 77
EP 88
DI 10.1111/tmi.12402
PG 12
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA AW0GX
UT WOS:000345970400010
PM 25328988
OA Bronze
DA 2020-12-09
ER

PT J
AU Aguiar, BGA
   Coelho, DL
   Costa, DL
   Drumond, BP
   Coelho, LFL
   Figueiredo, LC
   Zacarias, DA
   da Silva, JC
   Alonso, DP
   Ribolla, PEM
   Ishikawa, EAY
   Gaido, SB
   Costa, CHN
AF Alcoforado Aguiar, Bruno Guedes
   Coelho, Daniela Lemos
   Costa, Dorcas Lamounier
   Drumond, Betania Paiva
   Leomil Coelho, Luiz Felipe
   Figueiredo, Livio Carvalho
   Zacarias, Danielle Alves
   da Silva, Jailthon Carlos
   Alonso, Diego Peres
   Martins Ribolla, Paulo Eduardo
   Yassui Ishikawa, Edna Aoba
   Gaido, Samara Belchior
   Nery Costa, Carlos Henrique
TI Genes that encodes NAGT, MIF1 and MIF2 are not virulence factors for
   kala-azar caused by Leishmania infantum
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Genetic diversity; Kala-azar; Visceral leishmaniasis; Macrophage
   inhibition factor; Tropical diseases; Single nucleotide polymorphism
ID MIGRATION-INHIBITORY FACTOR; VISCERAL LEISHMANIASIS; SUSCEPTIBILITY;
   MACROPHAGES; EPIDEMIOLOGY; INFECTION; GENOTYPES; DONOVANI; DISEASE;
   BINDING
AB Introduction: Kala-azar is a disease resulting from infection by Leishmania donovani and Leishmania infantum. Most patients with the disease exhibit prolonged fever, wasting, anemia and hepatosplenomegaly without complications. However, some patients develop severe disease with hemorrhagic manifestations, bacterial infections, jaundice, and edema dyspnea, among other symptoms, followed by death. Among the parasite molecules that might influence the disease severity are the macrophage migration inhibitory factor-like proteins (MIF1 and MIF2) and N-acetylglucosamine-1-phosphotransferase (NAGT), which act in the first step of protein N-glycosylation. This study aimed to determine whether MIF1, MIF2 and NAGT are virulence factors for severe kala-azar. Methods: To determine the parasite genotype in kala-azar patients from Northeastern Brazil, we sequenced the NAGT genes of L. infantum from 68 patients as well as the MIF1 and MIF2 genes from 76 different subjects with diverse clinical manifestations. After polymerase chain reaction (PCR), the fragments were sequenced, followed by polymorphism identification. Results: The nucleotide sequencing of the 144 amplicons revealed the absence of genetic variability of the NAGT, MIF1 and MIF2 genes between the isolates. The conservation of these genes suggests that the clinical variability of kala-azar does not depend upon these genes. Additionally, this conservation suggests that these genes may be critical for parasite survival. Conclusions: NAGT, MIF1 and MIF2 do not alter the severity of kala-azar. NAGT, MIF1 and MIF2 are highly conserved among different isolates of identical species and exhibit potential for use in phylogenetic inferences or molecular diagnosis.
C1 [Alcoforado Aguiar, Bruno Guedes; Coelho, Daniela Lemos; Costa, Dorcas Lamounier; Zacarias, Danielle Alves; da Silva, Jailthon Carlos; Gaido, Samara Belchior; Nery Costa, Carlos Henrique] Univ Fed Piaui, Inst Doencas Trop Natan Portella, Lab Leishmanioses, Teresina, PI, Brazil.
   [Drumond, Betania Paiva] Univ Fed Juiz de Fora, Virol Lab, Juiz De Fora, MG, Brazil.
   [Leomil Coelho, Luiz Felipe] Univ Fed Alfenas, Lab Vacinas, Alfenas, MG, Brazil.
   [Figueiredo, Livio Carvalho] Univ Fed Paraiba, Ctr Ciencias Humanas Sociais & Agr, Dept Agr, Bananeiras, PB, Brazil.
   [Alonso, Diego Peres; Martins Ribolla, Paulo Eduardo] Univ Estadual Paulista, Dept Parasitol, Inst Biociencias, Sao Paulo, Brazil.
   [Yassui Ishikawa, Edna Aoba] Fed Univ Para, Nucleo Med Trop, Mol Biol Lab, BR-66059 Belem, Para, Brazil.
RP Costa, CHN (corresponding author), Univ Fed Piaui, Inst Doencas Trop Natan Portella, Lab Leishmanioses, Rua Artur de Vasconcelos 151 Sul, BR-64001450 Teresina, PI, Brazil.
EM chncosta@gmail.com
RI Alonso, Diego P/C-1079-2012; Ribolla, Paulo/AAH-3354-2020; Coelho, Luiz
   FL/G-5853-2012; Ribolla, Paulo EM/B-9122-2012; FIGUEIREDO, LIVIO
   C/B-6455-2008
OI Ribolla, Paulo EM/0000-0001-8735-6090; FIGUEIREDO, LIVIO
   C/0000-0002-0775-5145; Coelho, Luiz Felipe/0000-0003-4289-384X; Guedes
   Alcoforado Aguiar, Bruno/0000-0001-7986-1759
FU Coordination of Training of Higher Education Graduate Foundation
   (CAPES)CAPES; National Council of Technological and Scientific
   Development (CNPq)National Council for Scientific and Technological
   Development (CNPq)
FX This study received financial support from the Coordination of Training
   of Higher Education Graduate Foundation (CAPES) and the National Council
   of Technological and Scientific Development (CNPq).
CR Akman L, 2000, J EUKARYOT MICROBIOL, V47, P545, DOI 10.1111/j.1550-7408.2000.tb00088.x
   Alonso DP, 2007, J INFECT DIS, V195, P1212, DOI 10.1086/512683
   Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004
   Alves WA, 2009, LEISHMANIOSE VISCERA, V6, P25
   BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639
   Burgos JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058967
   Cordery DV, 2007, J INFECT DIS, V195, P905, DOI 10.1086/511309
   Denkers EY, 2005, TRENDS PARASITOL, V21, P35, DOI 10.1016/j.pt.2004.10.004
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   Falcone FH, 2001, J IMMUNOL, V167, P5348, DOI 10.4049/jimmunol.167.9.5348
   Flower DR, 2008, BIOINFORMATICS VACCI
   Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868
   Juttner S, 1998, J IMMUNOL, V161, P2383
   Kamir D, 2008, J IMMUNOL, V180, P8250, DOI 10.4049/jimmunol.180.12.8250
   Khamesipour A, 2006, INDIAN J MED RES, V123, P423
   Kimblin N, 2008, P NATL ACAD SCI USA, V105, P10125, DOI 10.1073/pnas.0802331105
   Lambertz U, 2012, J LEUKOCYTE BIOL, V91, P887, DOI 10.1189/jlb.0611326
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lipoldova M, 2006, NAT REV GENET, V7, P294, DOI 10.1038/nrg1832
   Lynn MA, 2008, TRENDS PARASITOL, V24, P103, DOI 10.1016/j.pt.2007.11.006
   McCall LI, 2012, EXP PARASITOL, V132, P109, DOI 10.1016/j.exppara.2012.06.001
   McGwire BS, 1996, J BIOL CHEM, V271, P7903, DOI 10.1074/jbc.271.14.7903
   Costa CHN, 2010, REV SOC BRAS MED TRO, V43, P386, DOI 10.1590/S0037-86822010000400010
   Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005
   Olivier M, 2003, ANN TROP MED PARASIT, V97, P79, DOI 10.1179/000349803225002561
   Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053
   Pearson W., 2009, LALIGN FIND MULTIPLE
   Richardson JM, 2009, BIOCHEM BIOPH RES CO, V380, P442, DOI 10.1016/j.bbrc.2009.01.030
   Samaranayake TN, 2010, TROP MED INT HEALTH, V15, P632, DOI 10.1111/j.1365-3156.2010.02491.x
   Satoskar AR, 2001, INFECT IMMUN, V69, P906, DOI 10.1128/IAI.69.2.906-911.2001
   Smith DF, 2007, INT J PARASITOL, V37, P1173, DOI 10.1016/j.ijpara.2007.05.015
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   ter Horst R, 2008, CLIN INFECT DIS, V46, P1702, DOI 10.1086/587899
   Vermeire JJ, 2008, TRENDS PARASITOL, V24, P355, DOI 10.1016/j.pt.2008.04.007
   Waki K, 2007, EUKARYOT CELL, V6, P198, DOI 10.1128/EC.00282-06
   WEISER WY, 1989, P NATL ACAD SCI USA, V86, P7522, DOI 10.1073/pnas.86.19.7522
   Werneck GL, 2002, ACTA TROP, V83, P13, DOI 10.1016/S0001-706X(02)00058-X
   WHO, 2010, WHO TECH REP SER, V949, P1
   World Health Organization, 2011, SPEC PROGR RES TRAIN
   Zhang JH, 2005, PLOS COMPUT BIOL, V1, P395, DOI 10.1371/journal.pcbi.0010053
   Zhang WW, 2003, J BIOL CHEM, V278, P35508, DOI 10.1074/jbc.M305030200
NR 41
TC 0
Z9 0
U1 0
U2 7
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD SEP-OCT
PY 2014
VL 47
IS 5
BP 593
EP 598
DI 10.1590/0037-8682-0183-2014
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA AU9LZ
UT WOS:000345915700011
PM 25467261
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Nogueira, M
   Colombo, T
   Vedovello, D
   Mondini, A
   Drumond, B
   Favaro, E
AF Nogueira, M.
   Colombo, T.
   Vedovello, D.
   Mondini, A.
   Drumond, B.
   Favaro, E.
TI Dengue virus surveillance in a medium size city in Brazil reveals a
   complex pattern of serotypes and strains circulation
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Nogueira, M.; Colombo, T.; Vedovello, D.; Mondini, A.; Favaro, E.] Fac Med Sao Jose Rio Preto, Sao Jose Do Rio Preto, SP, Brazil.
   [Drumond, B.] Univ Fed Juiz de Fora, Juiz De Fora, Brazil.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD APR
PY 2014
VL 21
SU 1
MA 07.003
BP 20
EP 20
DI 10.1016/j.ijid.2014.03.452
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA V43TP
UT WOS:000209704000041
OA DOAJ Gold
DA 2020-12-09
ER

PT J
AU Drumond, BP
   Mondini, A
   Schmidt, DJ
   Bronzoni, RVD
   Bosch, I
   Nogueira, ML
AF Drumond, Betania Paiva
   Mondini, Adriano
   Schmidt, Diane J.
   de Morais Bronzoni, Roberta Vieira
   Bosch, Irene
   Nogueira, Mauricio Lacerda
TI Circulation of Different Lineages of Dengue Virus 2, Genotype
   American/Asian in Brazil: Dynamics and Molecular and Phylogenetic
   Characterization
SO PLOS ONE
LA English
DT Article
ID POPULATION-DYNAMICS; CO-CIRCULATION; SHOCK SYNDROME; TYPE-2;
   EPIDEMIOLOGY; EVOLUTION; INFECTION
AB The American/Asian genotype of Dengue virus type 2 (DENV-2) was introduced into the Americas in the 80's. Although there is no data showing when this genotype was first introduced into Brazil, it was first detected in Brazil in 1990. After which the virus spread throughout the country and major epidemics occurred in 1998, 2007/08 and 2010. In this study we sequenced 12 DENV-2 genomes obtained from serum samples of patients with dengue fever residing in Sao Jose do Rio Preto, Sao Paulo (SJRP/SP), Brazil, in 2008. The whole open reading frame or envelope sequences were used to perform phylogenetic, phylogeographic and evolutionary analyses. Isolates from SJRP/SP were grouped within one lineage (BR3) close to isolates from Rio de Janeiro, Brazil. Isolates from SJRP were probably introduced there at least in 2007, prior to its detection in the 2008 outbreak. DENV-2 circulation in Brazil is characterized by the introduction, displacement and circulation of three well-defined lineages in different times, most probably from the Caribbean. Thirty-seven unique amino acid substitutions were observed among the lineages, including seven amino acid differences in domains I to III of the envelope protein. Moreover, we dated here, for the first time, the introduction of American/Asian genotype into Brazil (lineage BR1) to 1988/89, followed by the introduction of lineages BR2 (1998-2000) and BR3 (2003-05). Our results show a delay between the introduction and detection of DENV-2 lineages in Brazil, reinforcing the importance and need for surveillance programs to detect and trace the evolution of these viruses. Additionally, Brazilian DENV-2 differed in genetic diversity, date of introduction and geographic origin and distribution in Brazil, and these are important factors for the evolution, dynamics and control of dengue.
C1 [Drumond, Betania Paiva] Univ Fed Juiz de Fora, Virol Lab, Juiz De Fora, MG, Brazil.
   [Mondini, Adriano] Univ Estadual Paulista, Fac Ciencias Farmaceut, Lab Saude Publ, Sao Paulo, Brazil.
   [Schmidt, Diane J.] Tufts Univ, Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA USA.
   [de Morais Bronzoni, Roberta Vieira] Univ Fed Mato Grosso, Sinop, Mato Grosso, Brazil.
   [Bosch, Irene] MIT, Genome Resources Dengue Consortium, Cambridge, MA 02139 USA.
   [Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto FAMERP, Lab Pesquisa Virol, Sao Paulo, Brazil.
RP Drumond, BP (corresponding author), Univ Fed Juiz de Fora, Virol Lab, Juiz De Fora, MG, Brazil.
EM betaniadrumond@ufjf.edu.br; mnogueira@famerp.br
RI Nogueira, Mauricio L/B-7599-2012; Mondini, Adriano/AAB-4358-2020;
   Mondini, Adriano/F-7446-2012
OI Nogueira, Mauricio L/0000-0003-1102-2419; Mondini,
   Adriano/0000-0002-5557-9721; Mondini, Adriano/0000-0002-5557-9721
FU Instituto Nacional de Ciencia e Tecnologia (INCT)-Dengue/Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq);
   FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   PRONEX Dengue; CNPqNational Council for Scientific and Technological
   Development (CNPq); Fundacao de Apoio a Pesquisa do Estado de Minas
   Gerais (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG)
FX This work was supported by Instituto Nacional de Ciencia e Tecnologia
   (INCT)-Dengue/Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), FAPESP, PRONEX Dengue and a CNPq Grant to MLN. This
   work was also supported by a Fundacao de Apoio a Pesquisa do Estado de
   Minas Gerais (FAPEMIG) grant to BPD. MLN is the recipient of a CNPq
   Scholarship. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Allicock OM, 2012, MOL BIOL EVOL, V29, P1533, DOI 10.1093/molbev/msr320
   Anez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027459
   Azevedo AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020528
   Bennett SN, 2010, MOL BIOL EVOL, V27, P811, DOI 10.1093/molbev/msp285
   Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481
   Carrillo-Valenzo E, 2010, ARCH VIROL, V155, P1401, DOI 10.1007/s00705-010-0721-1
   Carrington CVF, 2005, J VIROL, V79, P14680, DOI 10.1128/JVI.79.23.14680-14687.2005
   Centro de Vigilancia Epidemiologica, 2007, CAS AUT CONF DENG MU
   Centro de Vigilancia Epidemiologica, 2008, CAS AUT CONF DENG MU
   Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562
   Cologna R, 2005, J VIROL, V79, P853, DOI 10.1128/JVI.79.2.853-859.2005
   Costa RL, 2012, INFECT GENET EVOL, V12, P309, DOI 10.1016/j.meegid.2011.12.011
   DATASUS-Ministry of Health, 2004, SIST INF AGR NOT
   de Souza RP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001439
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429
   Dettogni RS, 2012, MOL BIOL REP, V39, P71, DOI 10.1007/s11033-011-0711-8
   dos Santos FB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-387
   Drummond A., 2002, BEAUTI BAYESIAN EVOL
   Drummond A.J., 2002, BEAST BAYESIAN EVOLU
   Drumond BP, 2012, ARCH VIROL, V157, P2061, DOI 10.1007/s00705-012-1393-9
   Figueiredo LTM, 2000, MICROBES INFECT, V2, P1643, DOI 10.1016/S1286-4579(00)01320-4
   de Araujo JMG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001784
   Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3
   KOURI GP, 1989, B WORLD HEALTH ORGAN, V67, P375
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   McElroy KL, 2011, EMERG INFECT DIS, V17, P64, DOI 10.3201/eid1701.100961
   Ministry of Health, 2007, INF EP DENG JAN DEZ
   Ministry of Health, 2002, B EL EP
   Ministry of Health, 2009, INF EP DENG JAN NOV
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448
   Neto RJP, 2005, BRAZ J MED BIOL RES, V38, P843, DOI 10.1590/S0100-879X2005000600005
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   NOGUEIRA RMR, 1991, MEM I OSWALDO CRUZ, V86, P269, DOI 10.1590/S0074-02761991000200018
   Oliveira MF, 2010, EMERG INFECT DIS, V16, P576, DOI 10.3201/eid1603.090996
   Pan American Health Organization, 2008, NUMB REP CAS DENG DE
   Pan American Health Organization, 2007, NUMB REP CAS DENG DE
   de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185
   Posada D, 2006, NUCLEIC ACIDS RES, V34, pW700, DOI 10.1093/nar/gkl042
   Rambaut A, 2002, TREEANOTATOR V1 6 1
   Rambaut A, 2006, TREE FIGURE DRAWING
   Rambaut A., 2003, TRACER MCMC TRACE AN
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504
   Romano CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011811
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Salda LTD, 2005, AM J TROP MED HYG, V73, P796, DOI 10.4269/ajtmh.2005.73.796
   Schmidt DJ, 2011, INFECT GENET EVOL, V11, P2011, DOI 10.1016/j.meegid.2011.09.010
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Thiel HJ, 2007, FIELDS VIROLOGY, P810
   Twiddy SS, 2002, J GEN VIROL, V83, P1679, DOI 10.1099/0022-1317-83-7-1679
   Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037
   Watts DM, 1999, LANCET, V354, P1431, DOI 10.1016/S0140-6736(99)04015-5
   World Health Organization, 1997, DENG HEM FEV DIAGN T
   WORLD HEALTH ORGANIZATION (WHO); Special Programme for Research and Training in Tropical Diseases (TDR), 2009, DENG GUID DIAGN TREA
   Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005
NR 57
TC 37
Z9 38
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 22
PY 2013
VL 8
IS 3
AR e59422
DI 10.1371/journal.pone.0059422
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 111VQ
UT WOS:000316549400061
PM 23533624
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Assis, FL
   Almeida, GMF
   Oliveira, DB
   Franco-Luiz, APM
   Campos, RK
   Guedes, MIM
   Fonseca, FG
   Trindade, GS
   Drumond, BP
   Kroon, EG
   Abrahao, JS
AF Assis, Felipe L.
   Almeida, Gabriel M. F.
   Oliveira, Danilo B.
   Franco-Luiz, Ana P. M.
   Campos, Rafael K.
   Guedes, Maria I. M.
   Fonseca, Flavio G.
   Trindade, Giliane S.
   Drumond, Betania P.
   Kroon, Erna G.
   Abrahao, Jonatas S.
TI Characterization of a New Vaccinia virus Isolate Reveals the C23L Gene
   as a Putative Genetic Marker for Autochthonous Group 1 Brazilian
   Vaccinia virus
SO PLOS ONE
LA English
DT Article
ID CHEMOKINE ACTIVITY; CANTAGALO VIRUS; ORTHOPOXVIRUS; STRAINS; POXVIRUS;
   OUTBREAK; CATTLE; DISCRIMINATION; SMALLPOX; PROTEIN
AB Since 1999, several Vaccinia virus (VACV) isolates, the etiological agents of bovine vaccinia (BV), have been frequently isolated and characterized with various biological and molecular methods. The results from these approaches have grouped these VACV isolates into two different clusters. This dichotomy has elicited debates surrounding the origin of the Brazilian VACV and its epidemiological significance. To ascertain vital information to settle these debates, we and other research groups have made efforts to identify molecular markers to discriminate VACV from other viruses of the genus Orthopoxvirus (OPV) and other VACV-BR groups. In this way, some genes have been identified as useful markers to discriminate between the VACV-BR groups. However, new markers are needed to infer ancestry and to correlate each sample or group with its unique epidemiological and biological features. The aims of this work were to characterize a new VACV isolate (VACV DMTV-2005) molecularly and biologically using conserved and non-conserved gene analyses for phylogenetic inference and to search for new genes that would elucidate the VACV-BR dichotomy. The VACV DMTV-2005 isolate reported in this study is biologically and phylogenetically clustered with other strains of Group 1 VACV-BR, the most prevalent VACV group that was isolated during the bovine vaccinia outbreaks in Brazil. Sequence analysis of C23L, the gene that encodes for the CC-chemokine-binding protein, revealed a ten-nucleotide deletion, which is a new Group 1 Brazilian VACV genetic marker. This deletion in the C23L open reading frame produces a premature stop-codon that is shared by all Group 1 VACV-BR strains and may also reflect the VACV-BR dichotomy; the deletion can also be considered to be a putative genetic marker for non-virulent Brazilian VACV isolates and may be used for the detection and molecular characterization of new isolates.
C1 [Assis, Felipe L.; Almeida, Gabriel M. F.; Oliveira, Danilo B.; Franco-Luiz, Ana P. M.; Campos, Rafael K.; Fonseca, Flavio G.; Trindade, Giliane S.; Kroon, Erna G.; Abrahao, Jonatas S.] Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Guedes, Maria I. M.] Univ Fed Minas Gerais, Dept Med Vet Prevent, Belo Horizonte, MG, Brazil.
   [Drumond, Betania P.] Univ Fed Juiz de Fora, Dept Parasitol Microbiol & Imunol, Juiz De Fora, MG, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Abrahao, Jonatas/B-3895-2015; Kroon, Erna/V-5444-2019; Almeida, Gabriel
   MF/I-8910-2012; Kroon, Erna Geessien/B-3631-2015; Campos, Rafael
   Kroon/AAB-5135-2020
OI Abrahao, Jonatas/0000-0001-9420-1791; Almeida, Gabriel
   MF/0000-0003-2317-5092; Kroon, Erna Geessien/0000-0003-2721-3826;
   Campos, Rafael Kroon/0000-0002-4852-0449
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais(FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG);
   Ministerio da Agricultura, Pecuaria e Abastecimento (MAPA); Pro-Reitoria
   de Pesquisa (PRPq-UFMG); Pro-Reitoria de Pesquisa da Universidade
   Federal de Minas Gerais (PRPq-UFMG); Fundacao de Amparo a Pesquisa de
   Minas Gerais (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG)
FX Financial support was provided by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo
   a Pesquisa do Estado de Minas Gerais(FAPEMIG) and Ministerio da
   Agricultura, Pecuaria e Abastecimento (MAPA) and Pro-Reitoria de
   Pesquisa (PRPq-UFMG). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.; We thank colleagues from the Laboratory of Virus for their
   excellent technical support. We thank Pro-Reitoria de Pesquisa da
   Universidade Federal de Minas Gerais (PRPq-UFMG) and Fundacao de Amparo
   a Pesquisa de Minas Gerais (FAPEMIG) for the financial support.
CR Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Abrahao JS, 2010, J MED VIROL, V82, P692, DOI 10.1002/jmv.21617
   Abrahao JS, 2009, VIROL J, V6, P1
   Alcami A, 1998, J IMMUNOL, V160, P624
   Brum MCS, 2010, J VET DIAGN INVEST, V22, P143
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   Campos RK, 2011, ARCH VIROL, V156, P275, DOI 10.1007/s00705-010-0857-z
   Carroll DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023086
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Damon I, 2007, FIELDS VIROLOGY, P2079
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Fenner F, 1988, SMALLPOX ITS ERADICA
   Graham KA, 1997, VIROLOGY, V229, P12, DOI 10.1006/viro.1996.8423
   Haenssle HA, 2006, J AM ACAD DERMATOL, V54, pS1, DOI 10.1016/j.jaad.2005.09.040
   Heymann DL, 2006, CURR TOP MICROBIOL, V304, P1
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Laassri M, 2003, J VIROL METHODS, V112, P67, DOI 10.1016/S0166-0934(03)00193-9
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   Medaglia MLG, 2009, EMERG INFECT DIS, V15, P1142, DOI 10.3201/eid1507.081702
   Megid J, 2008, AM J TROP MED HYG, V79, P647, DOI 10.4269/ajtmh.2008.79.647
   Posada D, 2006, NUCLEIC ACIDS RES, V34, pW700, DOI 10.1093/nar/gkl042
   Reynolds MG, 2006, J INFECT DIS, V194, P773, DOI 10.1086/505880
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   Ryabinin VA, 2006, J MED VIROL, V78, P1325, DOI 10.1002/jmv.20698
   Sambrook J, 2001, MOL CLONING LAB MANU
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043
   Smith CA, 1997, VIROLOGY, V236, P316, DOI 10.1006/viro.1997.8730
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2009, CLIN INFECT DIS, V48, pE37, DOI 10.1086/595856
NR 34
TC 4
Z9 5
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 26
PY 2012
VL 7
IS 11
AR e50413
DI 10.1371/journal.pone.0050413
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 048RI
UT WOS:000311929800077
PM 23189200
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Drumond, BP
   Mondini, A
   Schmidt, DJ
   Bosch, I
   Nogueira, ML
AF Drumond, Betania Paiva
   Mondini, Adriano
   Schmidt, Diane J.
   Bosch, Irene
   Nogueira, Mauricio Lacerda
TI Population dynamics of DENV-1 genotype V in Brazil is characterized by
   co-circulation and strain/lineage replacement
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID DENGUE VIRUS TYPE-1; PHYLOGENETIC ANALYSIS; NATURAL-POPULATIONS;
   RECOMBINATION; EPIDEMIOLOGY; TRANSMISSION; SEQUENCES; REVEALS; TARGET
AB Following successive outbreaks of dengue fever caused predominantly by dengue virus (DENV) 2 and 3, DENV-1 is now the primary serotype circulating in Brazil. We sequenced and analyzed Brazilian DENV-1 genomes and found that all isolates belong to genotype V and are subdivided into three lineages, which were introduced during four different events. The first introduction occurred in 1984-85, the second in 1997-99, and the third and fourth occurred from 2004 to 2007. These events were associated with an increase in genetic diversity but not with positive selection. Moreover, a potential new recombinant strain derived from two distinct lineages was detected. We demonstrate that the dynamics of DENV-1 in Brazil is characterized by introduction, movement, local evolution, and lineage replacement. This study strengthens the relevance of genotype surveillance in order to identify, trace, and control virus populations circulating in Brazil and Latin America.
C1 [Drumond, Betania Paiva] Univ Fed Juiz de Fora, Virol Lab, Juiz De Fora, MG, Brazil.
   [Mondini, Adriano] Fac Ciencias Farmaceut UNESP, Lab Saude Publ, Sao Paulo, Brazil.
   [Schmidt, Diane J.] Tufts Cummings Sch Vet Med, North Grafton, MA 01536 USA.
   [Bosch, Irene] MIT, Genome Resources Dengue Consortium, Cambridge, MA 02139 USA.
   [Nogueira, Mauricio Lacerda] Fac Med Sao Jose Rio Preto FAMERP, Lab Pesquisa Virol, Sao Paulo, Brazil.
RP Drumond, BP (corresponding author), Univ Fed Juiz de Fora, Virol Lab, Juiz De Fora, MG, Brazil.
EM betaniadrumond@gmail.com
RI Nogueira, Mauricio L/B-7599-2012; Mondini, Adriano/F-7446-2012; Mondini,
   Adriano/AAB-4358-2020
OI Nogueira, Mauricio L/0000-0003-1102-2419; Mondini,
   Adriano/0000-0002-5557-9721; Mondini, Adriano/0000-0002-5557-9721
FU Instituto Nacional de Ciencia e Tecnologia (INCT)-Dengue/Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq); Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas Gerais State
   Research Foundation (FAPEMIG); CNPqNational Council for Scientific and
   Technological Development (CNPq)
FX We thank the Broad Institute for sequencing our sample. This work was
   supported by Instituto Nacional de Ciencia e Tecnologia
   (INCT)-Dengue/Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais (FAPEMIG). MLN is recipient of a CNPq Scholarship.''
CR A-Nuegoonpipat A, 2004, VIROLOGY, V329, P505, DOI 10.1016/j.virol.2004.08.029
   Aaskov J, 2007, J GEN VIROL, DOI [10.1099/vir.083122-0, DOI 10.1099/VIR.083122-0]
   Allicock OM, 2012, MOL BIOL EVOL, V29, P1533, DOI 10.1093/molbev/msr320
   ANDERSON R, 1992, J GEN VIROL, V73, P2155, DOI 10.1099/0022-1317-73-8-2155
   Carvalho SES, 2010, VIRUS GENES, V40, P60, DOI 10.1007/s11262-009-0428-0
   Chen SP, 2008, ARCH VIROL, V153, P1175, DOI 10.1007/s00705-008-0090-1
   Chen YP, 1996, J VIROL, V70, P8765, DOI 10.1128/JVI.70.12.8765-8772.1996
   Costa RL, 2012, INFECT GENET EVOL, V12, P309, DOI 10.1016/j.meegid.2011.12.011
   dos Santos CND, 2002, VIRUS RES, V90, P197, DOI 10.1016/S0168-1702(02)00180-6
   dos Santos FB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-387
   Drummond A., 2002, BEAUTI BAYESIAN EVOL
   Drummond A.J., 2002, BEAST BAYESIAN EVOLU
   Duong V, 2013, INFECT GENET EVOL, V15, P59, DOI 10.1016/j.meegid.2011.06.019
   Figueiredo LTM, 2000, MICROBES INFECT, V2, P1643, DOI 10.1016/S1286-4579(00)01320-4
   Goncalvez AP, 2002, VIROLOGY, V303, P110, DOI 10.1006/viro.2002.1686
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003
   Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3
   Laille M, 2004, AM J TROP MED HYG, V71, P478, DOI 10.4269/ajtmh.2004.71.478
   Lambrechts L, 2012, J VIROL, V86, P1853, DOI 10.1128/JVI.06458-11
   Lee KS, 2012, INFECT GENET EVOL, V12, P77, DOI 10.1016/j.meegid.2011.10.012
   Lee KS, 2010, EMERG INFECT DIS, V16, P847, DOI 10.3201/eid1605.091006
   Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467
   Mendez JA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-226
   Ministry of Health-Brazil, 2010, NOT TECHN CGPNCD DEV
   Ministry of Health-Brazil, 2010, 118 CGPNCDDEVEPSVSMS
   Mondini A, 2005, REV SAUDE PUBL, V39, P444, DOI 10.1590/s0034-89102005000300016
   Neto RJP, 2005, BRAZ J MED BIOL RES, V38, P843, DOI 10.1590/S0100-879X2005000600005
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   Pan American Health Organization, 2010, NUMB REP CAS DENG FI
   Pan American Health Organization, 1979, PAHO SCI PUBL
   Perera R, 2008, ANTIVIR RES, V80, P11, DOI 10.1016/j.antiviral.2008.05.004
   Perez-Ramirez G, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-260
   Pierson Theodore C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000665
   de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185
   Rambaut A, 2002, TREEANOTATOR V1 6 1
   Rambaut A, 2006, TREE FIGURE DRAWING
   Rambaut A., 2003, TRACER MCMC TRACE AN
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   Schmidt DJ, 2011, INFECT GENET EVOL, V11, P2011, DOI 10.1016/j.meegid.2011.09.010
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Thiel HJ, 2007, FIELDS VIROLOGY, P810
   Tolou HJG, 2001, J GEN VIROL, V82, P1283, DOI 10.1099/0022-1317-82-6-1283
   Twiddy SS, 2003, MOL BIOL EVOL, V20, P122, DOI 10.1093/molbev/msg010
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   World Health Organization, 1997, DENG HEM FEV DIAGN T
   Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088
   Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005
NR 51
TC 32
Z9 32
U1 0
U2 7
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD NOV
PY 2012
VL 157
IS 11
BP 2061
EP 2073
DI 10.1007/s00705-012-1393-9
PG 13
WC Virology
SC Virology
GA 031AK
UT WOS:000310611100002
PM 22777179
DA 2020-12-09
ER

PT J
AU Gomes, JAS
   de Araujo, FF
   Trindade, GD
   Quinan, BR
   Drumond, BP
   Ferreira, JMS
   Mota, BEF
   Nogueira, ML
   Kroon, EG
   Abrahao, JS
   Correa-Oliveira, R
   da Fonseca, FG
AF Silva Gomes, Juliana Assis
   de Araujo, Fernanda Fortes
   Trindade, Giliane de Souza
   Quinan, Barbara Resende
   Drumond, Betania Paiva
   Siqueira Ferreira, Jaqueline Maria
   Fernandes Mota, Bruno Eduardo
   Nogueira, Mauricio Lacerda
   Kroon, Erna Geessien
   Abrahao, Jonatas Santos
   Correa-Oliveira, Rodrigo
   da Fonseca, Flavio Guimaraes
TI Immune Modulation in Primary Vaccinia virus Zoonotic Human Infections
SO CLINICAL & DEVELOPMENTAL IMMUNOLOGY
LA English
DT Article
ID T-CELL RESPONSES; MHC CLASS-II; SMALLPOX VACCINATION; ANTIGEN
   PRESENTATION; POXVIRUS INFECTION; MONKEYPOX VIRUS; BRAZIL; IMMUNIZATION;
   PROTECTION; EVASION
AB In 2010, the WHO celebrated the 30th anniversary of the smallpox eradication. Ironically, infections caused by viruses related to smallpox are being increasingly reported worldwide, including Monkeypox, Cowpox, and Vaccinia virus (VACV). Little is known about the human immunological responses elicited during acute infections caused by orthopoxviruses. We have followed VACV zoonotic outbreaks taking place in Brazil and analyzed cellular immune responses in patients acutely infected by VACV. Results indicated that these patients show a biased immune modulation when compared to noninfected controls. Amounts of B cells are low and less activated in infected patients. Although present, T CD4(+) cells are also less activated when compared to noninfected individuals, and so are monocytes/macrophages. Similar results were obtained when Balb/C mice were experimentally infected with a VACV sample isolated during the zoonotic outbreaks. Taking together, the data suggest that zoonotic VACVs modulate specific immune cell compartments during an acute infection in humans.
C1 [Trindade, Giliane de Souza; Quinan, Barbara Resende; Drumond, Betania Paiva; Fernandes Mota, Bruno Eduardo; Kroon, Erna Geessien; Abrahao, Jonatas Santos; da Fonseca, Flavio Guimaraes] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Silva Gomes, Juliana Assis] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Silva Gomes, Juliana Assis; de Araujo, Fernanda Fortes; Siqueira Ferreira, Jaqueline Maria; Correa-Oliveira, Rodrigo; da Fonseca, Flavio Guimaraes] Fundacao Oswaldo Cruz, IRR, BR-30190002 Belo Horizonte, MG, Brazil.
   [Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto FAMERP, Dept Doencas Infecciosas & Parasitarias, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com; fdafonseca@cpqrr.fiocruz.br
RI Nogueira, Mauricio L/B-7599-2012; Ferreira, Jaqueline/E-4630-2018;
   Abrahao, Jonatas/B-3895-2015; Kroon, Erna Geessien/B-3631-2015; Gomes,
   Juliana A. S./M-4083-2017; Kroon, Erna/V-5444-2019
OI Nogueira, Mauricio L/0000-0003-1102-2419; Ferreira,
   Jaqueline/0000-0002-1779-1975; Abrahao, Jonatas/0000-0001-9420-1791;
   Kroon, Erna Geessien/0000-0003-2721-3826; Gomes, Juliana A.
   S./0000-0002-8332-2907; Mota, Bruno/0000-0003-0348-4875;
   Correa-Oliveira, Rodrigo/0000-0001-6419-9459
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [473205/2009-2]; FAPEMIGMinas Gerais State Research Foundation (FAPEMIG)
   [CBB-APQ-00299-08]; National Institute of Science and Technology in
   Vaccines (INCTV)
FX The authors thank all patients for their willingness to participate in
   this study and Jaqueline de Oliveira and Luciana Arruda for critical
   reading of the paper. Special thanks to Clari Gandra, for administrative
   support. They also thank health officials and professionals from the
   cities of Serro, Ponte Nova, and Bambui, MG, Brazil. J. A. S. Gomes, G.
   S. Trindade, M. L. Nogueira, E. G. Kroon, R. Correa-Oliveira, and F. G.
   da Fonseca are CNPq fellowship recipients. This work was supported by
   Grants from FAPEMIG (CBB-APQ-00299-08, Universal Demand), CNPq
   (473205/2009-2, Universal Demand) and by the National Institute of
   Science and Technology in Vaccines (INCTV). Other than funding,
   supporting agencies had no role in conducting the study or writing the
   paper.
CR Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187
   AlYaman F, 1997, PARASITE IMMUNOL, V19, P207, DOI 10.1046/j.1365-3024.1997.d01-198.x
   Amanna IJ, 2006, IMMUNOL REV, V211, P320, DOI 10.1111/j.0105-2896.2006.00392.x
   Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123
   Belyakov IM, 2003, P NATL ACAD SCI USA, V100, P9458, DOI 10.1073/pnas.1233578100
   Blendon RJ, 2003, NEW ENGL J MED, V348, P426, DOI 10.1056/NEJMsa023184
   Chaudhri G, 2006, J VIROL, V80, P6339, DOI 10.1128/JVI.00116-06
   da Fonseca FG, 2011, FUTURE VIROL, V6, P697, DOI 10.2217/FVL.11.46
   Dasgupta A, 2007, J IMMUNOL, V178, P1654, DOI 10.4049/jimmunol.178.3.1654
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Dunlop LR, 2003, MICROBES INFECT, V5, P1049, DOI 10.1016/S1286-4579(03)00194-1
   Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261
   Essbauer S, 2010, VET MICROBIOL, V140, P229, DOI 10.1016/j.vetmic.2009.08.026
   Fang M, 2005, J IMMUNOL, V175, P6829, DOI 10.4049/jimmunol.175.10.6829
   Frey SE, 2004, NEW ENGL J MED, V350, P324, DOI 10.1056/NEJMp038208
   Haga IR, 2005, PARASITOLOGY, V130, pS11, DOI 10.1017/S0031182005008127
   Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917
   Hammarlund E, 2008, P NATL ACAD SCI USA, V105, P14567, DOI 10.1073/pnas.0800589105
   Johnston JB, 2003, J VIROL, V77, P6093, DOI 10.1128/JVI.77.11.6093-6100.2003
   Kennedy RB, 2009, CURR OPIN IMMUNOL, V21, P314, DOI 10.1016/j.coi.2009.04.004
   Lauterbach H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009659
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Li GY, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-88
   Li P, 2005, J IMMUNOL, V175, P6481, DOI 10.4049/jimmunol.175.10.6481
   Martinez J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000811
   Mathew A, 2000, CLIN IMMUNOL, V96, P100, DOI 10.1006/clim.2000.4887
   Mota BEF, 2010, ARCH VIROL, V155, P1139, DOI 10.1007/s00705-010-0675-3
   Moulton EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000249
   Moyron-Quiroz JE, 2009, VACCINE, V28, P140, DOI 10.1016/j.vaccine.2009.09.086
   Panchanathan V, 2010, IMMUNOL CELL BIOL, V88, P461, DOI 10.1038/icb.2009.110
   Parker AK, 2007, J VIROL, V81, P4070, DOI 10.1128/JVI.02061-06
   Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363
   Putz MM, 2006, NAT MED, V12, P1310, DOI 10.1038/nm1457
   Rehm KE, 2010, VIROLOGY, V397, P176, DOI 10.1016/j.virol.2009.11.008
   Rehm KE, 2009, IMMUNOLOGY, V128, P381, DOI 10.1111/j.1365-2567.2009.03120.x
   RILEY E, 1990, IMMUNOL LETT, V25, P221, DOI 10.1016/0165-2478(90)90119-B
   Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049
   Sejvar JJ, 2004, J INFECT DIS, V190, P1833, DOI 10.1086/425039
   Sepkowitz KA, 2003, NEW ENGL J MED, V348, P439, DOI 10.1056/NEJMra022500
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2009, CLIN INFECT DIS, V48, pE37, DOI 10.1086/595856
   Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912
   Venkatesan G, 2010, VET ITAL, V46, P439
   Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668
   Vorou RM, 2008, CURR OPIN INFECT DIS, V21, P153, DOI 10.1097/QCO.0b013e3282f44c74
   Xu R, 2004, J IMMUNOL, V172, P6265, DOI 10.4049/jimmunol.172.10.6265
NR 49
TC 4
Z9 4
U1 0
U2 4
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1740-2522
EI 1740-2530
J9 CLIN DEV IMMUNOL
JI Clin. Dev. Immunol.
PY 2012
AR 974067
DI 10.1155/2012/974067
PG 11
WC Immunology
SC Immunology
GA 872OX
UT WOS:000298820300001
PM 22229039
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Magalhaes, CLD
   Drumond, BP
   Novaes, RFV
   Quinan, BR
   de Magalhaes, JC
   dos Santos, JR
   Pinto, CD
   Assis, MTD
   Bonjardim, CA
   Kroon, EG
   Ferreira, PCP
AF de Brito Magalhaes, Cintia Lopes
   Drumond, Betania Paiva
   Vianna Novaes, Renata Franco
   Quinan, Barbara Rezende
   de Magalhaes, Jose Carlos
   dos Santos, Joao Rodrigues
   Pinto, Carla do Amaral
   de Abreu Assis, Marieta Torres
   Bonjardim, Claudio Antonio
   Kroon, Erna Geessien
   Peregrino Ferreira, Paulo Cesar
TI Identification of a phylogenetically distinct orthobunyavirus from group
   C
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID ARTHROPOD-BORNE VIRUSES; FAMILY BUNYAVIRIDAE; RNA SEGMENT;
   NUCLEOTIDE-SEQUENCE; HEMORRHAGIC-FEVER; BUNYAMWERA VIRUS; OROPOUCHE
   VIRUS; AMAZON REGION; BRAZIL; EPIDEMIOLOGY
AB Apeu virus (APEUV) (family Bunyaviridae, genus Orthobunyavirus) was plaque purified and characterised by serological and molecular analysis. Neutralising assays confirmed cross-reactivity between purified APEUV clones and the Caraparu virus complex of group C orthobunyaviruses. Partial sequencing of the L, M and S segments of one APEUV clone (APEUV-CL5) was carried out. A phylogenetic tree constructed with the L amino acid sequences clustered APEUV-CL5 within the genus Orthobunyavirus, confirming its serological classification. Analysis of M segment sequences clustered APEUV-CL5 in the Caraparu virus complex (Group C), in agreement with serological tests and previous molecular characterisation. However, the sequence of the nucleocapsid gene (N) gave low identity values when compared to those of the group C viruses. The phylogenetic tree based on N nucleotide sequences clustered APEUV-CL5 next to the California and Bwamba groups. This remarkable S nucleotide variability suggests that APEUV-CL5 could be a genetic reassortant and that this evolutionary mechanism is present in the history of the group C viruses.
C1 [de Brito Magalhaes, Cintia Lopes; Drumond, Betania Paiva; Vianna Novaes, Renata Franco; Quinan, Barbara Rezende; dos Santos, Joao Rodrigues; Pinto, Carla do Amaral; de Abreu Assis, Marieta Torres; Bonjardim, Claudio Antonio; Kroon, Erna Geessien; Peregrino Ferreira, Paulo Cesar] Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [de Brito Magalhaes, Cintia Lopes] Univ Fed Ouro Preto, Dept Ciencias Biol, Lab Bioquim Metabol, Inst Ciencias Exatas & Biol, Ouro Preto, MG, Brazil.
   [Drumond, Betania Paiva] Univ Fed Juiz de Fora, Dept Parasitol Microbiol & Imunol, Virol Lab, Inst Ciencias Biol, Juiz De Fora, MG, Brazil.
   [Vianna Novaes, Renata Franco] Dept Policia Civil Estado Minas Gerais, Secao Reg Criminalist Delegacia Reg Policia 2A 5, Araxa, MG, Brazil.
   [Quinan, Barbara Rezende] Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, Lab Virol Comparada, BR-31270901 Belo Horizonte, MG, Brazil.
   [de Magalhaes, Jose Carlos] Univ Fed Sao Joao, Microbiol Lab, Ouro Branco, MG, Brazil.
RP Ferreira, PCP (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, Virus Lab, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM cintia.magalhaes@gmail.com; paulo.peregrino@pq.cnpq.br
RI Bonjardim, Claudio A/J-2601-2014; Kroon, Erna/V-5444-2019; Kroon, Erna
   Geessien/B-3631-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG)
FX The authors are grateful to colleagues from Virus Laboratory (ICB-UFMG)
   for their technical and scientific supports. This work was supported by
   research grants from Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), Coordenadoria de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES), and Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais (FAPEMIG). P.C.P. Ferreira, E. G. Kroon, and C. A. Bonjardim are
   CNPq researchers. We thank Dr. G. S. Trindade and Dr. Jaquelline G.
   Oliveira for helpful scientific discussions. We thank the Laboratory of
   Biodiversity and Molecular Evolution (ICB-UFMG), where sequences were
   determined.
CR Aquino VH, 2004, J VIROL METHODS, V115, P51, DOI 10.1016/j.jviromet.2003.09.018
   BISHOP DHL, 1985, INTERVIROLOGY, V24, P79, DOI 10.1159/000149623
   Bowen MD, 2001, VIROLOGY, V291, P185, DOI 10.1006/viro.2001.1201
   Bridgen A, 2001, P NATL ACAD SCI USA, V98, P664, DOI 10.1073/pnas.98.2.664
   Calisher C. H., 1996, The Bunyaviridae., P1
   CALISHER CH, 1988, INTERVIROLOGY, V29, P268, DOI 10.1159/000150055
   CASALS J, 1961, AM J TROP MED HYG, V10, P250, DOI 10.4269/ajtmh.1961.10.250
   CAUSEY OR, 1961, AM J TROP MED HYG, V10, P227, DOI 10.4269/ajtmh.1961.10.227
   DULBECCO R, 1952, P NATL ACAD SCI USA, V38, P747, DOI 10.1073/pnas.38.8.747
   Eifan SA, 2009, J VIROL, V83, P11307, DOI 10.1128/JVI.01460-09
   Elliott RM, 1997, MOL MED, V3, P572, DOI 10.1007/BF03401814
   ELLIOTT RM, 1985, VIROLOGY, V143, P119, DOI 10.1016/0042-6822(85)90101-1
   ELLIOTT RM, 1989, VIROLOGY, V173, P426, DOI 10.1016/0042-6822(89)90555-2
   Fauquet C. M., 2005, 8 ICTV
   FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   GENTSCH JR, 1979, J VIROL, V30, P767, DOI 10.1128/JVI.30.3.767-770.1979
   Gerrard SR, 2004, J VIROL, V78, P8922, DOI 10.1128/JVI.78.16.8922-8926.2004
   GIBBS CJ, 1964, AM J TROP MED HYG, V13, P108, DOI 10.4269/ajtmh.1964.13.108
   Henderson WW, 1995, VIROLOGY, V214, P602, DOI 10.1006/viro.1995.0071
   Holland J, 1998, VIRUS GENES, V16, P13, DOI 10.1023/A:1007989407305
   HRONOVSKY V, 1981, ACTA VIROL, V25, P295
   Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868
   Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150
   Kuno G, 1996, J CLIN MICROBIOL, V34, P1184, DOI 10.1128/JCM.34.5.1184-1188.1996
   MACIAS JD, 1969, SALUD PUBLICA MEXICO, V11, P323
   Magalhaes CLD, 2007, VIRUS GENES, V35, P681, DOI 10.1007/s11262-007-0138-4
   Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490
   Nichol S. T., 2001, FIELDS VIROLOGY, P1603
   Nunes MRT, 2005, J VIROL, V79, P10561, DOI 10.1128/JVI.79.16.10561-10570.2005
   Posada D, 2006, NUCLEIC ACIDS RES, V34, pW700, DOI 10.1093/nar/gkl042
   Reese SM, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-164
   Saeed MF, 2001, VIRUS RES, V77, P25, DOI 10.1016/S0168-1702(01)00262-3
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Sall AA, 1999, J VIROL, V73, P8196, DOI 10.1128/JVI.73.10.8196-8200.1999
   Schmaljohn C, 2007, FIELDS VIROLOGY, P1741
   SHOPE RE, 1962, AM J TROP MED HYG, V11, P283, DOI 10.4269/ajtmh.1962.11.283
   SHOPE RE, 1966, AM J TROP MED HYG, V15, P772, DOI 10.4269/ajtmh.1966.15.772
   Soldan SS, 2005, J NEUROVIROL, V11, P412, DOI 10.1080/13550280591002496
   TAMURA K, 1992, MOL BIOL EVOL, V9, P678
   Terzian ACB, 2009, EMERG INFECT DIS, V15, P348, DOI 10.3201/eid1502.080401
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   van Knippenberg I, 2010, J GEN VIROL, V91, P2002, DOI 10.1099/vir.0.021774-0
   Vasconcelos HB, 2009, J CLIN VIROL, V44, P129, DOI 10.1016/j.jcv.2008.11.006
   Vasconcelos P., 1998, OVERVIEW ARBOVIROLOG, P72
   VASCONCELOS PFD, 1991, REV INST MED TROP SP, V33, P465, DOI 10.1590/S0036-46651991000600007
   Weber F, 2002, VIRUS RES, V88, P129, DOI 10.1016/S0168-1702(02)00125-9
   Yanase T, 2006, ARCH VIROL, V151, P2253, DOI 10.1007/s00705-006-0808-x
NR 48
TC 13
Z9 13
U1 0
U2 4
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD JUL
PY 2011
VL 156
IS 7
BP 1173
EP 1184
DI 10.1007/s00705-011-0976-1
PG 12
WC Virology
SC Virology
GA 784LW
UT WOS:000292159800008
PM 21465087
DA 2020-12-09
ER

PT J
AU Terzian, ACB
   Mondini, A
   Bronzoni, RVD
   Drumond, BP
   Ferro, BP
   Cabrera, EMS
   Figueiredo, LTM
   Chiaravalloti-Neto, F
   Nogueira, ML
AF Bernardes Terzian, Ana Carolina
   Mondini, Adriano
   de Moraes Bronzoni, Roberta Vieira
   Drumond, Betania Paiva
   Ferro, Bianca Piovezan
   Sotello Cabrera, Eliana Marcia
   Moraes Figueiredo, Luis Tadeu
   Chiaravalloti-Neto, Francisco
   Nogueira, Mauricio Lacerda
TI Detection of Saint Louis Encephalitis Virus in Dengue-Suspected Cases
   During a Dengue 3 Outbreak
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Article
DE Acute febrile illness; Arbovirus; Dengue virus; Molecular diagnostic;
   SLEV envelope gene
ID GENETIC-VARIATION; NESTED PCR; INFECTION; IDENTIFICATION; ALPHAVIRUSES;
   STRAINS; DENV-3; ASSAYS
AB Arboviruses are frequently associated with outbreaks in humans and represent a serious public health problem. Among the Brazilian arboviruses, Mayaro virus, Dengue virus (DENV), Yellow Fever virus, Rocio virus, Saint Louis Encephalitis virus (SLEV), and Oropouche virus are responsible for most of human cases. All these arboviruses usually produce undistinguishable acute febrile illness, especially in the acute phase of infection. In this study we investigated the presence of arboviruses in sera of 519 patients presenting acute febrile illness, during a dengue outbreak in Sao Jose do Rio Preto City (Sao Paulo, Brazil). A multiplex-nested RT-polymerase chain reaction assay was applied to detect and identify the main Brazilian arboviruses (Flavivirus, Alphavirus, and Orthobunyavirus genera). The molecular analysis showed that 365 samples were positive to DENV-3, 5 to DENV-2, and 8 to SLEV. Among the positive samples, one coinfection was detected between DENV-2 and DENV-3. The phylogenetic analysis of the SLEV envelope gene indicated that the virus circulating in city is related to lineage V strains. These results indicated that during that large DENV-3 outbreak in 2006, different arboviruses cocirculated causing human disease. Thus, it is necessary to have an efficient surveillance system to control the dissemination of these arboviruses in the population.
C1 [Bernardes Terzian, Ana Carolina; Mondini, Adriano; de Moraes Bronzoni, Roberta Vieira; Ferro, Bianca Piovezan; Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto FAMERP, Lab Pesquisa Virol, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
   [Drumond, Betania Paiva] FIOCRUZ MG, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
   [Sotello Cabrera, Eliana Marcia] Fac Med Sao Jose do Rio Preto FAMERP, Dept Saude Colet, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
   [Moraes Figueiredo, Luis Tadeu] Fac Med Ribeirao Preto, Ctr Pesquisa Virol, Ribeirao Preto, Brazil.
   [Chiaravalloti-Neto, Francisco] Superintendencia Controle Endemias SUCEN, Sao Jose Do Rio Preto, Brazil.
RP Nogueira, ML (corresponding author), Fac Med Sao Jose do Rio Preto FAMERP, Lab Pesquisa Virol, Av Brigadeiro Faria Lima,5416 Vila Sao Pedro, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
EM mauricio.nogueira@pq.cnpq.br
RI Neto, Francisco Chiaravalloti/F-8006-2012; Figueiredo, Luiz
   T/E-3702-2012; Mondini, Adriano/AAB-4358-2020; Cabrera,
   Eliana/B-3190-2016; Bronzoni, Roberta/J-8917-2012; Nogueira, Mauricio
   L/B-7599-2012; Mondini, Adriano/F-7446-2012
OI Neto, Francisco Chiaravalloti/0000-0003-2686-8740; Mondini,
   Adriano/0000-0002-5557-9721; Cabrera, Eliana/0000-0002-6967-5773;
   Nogueira, Mauricio L/0000-0003-1102-2419; Mondini,
   Adriano/0000-0002-5557-9721; Bronzoni, Roberta/0000-0002-9403-5284
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [04/11098-2]; Conselho
   Nacional de Desenvolvimento Cientifico e TecnologicoNational Council for
   Scientific and Technological Development (CNPq) [401396/2004-5]; Viral
   Genetic Diversity Network (VGDN-FAPESP-Brazil)
FX The authors thank all staff of the County Office of Health and Hygiene,
   Basic Unities of Health, Emergency Unities and Hospitals from the Sao
   Jose do Rio Preto City. They also thank Milena Polloto for sample
   sequencing. This work was supported by grants from Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) (grant no. 04/11098-2) and
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grant no.
   401396/2004-5). This work was also partially supported by the Viral
   Genetic Diversity Network (VGDN-FAPESP-Brazil).
CR Auguste AJ, 2009, INFECT GENET EVOL, V9, P709, DOI 10.1016/j.meegid.2008.07.006
   Baillie GJ, 2008, MOL PHYLOGENET EVOL, V47, P717, DOI 10.1016/j.ympev.2008.02.015
   Bharaj P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-1
   Borst A, 2004, EUR J CLIN MICROBIOL, V23, P289, DOI 10.1007/s10096-004-1100-1
   *BRAZ MIN HLTH, 2009, INF EP
   *BRAZ MIN HLTH, 2009, DENG BRAS INF EP
   *BRAZ MIN HLTH, 2008, INF EP DENG
   *BRAZ MIN HLTH, 2007, INF EP DENG
   *BRAZ MIN HLTH, 2005, SECR VIG SAUD GUIA V
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Bronzoni RVM, 2004, T ROY SOC TROP MED H, V98, P456, DOI 10.1016/j.trstmh.2003.09.002
   BURKE DS, 2001, FLAVIVIRUSES FIELDS
   Chandler LJ, 1999, J VIROL METHODS, V80, P169, DOI 10.1016/S0166-0934(99)00044-0
   Araujo FMD, 2006, MEM I OSWALDO CRUZ, V101, P925, DOI 10.1590/S0074-02762006000800017
   De Simone TS, 2004, T ROY SOC TROP MED H, V98, P553, DOI 10.1016/j.trstmh.2003.09.003
   Figueiredo L T, 1990, Rev Soc Bras Med Trop, V23, P13, DOI 10.1590/S0037-86821990000100003
   Figueiredo LTM, 2000, MICROBES INFECT, V2, P1643, DOI 10.1016/S1286-4579(00)01320-4
   FONSECA BAL, 2005, ATHENEU, P343
   FULOP L, 1993, J VIROL METHODS, V44, P179, DOI 10.1016/0166-0934(93)90053-T
   GUBLER DJ, 1985, AM J TROP MED HYG, V34, P170, DOI 10.4269/ajtmh.1985.34.170
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   KANESATHASAN N, 1994, LANCET, V343, P678, DOI 10.1016/S0140-6736(94)92678-6
   Kramer LD, 1997, AM J TROP MED HYG, V57, P222, DOI 10.4269/ajtmh.1997.57.222
   Kramer LD, 2001, ARCH VIROL, V146, P2341, DOI 10.1007/s007050170007
   Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150
   LAILLE M, 1991, J MED VIROL, V34, P51, DOI 10.1002/jmv.1890340109
   LOPES ODS, 1979, AM J TROP MED HYG, V28, P583
   May FJ, 2008, J GEN VIROL, V89, P1901, DOI 10.1099/vir.0.2008/000190-0
   Mondini A, 2005, REV SAUDE PUBL, V39, P444, DOI 10.1590/s0034-89102005000300016
   Mondini A, 2007, J CLIN VIROL, V40, P84, DOI 10.1016/j.jcv.2007.06.007
   Mondini A, 2007, EMERG INFECT DIS, V13, P176, DOI 10.3201/eid1301.060905
   Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448
   Figueiredo LTM, 2007, REV SOC BRAS MED TRO, V40, P224, DOI 10.1590/S0037-86822007000200016
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   Peng WM, 2005, J CLIN VIROL, V32, P194, DOI 10.1016/j.jcv.2004.04.010
   Pfeffer M, 1997, AM J TROP MED HYG, V57, P709, DOI 10.4269/ajtmh.1997.57.709
   de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185
   Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121
   Rocco Iray M., 2005, Rev. Inst. Med. trop. S. Paulo, V47, P281, DOI 10.1590/S0036-46652005000500008
   SABATTINI M, 1998, OVERVIEW ARBOVIROLOG, P114
   Sambrook D, 2001, MOL CLONING LAB MANU
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Shope RE, 1979, DIAGNOSTIC PROCEDURE, P767
   SILVA JR, 2009, REV RES, V14, P115
   SUZUKI A, 2006, J BRAZ SOC VIROL, V11, P129
   Terzian ACB, 2009, EMERG INFECT DIS, V15, P348, DOI 10.3201/eid1502.080401
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Trent D W, 1980, Ann N Y Acad Sci, V354, P219, DOI 10.1111/j.1749-6632.1980.tb27969.x
   Twiddy SS, 2003, J GEN VIROL, V84, P429, DOI 10.1099/vir.0.18660-0
   Vasconcelos P., 1998, OVERVIEW ARBOVIROLOG, P72
   VASCONCELOS PFC, 2005, ARBOVIROSES VERONESI, P289
   Wang Wei-Kung, 2003, Journal of Microbiology Immunology and Infection, V36, P89
   *WHO, 1997, DENG DENG HAEM FEV D
   2005, B EPIDEMIOLOGICO PAU, V2, P20
NR 54
TC 36
Z9 37
U1 0
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD MAR
PY 2011
VL 11
IS 3
BP 291
EP 300
DI 10.1089/vbz.2009.0200
PG 10
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 741UZ
UT WOS:000288892200013
PM 20645866
DA 2020-12-09
ER

PT J
AU Campos, RK
   Brum, MCS
   Nogueira, CEW
   Drumond, BP
   Alves, PA
   Siqueira-Lima, L
   Assis, FL
   Trindade, GS
   Bonjardim, CA
   Ferreira, PC
   Weiblen, R
   Flores, EF
   Kroon, EG
   Abrahao, JS
AF Campos, Rafael K.
   Brum, Mario C. S.
   Nogueira, Carlos E. W.
   Drumond, Betania P.
   Alves, Pedro A.
   Siqueira-Lima, Larissa
   Assis, Felipe L.
   Trindade, Giliane S.
   Bonjardim, Claudio A.
   Ferreira, Paulo C.
   Weiblen, Rudi
   Flores, Eduardo F.
   Kroon, Erna G.
   Abrahao, Jonatas S.
TI Assessing the variability of Brazilian Vaccinia virus isolates from a
   horse exanthematic lesion: coinfection with distinct viruses
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID VESICULAR STOMATITIS-VIRUS; SMALLPOX VACCINE; BOVINE VACCINIA;
   LYMPHOID-TISSUE; STRAINS; ORTHOPOXVIRUS; OUTBREAK; POXVIRUS; GENOME
AB During the last bovine vaccinia (BV) outbreaks, several Vaccinia virus (VACV) strains were isolated and characterised, revealing significant polymorphisms between strains, even within conserved genes. Although the epidemiology of VACV has been studied in BV outbreaks, there is little data about the circulation of the Brazilian VACV isolates. This study describes the genetic and biological characterisation of two VACV isolates, Pelotas 1 virus (P1V) and Pelotas 2 virus (P2V), which were obtained concomitantly from a horse affected by severe cutaneous disease. Despite being isolated from the same exanthematic clinical sample, P1V and P2V showed differences in their plaque phenotype and in one-step growth curves. Moreover, P1V and P2V presented distinct virulence profiles in a BALB/c mouse model, as observed with other Brazilian VACV isolates. Sequencing and phylogenetic analysis of four different genes demonstrated that the isolates are segregated in different VACV clusters. Our results raise interesting questions about the diversity of VACV isolates in Brazil.
C1 [Campos, Rafael K.; Drumond, Betania P.; Alves, Pedro A.; Siqueira-Lima, Larissa; Assis, Felipe L.; Trindade, Giliane S.; Bonjardim, Claudio A.; Ferreira, Paulo C.; Kroon, Erna G.; Abrahao, Jonatas S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [Brum, Mario C. S.; Weiblen, Rudi; Flores, Eduardo F.] Univ Fed Santa Maria, Dept Vet Prevent Med, BR-97105900 Santa Maria, RS, Brazil.
   [Nogueira, Carlos E. W.] Univ Fed Pelotas, Dept Clin Vet, BR-96010610 Pelotas, RS, Brazil.
RP Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM jonatas.abrahao@gmail.com
RI Alves, Pedro/T-7203-2019; flores, eduardo furtado/H-5125-2016; Kroon,
   Erna/V-5444-2019; Weiblen, Rudi/H-7003-2014; Kroon, Erna
   Geessien/B-3631-2015; Abrahao, Jonatas/B-3895-2015; Campos, Rafael
   Kroon/AAB-5135-2020; Bonjardim, Claudio A/J-2601-2014; Brum, Mario Celso
   Sperotto/M-8557-2017
OI Alves, Pedro/0000-0002-9659-5621; Weiblen, Rudi/0000-0002-1737-9817;
   Kroon, Erna Geessien/0000-0003-2721-3826; Abrahao,
   Jonatas/0000-0001-9420-1791; Campos, Rafael Kroon/0000-0002-4852-0449;
   Brum, Mario Celso Sperotto/0000-0002-1643-1126
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Ministerio da
   Agricultura, Pecuaria e Abastecimento (MAPA)
FX Financial support was provided by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and the Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Ministerio da
   Agricultura, Pecuaria e Abastecimento (MAPA). The study sponsors had no
   involvement in the study design, the collection, analysis and
   interpretation of data, the writing of the manuscript, or the decision
   to submit the manuscript for publication.
CR Abrahao JS, 2010, J CLIN VIROL, V48, P69, DOI 10.1016/j.jcv.2010.02.001
   Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428
   Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762
   Brum MCS, 2010, J VET DIAGN INVEST, V22, P143
   Carrillo FYE, 2008, INFECT GENET EVOL, V8, P614, DOI 10.1016/j.meegid.2008.04.008
   Carrillo FYE, 2007, INFECT GENET EVOL, V7, P69, DOI 10.1016/j.meegid.2006.04.004
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   DAMON I, 2007, FIELDS VIROLOGY, P2079
   Dasgupta A, 2007, J IMMUNOL, V178, P1654, DOI 10.4049/jimmunol.178.3.1654
   Doceul V, 2010, SCIENCE, V327, P873, DOI 10.1126/science.1183173
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Fenner F., 1989, ORTHOPOXVIRUSES
   Fenner F, 1988, SMALLPOX ITS ERADICA
   Grivel JC, 2001, NAT MED, V7, P1232, DOI 10.1038/nm1101-1232
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   KATZ E, 1973, J GEN VIROL, V21, P469, DOI 10.1099/0022-1317-21-3-469
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Lisco A, 2007, J VIROL, V81, P708, DOI 10.1128/JVI.01367-06
   Marques JT, 2001, VIRUS GENES, V23, P291, DOI 10.1023/A:1012521322845
   MARQUES JT, 2006, AM J TROP MED HYG, V75, P486
   Osborne JD, 2007, VACCINE, V25, P8807, DOI 10.1016/j.vaccine.2007.10.040
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   SAMBROOK J, 1989, MOL CLONING LAB MANU, V3, pA1
   Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043
   Stapleton JT, 2009, AIDS, V23, P605, DOI 10.1097/QAD.0b013e32831f1b00
   Trindade GD, 2008, J VIROL METHODS, V152, P63, DOI 10.1016/j.jviromet.2008.05.028
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2009, CLIN INFECT DIS, V48, pE37, DOI 10.1086/595856
   Tulman ER, 2006, J VIROL, V80, P9244, DOI 10.1128/JVI.00945-06
   Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364
   Zhang WH, 2000, J VIROL, V74, P11654, DOI 10.1128/JVI.74.24.11654-11662.2000
NR 32
TC 35
Z9 36
U1 0
U2 4
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD FEB
PY 2011
VL 156
IS 2
BP 275
EP 283
DI 10.1007/s00705-010-0857-z
PG 9
WC Virology
SC Virology
GA 714SE
UT WOS:000286828500009
PM 21080203
DA 2020-12-09
ER

PT J
AU Abrahao, JS
   Silva-Fernandes, AT
   Assis, FL
   Guedes, MI
   Drumond, BP
   Leite, JA
   Coelho, LFL
   Turrini, F
   Fonseca, FG
   Lobato, ZIP
   Madureira, M
   Ferreira, PC
   Bonjardim, CA
   Trindade, GS
   Kroon, EG
AF Abrahao, Jonatas S.
   Silva-Fernandes, Andre T.
   Assis, Felipe L.
   Guedes, Maria I.
   Drumond, Betania P.
   Leite, Juliana A.
   Coelho, Luiz F. L.
   Turrini, Filippo
   Fonseca, Flavio G.
   Lobato, Zelia I. P.
   Madureira, Marieta
   Ferreira, Paulo C.
   Bonjardim, Claudio A.
   Trindade, Giliane S.
   Kroon, Erna G.
TI Human Vaccinia virus and Pseudocowpox virus co-infection: Clinical
   description and phylogenetic characterization
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Vaccinia virus; Orthopoxvirus; Pseudocowpox virus; Parapoxvirus;
   Co-infection
ID RIO-DE-JANEIRO; PARAPOXVIRUS; INFECTION; DIAGNOSIS; SMALLPOX; POXVIRUS;
   STRAIN; CATTLE; STATE
AB Background: Occupational exanthematic diseases represent an important cause of public health impact and economical losses. Among the viral exanthematic diseases, two caused by poxviruses are noteworthy: the bovine vaccinia (BV), caused by the Vaccinia virus (VACV); and the milker's nodule, in which the agent is the Pseudocowpox virus (PCPV). Both agents are zoonotic and have been associated with several cases of bovine infection. In Brazilian rural areas BV has been highly prevalent, particularly in milk herds. Farmers, milkers and their close contacts developed lesions on the hands, forearms, legs and face accompanied by several systemic symptoms. Although VACV and PCPV present with similar epidemiological and transmission patterns, no VACV and PCPV co-infection cases have to date been described.
   Objectives: To describe the first case of zoonotic VACV and PCVP co-infection, based on serological and molecular methods.
   Study design and results: In this work we report a case of a Brazilian rural worker who presented with a large severely ulcerated-pustule skin lesion, associated with fever, headache, malaise, myalgia and axillary, inguinal and cervical limphadenopathy. The worker declared occupational contact with cattle that had notable injuries on their teats. Human and bovine clinical samples were collected and submitted to serological and molecular tests. PCR and phylogenetic analysis revealed the presence of VACV DNA and PCPV DNA in the patient's lesion. Serological tests indicated anti-VACV neutralizing antibodies and molecular assays showed the presence of VACV and PCPV DNA in the patient sera. VACV and PCPV also were detected in dairy cattle.
   Conclusion: Together, these results indicate a case of zoonotic VACV/PCPV co-infection. Epidemiological surveillance and appropriate medical treatment are essential for the control of both diseases, especially in the most severe cases, as described in the present study. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Kroon, Erna G.] Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Drumond, Betania P.] Ctr Pesquisas Rene Rachou Fiocruz, BR-30190 Belo Horizonte, MG, Brazil.
   [Leite, Juliana A.] Embrapa Gado Leite, Empresa Brasileira Pesquisa Agropecuaria, Juiz De Fora, MG, Brazil.
   [Coelho, Luiz F. L.] Univ Fed Alfenas, Alfenas, MG, Brazil.
   [Turrini, Filippo] Alma Mater Studiorum Univ Bologna, Bologna, Italy.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI brasileira, Inct Pecuaria/J-9542-2013; Abrahao, Jonatas/B-3895-2015;
   Kroon, Erna/V-5444-2019; Turrini, Filippo/I-3677-2018; Kroon, Erna
   Geessien/B-3631-2015; Coelho, Luiz FL/G-5853-2012; Bonjardim, Claudio
   A/J-2601-2014
OI Abrahao, Jonatas/0000-0001-9420-1791; Turrini,
   Filippo/0000-0002-9121-9117; Kroon, Erna Geessien/0000-0003-2721-3826;
   Lobato, Zelia/0000-0002-9399-3691; Coelho, Luiz
   Felipe/0000-0003-4289-384X
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG); MAPA
FX We thank MSc. Joao R. dos Santos, Angela S. Lopes, Ilda M. V. Gama, and
   colleagues from Laboratorio de Virus (ICB-UFMG). Financial support was
   provided by CNPq, CAPES, FAPEMIG and MAPA. GST, FGF, ZIPL, EGK, CAB and
   PCPF received fellowship from CNPq.
CR Abdalrhman I, 2006, VACCINE, V24, P4152, DOI 10.1016/j.vaccine.2006.02.012
   Abrahao JS, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-140
   Abrahao JS, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-47
   Cohen JI, 2007, VACCINE, V25, P4571, DOI 10.1016/j.vaccine.2007.03.044
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   DAMON IK, 2007, FIELDS VIROLOGY, V2, P181
   Erbagci Z, 2005, J DERMATOL TREAT, V16, P353, DOI 10.1080/09546630500375734
   Iketani Y, 2002, MICROBIOL IMMUNOL, V46, P285, DOI 10.1111/j.1348-0421.2002.tb02697.x
   Inoshima Y, 2000, J VIROL METHODS, V84, P201, DOI 10.1016/S0166-0934(99)00144-5
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Nitsche A, 2006, CLIN CHEM, V52, P316, DOI 10.1373/clinchem.2005.060335
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P625, DOI 10.1590/S0074-02762000000500007
   Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007
   Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GD, 2008, J VIROL METHODS, V152, P63, DOI 10.1016/j.jviromet.2008.05.028
NR 17
TC 30
Z9 34
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD MAY
PY 2010
VL 48
IS 1
BP 69
EP 72
DI 10.1016/j.jcv.2010.02.001
PG 4
WC Virology
SC Virology
GA 583JC
UT WOS:000276669700017
PM 20207192
DA 2020-12-09
ER

PT J
AU Abrahao, JS
   Drumond, BP
   Trindade, GD
   da Silva-Fernandes, AT
   Ferreira, JMS
   Alves, PA
   Campos, RK
   Siqueira, L
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Abrahao, Jonatas Santos
   Drumond, Betania Paiva
   Trindade, Giliane de Souza
   da Silva-Fernandes, Andre Tavares
   Siqueira Ferreira, Jaqueline Maria
   Alves, Pedro Augusto
   Campos, Rafael Kroon
   Siqueira, Larissa
   Bonjardim, Claudio Antonio
   Peregrino Ferreira, Paulo Cesar
   Kroon, Erna Geessien
TI Rapid Detection of Orthopoxvirus by Semi-Nested PCR Directly From
   Clinical Specimens: A Useful Alternative for Routine Laboratories
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE viral diagnosis; vaccinia outbreaks; poxvirus; Orthopoxvirus
ID VACCINIA-VIRUS-STRAINS; REAL-TIME PCR; BOVINE VACCINIA; DIAGNOSTIC PCR;
   INFECTION; ASSAY; SMALLPOX; OUTBREAK; BRAZIL; DIFFERENTIATION
AB Orthopoxvirus (OPV) has been associated with worldwide exanthematic outbreaks, which have resulted in serious economic losses as well as impact on public health. Although the current classical and molecular methods are useful for the diagnosis of OPV, they are largely inaccessible to unsophisticated clinical laboratories. The major reason for the inaccessibility is that they require both virus isolation and DNA manipulation. In this report, a rapid, sensitive and low-cost semi-nested PCR method is described for the detection of OPV DNA directly from clinical specimens. A set of primers was designed to amplify the conserved OPV vgf gene. The most useful thermal and chemical conditions were selected and minimum non-inhibitory dilutions were determined. More than 100 Brazilian Vaccinia virus (VACV) field clinical specimens were tested using this semi-nested PCR in order to confirm its applicability. Cowpox virus was also detected by PCR from the ear scabs of scarified Balb/c mice. In addition, the method was highly sensitive for the detection of VACV DNA in murine blood and excreta, which are among the suggested reservoirs of OPV. Together, these data suggest that semi-nested PCR can be used for initial screening for OPV and as a routine diagnostic laboratory method. J. Med. Virol. 82:692-699, 2010. (C) 2010 Wiley-Liss, Inc.
C1 [Abrahao, Jonatas Santos; Drumond, Betania Paiva; Trindade, Giliane de Souza; da Silva-Fernandes, Andre Tavares; Siqueira Ferreira, Jaqueline Maria; Alves, Pedro Augusto; Campos, Rafael Kroon; Siqueira, Larissa; Bonjardim, Claudio Antonio; Peregrino Ferreira, Paulo Cesar; Kroon, Erna Geessien] Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Alves, Pedro/T-7203-2019; Bonjardim, Claudio A/J-2601-2014; Kroon, Erna
   Geessien/B-3631-2015; Kroon, Erna/V-5444-2019; Campos, Rafael
   Kroon/AAB-5135-2020; Abrahao, Jonatas/B-3895-2015
OI Alves, Pedro/0000-0002-9659-5621; Kroon, Erna
   Geessien/0000-0003-2721-3826; Campos, Rafael Kroon/0000-0002-4852-0449;
   Abrahao, Jonatas/0000-0001-9420-1791
FU CNPq CAPES FAPEMIG
FX Grant sponsor: CNPq CAPES FAPEMIG.
CR Abdalrhman I, 2006, VACCINE, V24, P4152, DOI 10.1016/j.vaccine.2006.02.012
   Abu Al-Soud W, 2000, J CLIN MICROBIOL, V38, P4463, DOI 10.1128/JCM.38.12.4463-4470.2000
   BOUILLANT A, 1965, CAN J COMP MED VET S, V29, P125
   Damaso CRA, 2007, DIAGN MICR INFEC DIS, V57, P39, DOI 10.1016/j.diagmicrobio.2006.07.012
   Essbauer S, 2007, ZOONOSES PUBLIC HLTH, V54, P118, DOI 10.1111/j.1863-2378.2007.01035.x
   Fedorko DP, 2005, J CLIN MICROBIOL, V43, P4602, DOI 10.1128/JCM.43.9.4602-4606.2005
   Fenner F., 1989, ORTHOPOXVIRUSES
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   GLEDHILL AW, 1962, NATURE, V196, P298, DOI 10.1038/196298a0
   Haenssle HA, 2006, J AM ACAD DERMATOL, V54, pS1, DOI 10.1016/j.jaad.2005.09.040
   Heymann DL, 1998, BRIT MED BULL, V54, P693, DOI 10.1093/oxfordjournals.bmb.a011720
   JAHRLING PB, 2007, MED ASPECTS BIOL WAR, P215
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Karem KL, 2005, CLIN DIAGN LAB IMMUN, V12, P867, DOI 10.1128/CDLI.12.7.867-872.2005
   Kulesh DA, 2004, J CLIN MICROBIOL, V42, P601, DOI 10.1128/JCM.42.2.601-609.2004
   Kurth A, 2008, EMERG INFECT DIS, V14, P670, DOI 10.3201/eid1404.070817
   LEDERMAN E, 2008, VACCINE
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   MAIBORODA AD, 1982, ACTA VIROL, V26, P288
   Malorny B, 2005, J CLIN MICROBIOL, V43, P3033, DOI 10.1128/JCM.43.7.3033-3037.2005
   Meyer H, 1997, J VIROL METHODS, V64, P217, DOI 10.1016/S0166-0934(96)02155-6
   Moss B., 2007, FIELDS VIROLOGY, V2, P2905
   Pelkonen PM, 2003, EMERG INFECT DIS, V9, P1458, DOI 10.3201/eid0911.020814
   Putkuri N, 2009, J MED VIROL, V81, P146, DOI 10.1002/jmv.21385
   Saijo M, 2008, JPN J INFECT DIS, V61, P140
   Sambrook J, 1989, MOL CLONING LAB MANU
   Sanchez-Seco MP, 2006, BRIT J BIOMED SCI, V63, P79, DOI 10.1080/09674845.2006.11732725
   SARKAR JK, 1974, INDIAN J MED RES, V62, P1800
   SARKAR JK, 1973, B WORLD HEALTH ORGAN, V48, P517
   Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Singh RK, 2008, J VIROL METHODS, V154, P146, DOI 10.1016/j.jviromet.2008.08.009
   Singh RX, 2006, REV SCI TECH OIE, V25, P981, DOI 10.20506/rst.25.3.1708
   Ferreira JMS, 2008, J GEN VIROL, V89, P2986, DOI 10.1099/vir.0.2008/003947-0
   STRENGER V, 2009, CLIN INFECT DIS, V34, P133
   Trindade GS, 2007, J VIROL METHODS, V141, P198, DOI 10.1016/j.jviromet.2006.12.006
   Trindade GD, 2008, J VIROL METHODS, V152, P63, DOI 10.1016/j.jviromet.2008.05.028
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Tscharke DC, 1999, J GEN VIROL, V80, P2751, DOI 10.1099/0022-1317-80-10-2751
   Vestergaard L, 2008, ACTA DERM-VENEREOL, V88, P188, DOI 10.2340/00015555-0375
NR 42
TC 25
Z9 25
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD APR
PY 2010
VL 82
IS 4
BP 692
EP 699
DI 10.1002/jmv.21617
PG 8
WC Virology
SC Virology
GA 560SA
UT WOS:000274921300021
PM 20166167
DA 2020-12-09
ER

PT J
AU Costa, EA
   Bomfim, MRQ
   da Fonseca, FG
   Drumond, BP
   Coelho, FM
   Vasconcelos, AC
   Furtini, R
   Paixao, TA
   Tsolis, RM
   Santos, RL
   Resende, M
AF Costa, Erica A.
   Bomfim, Maria Rosa Q.
   da Fonseca, Flavio G.
   Drumond, Betania P.
   Coelho, Fabiana Magalhaes
   Vasconcelos, Anilton C.
   Furtini, Ronaldo
   Paixao, Tatiane A.
   Tsolis, Renee M.
   Santos, Renato L.
   Resende, Mauricio
TI Ovine Herpesvirus 2 Infection in Foal, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID MALIGNANT CATARRHAL FEVER; VIRUS
C1 [Costa, Erica A.] Univ Fed Minas Gerais, Lab Patol Mol, Dept Clin & Cirurgia Vet, Escola Vet, BR-30123970 Belo Horizonte, MG, Brazil.
   [Furtini, Ronaldo] Inst Mineiro Agropecuaria, Belo Horizonte, MG, Brazil.
   [Tsolis, Renee M.] Univ Calif Davis, Davis, CA 95616 USA.
RP Costa, EA (corresponding author), Univ Fed Minas Gerais, Lab Patol Mol, Dept Clin & Cirurgia Vet, Escola Vet, Av Antonio Carlos 6627, BR-30123970 Belo Horizonte, MG, Brazil.
EM azevedoec@yahoo.com.br
RI brasileira, Inct Pecuaria/J-9542-2013; Coelho, Fabiana
   Magalhaes/K-6001-2013; de Lima Santos, Renato/A-1134-2008; Paixao,
   Tatiane/A-2871-2013; BOMFIM, MARIA ROSA/AAT-8359-2020
OI de Lima Santos, Renato/0000-0002-4830-0470; Paixao,
   Tatiane/0000-0001-8284-9902; BOMFIM, MARIA ROSA/0000-0001-5738-3952;
   Tsolis, Renee/0000-0001-9131-6657
CR *AN HLTH AUSTR, MAL CAT FEV AUSTR SI
   Anderson IE, 2007, J COMP PATHOL, V136, P156, DOI 10.1016/j.jcpa.2007.01.007
   BAXTER SIF, 1993, ARCH VIROL, V132, P145, DOI 10.1007/BF01309849
   Echeverria MG, 2003, REV SCI TECH OIE, V22, P1029, DOI 10.20506/rst.22.3.1458
   EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998
   Katz J, 1991, J Vet Diagn Invest, V3, P193
   Li H, 2001, J GEN VIROL, V82, P227, DOI 10.1099/0022-1317-82-1-227
   OTOOLE D, 1995, J VET DIAGN INVEST, V7, P108, DOI 10.1177/104063879500700118
   Simon S, 2003, J GEN VIROL, V84, P2009, DOI 10.1099/vir.0.19048-0
   Varrasso A, 2001, AUST VET J, V79, P563, DOI 10.1111/j.1751-0813.2001.tb10751.x
NR 10
TC 5
Z9 5
U1 0
U2 1
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2009
VL 15
IS 5
BP 844
EP 845
DI 10.3201/eid1505.081664
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 437WY
UT WOS:000265518800041
PM 19402994
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Ferreira, JMS
   Drumond, BP
   Abrahao, JS
   Lobato, ZIP
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Siqueira Ferreira, Jaqueline Maria
   Drumond, Betania Paiva
   Abrahao, Jonatas Santos
   Portal Lobato, Zelia Ines
   Bonjardim, Claudio Antonio
   Peregrino Ferreira, Paulo Cesar
   Kroon, Erna Geessien
TI Brazilian vaccinia virus strains show a classical orthopoxvirus
   infection course and cross-protection
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Orthopoxvirus; Zoonoses; Balb/c mice; Intradermal injection; Vaccinia
   virus; Bovine vaccinia outbreaks
ID RIO-DE-JANEIRO; COWPOX VIRUS; POXVIRUS PATHOGENESIS; RESERVOIR HOSTS;
   HUMAN MONKEYPOX; OUTBREAK; CATTLE; MICE; HUMANS; STATE
AB Objectives: The purpose of this work was to study the infection course and cross-protection in mice after intradermal injection of Vaccinia virus (VACV) strain Western Reserve and three Brazilian VACV strains: Aracatuba, Muriae and BeAn58058 isolated from cow, human and rodent, respectively. Methods: Balb/c mice were inoculated by footpad and back scarification and daily monitored regarding lesion development and weight loss. To check cross protection after intradermal VACV inoculation, mice were subsequently infected with different VACV strains and monitored to check lesion development. Serum neutralization assays were performed to check for the presence of antibodies against Orthopoxvirus. Results: After VACV intradermal inoculation the lesion development pattern was similar in mice infected with the different virus strains. By using the footpad scarification model, cross-protection among VACV strains was observed. Moreover, neutralizing antibodies against Orthopoxvirus were detected in sera from mice infected with all VACV strains. Conclusion: Although it was not possible to observe virulence differences among VACV strains isolated from cow, rodent and human using the murine model, this inoculation route showed to be an appropriated model to study lesions development since it mimics natural infections by VACV in nature.
C1 [Siqueira Ferreira, Jaqueline Maria; Drumond, Betania Paiva; Abrahao, Jonatas Santos; Bonjardim, Claudio Antonio; Peregrino Ferreira, Paulo Cesar; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [Portal Lobato, Zelia Ines] Univ Fed Minas Gerais, Escola Vet, Dept Vet Prevent Med, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Ave Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM masc.egk@terra.com.br
RI Abrahao, Jonatas/B-3895-2015; Kroon, Erna/V-5444-2019; Ferreira,
   Jaqueline/E-4630-2018; Bonjardim, Claudio A/J-2601-2014
OI Abrahao, Jonatas/0000-0001-9420-1791; Ferreira,
   Jaqueline/0000-0002-1779-1975; 
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG)
FX Financial support was provided by CNPq, CAPES and FAPEMIG. Jaqueline M.
   S. Ferreira received fellowship from CAPES. R. M. E. P. C. P. Ferreira,
   C. A. Bonjardim, Z. I. P. Lobato and E. G. Kroon are recipients of
   research fellowship from CNPq.
CR Abdalrhman I, 2006, VACCINE, V24, P4152, DOI 10.1016/j.vaccine.2006.02.012
   BAXBY D, 1994, BRIT J DERMATOL, V131, P598, DOI 10.1111/j.1365-2133.1994.tb04969.x
   Baxby D, 1981, J Hist Med Allied Sci, V36, P218
   Brandt T, 2005, VIROLOGY, V333, P263, DOI 10.1016/j.virol.2005.01.006
   BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   Chantrey J, 1999, EPIDEMIOL INFECT, V122, P455, DOI 10.1017/S0950268899002423
   CROUCH AC, 1995, EPIDEMIOL INFECT, V115, P185, DOI 10.1017/S0950268800058258
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Diniz S, 2001, ARQ BRAS MED VET ZOO, V53, P152, DOI 10.1590/S0102-09352001000200003
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   FENNER F, 1949, J IMMUNOL, V63, P341
   FENNER F, 1989, RES VIROLOGY, V140, P465, DOI 10.1016/S0923-2516(89)80126-8
   Fenner F, 1988, SMALLPOX ITS ERADICA
   FERREIRA JMS, PLOS ONE, V3, pE3043
   Ferrier-Rembert A, 2007, VACCINE, V25, P4809, DOI 10.1016/j.vaccine.2007.04.011
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Karem KL, 2005, CLIN DIAGN LAB IMMUN, V12, P867, DOI 10.1128/CDLI.12.7.867-872.2005
   Kolhapure RM, 1997, INDIAN J MED RES, V106, P441
   Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   MILLER CG, 1995, CELL IMMUNOL, V162, P326, DOI 10.1006/cimm.1995.1086
   Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004
   Pahlitzsch R, 2006, CLIN INFECT DIS, V43, P737, DOI 10.1086/506937
   Quenelle DC, 2004, ANTIVIR RES, V63, P33, DOI 10.1016/j.antiviral.2004.02.003
   Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299
   Reynolds MG, 2006, J INFECT DIS, V194, P773, DOI 10.1086/505880
   Rimoin AW, 2007, EMERG INFECT DIS, V13, P934, DOI 10.3201/eid1306.061540
   Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P625, DOI 10.1590/S0074-02762000000500007
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Tscharke DC, 2002, J GEN VIROL, V83, P1977, DOI 10.1099/0022-1317-83-8-1977
   Turner G S, 1967, J Gen Virol, V1, P399, DOI 10.1099/0022-1317-1-3-399
   UEDA Y, 1978, J GEN VIROL, V40, P263, DOI 10.1099/0022-1317-40-2-263
NR 38
TC 1
Z9 1
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD APR
PY 2009
VL 2
IS 2
BP 21
EP 26
PG 6
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 662CU
UT WOS:000282785500004
DA 2020-12-09
ER

PT J
AU Trindade, GS
   Guedes, MIC
   Drumond, BP
   Mota, BEF
   Abrahao, JS
   Lobato, ZIP
   Gomes, JAS
   Correa-Oliveira, R
   Nogueira, ML
   Kroon, EG
   da Fonseca, FG
AF Trindade, Giliane S.
   Guedes, Maria I. C.
   Drumond, Betania P.
   Mota, Bruno E. F.
   Abrahao, Jonatas S.
   Lobato, Zelia I. P.
   Gomes, Juliana A. S.
   Correa-Oliveira, Rodrigo
   Nogueira, Mauricio L.
   Kroon, Erna G.
   da Fonseca, Flavio G.
TI Zoonotic Vaccinia Virus: Clinical and Immunological Characteristics in a
   Naturally Infected Patient
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
ID COWPOX; BRAZIL; HUMANS
AB Vaccinia virus was used as vaccine to eradicate smallpox. We report a zoonotic case of vaccinia virus infection in a 30-year-old patient who became infected after handling sick dairy cattle. The patient had inflamed lesions and systemic symptoms. Laboratory findings were indicative of down-modulated immune responses to the virus.
C1 [Trindade, Giliane S.; Guedes, Maria I. C.; Drumond, Betania P.; Mota, Bruno E. F.; Abrahao, Jonatas S.; Kroon, Erna G.; da Fonseca, Flavio G.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Lobato, Zelia I. P.] Univ Fed Minas Gerais, Escola Vet, BR-31270901 Belo Horizonte, MG, Brazil.
   [Gomes, Juliana A. S.; Correa-Oliveira, Rodrigo; da Fonseca, Flavio G.] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
   [Nogueira, Mauricio L.] Fac Med Sao Jose do Rio Preto, Dept Doencas Infecciosas & Parasitarias, Sao Jose Do Rio Preto, Brazil.
RP da Fonseca, FG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM fdafonseca@cpqrr.fiocruz.br
RI Abrahao, Jonatas/B-3895-2015; Gomes, Juliana A. S./M-4083-2017;
   Nogueira, Mauricio L/B-7599-2012; Kroon, Erna Geessien/B-3631-2015;
   Kroon, Erna/V-5444-2019
OI Abrahao, Jonatas/0000-0001-9420-1791; Gomes, Juliana A.
   S./0000-0002-8332-2907; Nogueira, Mauricio L/0000-0003-1102-2419; Kroon,
   Erna Geessien/0000-0003-2721-3826; Mota, Bruno/0000-0003-0348-4875;
   Correa-Oliveira, Rodrigo/0000-0001-6419-9459; Lobato,
   Zelia/0000-0002-9399-3691
FU Brazilian National Council of Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas GeraisMinas
   Gerais State Research Foundation (FAPEMIG); Division of Microbiology and
   Infectious Diseases; National Institute of Allergy and Infectious
   DiseaseUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID); National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA
FX Brazilian National Council of Scientific and Technological Development
   (through a Strategic Program for Health Research IV grant and
   fellowships to F.G.d.F., E.G.K., Z.I.P.L., and R.C.-O.), Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais, and the Division of
   Microbiology and Infectious Diseases, National Institute of Allergy and
   Infectious Disease, National Institutes of Health Opportunity Pool fund.
CR Amanna IJ, 2006, IMMUNOL REV, V211, P320, DOI 10.1111/j.0105-2896.2006.00392.x
   Coras B, 2005, LANCET, V365, P446
   Ferrier-Rembert A, 2007, VACCINE, V25, P4809, DOI 10.1016/j.vaccine.2007.04.011
   Gomes JAS, 2005, INFECT IMMUN, V73, P7960, DOI 10.1128/IAI.73.12.7960-7966.2005
   Honlinger B, 2005, BRIT J DERMATOL, V153, P451, DOI 10.1111/j.1365-2133.2005.06731.x
   Johnston JB, 2003, J VIROL, V77, P6093, DOI 10.1128/JVI.77.11.6093-6100.2003
   Kolhapure RM, 1997, INDIAN J MED RES, V106, P441
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Lewis-Jones S, 2004, CURR OPIN INFECT DIS, V17, P81, DOI 10.1097/00001432-200404000-00003
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668
NR 13
TC 27
Z9 27
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD FEB 1
PY 2009
VL 48
IS 3
BP E37
EP E40
DI 10.1086/595856
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 392GM
UT WOS:000262291200022
PM 19115976
OA Bronze
DA 2020-12-09
ER

PT J
AU Terzian, ACB
   Bronzoni, RVD
   Drumond, BP
   da Silva-Nunes, M
   da Silva, NS
   Ferreira, MU
   Speranca, MA
   Nogueira, ML
AF Terzian, Ana Carolina Bernardes
   de Moraes Bronzoni, Roberta Vieira
   Drumond, Betania Paiva
   da Silva-Nunes, Monica
   da Silva, Natal Santos
   Ferreira, Marcelo Urbano
   Speranca, Marcia Aparecida
   Nogueira, Mauricio Lacerda
TI Sporadic Oropouche Virus Infection, Acre, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID NESTED-PCR
C1 [Nogueira, Mauricio Lacerda] FAMERP, Dept Doencas Infecciosas & Parasitarias, Lab Pesquisas Virol, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
   [Terzian, Ana Carolina Bernardes] IBILCE, Sao Jose Do Rio Preto, Brazil.
   [Drumond, Betania Paiva] Univ Estudal Montes Claros, Montes Claros, Brazil.
   [da Silva-Nunes, Monica; da Silva, Natal Santos; Ferreira, Marcelo Urbano] Univ Sao Paulo, Inst Ciencias Biol, Sao Paulo, Brazil.
   [Speranca, Marcia Aparecida] Fac Med Marilia, Sao Paulo, Brazil.
RP Nogueira, ML (corresponding author), FAMERP, Dept Doencas Infecciosas & Parasitarias, Lab Pesquisas Virol, Av Brigadeiro Faria Lima 5416, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
EM mnogueira@tamerp.br
RI Bronzoni, Roberta/J-8917-2012; Ferreira, Marcelo U/G-8289-2011;
   Speranca, Marcia Aparecida/D-2310-2012; Nogueira, Mauricio
   L/B-7599-2012; da Silva, Natal Santos/Y-1913-2019; da Silva-Nunes,
   Monica/A-1885-2008; da Silva, Natal Santos/E-9579-2015
OI Ferreira, Marcelo U/0000-0002-5293-9090; Speranca, Marcia
   Aparecida/0000-0002-1178-3747; Nogueira, Mauricio L/0000-0003-1102-2419;
   da Silva, Natal Santos/0000-0002-0856-1748; da Silva, Natal
   Santos/0000-0002-0856-1748
CR ANDERSON CR, 1961, AM J TROP MED HYG, V10, P574, DOI 10.4269/ajtmh.1961.10.574
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Azevedo RDD, 2007, EMERG INFECT DIS, V13, P912
   Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150
   Moreli ML, 2002, J MED VIROL, V66, P139, DOI 10.1002/jmv.2122
   Nunes WRT, 2005, EMERG INFECT DIS, V11, P1610, DOI 10.3201/eid1110.050464
   Pinheiro F.P., 2004, TXB PEDIAT INFECT DI, P2418
   Saeed MF, 2000, J GEN VIROL, V81, P743, DOI 10.1099/0022-1317-81-3-743
   SHOPE ROBERT E., 1963, AN MICROBIOL, V11, P167
   Silva-Nunes Mônica da, 2006, Cad. Saúde Pública, V22, P1325, DOI 10.1590/S0102-311X2006000600021
NR 10
TC 18
Z9 18
U1 0
U2 1
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD FEB
PY 2009
VL 15
IS 2
BP 348
EP 350
DI 10.3201/eid1502.080401
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 405NE
UT WOS:000263230700040
PM 19193295
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Ferreira, JMS
   Abrahao, JS
   Drumond, BP
   Oliveira, FM
   Alves, PA
   Pascoal-Xavier, MA
   Lobato, ZIP
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Siqueira Ferreira, Jaqueline Maria
   Abrahao, Jonatas Santos
   Drumond, Betania Paiva
   Oliveira, Fernando Meireles
   Alves, Pedro Augusto
   Pascoal-Xavier, Marcelo Antonio
   Portela Lobato, Zelia Ines
   Bonjardim, Claudio Antonio
   Peregrino Ferreira, Paulo Cesar
   Kroon, Erna Geessien
TI Vaccinia virus: shedding and horizontal transmission in a murine model
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
ID SENTINEL MICE; COWPOX VIRUS; INFECTION; ORTHOPOXVIRUS; OUTBREAK;
   POXVIRUS; STRAINS; BRAZIL; REPLICATION; ANTIBODIES
AB Vaccinia virus (VACV) has been associated with several bovine vaccinia outbreaks in Brazil, affecting cattle and humans. There are no available data about VACV environmental circulation or the role of wildlife in the emergence of an outbreak. Since VACV was isolated from rodents in Brazil, we investigated shedding and transmission of VACV strains in mice. The VACV excretion profile was assessed by PCR and chicken chorioallantoic membrane infection, revealing viral DNA and infectious virus in the faeces and urine of intranasally infected mice. Horizontal transmission was assessed by exposure of sentinel mice to wood shavings contaminated with excrement, to mimic a natural infection. Sentinel mice showed orthopoxvirus antibodies, and VACV DNA and infectious virus were detected in their faeces and intestines, even after six rounds of natural transmission. Together, these data suggest that murine excrement could play a relevant role in VACV spread and transmission, perhaps helping to explain how these viruses circulate between their natural hosts.
C1 [Siqueira Ferreira, Jaqueline Maria; Abrahao, Jonatas Santos; Drumond, Betania Paiva; Oliveira, Fernando Meireles; Alves, Pedro Augusto; Pascoal-Xavier, Marcelo Antonio; Bonjardim, Claudio Antonio; Peregrino Ferreira, Paulo Cesar; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [Portela Lobato, Zelia Ines] Univ Fed Minas Gerais, Escola Vet, Dept Vet Prevent Med, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM masc.egk@terra.com.br
RI Alves, Pedro/T-7203-2019; Bonjardim, Claudio A/J-2601-2014; Kroon, Erna
   Geessien/B-3631-2015; Ferreira, Jaqueline/E-4630-2018; Kroon,
   Erna/V-5444-2019; Abrahao, Jonatas/B-3895-2015
OI Alves, Pedro/0000-0002-9659-5621; Kroon, Erna
   Geessien/0000-0003-2721-3826; Ferreira, Jaqueline/0000-0002-1779-1975;
   Abrahao, Jonatas/0000-0001-9420-1791; Lobato, Zelia/0000-0002-9399-3691
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG)
FX We thank Jaquelline G. de Oliveira for critical reading of the
   Marioscript; Joao R. dos Santos, Angela S. Lopes, Ilda M. V. Garnina and
   colleagues from Laboratorio de Virus (ICB-UFMG). Financial Support was
   provided by CNPq, CAPES and FAPEMIG. E.G.K., C. A. B., P. C. P. F. and
   Z. I. P. L. received fellowships from CNPq.
CR Abdalrhman I, 2006, VACCINE, V24, P4152, DOI 10.1016/j.vaccine.2006.02.012
   Brandt TA, 2001, J VIROL, V75, P850, DOI 10.1128/JVI.75.2.850-856.2001
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   CROUCH AC, 1995, EPIDEMIOL INFECT, V115, P185, DOI 10.1017/S0950268800058258
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   Essbauer S, 2007, ZOONOSES PUBLIC HLTH, V54, P118, DOI 10.1111/j.1863-2378.2007.01035.x
   FENNER F, 1989, ORTHOPOXVIRUSES, P85
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Gaertner DJ, 2003, COMPARATIVE MED, V53, P85
   GLEDHILL AW, 1962, NATURE, V196, P298, DOI 10.1038/196298a0
   Goff A, 2007, VIRUS RES, V128, P88, DOI 10.1016/j.virusres.2007.04.014
   Haenssle HA, 2006, J AM ACAD DERMATOL, V54, pS1, DOI 10.1016/j.jaad.2005.09.040
   HJELLE B, 1995, CRIT REV CL LAB SCI, V32, P469, DOI 10.3109/10408369509082592
   Hutson CL, 2007, AM J TROP MED HYG, V76, P757, DOI 10.4269/ajtmh.2007.76.757
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Laakkonen J, 2006, J WILDLIFE DIS, V42, P672, DOI 10.7589/0090-3558-42.3.672
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   LOPES ODS, 1965, AM J TROP MED HYG, V14, P156
   MAIBORODA AD, 1982, ACTA VIROL, V26, P288
   MOSS B, 1970, J VIROL, V5, P99, DOI 10.1128/JVI.5.2.99-108.1970
   Pelkonen PM, 2003, EMERG INFECT DIS, V9, P1458, DOI 10.3201/eid0911.020814
   Reynolds MG, 2006, J INFECT DIS, V194, P773, DOI 10.1086/505880
   SARKAR JK, 1973, B WORLD HEALTH ORGAN, V48, P523
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2004, J GEN VIROL, V85, P2015, DOI 10.1099/vir.0.79840-0
   Tryland M, 1998, VET REC, V143, P105, DOI 10.1136/vr.143.4.105
   Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373
NR 32
TC 21
Z9 21
U1 0
U2 5
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD DEC
PY 2008
VL 89
BP 2986
EP 2991
DI 10.1099/vir.0.2008/003947-0
PN 12
PG 6
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA 381HY
UT WOS:000261527800007
PM 19008383
OA Bronze
DA 2020-12-09
ER

PT J
AU Ferreira, JMS
   Drumond, BP
   Guedes, MIMC
   Pascoal-Xavier, MA
   Almeida-Leite, CM
   Arantes, RME
   Mota, BEF
   Abrahao, JS
   Alves, PA
   Oliveira, FM
   Ferreira, PCP
   Bonjardim, CA
   Lobato, ZIP
   Kroon, EG
AF Siqueira Ferreira, Jaqueline Maria
   Drumond, Betania Paiva
   Maldonado Coelho Guedes, Maria Isabel
   Pascoal-Xavier, Marcelo Antonio
   Almeida-Leite, Camila Megale
   Esteves Arantes, Rosa Maria
   Fernandes Mota, Bruno Eduardo
   Abrahao, Jonatas Santos
   Alves, Pedro Augusto
   Oliveira, Fernando Meireles
   Peregrino Ferreira, Paulo Cesar
   Bonjardim, Claudio Antonio
   Portela Lobato, Zelia Ines
   Kroon, Erna Geessien
TI Virulence in Murine Model Shows the Existence of Two Distinct
   Populations of Brazilian Vaccinia virus Strains
SO PLOS ONE
LA English
DT Article
AB Brazilian Vaccinia virus had been isolated from sentinel mice, rodents and recently from humans, cows and calves during outbreaks on dairy farms in several rural areas in Brazil, leading to high economic and social impact. Some phylogenetic studies have demonstrated the existence of two different populations of Brazilian Vaccinia virus strains circulating in nature, but little is known about their biological characteristics. Therefore, our goal was to study the virulence pattern of seven Brazilian Vaccinia virus strains. Infected BALB/c mice were monitored for morbidity, mortality and viral replication in organs as trachea, lungs, heart, kidneys, liver, brain and spleen. Based on the virulence potential, the Brazilian Vaccinia virus strains were grouped into two groups. One group contained GP1V, VBH, SAV and BAV which caused disease and death in infected mice and the second one included ARAV, GP2V and PSTV which did not cause any clinical signals or death in infected BALB/c mice. The subdivision of Brazilian Vaccinia virus strains into two groups is in agreement with previous genetic studies. Those data reinforce the existence of different populations circulating in Brazil regarding the genetic and virulence characteristics.
C1 [Siqueira Ferreira, Jaqueline Maria; Drumond, Betania Paiva; Maldonado Coelho Guedes, Maria Isabel; Pascoal-Xavier, Marcelo Antonio; Fernandes Mota, Bruno Eduardo; Abrahao, Jonatas Santos; Alves, Pedro Augusto; Oliveira, Fernando Meireles; Peregrino Ferreira, Paulo Cesar; Bonjardim, Claudio Antonio; Kroon, Erna Geessien] Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Portela Lobato, Zelia Ines] Univ Fed Minas Gerais, Escola Vet, Dept Med Vet Prevent, Virus Lab, Belo Horizonte, MG, Brazil.
   [Almeida-Leite, Camila Megale; Esteves Arantes, Rosa Maria] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Lab Neuro Imuno Patol Expt, Belo Horizonte, MG, Brazil.
RP Ferreira, JMS (corresponding author), Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, Ave Antonio Carlos, Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg
RI Arantes, Rosa ME/C-5749-2013; brasileira, Inct Pecuaria/J-9542-2013;
   Ferreira, Jaqueline/E-4630-2018; Alves, Pedro/T-7203-2019; Abrahao,
   Jonatas/B-3895-2015; Bonjardim, Claudio A/J-2601-2014; Kroon,
   Erna/V-5444-2019; Kroon, Erna Geessien/B-3631-2015
OI Arantes, Rosa ME/0000-0003-1428-9717; Ferreira,
   Jaqueline/0000-0002-1779-1975; Alves, Pedro/0000-0002-9659-5621;
   Abrahao, Jonatas/0000-0001-9420-1791; Kroon, Erna
   Geessien/0000-0003-2721-3826; Lobato, Zelia/0000-0002-9399-3691; Mota,
   Bruno/0000-0003-0348-4875
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [fellowship]; CAPESCAPES [fellowship]; FAPEMIGMinas Gerais State
   Research Foundation (FAPEMIG); PCPF [fellowship]; CAB [fellowship]; ZILP
   [fellowship]; RMEA [fellowship]; EGK [fellowship]
FX Sources of support was provided by CNPq, CAPES and FAPEMIG. J. M. S.
   Ferreira received fellowship from CAPES and PCPF, CAB, ZILP, RMEA and
   EGK are CNPq fellows.
CR Abdalrhman I, 2006, VACCINE, V24, P4152, DOI 10.1016/j.vaccine.2006.02.012
   ANDREW ME, 1989, IMMUNOL CELL BIOL, V67, P331, DOI 10.1038/icb.1989.48
   Baxby D, 1981, J Hist Med Allied Sci, V36, P218
   Brandt TA, 2001, J VIROL, V75, P850, DOI 10.1128/JVI.75.2.850-856.2001
   Bray M, 2000, J INFECT DIS, V181, P10, DOI 10.1086/315190
   Breman JG, 2002, NEW ENGL J MED, V346, P1300, DOI 10.1056/NEJMra020025
   BRIODY BA, 1959, BACTERIOL REV, V23, P61, DOI 10.1128/MMBR.23.2.61-95.1959
   BULLER RML, 1985, CURR TOP MICROBIOL, V122, P148
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   da Fonseca FG, 2000, J VIROL, V74, P7508, DOI 10.1128/JVI.74.16.7508-7517.2000
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   DAMON IK, 2007, FIELDS VIROLOGY, P2947
   Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005
   FENNER R, 1988, SMALLPOX ITS ERADICA
   Ferrier-Rembert A, 2007, VACCINE, V25, P4809, DOI 10.1016/j.vaccine.2007.04.011
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Hayasaka D, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-22
   Jacobs N, 2006, J GEN VIROL, V87, P1157, DOI 10.1099/vir.0.81556-0
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Karem KL, 2005, CLIN DIAGN LAB IMMUN, V12, P867, DOI 10.1128/CDLI.12.7.867-872.2005
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   LOPES ODS, 1965, AM J TROP MED HYG, V14, P156
   MAIBORODA AD, 1982, ACTA VIROL, V26, P288
   Morikawa S, 2005, J VIROL, V79, P11873, DOI 10.1128/JVI.79.18.11873-11891.2005
   Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004
   Pahlitzsch R, 2006, CLIN INFECT DIS, V43, P737, DOI 10.1086/506937
   Reading PC, 2003, J VIROL, V77, P9960, DOI 10.1128/JVI.77.18.9960-9968.2003
   Rimoin AW, 2007, EMERG INFECT DIS, V13, P934, DOI 10.3201/eid1306.061540
   SARKAR JK, 1973, B WORLD HEALTH ORGAN, V48, P523
   SEHGAL C L, 1977, Journal of Communicable Diseases, V9, P171
   Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
   Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2004, J GEN VIROL, V85, P2015, DOI 10.1099/vir.0.79840-0
   Tscharke DC, 2002, J GEN VIROL, V83, P1977, DOI 10.1099/0022-1317-83-8-1977
   Turner G S, 1967, J Gen Virol, V1, P399, DOI 10.1099/0022-1317-1-3-399
   UEDA Y, 1978, J GEN VIROL, V40, P263, DOI 10.1099/0022-1317-40-2-263
NR 42
TC 31
Z9 32
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 26
PY 2008
VL 3
IS 8
AR e3043
DI 10.1371/journal.pone.0003043
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 427RL
UT WOS:000264796300001
PM 18725979
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Drumond, BP
   Leite, JA
   da Fonseca, FG
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Drumond, Betania Paiva
   Leite, Juliana Almeida
   da Fonseca, Flavio Guimaraes
   Bonjardim, Claudio Antonio
   Peregrino Ferreira, Paulo Cesar
   Kroon, Erna Geessien
TI Brazilian Vaccinia virus strains are genetically divergent and differ
   from the Lister vaccine strain
SO MICROBES AND INFECTION
LA English
DT Article
DE poxvirus; Vaccinia virus; smallpox; vaccine; poxvirus infections;
   phylogeny; genetic diversity; genetic polymorphisms
ID GENOME SEQUENCE; POXVIRUS; ATI
AB Vaccinia virus is responsible for an important zoonotic disease affecting dairy cattle and humans in Brazil, but little is known about the origin, epidemiology and evolution of these Brazilian Vaccinia virus strains. In this work, seven Brazilian Vaccinia virus strains and the Lister-derived Brazilian vaccine strain, named Lister-Butantan, were compared based on the sequences of ten host range and virulence related genes. Comparison of Brazilian Vaccinia virus strains with Lister-Butantan revealed several differences. Phylogenetic analyses confirmed the existence of genetically distinct Brazilian Vaccinia virus groups and has not thus far demonstrated a close relationship between Brazilian strains and Lister-Butantan. In this study, the BeAn58058 and SPAn232 strains were grouped together with the Belo Horizonte and Guarani PI strains. Additionally, genetic polymorphisms in host range and virulence genes as well as differences in the deduced amino acid sequences were detected among Brazilian Vaccinia virus. This genetic diversity may result in a plethora of different biological properties presented by Brazilian Vaccinia virus, including differences in adaptation to the host as well as pathogenic properties. Furthermore, co-circulation of these divergent strains could increase the possibility of recombination events in nature, leading to the formation of new variants with unpredictable pathogenic potential. (C) 2007 Elsevier Masson SAS. All rights reserved.
C1 [Drumond, Betania Paiva; Leite, Juliana Almeida; da Fonseca, Flavio Guimaraes; Bonjardim, Claudio Antonio; Peregrino Ferreira, Paulo Cesar; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Avenida Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Kroon, Erna Geessien/B-3631-2015; Bonjardim, Claudio A/J-2601-2014;
   Kroon, Erna/V-5444-2019
OI Kroon, Erna Geessien/0000-0003-2721-3826; 
CR Aldaz-Carroll L, 2005, J VIROL, V79, P6260, DOI 10.1128/JVI.79.10.6260-6271.2005
   BULLER RM, 2005, POXVIRIDAE VIRUS TAX, P117
   Chen NH, 2005, VIROLOGY, V340, P46, DOI 10.1016/j.virol.2005.05.030
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Esposito JJ, 2006, SCIENCE, V313, P807, DOI 10.1126/science.1125134
   FENNER R, 1988, SMALLPOX ITS ERADICA
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Gubser C, 2004, J GEN VIROL, V85, P105, DOI 10.1099/vir.0.19565-0
   Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9
   Lewis-Jones S, 2004, CURR OPIN INFECT DIS, V17, P81, DOI 10.1097/00001432-200404000-00003
   Li G, 2005, J GEN VIROL, V86, P2969, DOI 10.1099/vir.0.81331-0
   Likos AM, 2005, J GEN VIROL, V86, P2661, DOI 10.1099/vir.0.81215-0
   Marques JT, 2001, VIRUS GENES, V23, P291, DOI 10.1023/A:1012521322845
   Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490
   Meng XZ, 2006, VIROLOGY, V353, P220, DOI 10.1016/j.virol.2006.05.032
   Morikawa S, 2005, J VIROL, V79, P11873, DOI 10.1128/JVI.79.18.11873-11891.2005
   Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   RISI JB, 1968, ARQUIVOS HIGIENE, V24, P119
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2004, J GEN VIROL, V85, P2015, DOI 10.1099/vir.0.79840-0
   Tulman ER, 2006, J VIROL, V80, P9244, DOI 10.1128/JVI.00945-06
   Turner PC, 2006, VIROLOGY, V347, P88, DOI 10.1016/j.virol.2005.11.012
NR 30
TC 35
Z9 36
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD FEB
PY 2008
VL 10
IS 2
BP 185
EP 197
DI 10.1016/j.micinf.2007.11.005
PG 13
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 285OF
UT WOS:000254785400011
PM 18248758
DA 2020-12-09
ER

PT J
AU Leite, JA
   Drumond, BP
   Trindade, GD
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Leite, Juliana Almeida
   Drumond, Betania Paiva
   Trindade, Giliane de Souza
   Bonjardim, Claudio Antonio
   Ferreira, Paulo Cesar Peregrino
   Kroon, Erna Geessien
TI Brazilian Vaccinia virus strains show genetic polymorphism at the ati
   gene
SO VIRUS GENES
LA English
DT Article
DE Brazilian vaccinia virus; bovine vaccinia outbreak; ati gene; genetic
   polymorphism; poxvirus; ha gene
ID A-TYPE INCLUSION; MAJOR PROTEIN; BODY PROTEIN; DIFFERENTIATION;
   POXVIRUS; HUMANS; DNA; ORTHOPOXVIRUSES; IDENTIFICATION; INFECTION
AB Nucleotide sequence comparison of the internal region of the ati gene of members of the Orthopoxvirus genera revealed that this gene is variable among different species, although within members of the same species it is considered to be well conserved. Previous studies indicated that there is genetic variability in the ati gene among some Brazilian Vaccinia virus strains. To further investigate this variability, we performed molecular analysis of the internal region of the ati gene of eight Brazilian Vaccinia virus strains. While the internal region of this gene in one strain was similar to the Western Reserve strain, four strains presented two blocks of deletions in the analyzed region, and the ati gene was almost entirely deleted from three other strains. These findings demonstrate that there is genetic polymorphism within the ati gene among different Brazilian Vaccinia virus strains.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
   Ctr Dis Control & Prevent, Atlanta, GA USA.
RP Leite, JA (corresponding author), Brazilian Agr Res Corp, EMBRAPA Dairy Cattle, Rue Eugenio Do Nascimento 610,Dom Bosco, BR-36038330 Juiz De Fora, Brazil.
EM ju@icb.ufmg.br; betaniadrumond@yahoo.com.br; dzj2@cdc.gov;
   claubonj@icb.ufmg.br; paulocpf@icb.ufmg.br; kroone@icb.ufmg.br
RI Kroon, Erna/V-5444-2019; Bonjardim, Claudio A/J-2601-2014; Kroon, Erna
   Geessien/B-3631-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826
CR AMEGADZIE BY, 1992, VIROLOGY, V186, P777, DOI 10.1016/0042-6822(92)90046-R
   Boulanger D, 2002, J VIROL, V76, P9844, DOI 10.1128/JVI.76.19.9844-9855.2002
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   Damaso CRA, 2007, DIAGN MICR INFEC DIS, V57, P39, DOI 10.1016/j.diagmicrobio.2006.07.012
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Diniz S, 2001, ARQ BRAS MED VET ZOO, V53, P152, DOI 10.1590/S0102-09352001000200003
   Downie AW, 1939, J PATHOL BACTERIOL, V48, P361, DOI 10.1002/path.1700480212
   Esposito J., 2001, FIELDS VIROLOGY, P2885
   ESPOSITO JJ, 1985, VIROLOGY, V143, P230, DOI 10.1016/0042-6822(85)90111-4
   Fenner F, 1988, SMALLPOX ITS ERADICA
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   FUNAHASHI S, 1988, J GEN VIROL, V69, P35, DOI 10.1099/0022-1317-69-1-35
   Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868
   ICHIHASHI Y, 1966, VIROLOGY, V29, P264, DOI 10.1016/0042-6822(66)90033-X
   ICHIHASHI Y, 1971, VIROLOGY, V46, P507, DOI 10.1016/0042-6822(71)90056-0
   JOHNSON GP, 1993, VIROLOGY, V196, P381, DOI 10.1006/viro.1993.1494
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   KNIGHT JC, 1992, VIROLOGY, V190, P423, DOI 10.1016/0042-6822(92)91228-M
   KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Loparev VN, 2001, J CLIN MICROBIOL, V39, P94, DOI 10.1128/JCM.39.1.94-100.2001
   Marques JT, 2001, VIRUS GENES, V23, P291, DOI 10.1023/A:1012521322845
   Meyer H, 1997, J VIROL METHODS, V64, P217, DOI 10.1016/S0166-0934(96)02155-6
   MEYER H, 1993, J GEN VIROL, V74, P1679, DOI 10.1099/0022-1317-74-8-1679
   MEYER H, 1994, J GEN VIROL, V75, P1975, DOI 10.1099/0022-1317-75-8-1975
   OSTERRIEDER N, 1994, VIRUS GENES, V8, P125, DOI 10.1007/BF01703611
   PATEL DD, 1986, VIROLOGY, V149, P174, DOI 10.1016/0042-6822(86)90119-4
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   SADASIV EC, 1985, AM J VET RES, V46, P529
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
   Trindade GS, 2004, J GEN VIROL, V85, P2015, DOI 10.1099/vir.0.79840-0
   Ulaeto D, 1996, J VIROL, V70, P3372, DOI 10.1128/JVI.70.6.3372-3377.1996
NR 38
TC 16
Z9 16
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-8569
EI 1572-994X
J9 VIRUS GENES
JI Virus Genes
PD DEC
PY 2007
VL 35
IS 3
BP 531
EP 539
DI 10.1007/s11262-007-0133-9
PG 9
WC Genetics & Heredity; Virology
SC Genetics & Heredity; Virology
GA 232ZM
UT WOS:000251060200008
PM 17671837
DA 2020-12-09
ER

PT J
AU Trindade, GDS
   Drumond, BP
   Guedes, MIMC
   Leite, JA
   Mota, BEF
   Campos, MA
   da Fonseca, FG
   Nogueira, ML
   Lobato, ZIP
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Trindade, Giliane de Souza
   Drumond, Betania Paiva
   Maldonado Coelho Guedes, Maria Isabel
   Leite, Juliana Almeida
   Fernandes Mota, Bruno Eduardo
   Campos, Marco Antnio
   da Fonseca, Flavio Guimaraes
   Nogueira, Mauricio Lacerda
   Portela Lobato, Zelia Ines
   Bonjardim, Claudio Antnio
   Peregrino Ferreira, Paulo Cesar
   Kroon, Erna Geessien
TI Zoonotic vaccinia virus infection in Brazil: Clinical description and
   implications for health professionals
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID SEQUENCE ALIGNMENT; HUMANS; POXVIRUS; CATTLE
AB Bovine vaccinia virus outbreaks have been occurring in different regions of Brazil. We report here the time course of natural human infection by vaccinia virus and describe important clinical and epidemiological aspects of this zoonotic infection. The diagnosis of vaccinia virus infection was based on clinical, serological, and molecular procedures.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
   Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Imunopatol, BR-30190002 Belo Horizonte, MG, Brazil.
   Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Imunol Celular & Mol, BR-30190002 Belo Horizonte, MG, Brazil.
   Fac Med Sao Jose Do Rio Preto, Dept Doencas Infecc & Parasitarias, Lab Pesquisas Virol, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
   Univ Fed Minas Gerais, Dept Prevent Med, Escola Vet, BR-31270901 Belo Horizonte, MG, Brazil.
RP Ferreira, PCP (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Dept Microbiol, Av Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM masc.egk@terra.com.br
RI Nogueira, Mauricio L/B-7599-2012; Kroon, Erna/V-5444-2019; Bonjardim,
   Claudio A/J-2601-2014; Kroon, Erna Geessien/B-3631-2015; Campos, Marco
   A/C-4000-2013
OI Nogueira, Mauricio L/0000-0003-1102-2419; Kroon, Erna
   Geessien/0000-0003-2721-3826; Campos, Marco A/0000-0003-4683-0176;
   Lobato, Zelia/0000-0002-9399-3691; Mota, Bruno/0000-0003-0348-4875
CR Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Lewis-Jones S, 2004, CURR OPIN INFECT DIS, V17, P81, DOI 10.1097/00001432-200404000-00003
   Malkin AJ, 2003, J VIROL, V77, P6332, DOI 10.1128/JVI.77.11.6332-6340.2003
   Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486
NR 10
TC 40
Z9 40
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD APR
PY 2007
VL 45
IS 4
BP 1370
EP 1372
DI 10.1128/JCM.00920-06
PG 3
WC Microbiology
SC Microbiology
GA 158GI
UT WOS:000245779300055
PM 17287326
OA Green Published, Bronze
DA 2020-12-09
ER

PT J
AU Trindade, GS
   Lobato, ZIP
   Drumond, BP
   Leite, JA
   Trigueiro, RC
   Guedes, MIMC
   Da Fonseca, FG
   Dos Santos, JR
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Trindade, Giliane S.
   Lobato, Zelia I. P.
   Drumond, Betania P.
   Leite, Juliana A.
   Trigueiro, Ricardo C.
   Guedes, Maria I. M. C.
   Da Fonseca, Flavio G.
   Dos Santos, Joao R.
   Bonjardim, Claudio A.
   Ferreira, Paulo C. P.
   Kroon, Erna G.
TI Short report: Isolation of two Vaccinia virus strains from a single
   bovine vaccinia outbreak in rural area from Brazil: Implications on the
   emergence of zoonotic orthopoxviruses
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID POLYMERASE CHAIN-REACTION; RIO-DE-JANEIRO; SEQUENCE ALIGNMENT;
   DNA-SEQUENCE; CATTLE; POXVIRUS; HUMANS; REGION; GENOME; STATE
AB Outbreaks of bovine vaccinia disease caused by circulation of Vaccinia virus (VACV) strains have been a common occurrence in Brazil in the recent years, being an important emergent zoonosis. During a single outbreak that took place in 2001, two genetically different VACV strains were isolated and named Guarani P1 virus (GP1V) and Guarani P2 virus (GP2V). Molecular diagnosis was done through restriction fragment length polymorphism (RFLP) of ati gene (A26L) and by sequence analysis of a group of five VACV genes including the C11R, J2R, A56R, B18R, and E3L genes. These findings confirmed the co-circulation of two different Vaccinia virus strains during the same outbreak, raising important questions about the origin, emergence, and circulation of VACV strains in Brazil.
C1 Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Escola Vet, Dept Med Vet Prevent, BR-31270901 Belo Horizonte, MG, Brazil.
   Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Inmunol Celular & Mol, Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, Av Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Kroon, Erna/V-5444-2019; Bonjardim, Claudio A/J-2601-2014; Kroon, Erna
   Geessien/B-3631-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826; Lobato,
   Zelia/0000-0002-9399-3691
CR da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2
   Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868
   JOHNSON GP, 1993, VIROLOGY, V196, P381, DOI 10.1006/viro.1993.1494
   Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150
   Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773
   Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001
   Malkin AJ, 2003, J VIROL, V77, P6332, DOI 10.1128/JVI.77.11.6332-6340.2003
   Marques JT, 2001, VIRUS GENES, V23, P291, DOI 10.1023/A:1012521322845
   Meyer H, 1997, J VIROL METHODS, V64, P217, DOI 10.1016/S0166-0934(96)02155-6
   Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004
   Neubauer H, 1997, LAB ANIM, V31, P201, DOI 10.1258/002367797780596275
   PEARSON W, 2006, LALIGN FIND MULTIPLE
   ROOP SL, 1995, J CLIN MICROBIOL, V33, P2069
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P625, DOI 10.1590/S0074-02762000000500007
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GS, 2004, J GEN VIROL, V85, P2015, DOI 10.1099/vir.0.79840-0
NR 22
TC 75
Z9 77
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD SEP
PY 2006
VL 75
IS 3
BP 486
EP 490
DI 10.4269/ajtmh.2006.75.486
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 083RR
UT WOS:000240476400019
PM 16968926
OA Bronze
DA 2020-12-09
ER

PT J
AU Leite, JA
   Drumond, BP
   Trindade, GS
   Lobato, ZIP
   da Fonseca, FG
   dos Santos, JR
   Madureira, MC
   Guedes, MIMC
   Ferreira, JMS
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Leite, JA
   Drumond, BP
   Trindade, GS
   Lobato, ZIP
   da Fonseca, FG
   dos Santos, JR
   Madureira, MC
   Guedes, MIMC
   Ferreira, JMS
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
TI Passatempo virus, a vaccinia virus strain, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID SEQUENCE ALIGNMENT; COWPOX VIRUS; GENE; SMALLPOX; POXVIRUS; HUMANS;
   FOREST; CATTLE
AB Passatempo virus was isolated during a zoonotic outbreak. Biologic features and molecular characterization of hemagglutinin, thymidine kinase, and vaccinia growth factor genes suggested a vaccinia virus infection, which strengthens the idea of the reemergence and circulation of vaccinia virus in Brazil. Molecular polymorphisms indicated that Passatemoo virus is a different isolate.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   Fdn Inst Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
   Inst Mineiro Agropecuaria, Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Av Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Kroon, Erna/V-5444-2019; Bonjardim, Claudio A/J-2601-2014; Kroon, Erna
   Geessien/B-3631-2015
OI Kroon, Erna Geessien/0000-0003-2721-3826; Lobato,
   Zelia/0000-0002-9399-3691
CR CROUCH AC, 1995, EPIDEMIOL INFECT, V115, P185, DOI 10.1017/S0950268800058258
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   da Fonseca FG, 1999, VIRUS GENES, V18, P151, DOI 10.1023/A:1008072720217
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150
   Meyer H, 1997, J VIROL METHODS, V64, P217, DOI 10.1016/S0166-0934(96)02155-6
   Morellato LPC, 2000, BIOTROPICA, V32, P786, DOI 10.1646/0006-3606(2000)032[0786:ITBAF]2.0.CO;2
   Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   Trindade GS, 2004, J GEN VIROL, V85, P2015, DOI 10.1099/vir.0.79840-0
   UNIVERSAL VIRUS DATA
NR 14
TC 79
Z9 81
U1 0
U2 0
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD DEC
PY 2005
VL 11
IS 12
BP 1935
EP 1938
DI 10.3201/eid1112.050773
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 990UI
UT WOS:000233768300021
PM 16485483
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

EF